70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title 1780 CHANAM MELODY DEVI A-411 DEVELOPMENT AND EVALUATION OF BRINZOLAMIDE LOADED SOLID LIPID NANOPARTICLES 939 ALISHA PARIDA F-110 Phytochemical and Physicochemical standardization of plant Cissus quadrangularis A SURVEY ON AWARENESS AND PROBLEMS MENSTRUATION AMONG FEMALE STUDENTS OF A. 302 GADAMSETTY. JAYA ALEKHYA SITA D-32 M.REDDY COLLEGE FORMULATION AND EVALUATION OF PHYTOSOME LOADED DRUG DELIVERY OF GINGEROL 58 RUDRA PRATAP SINGH 1A-1 A-22 FOR THE TREATMENT OF RESPIRATORY INFECTION FORMULATION AND OPTIMIZATION OF GASTRORETENTIVE BIOADHESIVE FLOATING TABLETS 181 DHARMAJIT PATTANAYAK 1A-10 A-148 OF ORAL HYPOGYSEMIC AGENTS. 1236 DILRAJ E 1A-100 A-594 CUMINCOMPARATIVE AND RESIDRONATE EVALUATION LOADED OF TABLETS CHITOSAN FORMULATED MICROPARTICLES BY ARTOCARPUS FOR TREATMENT HETEROPHYLLUS, OF 1241 MOHAMMAD RASHID 1A-101 A-597 OSTEOPOROSISFLAX SEED AND GUM ACACIA AS NATURAL GUM EXPLORING MALTODEXTRIN AS TASTE MASKING AGENT FOR OSELTAMIVIR PHOSPHATE- 1252 ATIN KALRA, INDU PAL KAUR, PRITISH BHAT 1A-102 A-561 MOLECULAR MODELING AND FORMULATION DEVELOPMENT 1262 ASHA ASHOK NEGINHAL 1A-103 A-564 “PREPARATION AND EVALUATION OF PULSINCAP OF PANTOPRAZOLE SODIUM” VARIOUS APPROACHES TO IMPROVE THE DISINTEGRATION AND DISSOLUTION OF GELATIN 1272 DEEPA N AMMINBAVI 1A-104 A-566 CAPSULE 1279 ATUL ADHIKARI 1A-105 A-567 ESTABLISHMENT OF IN-VITRO IN-VIVO DATA FROM GASTRO-RETENTIVE MATRIX TABLETS DESIGN AND DEVELOPMENT OF EXTENDED RELEASE TABLET CONTAINING VERAPAMIL HCL TO 1286 PANKAJ KOTVAL 1A-106 A-569 OVERCOME THE HYDRO ALCOHOLIC MEDIA INDUCED DOSE DUMPING 1318 ATUL 1A-107 A-547 PRONIOSOMES: A NOVEL VESICULAR DRUG DELIVERY SYSTEM PREPARATION AND INVITRO EVALUATION OF LIPOSOMAL DRUG DELIVERY SYSTEM FOR 1326 DEEPIKA SHARMA 1A-108 A-551 SITAGLIPTIN BY ETHANOL INJECTION METHOD FAST DISSOLVING FILMS OF ONDANSETRON HYDROCHLORIDE: DEVELOPMENT AND 1334 MANIMA MAHARJAN 1A-109 A-555 OPTIMIZATION BY DESIGN EXPERT STUDY OF FORMULATION AND EVALUATION OF FAST DISINTEGRATING TABLET OF 182 SIDHARTHA SANKAR PADHY 1A-11 A-149 BISOPROLOL 6 SURADA NOOKA RAJU 1A-110 A-2 FORMULATION AND EVALUATION OF SR TABLETS OF GLICLAZIDE FORMULATION AND DESIGN OF MICROPARTICULATE DRUG DELIVERY SYSTEM OF LAMIVUDINE 1341 P UMA HARI PRIYA 1A-111 A-557 BY CHITOSAN AS NATURAL POLYMER DEVELOPMENT AND INVESTIGATION OF CONTROLLED RELEASE POTENTIAL OF 1345 RAUT SUSHIL YADAORAO 1A-112 A-559 NANOCOMPOSITE CLAY AND BIOPOLYMER HYBRID MICROBEADS DESIGN AND DEVELOPMENT OF DICLOFENAC BILAYERD TABLTES BY USING NATURAL GUM AS 1364 DHULIPALLA NAGA HARISH 1A-113 A-530 A KEY EXCIPENT FORMULATION DEVELOPMENT AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS 1377 V D SUNDAR 1A-114 A-531 OF RANOLAZINE 1390 DEBANKINI DASGUPTA 1A-115 A-534 FORMULATION AND EVALUATION OF RANITIDINE AND ALOEVERA FLOATING TABLET SOLID DISPERSIONS OF NAPROXEN WITH BINARY HYDROTROPIC BLENDS FOR DISSOLUTION 1402 POONAM CHAUDHARY 1A-116 A-512 RATE ENHANCEMENT DESIGN AND CHARACTERIZATION OF SITAGLIPTIN LOADED NANOSTRUCTURED LIPID 1437 REVATHI SUNDARAMOORTHY 1A-117 A-521 CARRIERS BY SOLVENT EVAPORATION DEVELOPMENT AND OPTIMIZATION OF AN ANTIDIABETIC MUCOADHESIVE EXTENDED RELEASE 1442 S. SATYA HARSHA 1A-118 A-523 TABLETS BY QBD TECHNOLOGY 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title FORMULATION AND EVALUATION OF ALGINATE MATRIX TABLET CONTAINING METOPROLOL 1450 B.DIVYA SHALINI 1A-119 A-527 SUCCINATE 185 SUPRITHA REDDY 1A-12 A-151 FORMULATION AND EVALUATION OF NICARDIPINE SUSTAINED RELEASE TABLETS 1455 A Ramu 1A-120 A-495 Formulation and Evaluation of Sustained Release Matrix Tablets of Dolutegravir Sodium DESIGN AND CHARACTERIZATION OF CONTROLLED RELEASE MATRIX TABLETS OF GLIPIZIDE 1465 P.N.MALLIKARJUN 1A-121 A-501 USING AVENA SATIVA GUM DESIGN AND CHARACTERIZATION OF CONTROLLED RELEASE MATRIX TABLETS OF GLIPIZIDE 1468 P.N.MALLIKARJUN 1A-122 A-502 USING AVENA SATIVA GUM 1487 NURUL AMIN 1A-123 A-508 FORMULATION AND CHARACTERIZATION OF MULTIPLE EMULSION OF PARACETAMOL DEVELOPMENT AND IN VITRO EVALUATION OF LIQUISOLID COMPACTS OF 1501 AKANKSHA 1A-124 A-474 LORNOXICAM FORMULATION AND EVALUATION OF FLOATING MICROBALOONS CONTAINING ZIPRASIDONE 1508 G.UMA RANI 1A-125 A-476 HYDROCHLORIDE FOR GASTRIC RETENTION FORMULATION AND EVALUATION OF DIPHENHYDRAMINE HCL ORALLY DISINTEGRATING 1517 CHARUMATHY A 1A-126 A-479 TABLETS 1519 DEEPIKA RAINA 1A-127 A-481 FORMULATION AND EVALUATION OF DULOXETINE LOADED BIO- NANOSUSPENSION 1542 AKANKSHA 1A-128 A-489 DEVELOPMENT AND OPTIMIZATION OF PRAVASTATIN NANOPARTICLES 1577 PRAVIN PANDURANG HONMANE 1A-129 A-466 FORMULATION AND CHARACTERIZATION OF ATORVASTATIN NANOCYSTAL TABLET FORMULATION AND CHARACTERIZATION OF KETACONAZOLE MICROSPONGES USING 213 PARIMALAKRISHNAN S 1A-13 A-60 VARIOUS POLYMERS FOR TOPICAL DRUG DELIVERY SYSTEM ENHANCEMENT OF SOUBILITY AND PERMEABILITY OF CEFPODOXIME PROXETIL BY SELF 1592 V.S.HARINI 1A-130 A-470 MICROEMULSIFYING DRUG DELIVERY SYSTEM FORMULATION AND EVALUATION OF OIL ENTRAPPED GASTRORETENTIVE FLOATING BEADS 1626 MAHESH KUMAR KATARIA 1A-131 A-451 OF METOPROLOL SUCCINATE FORMULATION AND EVALUATION OF FLOATING PULSATILE DRUG DELIVERY SYSTEM OF 1634 RAJAT PRAJAPAT 1A-132 A-456 LAFUTIDINE STATISTICAL DESIGN, OPTIMIZATION AND EVALUATION OF AN ORAL IN SITU GEL OF AN 1666 SURESH CHAPAGAIN 1A-133 A-430 ANTIDIABETIC DRUG FOR SUSTAINED RELEASE 1668 AISHWARYA C. PATIL 1A-134 A-432 “STUDIES OF SOLUBILITY ENHANCEMENT OF GEFITINIB” 1705 SHIVAM VASHIST 1A-135 A-418 NANOMEDICINE FOR CANCER THERAPY "DEVELOPMENT FORMULATION AND EVALUATION OF CONTROL RELEASE TABLET OF 1726 CHANDRA KUMAR SHARMA 1A-136 A-422 TRAMADOL USING NATURAL AND SYNTHETIC POLYMER" FORMULATION AND EVALUATION OF IMMEDIATE RELEASE TABLETS OF LINAGLIPTIN BY 1738 J NAGA VENKATA PAVAN 1A-137 A-427 DIRECT COMPRESSION TECHNIQUES DEVELOPMENT OF PRESSED TABLET OF FELODIPINE AND EFFECT OF DIFFERENT POLYMER 1778 SHWETA SINGH CHAUHAN 1A-138 A-409 VISCOSITY AND COMBINATION ON RELEASE PROFILE IMPROVING SOLUBILIZATION AND BIOAVAILABILITY ENHANCEMENT OF LIPOPHILLIC DRUG 1779 GIRISH CHANDRA SONI 1A-139 A-410 REPAGLINIDE USING SELF EMULSIFYING DRUG DELIVERY SYSTEM (SNEDDS) TECHNIQUE. Design and in vitro evaluation of gastro retentive oral matrix tablet formulations of Ketorolac 237 MANISH KUMAR THIMMARAJU 1A-14 A-64 Tromethamine 1782 B.Sai Rohith 1A-140 A-412 Optimization of Cinnarizine Buccal Patches & In-Vitro Evaluation by using QBD 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title 1786 AYUSH 1A-141 A-413 Formulation and Evaluation of Medicated Chewing Gum for Tooth Decay. 1789 D.SRINIVAS 1A-142 A-415 D.Srinivas DEVELOPMENT AND CHARACTERIZATION OF GASTRORETENTIVE HIGHDENSITY PELLETS 1799 AMIT SHARMA 1A-143 A-417 LODGED WITH ZERO VALENT IRON NANOPARTICLES IMPROVING SOLUBILIZATION AND BIOAVAILABILITY ENHANCEMENT OF LIPOPHILLIC DRUG 1820 GIRISH CHANDRA SONI 1A-148 A-396 REPAGLINIDE USING SELF EMULSIFYING DRUG DELIVERY (SNEDDS) TECHNIQUE FORMULATION AND EVALUATION OF SUMATRIPTAN ORAL DISINTEGRATING TABLETS BY 241 T.SNEHAREDDY 1A-15 A-65 USING HIBISCUS ROSA SINESIS DEVELOPMENT OF GASTRO RETENTIVE DRUG DELIVERY SYSTEM FOR ANTIHYPERTENSIVE 1833 SREENIVASA REDDY N 1A-151 A-400 DRUGS: THEIR IN VITRO & IN VIVO EVALUATION. SYSTEMATIC FORMULATION AND DEVELOPMENT OF EMTRICITABANE FLOATING 1868 ANNAMMADEVI G S 1A-153 A-384 MICROSPHERES 1937 PRAGYA . SHARMA 1A-159 A-376 BETA-GALACTOSIDASE BASED GELATIN MICROSPHERES FOR LACTOSE INTOLERANCE CHITOSAN-GLICLAZIDE MUCOADHESIVE MICROPARTICLES: PREPARATION AND INVITRO AND 249 P. VEERA LAKSHMI 1A-16 A-67 INVIVO EVALUATION FORMULATION AND EVALUATION OF METFORMIN HCL MATRIX TABLET USING NATURAL 1948 TRIDEEP SAIKIA 1A-160 A-379 POLYMER FUROSEMIDE-LOADED ALGINATE MICROSPHERES PREPARED BY IONIC CROSS-LINKING 1976 SRIGADE YASHASWINI 1A-161 A-361 TECHNIQUE 1986 VHORA TEJAS JITENDRA 1A-162 A-366 pH Sensitive Colon Specific Drug Delivery System DEVOLOPEMENT AND EVALUTION OF OPTIMISED FORMULATION OF LORAZEPAM MATRIX 1991 SRIDHAR REDDY 1A-163 A-367 TABLET 2000 SWATI B KAVADE 1A-164 A-368 “REVIEW ON ORAL DISINTEGRATED TABLET” FUROSEMIDE-LOADED ALGINATE MICROSPHERES PREPARED BY IONIC CROSS-LINKING 2005 SRIGADHE YASHASWINI 1A-165 A-347 TECHNIQUE 2015 MONA 1A-166 A-350 FORMULATION AND EVALUATION OF ORODIAPERSIBLE TABLETS OF TRANDOLAPRIL PREPARATION AND EVALUATION OF TOLCAPONE LOADED ALGINATE MICROSPHERES FOR 2016 SARITHA 1A-167 A-351 CONTROLLED RELEASE Formulation and Evaluation of pH Sensitive Superporous Hydrogels of Glipizide using Design of 2103 M P GOWRAV 1A-168 A-329 Experimentation 2029 SWATI B.KAWADE 1A-169 A-353 REVIEW ON ORAL DISINTEGRATED TABLET 5 KARRI SRINIVASA REDDY 1A-17 A-6 FORMULATION AND OPTIMIZATION OF VALSARTAN SUSTAINED RELEASE FLOATING TABLETS KINETIC MODELLING OF DRUG RELEASE FROM DILTIAZEM MATRIX TABLETS BASED ON 2043 DEEPAK TAYAL 1A-170 A-355 NATURE OF MATRIX FORMING SYNTHETIC AND NATURAL POLYMERS FORMULATION & EVALUATION OF KETOROLAC TROMETHAMINE FAST DISSOLVING TABLETS BY 2051 M.VAISHNAVI BAI 1A-171 A-330 USING NATURAL GUM AS KEY EXCIPIENT KINETIC MODELLING OF DRUG RELEASE FROM DILTIAZEM MATRIX TABLETS BASED ON 2054 DEEPAK TAYAL 1A-172 A-332 NATURE OF MATRIX FORMING SYNTHETIC AND NATURAL POLYMERS FORMULATION AND EVALUATION OF IMMEDIATE RELEASE TABLETS OF NEVIRAPINE SOLID 255 N.HARSHITHA 1A-18 A-68 DISPERSIONS FORMULATION AND EVALUATION OF SUSTAINED RELEASE BUCCAL TABLETS OF LABETALOL 284 RAJARAM V 1A-19 A-189 HYDROCHLORIDE 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title 61 SARITHA DAMINENI 1A-2 A-24 FORMULATION AND IN VIVO EVALUATION OF FLUVASTATIN MICROSPHERES CONJUGATION OF ACYCLOVIR TO POLY (ETHYLENE GLYCOL) THROUGH AMINO ACID AND 291 SIKHAMONI DUTTA 1A-20 A-190 DIPEPTIDE SPACERS AND IN VITRO DRUG RELEASE EVALUATION 308 S C MARAPUR 1A-21 A-76 FORMULATION AND EVALUATION OF SUSTAINED RELEASE TABLETS OF MERCAPTOPURINE 309 AKANKSHA SINGH 1A-22 A-77 ADDITIVE MANUFACTURING: A BOON TO PHARMACEUTICAL FORMULATIONS FORMULATION AND CHARACTERIZATION OF ONCE DAILY THEOPHYLLINE TABLETS BY WET 316 PALLAVI 1A-23 A-79 GRANULATION METHOD 322 SUBHAM PATTNAIK 1A-24 A-80 Formulation and Evaluation of Microballons of Ondansetron Hydrochloride FORMULATION AND OPTIMIZATION OF EFAVIRENZ TABLETS TO ACHIEVE THE DESIRED 333 M.PRIYADARSINI 1A-25 A-84 DISSOLUTION RATE FORMULATION AND EVALUATION OF BILAYER TABLET OF A NSAID AS AN IMMEDIATE RELEASE 364 GANESH HEBBAR 1A-26 A-89 LAYER AND SUSTAINED RELEASE LAYER FORMULATION AND EVALUATION OF CIPROFLOXACIN HYDROCHLORIDE MATRIX TABLETS BY 379 LACHIREDDY NIRMALA DEVI 1A-27 A-192 SINTERING TECHNIQUE FORMULATE AND EVALUATION OF THE CONTROLLED RELEASE MICROSPHERE USING 382 PRASHANT N JORAPUR 1A-28 A-195 POLYMETHACRYLATES (EUDRAGITS) IS RELEASE RETARDING POLYMERS. DEVELOPMENT AND INVITRO CHARACTERIZATION OF RISEDRONATE SODIUM FLOATING 385 MUNIJA PANCHEDDULA 1A-29 A-196 MICROBALLOONS FORMULATION, CHARACTERIZATION AND EVALUATION OF FAST DISSOLVING FILMS (FDF) 73 SOUMYASHREE TRIPATHY 1A-3 A-28 CONTAINING COMBINATION OF LISINOPRIL AND CARVEDILOL 3 (2) TAGUCHI FACTORIAL DESIGN ASSISTED HYDRODYNAMICALLY BALANCED SYSTEM OF 388 DEEPANKAR BAHUGUNA 1A-30 A-197 METOPROLOL SUCCINATE HIBISCUS ESCULENTUS: A REVIEW OF SUSTAINED RELEASE ACTION OF PROPANOLOL 395 AVINANDAN ASH 1A-31 A-201 HYDROCHLORIDE IN SOLID ORAL DOSAGE FORM DEVELOPMENT AND EVALUATION OF HYDRODYNAMICALLY BALANCED SYSTEM OF TRAMADOL 399 SANDHYA SEMWAL 1A-32 A-203 HYDROCHLORIDE BY USING CHITOSAN AND LOCUST BEAN NOVEL GASTRORETENTIVE ORAL IN SITU GELLING SYSTEM OF NIFEDIPINE – FORMULATION, 413 AKANKSHA TOMAR 1A-33 A-95 OPTIMIZATION AND EVALUATION EVALUATION OF IN VITRO AND IN VIVO EFFICACY OF PRUSSIAN BLUE ALGINATE BEADS FOR 421 POOJA SHARMA 1A-34 A-97 REMOVAL OF CESIUM IN MICE 425 CHERUKURI POOJITHA 1A-35 A-99 FORMULATION AND EVALUATION OF FAST DISSOLVING FILMS OF CANDESARTAN EFFECT OF PSYLLIUM HUSK IN THE FORMULATION DEVELOPMENT AND EVALUATION OF 465 UDHAYAKUMAR V 1A-36 A-210 LOSARTAN POTASSIUM FLOATING TABLETS BY DIRECT COMPRESSION METHOD FORMULATION AND EVALUATION OF DICLOFENAC MEDICATED LOLLIPOPS BY HEATING AND 498 DAYA RATNAM MADUGULA 1A-37 A-217 CONGEALING METHOD FORMULATION AND EVALUATION OF DICLOFENAC MEDICATED LOLLIPOPS BY HEATING AND 502 DAYA RATNAM MADUGULA 1A-38 A-102 CONGEALING METHOD FORMULATION AND IN-VITRO EVALUATION OF ORAL DISSOLVING TABLET USING 534 MISS. SARITA ANADEO UKEY 1A-39 A-109 ANTIMIGRAINE DURG 95 DIBYA RANJAN 1A-4 A-38 FORMULATION AND EVALUATION OF ATENOLOL LIQUISOLID COMPACTS FORMULATION AND DEVELOPMENT OF DRUG LOADED DELAYED RELEASE MINI TABLETS IN 536 L SONALI MEHTA 1A-40 A-111 CAPSULES 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title FORMULATION OF MONODISPERSE (MICRO) SPHERES CONTAIN LAMIVUDINE FOR EXTENDED 541 GUNJA.VENKATASIVA S S KONDALA RAO 1A-41 A-112 RELEASE DOSAGE FORM 554 CHIRRAVURI. S. PHANI KUMAR 1A-42 A-186 FORMULATION AND EVALUATION OF GASTRO-RETENTIVE SYSTEMS OF NATEGLINIDE DEVELOPMENT AND EVALUATION OF HYDRODYNAMICALLY BALANCED SYSTEM OF TRAMADOL 573 SANDHYA SEMWAL 1A-43 A-224 HYDROCHLORIDE BY USING CHITOSAN AND LOCUST BEAN DEVELOPMENT AND CHARACTERIZATION OF NOVEL GASTRORETENTIVE EXPANDABLE FILMS 574 SRIKANTH PAREPALLI 1A-44 A-225 OF METOPROLOL TARTRATE 583 ARUN SAHARAWAT 1A-45 A-227 DESIGN AND IN-VITRO EVALUATION OF ATENOLOL MICROBALLONS AN INVESTIGATION OF IN-VITRO RELEASE OF RABEPRAZOLE SODIUM FROM PULSATILE 585 JYOTI JOSHI 1A-46 A-228 RELEASE TABLETS CONTAINING HPMC-EC BLEND AS TIME LAGGED PRESS COATING FORMULATION AND EVALUATION OF TOLMITIN ENTERIC COATED TABLETS AND INVITRO 589 PALLEPATI NITHIN 1A-47 A-229 EVALUATION DEVELOPMENT AND IN VITRO CHARACTERIZATION OF PULSATILE DRUG DELIVERY OF 604 MOHAMMED FAIZAN ALI 1A-48 A-115 TOFACITINIB BY OSMOTIC CONTROLLED RELEASE ORAL SYSTEM CO-POLYMERIC CONSEQUENCES ON IN VITRO, EX VIVO AND IN SITU STUDIES OFCLINDAMYCIN 616 PATEL VRUNDA RATILAL 1A-49 A-121 PHOSPHATE NANOPARTICLES-LOADED FILMS FOR SUB-GINGIVAL DELIVERY 103 URAVI PATEL 1A-5 A-41 Preparation and Development of Domperidone Oral Thin Films: A New Global Approach FORMULATION AND EVALUATION OF BI LAYER TABLETS OF SUSTAINED RELEASE NSAID’S 617 VISHAL CS 1A-50 A-122 AND IMMEDIATE RELEASE PROTON PUMP INHIBITOR DEVELOPMENT AND INVITRO CHARACTERIZATION OF PULSATILE DRUG DELIVERY OF 618 MOHAMMED FAIZAN ALI 1A-51 A-123 TOFACITINIB BY OSMOTIC CONTROLLED RELEASE ORAL SYSTEM 628 TANZEEL MAJEED LONE 1A-52 A-129 DEVELOPMENT AND CHARACTERISATION OF SIMVASTATIN NANOSUSPENSION FORMULATION AND EVALUATION OF GEMIFLOXACIN MESYLATE MICROSPHERES BY 647 K NAGASREE 1A-54 A-157 IONOTROPIC GELATION METHOD Colon Specific Targeting of Cardioselective Drug by using Guar Gum Microsphere for Treatment of Heart 653 TANUSHREE PRADHAN 1A-55 A-159 Failure FABRICATION AND IN VITRO EVALUATION OF CROSS-LINKED CHITOSAN MICRO-PARTICLE 677 RAJAT BHATTACHARJEE 1A-56 A-167 CONTAINING ACECLOFENAC 696 SUBHAM PATTNAIK 1A-58 A-173 Formulation and Evaluation of Microballons of Ondansetron Hydrochloride STUDIES ON ENHANCEMENT OF BIOAVAILABILITY OF ATORVASTATIN CALCIUM THROUGH 718 JAYAPAL REDDY GANGADI 1A-59 A-176 GASTRIC RESIDENT FORMULATION APPROACH 105 ALOK MOHAPATRA 1A-6 A-43 DEVELOPMENT AND EVALUATION OF BUCCAL FILM OF NIFEDIPINE FORMULATION DEVELOPMENT AND EVALUATION OF MUCOADHESIVE TABLET OF 720 DEEPAK KUMAR LODHA 1A-60 A-177 NORFLOXACIN CONTAINING NATURAL POLYMER DEVELOPMENT AND EVALUATION OF SELF-EMULSIFYING SPHERULES FOR IMPROVEMENT OF 800 CHETAN KUMAR VH 1A-62 A-239 DISSOLUTION “DESIGN AND DEVELOPMENT OF SUSTAINED RELESAE ONDANSETRON HCl MATRIX TABLETS 829 NISHITHA ALURU, K.RAMARAO, A.ANILKUMAR 1A-63 A-248 BY USING POLYMERIC PRECIPITATION INHIBITORS” 831 SARITHA CHUKKA 1A-64 A-249 FORMULATION AND EVALUATION OF CAPTOPRIL FLOATING TABLETS 840 MURHULA MONGANE PASCAL 1A-65 A-252 Pectin based nanocarrier for an anticancer drug FORMULATIONS AND STATISTICAL OPTIMIZATION OF INTRA GASTRIC FLOATING MATRIX 845 SUSHREE NISITA BARDHAN 1A-66 A-253 TABLETS OF CEFUROXIME AXETIL 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title FABRICATION OF LIPID BASED NANOFORMULATION OF POORLY WATER-SOLUBLE DRUG 852 ARCHU SINGH 1A-67 A-254 EXEMESTANE: FORMULATION DEVELOPMENT, IN VITRO AND EX VIVO INVESTIGATIONS APPLICATION OF DESIGN OF EXPERIMENT (DOE) IN THE DEVELOPMENT OF AN ORAL 880 GOLLA BALA ANUSHA 1A-68 A-262 ANTIHYPERTENSIVE NANOFORMULATION DEVELOPMENT OF SUSTAINED RELEASE FORMULATION OF ALPRAZOLAM BY USING 888 NEELU YADAV 1A-69 A-264 DIFFERENT VISCOSITY GRADE POLYMER HPMC FORMULATION AND EVALUATION OF NOVEL METFORMIN TABLET TO REDUCE GASTRITIC 119 UTTAM CHOUDHURY 1A-7 A-53 ACIDOSIS ON ITS CHRONIC USE Development and Evaluation of Mucoadhesive Buccal Patches of Esomeprazole for the Treatment of 911 AMIT KUMAR SAHOO 1A-70 A-268 GERD 914 ROHINI AHER 1A-71 A-270 TO FORMULATE AND EVALUATE BILAYER TABLET OF ALOGLIPTIN AND METFORMIN HCL 935 Archta Katrolia 1A-73 A-279 Curcumin-lycopene conjugates in the treatment of Diabetes mellitus type II DEVELOPMENT OF PH DEPENDENT STAGGERED RELEASE DOSAGE FORM CONTAINING ANTI 1005 ABHISHEK ANIL SHET 1A-75 A-290 TUBERCULAR DRUGS DEVELOPMENT & CHARACTERIZATION OF METFORMIN LOADED FLOATING MICROSPHERES OF 1015 NIKHAR VISHWAKARMA 1A-76 A-292 CHITOSAN FOR THE MANAGEMENT OF DIABETES MELLITUS 1022 SHOUVIK MONDAL 1A-77 A-294 DESIGN AND IN VITRO EVALUATION OF LIPOSOME CONTAINING ANTICANCER DRUG 3 HARITHA VINOD 1A-78 A-4 FORMULATION AND EVALUATION OF INLAY TABLET OF VALSARTAN 1032 VINOD N BABALESHWAR 1A-79 A-298 FORMULATION AND EVALUATION OF MATRIX TABLETS OF LOSARTAN POTASSIUM 120 SAMEER KUMAR BISSOI 1A-8 A-54 DESIGN AND EVALUATION OF COLON SPECIFIC DRUG DELIVERY SYSTEM OF CURCUMIN DEVELOPMENT OF SUITABLE METHOD FOR PREPARATION OF MICRO CAPSULES FOR BOTH 1034 HIMAL BARAKOTI 1A-80 A-299 WATER SOLUBLE AND INSOLUBLE DRUG FORMULATION AND CHARACTERIZATION OFGASTRORETENTIVE SUSTAINED RELEASE 1047 KRUNAL D. DHOTE 1A-81 A-303 DOSAGE FORM OF METFORMIN HYDROCHLORIDE 1056 NIKHIL BHANDARI 1A-82 A-304 FORMULATION AND EVALUATION OF ATORVASTATIN CALCIUM POLYMERIC MICELLES BOX-BEHNKEN DESIGN BASED DEVELOPMENT AND CHARACTERIZATION OF EXEMESTANE 4 MD. RIZWANULLAH 1A-83 A-5 LOADED POLYMER-LIPID HYBRID NANOPARTICLES DESIGN, FORMULATION AND CHARACTERIZATION OF ANTIBIOTIC MICROSPHERES FOR 1062 MANAS DAHAL 1A-84 A-305 PERIODONTAL DRUG DELIVERY 1081 ANINDA BHATTACHARJEE 1A-85 A-311 A NOVEL APPROACH ON MICROSPONGE STUDY OF EFFECT OF PROCESS VARIABLES ON FLOATING MICROSPHERES OF IBUPROFEN BY 1085 KEERTHI VENKUMAHANTI 1A-86 A-313 TAGUCHI DESIGN FORMULATION AND EVALUATION OF TELMISARTAN IMMEDIATE RELEASE TABLET BY SOLVENT 1110 K SRI GREESHMA SWETHA 1A-87 A-318 EVAPORATION METHOD 1131 GAJAVELLY SWATHI 1A-88 A-324 FORMULATION AND EVALUATION OF ORO- DISPERSABLE TABLETS BY PIROXICAM SCREENING OF IBUPROFEN FLOATING MICROSPHERES EMPLOYING TAGUCHI ORTHOGONAL 1154 SAILAJA NAMBAARU 1A-89 A-600 ARRAY DESIGN FORMULATION AND EVALUATION OF NANOSTRUCTURED LIPID CARRIERS OF GLIPIZIDE FOR 121 SHARMILA DAS 1A-9 A-55 ORAL DELIVERY 1155 DEEPALI 1A-90 A-601 Formulation and Evaluation of Sustained Release of Microspheres of Acarbose 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title FORMULATION AND EVALUATION OF COMPRESS COATED PULSATILE TABLET OF NICORANDIL 1156 V D SUNDAR 1A-91 A-602 FOR TREATMENT OF ANGINA PECTORIS POLYMER ASSISTED FABRICATION OF HYDROXYAPATITE BASED NANOCOMPOSITES FOR 1172 INDU LATA KANWAR 1A-92 A-609 LOCAL DELIVERY TO PERIODONTAL POCKETS: DEVELOPMENT AND CHARACTERIZATION 1193 ANURADHA MISHRA 1A-93 A-614 RAMIFICATION OF VARIABLES ON GREEN SYNTHESIS OF NANOFORMULATIONS STUDIES ON DESIGN AND DEVELOPMENT OF TABLET IN CAPSULE SYSTEM OF ZOLPIDEM 1203 KUSHWAHA ANKIT KUMAR S. 1A-94 A-576 TARTRATE PREPARATION AND EVALUATON OF ACECLOFENAC EXTENDED RELEASE MATRIX TABLETS BY 1204 UDAY KIRAN 1A-95 A-577 USING NEEM GUM DEVELOPMENT AND IN VITRO CHARACTERIZATION OF GASTRO-RETENTIVE MATRIX TABLET 1214 SEEMA 1A-96 A-583 FOR ANTIHYPERTENSIVE DRUGS FORMULATION DEVELOPMENT AND EVALUATION OF FAST RELEASE BUFFERED TABLET OF 1217 TILOTTAMA M. GATKINE 1A-97 A-585 ESOMEPRAZOLE FORMULATING NOVEL GASTRORETENTIVE AIR-BUBBLE BEADS BY CO-AXIAL NEEDLE AIR- 1218 DR. JASBIR SINGH 1A-98 A-586 INJECTION METHOD AND IN VIVO EVALUATION BY ULTRASOUND IMAGING 1225 SHWETA R. JAWANJAR 1A-99 A-589 DESIGN, DEVELOPMENT AND EVALUATION OF ORAL SUSPENSION ANTIEMETIC DRUG 204 DHANANJOY SAHA 10A-10 J-9 IMPORTANCE & BENEFITS OF IPR IN PHARMACEUTICAL INDUSTRY COMPARATIVE STUDY OF FACTORS AFFECTING PHARMACEUTICAL DRUG SUPPLY CHAIN FOR 223 MALLIKARJUN NAGUR 10A-11 J-10 REGULATED, NON REGULATED COUNTRIES AND ITS IMPACT & KEY SUCCESS 228 ANSHUL BANSAL, 10A-12 J-11 IMPACT OF NPPA ON MEDICAL DEVICES: PRESENT AND FUTURE 246 PANKAJ SHARMA 10A-13 J-12 THE DEVELOPMENT AND FUTURE OF BRICS COUNTRIES IN THE PHARMACEUTICAL SECTOR STRATEGIES INVOLVING TECHNOLOGICAL CAPABILITY USED BY INDIAN PHARMACEUTICAL 528 ELLAPU SRIJHA 10A-14 J-13 INDUSTRIES FOR RESTRUCTURING 563 A.HIMABINDU 10A-15 J-20 GMP FOR STERILE DOSAGE FORMS-A COMPARISION FOR VARIOUS REGULATORY GUIDELINES FIXED DOSE COMBINATION OR IRRATIONAL DRUG COMBINATION? :PHARMACOLOGY AND 590 SURESHA M 10A-16 J-21 REGULATORY CONSIDERATIONS 592 ABHISHEK 10A-17 J-22 SUBMISSION PATHWAY FOR POST-APPROVAL CHANGES IN AUSTRALIA & CANADA 593 YAMINI KRISHNA TUPILI 10A-18 J-23 REGULATORY REQUIREMENTS FOR BLOOD BAGS IN INDIA AND EUROPE 608 VENKATESH M P 10A-19 J-14 PHASE III CLINICAL TRIALS: A FATE DECIDER IN THE DRUG DEVELOPMENT 55 SRIDHAR S 10A-2 J-2 COMPARATIVE STUDY OF MEDICAL DEVICE VIGILANCE IN CANADA, USA, AUSTRALIA 621 AISHWARYA RAMCHANDRA BHANDARE 10A-20 J-15 A study on regulatory status of cosmeceuticals in India compared with some major 657 C. VENKATESWARA REDDY 10A-21 J-17 IMPACT OF MDR &IVDR IN EUROPEAN REGULATION MARKET – A REGULATORY CHALLENGES THE ESSENTIALS OF ICH GUIDELINES (QSEM) IN ADVANCING PHARMACEUTICAL INDUSTRY: A 683 Y SWETHA 10A-22 J-18 REGULATORY PRESPECTIVE 699 AMAR S 10A-23 J-19 COMPARATIVE STUDY OF BOTANICAL REGULATIONS IN US & HEALTH CANADA 785 SARA JABEEN 10A-24 J-24 THE FUTURE BULLET FOR MALADY: XENOTRANSPLANTATION AS REMEDY 788 GREESHMA. G 10A-25 J-25 MANAGING RISK FOR CLINICAL TRIALS IN MEDICAL DEVICE 791 SHIKHA NITIN TAMBE 10A-26 J-26 ARTIFICIAL INTELLIGENCE: THE FUTURE OF PHARMA 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title 792 KARUNA KAMIREDDY 10A-27 J-27 COSMETIC DEVICE-DERMAL FILLERS: A REGULATORY OVERVIEW CURRENT APPROVAL PROCEDURES AND REGULATIONS FOR VETERINARY MEDICINAL 798 BHARATH B C 10A-28 J-28 PRODUCTS IN INDIA 823 NANDHINI.B 10A-29 J-29 CURRENT SCENARIO OF EPHARMACY REGULATIONS IN INDIAE IMPLEMENTATION DRUGS AND COSMETICS ACT, 1940 AND RULES, 1945 AMONG THE STATES 62 KEMPAIAH SURESH 10A-3 J-3 OF INDIA 832 KALPANA KAMNOORE 10A-30 J-30 A REGULATORY OVERVIEW ON US-FDA MOBILE MEDICAL APPLICATION 861 AKIL 10A-31 J-31 REGENERATIVE MEDICINE: ANALYSIS, FORECAST AND REGULATORY REQUIREMENTS A CRITICAL REVIEW ON CURRENT REGULATORY GUIDELINES AND APPROVAL PROCESS OF 864 ROHIT BHATIA 10A-32 J-32 BIOSIMILARS IN INDIA AND USA 954 NITIN SINGH 10A-33 J-33 CURRENT REGULATORY REQUIREMENTS FOR REGISTRATION OF NUTRACEUTICALS IN INDIA 967 G SAI BHAVANI 10A-34 J-34 REGULATORY DRUG APPROVAL PROCESS IN USA, EUROPE AND INDIA 978 SAVITHA S BHAT 10A-35 J-35 REGULATORY ASPECTS OF 3D PRINTING IN UNITED STATES, EUROPE AND AUSTRALIA 989 S ARJUN 10A-36 J-36 EXPEDITED PROGRAMS FOR DRUG DEVELOPMENT AND APPROVAL IN USA 992 SHASHANK N 10A-37 J-37 MEDICAL DEVICES VIGILANCE SYSTEMS IN US AND EU: A REGULATORY PERSPECTIVE ORPHAN DRUG-THE PRESENT SCENARIO AND FUTURE PROSPECTIVES IN THE GLOBAL 1084 BHARATLAL SAIN 10A-38 J-38 MARKET 1113 A. HIMABINDU 10A-39 J-39 GMP FOR STERILE DOSAGE FORMS-A COMPARISION FOR VARIOUS REGULATORY GUIDELINES 122 BALAMURALIDHARA V 10A-4 J-4 LIFE-CYCLE MANAGEMENT OF DRUGS IN US: A REGULATORY PERSPECTIVE 1132 DHRUVAL NANDURKAR 10A-40 J-40 ELECTROCEUTICALS -THE FUTURE OF MEDICINE 1180 G. GREESHMA 10A-41 J-53 MANAGING RISK FOR CLINICAL TRIALS IN MEDICAL DEVICE REGULATORY ADVANCES IN GENERIC DRUG APPROVALS IN USA UNDER GDUFA – POTENTIAL 1244 RAJENDER SINGH 10A-42 J-52 OPPORTUNITIES 1273 AKIL 10A-43 J-51 REGENERATIVE MEDICINE: ANALYSIS, FORECAST AND REGULATORY REQUIREMENTS PHARMACOVIGILANCE IN PAEDIATRIC POPULATION: A SYSTEMATIC REVIEW OF PROMOTING 1451 REETU MALIK 10A-45 J-45 SAFETY OF MEDICINES IN CHILDREN PHARMACOVIGILANCE IN PAEDIATRIC POPULAION: ASYSTEMATIC REVIEW OF PROMOTING 1452 REETU MALIK 10A-46 J-46 SAFETY OF MEDICINES IN CHILDREN 1462 HIMANI JAISWAL 10A-47 J-47 DATA INTEGRITY VIOLATION AS A CHALLENGE TO THE PHARMACEUTICAL INDUSTRY 1463 HIMANI JAISWAL 10A-48 J-48 Data integrity violation as a challenge to the pharmaceutical industry 1483 MAHALAKSHMY R 10A-49 J-49 CONTROLLED DRUG REGULATION: FOCUS ON U.S. AND JAPAN COMPARATIVE STUDY OF PREMARKET APPROVAL PROCESS AND DENOVO PROCESS FOR 129 AKASH D 10A-5 J-5 MEDICAL DEVICES 1499 MAHALAKSHMY 10A-50 J-50 REGULATION OF CONTROLLED DRUG: FOCUS ON U.S. AND JAPAN REGULATORY REQUIREMENTS FOR THE REVERSE LOGISTICS OF PHARMACEUTICALS IN 1504 MONIVEENA.M.G 10A-51 J-44 INDIA- COMPARISON WITH REGULATED COUNTRIES. HERBAL DRUG REGULATORY LANDSCAPE: KEY COMPARISON BETWEEN INDIA AND UNITED 1694 NISHITH M.C 10A-52 J-43 STATES 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title 1821 NITAL PUROHIT 10A-53 J-42 PIC/S : A BOON OR CURSE FOR PHARMACEUTICAL INDUSTRIES 2083 KANCHAN GURUNATH SWAMI 10A-54 J-41 IMPACT OF GST ON PHARMACEUTICAL INDUSTRY REGULATORY PERSPECTIVES OF DRUG-DEVICE COMBINATION PRODUCT IN UNITED STATES 130 THAIKADAN SOORYA SUKUMARAN 10A-6 J-6 & EUROPE 131 ANJANA B 10A-7 J-7 APPROVED PRODUCT LIFE CYCLE MANAGEMENT FOR U.S. GENERIC SUBMISSION 137 BALAMURALIDHARA V 10A-8 J-8 LIFE-CYCLE MANAGEMENT OF DRUGS IN US: A REGULATORY PERSPECTIVE DIFFERENT BIOWAIVER PROVISIONS, APPLICATION REQUIREMENTS AND ITS IMPORTANCE IN 180 MUDIT DIXIT 10A-9 J-16 PHARMA INDUSTRY 422 RAMA SHUKLA 11A-1 K-1 ONLINE PHARMACIES: A FUTURE REPLACEMENT- BOON OR BANE…..? 1993 ARVIND SINGH JADON 11A-10 K-6 PHARMA INDUSTRY IN INDIA: AN OVERVIEW ON CURRENT STATUS AND FUTURE PROSPECTS. HERBAL COSMETICS: A SURVEY ON THE USE, KNOWLEDGE AND ATTITUDE AMONG 1997 POONAM BHADAURIYA 11A-11 K-7 CONSUMERS IN GWALIOR REGION. 2041 SAGAR P MAHAJAN 11A-12 K-4 FDC DRUG BAN “IMPACT ON PHARMACEUTICAL BIZ” 438 MUDIT 11A-2 K-2 MANAGEMENT OF PHARMACEUTICAL MARKETING AND IMPORTANCE PRESCRIBING PATTERNS OF ANALGESICS IN A TERTIARY CARE HOSPITAL: A PROSPECTIVE 1003 VINOD M. 11A-3 K-3 AND OBSERVATIONAL STUDY PATIENT COMPLIANCE ON ANTIPLATELET DRUGS AFTER PERCUTANEOUS CORONARY 1502 POTLURI MOUNIKA SPOORTHY 11A-4 K-11 INTERVENTION DEVELOPMENT AND IMPLEMENTATION OF MEDICATION THERAPY MANAGEMENT AT TERTIARY 1506 DONGA PAVITHRA 11A-5 K-12 CARE HOSPITAL IN SOUTH INDIA, BHIMAVARAM A CROSS-SECTIONAL STUDY OF PHARMACY STUDENTS’ ONLINE HEALTH INFORMATION 1768 ROSHAN M 11A-6 K-10 ACCESS AND UTILIZATION A STUDY ON THE MANAGEMENT AND OUTCOMES OF HEMODIALYSIS CATHETER RELATED 1825 JOANN JOJI 11A-7 K-8 INFECTIONS INDIAN API INDUSTRY: CURRENT SCENARIO, CHALLENGES, POLICY SUPPORT & 1838 HARSHA FARENJIYA KHATIK 11A-8 K-9 OPPORTUNITIES 1967 SANA FAIYAZ 11A-9 K-5 CURRENT STATUS OF TQM IN PHARMACEUTICAL INDUSTRY IN INDIA 786 AMOUGH KULKARNI 12A-10 L-10 PHARMACOGENOMICS OF METFORMIN A CROSS SECTIONAL STUDY OF CLINICAL TRIALS REGISTERED IN INTERNATIONAL CLINICAL 899 LATA PATIL 12A-11 L-11 TRIAL REGISTRY PLATFORM (ICTRP) FOR FILARIASIS AUDIT AND EVALUATION OF COMPLETENESS OF SUSPECTED ADVERSE DRUG REACTION 35 LAKSHMI SIRISHA 12A-12 L-1 REPORTS OF AN ADR MONITORING CENTRE IN ANDHRA PRADESH. EFFECT OF SOCIO-ECONOMIC FACTORS IN UNDERSTANDING THE PARADIGM OF GENERAL 1048 PARTH BHATIA 12A-13 L-12 HEALTH AND AUTISM IN DELHI-NCR ASSESSMENT OF PARENTS’ KNOWLEDGE, ATTITUDE AND PRACTICE TOWARDS INFLUENZA 1066 RECHITHA MARY MATHEWS 12A-14 L-13 VACCINE ASSESSMENT OF PARENTS’ KNOWLEDGE, ATTITUDE AND PRACTICE (KAP) TOWARDS 1077 RECHITHA MARY MATHEWS 12A-15 L-14 INFLUENZA VACCINE ASSESSMENT OF ANTIOXIDANT SUPPLEMENTATION ON THE NEUROPATHIC PAIN SCORE AND 1107 SOURABH KOSEY 12A-16 L-15 QUALITY OF LIFE IN DIABETIC NEUROPATHY PATIENTS – A RANDOMIZED CONTROLLED STUDY 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title 1242 VISHAKHA PRASAD 12A-17 L-28 INDIAN PHARMA INDUSTRY: CURRENT SCENARIO AND FUTURE PROSPESCTS AUDIT AND EVALUATION OF COMPLETENESS OF SUSPECTED ADVERSE DRUG REACTION 1338 P.LAKSHMI SIRISHA 12A-18 L-27 REPORTS OF AN ADR MONITORING CENTRE IN ANDHRA PRADESH 128 HARIKIRAN GELLELA 12A-2 L-2 HEADACHE : A BURDEN IN FEMALE LIFE AND ITS SELF CARE SURVEY REPORT ON ANTIFUNGAL DISEASE “A MODERN NEEDS FOR A CHANGE ON PUBLIC 1524 GARIMA MISHRA 12A-22 L-26 HEALTH” PRICING AND REIMBURSEMENT POLICIES IN PHARMAEMERGING AND MATURE PHARMA 1580 DARVESH KHARB 12A-23 L-25 MARKETS: A COMPARATIVE EVALUATION RISK FACTORS FOR CORONARY ARTERY DISEASES IN A RURAL POPULATION OF WARANGAL 1619 P. CHIRANJEEVI 12A-26 L-24 DISTRICT SURVEY REPORT ON ANTIFUNGAL DISEASE “A MODERN NEEDS FOR A CHANGE ON PUBLIC 1677 GARIMA MISHRA 12A-27 L-23 HEALTH” CARDIAC, HEPATIC AND HEMATOLOGICAL INVOLVEMENT IN PATIENTS WITH PULMONARY 1703 M. RAM REDDY 12A-28 L-22 TUBERCULOSI 1831 ARUN CHANDRAN R 12A-29 L-20 OSTEOPOROSIS - A HIDDEN DISEASE AND ITS MANAGEMENT DRUG UTILIZATION PATTERNS USING WHO CORE PRESCRIBING INDICATORS IN 163 SHUBHANGI CHATTERJEE 12A-3 L-6 GYNAECOLOGY DEPARTMENT AT A PRIMARY CARE HOSPITAL 1841 SHARAYU RAJENDRA GOVARDHANE 12A-30 L-21 GENERIC DRUGS : NOT ALWAYS SO CHEAP CARDIAC, HEPATIC AND HEMATOLOGICAL INVOLVEMENT IN PATIENTS WITH PULMONARY 2101 M. RAM REDDY 12A-31 L-16 TUBERCULOSIS-A PROSPECTIVE STUDY 1869 JUVERIA TARANNUM 12A-31 L-19 ELUCIDATIVE EPIDEMIOLOGICAL STUDY IN FEMALE CANCER PATIENTS CARDIAC, HEPATIC AND HEMATOLOGICAL INVOLVEMENT IN PATIENTS WITH PULMONARY 2061 M. RAM REDDY 12A-32 L-17 TUBERCULOSIS-A PROSPECTIVE STUDY IMPORTANCE AND ROLE OF PHARMACOECONOMICS (PE) IN CURRENT INDIAN HEALTHCARE 2084 J.SAI SANDEEP 12A-33 L-18 SYSTEM ASSESMENT OF DEPRESSION IN TARGETED GROUP(STUDENTS OF 11 AND 12 STANDARD) BY 201 G.HARI PRAKASH 12A-4 L-3 DEVELOPING AN DEPRESSION ASSESMENT SCALE A STUDY ON THE COSTS INVOLVED IN THE MANAGEMENT OF ADVERSE DRUG REACTIONS IN 355 SHARON MARY STANLY 12A-5 L-4 THE GENERAL MEDICINE DEPARTMENT OF A TERTIARY CARE HOSPITAL Comparative Evaluation of Aceclofenac and Etoricoxib in the Management of Acute Low Back Pain in a 460 HEMA J 12A-6 L-7 Tertiary Care Hospital. 488 NEHA YADAV 12A-7 L-8 PHARMA-IOT :ITS OPPORTUNITIES AND CHALLENGES IN DIGITAL INDIA 537 SATYAJIT PRUSTY 12A-8 L-5 GST: A CHALLENGING ASPECT FOR PHARMACEUTICAL INDUSTRY AND ITS AWARNESS. CLINICAL AND MEDICATION USE CHARACTERISTICS OF A US NATIONAL COHORT OF OLDER 564 RAJENDER R. APARASU 12A-9 L-9 DEMENTIA PATIENTS AN INNOVATIVE APPROACH IN DELIVERY OF NANOSIZED TOPIRAMATE USING NOVELISTIC ORO 87 SUGANDHA VARSHNEY 1B-1 A-34 SOFTPALATAL PLATFORM 1101 ANKITA VIJAY KHADE 1B-10 A-315 TO FORMULATION AND EVALUATION IN VITRO BUCCOADHESIVE DISCS OF BIFONAZOLE 1200 BENITA.A 1B-11 A-615 FORMULATION AND EVALUATION OF METHOTREXATE CREAM Design and evaluation of oral mucoadhesive gels of dexamethasone sodium phosphate for the treatment 1283 VIJAY BHASKAR DESAI 1B-12 A-568 of oral submucous fibrosis. 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title A SMART NATURAL POLYMERIC CARRIER FOR DESIGNING MUCOADHESIVE FLEXY FILMS 1518 VISHAKHA JAISWAL 1B-13 A-480 LOADED WITH BROMOCRIPTINE FROM SEEDS OF T. AMMI OPTIMIZATION OF THERMOREVERSIBLE NASAL IN- SITU GEL OF ATOMOXETINE 1588 TALLA PRANNOY 1B-14 A-469 HYDROCHLORIDE USING TAGUCHI DESIGN OF EXPERIMENTS DEVELOPMENT AND EVALUATION OF FLOATING MUCOADHESIVE TABLETS OF PIOGLITAZONE 1667 YOGITA TUKARAM RAYATE 1B-15 A-431 BY USING RESPONSE SUIRFACE METHODOLOGY 1762 M.SRIRAM 1B-16 A-405 PREPARATION AND EVALUATION OF BUCCAL BIO-ADHESIVE TABLETS CONTAINING GLIMIPRIDE 1808 R.VENKATA KOTESWARARAO 1B-17 A-392 By using QbD Expert, Preparation & In-Vitro Evaluation of Buccal Patches of Nisoldipine DEVELOPMENT, OPTIMIZATION, AND CHARACTERIZATION OF POLYMERIC ELECTROSPUN NANOFIBER: A NEW ATTEMPT IN SUBLINGUAL DELIVERY OF NICORANDIL FOR THE 1824 VISHESH SINGH 1B-18 A-397 MANAGEMENT OF ANGINA PECTORIS. FORMULATION AND EVALUATION OF INTRANASAL MUCOADHESIVE MICROSPHERES OF CNS 1832 SHOAIB KHAN ASLAM KHAN 1B-19 A-399 ACTING DRUG 108 ANUSHA M 1B-2 A-44 FORMULATION AND EVALUATION OF FAST DISSOLVING ORAL FILMS OF ZOLMITRIPTAN Development of Sublingual Tablets of Propranolol Hydrochloride with Enhanced Permeation through 1927 VARSHA BANDARI 1B-20 A-375 Mucosa DEVELOPMENT OPTIMIZATION AND EVALUATION OF FAST DISSOLVING ORAL FILM OF 1983 SUMIT ASHOK JOSHI 1B-21 A-364 CINNAREZINE FORMULATION AND EVALUATION OF MOUTH DISSOLVING TABLET OF SERTRALINE 1984 DEEPAK GOVIND UMALKAR 1B-22 A-365 HYDROCHLORIDE FORMULATION DEVELIOPMET OF FAST DISINTEGRATING TABLETS OF ROSUVASTATIN. NEW 2057 DR SUNIL REDDY 1B-23 A-333 GENERATION SUPER DISINTEGRATS 2097 PRANAV ASHOKKUMAR GANORKAR 1B-24 A-344 Formulation and evaluation of xanthan gum based mouth dissolving films of model antiallergic drug." FORMULATION AND EVALUATION OF FAST DISSOLVING TABLETS OF PRAZOSIN 118 SRI CHAYA M V 1B-3 A-52 HYDROCHLORIDE IN-SITU GELLING MUCOADHESIVE LIPOSOMES FOR NOSE TO BRAIN DELIVERY OF 264 MANOJ PAWAR 1B-4 A-71 RIVASTIGMINE: ENHANCED PHARMACOKINETICS AND BRAIN DISTRIBUTION PREPARATION AND CHARACTERIZATION OF MUCOADHESIVE MICROPARTICLES OF 439 ARITRA PRAMANICK 1B-5 A-205 SUMATRIPTAN SUCCINATE FOR INTRANASAL DELIVERY OPTIMIZING THE PROCESS VARIABLES IN FORMULATION OF MUCOADHESIVE MICROSPHERES CONTAINING ANTI- CANCER AGENT AND CHARACERIZATION OF FORMULATED MUCOADHESIVE 547 BANDARU LAKSHMI NARAYANA RAO 1B-6 A-219 MICROSPHERES FOR SITE SPECIFIC DELIVERY FORMULATION AND OPTIMIZATION OF GASTRORETENTIVE MUCOADHESIVE FLOATING 701 DHARMAJIT PATTANAYAK 1B-7 A-175 TABLETS OF ORAL HYPOGLYCEMIC AGENTS DEVELOPMENT AND EVALUATION OF NANOSIZED TOPIRAMATE LOADED BIO-FLEXY FILMS 968 SUGANDHA VARSHNEY 1B-8 A-284 USING COCOS NUCIFERA BIOPOLYMER FOR ORO-TRANS SOFT PALATAL DELIVERY FORMULATION AND EVALUATION OF IN SITU GEL CONTANING CINNARIZINE LOADED 1037 SHIPRA YADAV 1B-9 A-300 NANOSTRUCTURDED LIPID CARRIER DESIGN AND IN VITRO CHARACTERIZATION OF ETHOSOMES CONTAINING TERBINAFINE 155 KRISHNANAND.A 1C-10 A-138 HYDROCHLORIDE FOR TRANSDERMAL DELIVERY 1500 NARESH KSHIRASAGAR 1C-100 A-510 MICROSPONGES: AS A DRUG DELIVERY SYSTEM FORMULATION AND EVALUATION OF GELS CONTAINING CALCIUM CHANNEL BLOCKER DRUG 1509 RAJESH KUMAR CHAUDHARY 1C-101 A-477 FOR THE TREATMENT OF ANAL FISSURE 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title SCREENING OF COMPONENTS OF NANOEMULSION SYSTEM FOR TRANSDERMAL DRUG 1516 RONAK BHAGUBHAI DAVE 1C-102 A-478 DELIVERY OF CILNIDIPINE AND DEVELOPMENT OF ANALYTICAL METHOD FORMULATION AND EVALUATION OF TIZANIDINE HYDROCHLORIDE LOADED ETHOSOMES FOR 1593 G. HARSHA 1C-103 A-471 TRANSDERMAL DELIVERY 1606 M. ARUN KUMAR 1C-104 A-444 ENHANCED TRANSDERMAL DELIVERY OF ATENOLOL USING IONTOPHORESIS TECHNIQUE OPTIMIZATION AND DEVELOPMENT OF NANOEMULSION SYSTEM FOR TRANSDERMAL 1608 MOHAMMAD WAIS 1C-105 A-445 DELIVERY OF GLIMEPIRIDE 1610 AJAY BILANDI 1C-106 A-446 FORMULATION AND EVALUATION OF CHLOREPHENICOL GEL FOR TOPICAL DRUG DELIVERY DEVELOPMENT OF PROTRANSFEROSOMAL GEL CONTAINING ALENDRONATE, A NITROGEN 1633 JAYANTI MISHRA 1C-107 A-455 CONTAINING BISPHOSPHONATE FOR TRANSDERMAL ROUTE FABRICATION AND EVALUATION OF BIOMATERIAL BASED MULTIPURPOSE THREE 1642 MANJUSHA 1C-108 A-460 DIMENSIONAL SCAFFOLD 1737 ROHIT BARUA 1C-109 A-426 Developement of Microneedle patches of Indomethacin by using 3D printing technology 187 K.HARSHITHA 1C-11 A-152 FORMULATION AND EVALUATION OF METFORMIN TRANSDERMAL PATCHES TO DEVELOP A NOVEL CARRIER SYSTEM FOR VAGINAL DELIVERY OF ANTIMICROBIALS 2 SUDHANSHU GUPTA*,RAJWINDER KAUR, GAURAV 1C-110 A-3 AGAINST URINARY TRACT INFECTIONS. DEVELOPMENT AND EVALUATION OF TRANSDERMAL PATCHES OF PLUMERIA PUDICA LINN. 1866 SUMAN GEHLOT 1C-111 A-382 FOR THE TREATMENT OF FUNGAL INFECTION 38 UDAI PRAKASH 1C-112 A-15 NOVEL BIODEGRADABLE POROUS CHITOSAN SCAFFOLD FOR ANTIBACTERIAL HEMOSTATIC DIFFUSION STUDIES OF DICLOFENAC SODIUM TOPICAL GEL USING DIFFERENT SYNTHETIC 1887 SOMARAJU REVANTH KUMAR 1C-112 A-386 MEMBRANES DEVELOPMENT AND OPTIMIZATION OF KOJIC ACID PHOSPHOLIPID COMPLEX FOR EFFECTIVE 1912 NISHITH K. PATEL 1C-113 A-371 TREATMENT IN MELASMA A STUDY ON THE SUITABILITY OF VARIOUS PERMEATION ENHANCERS FOR TRANSDERMAL 1942 ROHITH GANAPATHI BHATTA 1C-114 A-377 DRUG DELIVERY OF RASAGILINE MESYLATE 1946 SHRADDHA SUNIL KALYANI 1C-115 A-378 FORMULATION AND EVALUATION OF PRONIOSOMALGEL CONTAINING CURCUMIN 1981 SUPRIYA SHAMRAO ALDAR 1C-116 A-363 Preparation and evaluation of mosquito repellent gel from lemongrass oil and basil oil 2064 POOJA 1C-117 A-335 Formulation and Evaluation of UV Protective synbiotic skin topical formulation FORMULATION, DEVELOPMENT AND EVALUATION OF NANOEMULSION OF CLINDAMYCIN HCL 2067 NEHA S. RAUT 1C-118 A-336 AND DOXYCYCLINE HYCLATE 2093 POOJA PRAVIN KOCHAR 1C-119 A-341 “Investigation, Formulation, And Evaluation of Polyherbal Wound Healing Gel” DEVELOPMENT OF CHITOSAN AND SODIUM ALGINATE BASED TOPICAL GEL FOR WOUND 226 KAUSHAL TRIPATHI 1C-12 A-62 HEALING TRANSDERMAL DELIVERY OF ETHINYLESTRADIOL AND LEVONORGESTREL FOR 2033 LAVAKESH KUMAR OMRAY 1C-120 A-354 CONTRACEPTION VIA SOLID LIPID NANOPARTICLES STUDIES ON FORMULATION AND EVALUATION OF GRISEOFULVIN LOADED MICROSPONGES 2052 RINKU YOGESH PATIL 1C-121 A-331 BASED GEL FOR TOPICAL DELIVERY 232 K.KRISHNASAI 1C-13 A-63 FORMULATION AND EVALUATION OF TRANSDERMAL PATCH OF ALFUZOSIN HYDROCHLORIDE DEVELOPMENT OF TOPICAL GEL OF METHOTREXATE INCORPORATED ETHOSOMES AND 258 AKHILESH CHANDRA 1C-14 A-69 SALICYLIC ACID FOR TREATMENT OF PSORIASIS 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title 325 SHRAVANI 1C-15 A-82 EFFECT OF NATURAL PERMEATION ENHANCERS ON CURCUMIN TOPICAL GEL A SMART DELIVERY APPROACH FOR OLANZAPINE VIA NOVELISTIC TRANS VERMILLION 337 BHAVANA SINGH 1C-16 A-85 PLATFORM DEVELOPMENT OF A TOPICAL ANTI-INFLAMMATORY GEL FROM VITEX NEGUNDO EXTRACTION 373 NAGA AASISH JAMPALA 1C-17 A-91 AND EVALUATING FORMULATION DEVELOPMENT AND EVALUATION OF TRANSDERMAL DRUG DELIVERY 391 AVIKUMAR HEMRAJ BAWANKAR 1C-18 A-198 SYSTEM OF AN ANTIANGINAL DRUG 440 KRITIKA GOSWAMI 1C-19 A-206 DEVELOPMENT AND EVALUATION OF ANTIAGING HERBAL TOPICAL FORMULATION MINIMALLY INVASIVE BIODEGRADABLE MICRONEEDLE FOR TOPICAL DRUG DELIVERY: 54 HITENDRA SHALIGRAM MAHAJAN 1C-2 A-20 DEVELOPMENT AND EVALUATION SYNTHESIS AND EVALUATION OF CHITOSAN BASED SCAFFOLDS FOR RADIOACTIVE 493 AKSHAY NARULA 1C-20 A-216 DECONATMINATION DEVELOPMENT OF TIZANIDINE HYDROCHLORIDE TRANSDERMAL PATCHES:IN-VITRO AND EX- 518 NUSRAT AYESHA 1C-21 A-105 VIVO CHARACTERIZATION STUDY OF IN-VITRO DRUG RELEASE AND PER-CUTANEOUS ABSORPTION OF TRANSPARENT 525 THULASI MANI.P 1C-22 A-106 LIPOGEL DELIVERY SYSTEMS OF KETOCONAZOLE 533 DHANASHREE R. AGARKAR 1C-23 A-108 TO STUDY THE EFFECT OF COW GHEE AND ALOE VERA ON THE PERMEATION OF ACYCLOVIR. DEVELOPMENT, EVALUATION AND COMPARISON OF HYDROGEL BASED NAIL LACQUER AND 535 RUPINDER KAUR DHAMOON 1C-24 A-110 HYDROPHOBIC NAIL LACQUER FOR TRANSUNGUAL DRUG DELIVERY FORMULATION AND OPTIMIZATION OF TOPICAL NANOEMULSION BASED GEL OF MOMETASONE 545 SOMYA VERMA 1C-25 A-218 FUROATE OPTIMIZED RP-HPLC METHOD FOR QUANTITATIVE ANALYSIS OF LINAGLIPTIN LOADED IN 565 HARSHA ASHTEKAR 1C-26 A-223 TRANSFERSOMES AND ITS APPLICATION IN VITRO SKIN PERMIATION STUDIES AN ELECTRICALLY RESPONSIVE POLY (ACRYLAMIDE)-G-PECTIN COPOLYMER FOR 598 SUDHA B PATIL 1C-27 A-232 TRANSDERMAL DRUG DELIVERY APPLICATION: DEVELOPMENT AND EVALUATION 599 RAJAN VERMA 1C-28 A-233 HYDRO-SWELLING DROPLET: NOVEL TOPICAL DRUG DELIVERY PREPARATION AND EVALUATION OF TAZAROTENE LOADED NANOSTRUCTURED LIPID 602 PRATIKSHA MISHRA 1C-29 A-114 CARRIERS GEL (NLCG) FOR ANTI-POSARIATIC ACTIVITY 60 SUBHASH CHANDRA BOSE PENJURI 1C-3 A-23 FORMULATION AND IN VIVO EVALUATION OF GLIBENCLAMIDE ETHOSOMES PERMEATION ENHANCEMENT OF MODEL ANTI-HYPERTENSIVE DRUG FROM TRANSDERMAL 605 GOHIL KRUPA MUKESHKUMAR 1C-30 A-116 PATCHES USING ESSENTIAL OILS TOPICALLY APPLIED ULTRADEFORMABLE TRANSFEROSOMAL BASED GEL FOR THE 607 NEEL SOLANKI 1C-31 A-117 TREATMENT OF PSORIASIS 609 EDUPUGANTI BHAVANA TARUNYA 1C-32 A-118 FORMULATION AND EVALUATION OF CINNARAZINE TRANSDERMAL PATCHES DEVELOPMENT OF MICROEMULSION BASED HYDROGEL CONTAINING HERBAL ACTIVES FOR 622 SAMINDER SINGH 1C-33 A-125 TOPICAL DELIVERY 626 ARPITHA KHARVI 1C-34 A-127 DESIGN AND CHARACTERIZATION OF PRONIOSOMAL GEL OF VALSARTAN DESIGN AND OPTIMIZATION OF ACECLOFENAC MICROSPONGES FOR TOPICAL DELIVERY 627 MOHD IQBAL BHAT 1C-35 A-128 SYSTEM FORMULATION AND EVALUATION OF GEL CONTAINING NANOPARTICLES OF CARICA PAPAYA 630 LIDIYA JOY 1C-36 A-131 LEAF EXTRACT 631 HABEEBU RAHMAN.KP 1C-37 A-132 FORMULATION AND CHARACTERIZATION OF PRONIOSOMAL GEL OF BACLOFEN 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title 649 N. DIVYA SUPRIYA 1C-38 A-158 DESIGN AND OPTIMIZATION OF ONDANSETRON TRANSDERMAL FILM USING RSM 669 RESHMA HULLUR 1C-39 A-164 FORMULATION AND EVALUATION OF TRANSDERMAL PATCH OF AZELNIDIPINE FORMULATION AND EVALUATION OF KETOPROFEN LOADED NIOSOMAL GEL FOR ENHANCED 72 PREM RANJAN MANDALA 1C-4 A-27 TRANSDERMAL DELIVERY 673 PAYAL S. MESHRAM 1C-40 A-165 Design and Optimization of Proniosomal Gel for Sustained Release of Paclitaxel MICRONEEDLE AIDED TRANSDERMAL DELIVERY OF OSELTAMIVIR AND MATHEMATICAL 727 BUCHI N. NALLURI 1C-45 A-179 MODELLING BY SCALING ANALYSIS EXPLORATION OF QBD OPTIMIZED TRANSNANOGEL FORMULATION FOR THE TREATMENT OF 764 ZEENAT IQBAL 1C-46 A-185 RHEUMATOID ARTHRITIS 819 SNEHA BALU GOVIND 1C-48 A-244 FORMULATION AND EVALUATION OF TOPICAL LIPOSOMAL GEL OF VORICONAZOLE 854 AMIT KUMAR BITTU 1C-49 A-255 RECENT TRENDS IN DEVELOPMENT OF TRANSDERMAL DRUG DELIVERY SYSTEM: A REVIEW FORMUALATION DEVELOPMENT STUDIES ON ALGINATE FORTIFIED NICOTINAMIDE LOADED 77 ESITA BOSE 1C-5 A-31 HYDROGEL DRESSINGS FORMULATION DEVELOPMENT AND IN-VITRO CHARACTERIZATION OF SCOPOLAMINE 865 M. SAI ADITYA 1C-50 A-257 TRANSDERMAL PATCHES FORMULATION AND EVALUATION OF NANOSTRUCTURED LIPID CARRIERS (NLC) OF 871 SNEHA WANI 1C-51 A-259 PONGAMIA PINNATA FORMULATION AND EVALUATION OF APREMILAST LOADED MICROSPONGE GEL FOR TOPICAL 894 SHELLY GUPTA 1C-52 A-265 DELIVERY DEVELOPMENT AND CHARACTERIZATION OF MUPIROCIN EMULGEL FOR THE TREATMENT OF 924 RAJSHRI KAUSDIKAR 1C-53 A-274 PRIMARY AND SECONDARY INFECTIONS IN DRY SKIN CONDITION DISEASES FORMULATION AND EVALUATION OF MATRIX TYPE TRANSDERMAL PATCHES OF ANTI- 925 ARPITA MANJUNATH GOWDAR 1C-54 A-275 HYPERTENSIVE DRUG. FORMULATION AND EVALUATION OF APREMILAST LOADED MICRO-SPONGE GEL FOR TOPICAL 928 SHELLY GUPTA 1C-55 A-276 DELIVERY HA-O3FA-NLCS: AN UPGRADED TRANSEPIDERMAL DELIVERY APPROACHES FOR EFFICACIOUS 995 KRISHNA YADAV 1C-57 A-287 MANAGEMENT OF PSORIASIS 997 MINAKSHI RATHEE 1C-58 A-288 ETHANOL BASED VESICULAR CARRIERS IN TRANSDERMAL DRUG DELIVERY PREPARATION AND EVALUATION OF TAZAROTENE LOADED NANOSTRUCTURED LIPID 1067 PRATIKSHA MISHRA 1C-59 A-307 CARRIERS (NLCG) FOR ANTI-PSORIATIC ACTIVITY FORMULATION AND EVALUATION OF KETOPROFEN LOADED NIOSOMAL GEL FOR ENHANCED 83 PREM RANJAN MANDALA 1C-6 A-32 TRANSDERMAL DELIVERY FORMULATION AND EVALUATION OF TRANSDERMAL DRUG DELIVERY SYSTEM OF VERAPAMIL 1071 BIRAJADAR LAXMAN 1C-60 A-308 HYDROCHLORIDE 1083 KOKILA CHADHA 1C-61 A-312 Preparation and Evaluation of Polyherbal Hydrogel Formulation for Diabetic Foot Ulcer ETHOSOMES BASED TRANSDERMAL FILM CONTAINING BUSPIRONE HYDROCHLORIDE FOR THE 1111 KARTIK B KHOT 1C-62 A-319 TREATMENT OF ANXIETY DEVELOPMENT AND CHARACTERIZATION OF HERBAL DOSAGE TOPICAL FORM FOR THE 1124 SHAMMY JINDAL 1C-63 A-323 TREATMENT OF PSORIASIS 1150 PRATIKSHA TIWARI 1C-64 A-328 Antioxidant loaded nanolipid carriers for treatment of rheumatoid arthritis DESIGN FORMULATION AND EVALUATION OF LOSARTAN POTASSIUM LOADED NIOSOMES FOR 1152 V D SUNDAR 1C-65 A-598 ANTIHYPERTENSIVE ACTIVITY 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title DEVELOPMENT AND EVALUATION OF ETHOSOMAL GEL OF LORNOXICAM AND 1190 AKSHAY VISHNU BANDIWADEKAR 1C-66 A-613 THIOCOLCHICOSIDE FOR RHEUMATOID ARTHRITIS FORMULATION AND EVALUATION OF TOPICAL GEL USING COLOCASIA AFFINIS STALK EXTRACT 1206 PRIYANKA GOSWAMI 1C-67 A-578 FOR SKIN INFECTIONS DESIGN, OPTIMIZATION AND EVALUATION OF TRANSFEROSOMAL GEL: EFFECTIVE AGAINST 1213 SWATI CHAUHAN 1C-68 A-582 ATOPIC DERMATITIS ROLE OF SMART NANO- SILVER AND HERBAL INFORMATICS IN THE TREATMENT OF DIABETIC 1223 REENA 1C-69 A-587 FOOT ULCER DESIGN AND DEVELOPMENT OF HERBOSOMES CREAM FOR THE PREVENTION AND 86 CHINMOY BHUYAN 1C-7 A-33 TREATMENT OF BLACK FLY BITES 1224 PASUNOORI LOKESH VAMSHI 1C-70 A-588 FORMULATION OF MICROSPONGES BASED GEL FOR TOPICAL DELIVERY OF CORTICOSTEROID 8 PRAFUL PRAKSH PATIL 1C-71 A-8 Transfersomal Gel of Lornoxicam and Thiocolchicoside For Rheumatoid Arthritis 1230 TALLA RAJESH 1C-72 A-590 NIOSOMAL BASED TRANSDERMAL GEL FOR ATTENTION-DEFICIT HYPERACTIVITY DISORDER 1266 SANJAY 1C-73 A-1 TEST 11102018 FORMULATION AND OPTIMIZATION OF MEMANTINEHCL TRANSDERMAL PATCH FOR THE 1269 ANSARI GAZALA MOHMMED YUSUFBHAI 1C-74 A-565 TREATMENT OF ALZHEIMER'S DISEASE 1288 SUJIT SHRESTHA 1C-75 A-570 NOVEL MICROGEL OF TRETINOIN: SUSTAINED RELEASE ANTI-ACNE TOPICAL FORMULATION DEVELOPMENT AND EVALUATION OF A CREAM INCORPORATED WITH SILVER NANOPARTICLES 1289 MANISH KUMAR SINGH 1C-76 A-571 OF NARDOSTACHYS JATAMANSI. SYNTHESIS OF DENTAL GEL CONTAINING ZINC NANOPARTICLES AND AZITHROMYCIN FOR 1292 NIDHI SINGH 1C-77 A-572 PERIODONTAL INFECTIONS DEVELOPMENT AND CHARACTERIZATION OF LULICONAZOLE ETHOGEL FOR TOPICAL USE IN 1314 VISHNU PRIYA 1C-78 A-544 THE TREATMENT OF ATHLETE’S FOOT INFECTION DRUG LOADED NANOSTRUCTURED LIPID CARRIER (NLC) GEL: - A NOVEL STRATEGY FOR 1319 NARAYAN HEMNANI 1C-79 A-548 TREATMENT OF ALOPECIA 104 SANDIP A. MURTALE 1C-8 A-42 Development And Evaluation Of Transdermal Delivery Of Selegiline Hydrochloride FORMULATION AND OPTIMIZATION OF POLYMERIC NANOPARTICLES WITH HERBAL BIOACTIVE 1321 SATISH PATEL 1C-80 A-549 AND PRELIMINARY IN VIVO STUDY FORMULATION AND OPTIMIZATION OF POLYMERIC NANOPARTICLES WITH HERBAL BIOACTIVE 1323 SATISH PATEL 1C-81 A-550 AND PRELIMINARY IN VIVO STUDY IBUPROFEN MICROEMULSION BASED MEDIA AS NOVEL DRUG DELIVERY SYSTEMS FOR 1329 KAMALIKA CHATTOPADHYAY 1C-82 A-553 IMPROVING THERAPY 1330 HANI SHARMA 1C-83 A-554 NANOEMULSION BASED DRUG DELIVERY FOR LIDOCAINE AS TOPICAL FORMULATION FORMULATION AND EVALUATION OF POLYHERBAL COSMETIC CREAM FOR MULTIPURPOSE 1349 TASLIMA AKHTER ROHMAN 1C-84 A-560 EFFECT FORMULATION AND OPTIMIZATION OF MEMANTINEHCL TRANSDERMAL PATCH FOR THE 1379 ANSARI GAZALA MOHMMED YUSUFBHAI 1C-85 A-532 TREATMENT OF ALZHEIMER’S DISEASE SCREENING OF COMPONENTS AND ANALYTICAL METHOD DEVELOPMENT APPROACH FOR 1394 GAYATHRI GOPAKUMARAN NAIR 1C-86 A-537 AGOMELATINE NANOEMULSION FOR TRANSDERMAL DRUG DELIVERY SYSTEM DEVELOPMENT AND OPTIMIZATION OF DIHYDROXYACETONE-PHOSPHOLIPID COMPLEX BASED 1404 PATHIKKUMAR J. PATEL 1C-87 A-514 COSMETIC PAINT 1428 JYOTHIRMAI KANAGALA 1C-88 A-519 NEEDLE FREE INJECTION SYSTEM 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title 1440 LEENA NALLI 1C-89 A-522 DESIGN AND DEVELOPMENT OF BIODEGRADABLE TRANSDERMAL DRUG DELIVERY SYSTEMS MICRONEEDLE AIDED TRANSDERMAL DELIVERY OF OSELTAMIVIR AND MATHEMATICAL 153 BUCHI N. NALLURI 1C-9 A-137 MODELLING BY SCALING ANALYSIS 14 PRASHANT BISHT 1C-90 A-14 FORMULATION AND EVALUATION OF TRANSDERMAL PATCH OF NIFEDIPINE 1448 S.SATYALAKSHMI 1C-91 A-526 FORMULATION AND EVALUATION OF ROSUVASTATIN-CALCIUM TRANSDERMAL PATCHES 1453 GUNJAN 1C-92 A-493 “FORMULATION DEVELOPMENT AND EVALUATION OF ANTI-SCAR HERBAL MICROEMULSION” 1454 S.SATYALAKSHMI 1C-93 A-494 FORMULATION AND EVALUATION OF ROSUVASTATIN-CALCIUM DRUG TRANSDERMAL PATCHES IN-VITRO AND EX-VIVO EVALUATION OF TENOXICAM DELIVERY USING NANOTRANSFERSOME 1456 D. MOUNIKA 1C-94 A-496 BASED FORMULATIONS FOMRULATION & INVITRO CHARACTERIZATION OF TERMINALIA CHEBULA EXTRACTS 1459 TASLIM BELLARI 1C-95 A-499 CONTAINING PHYTOSOMES LOADED MICROSPHERES FORMULATION, CHARACTERIZATION AND PHARMACOLOGICAL STUDY OF PTEROCARPUS 1460 V. VYSHNAVI 1C-96 A-500 MARSUPIUM TOPICAL EMULGEL Antioxidant activity and Antimicrobial study of Hydrogel containing fresh leaves extract of Aloe 1469 SUCHITA WAMANKAR 1C-97 A-503 Barbedensis Mill. 1479 G.NIHARIKA 1C-98 A-507 NOVEL CARRIER BASED GEL FOR TOPICAL DELIVERY OF MINOXIDIL 1489 M.KAVYA SREE 1C-99 A-509 MICROEMULSION BASED GEL FOR TOPICAL DELIVERY OF MUPIROCIN FORMULATION AND EVALUATION OF TROPICAMIDE SOLID LIPID NANOPARTICLES LOADED IN- 41 YERIKALA RAMESH 1D-1 A-16 SITU GELS FOR OCULAR DRUG DELIVERY IN-VITRO AND IN VIVO EVALUATION OF OPTIMIZED OCULAR NANO IN SITU GEL OF 9 SRIVIDYA GORANTLA 1D-11 A-9 CIPROFLOXACIN HYDROCHLORIDE DEVELOPMENT OF MICELLES LOADED WITH NEPAFENAC FOR EFFECTIVE TREATMENT OF 1234 SELUKAR PR 1D-12 A-593 UVETIES ESTIMATION OF PHYSICO-CHEMICAL CHARACTERISTICS OF SIROLIMUS FOR THE DEVELOPMENT OF OPTIMIZED NANOFORMULATION FOR NEURODEGENERATIVE DISEASE OF 1253 RESHAL SURI 1D-13 A-562 THE POSTERIOR EYE 1470 ANSHIKA SAINI 1D-14 A-504 APPRAISEL OF OCUSERT AS NOVEL DRUG DELIVERY SYSTEM DEVELOPMENT OF METALLIC NANOPARTICLES TO ERADICATE BACTERIAL BIOFILM FOR 1688 NAGENDRA BHUWANE 1D-15 A-438 EFFECTIVE TREATMENT OF BACTERIAL KERATITIS 1723 ROHAN AGGARWAL 1D-16 A-421 Chitosan Niosomes for Controlled Delivery of Brimonidine Tartrate to the Ocular Membrane AN IMMUNOSUPPRESSIVE DRUG BASED NANOMICELLES TARGETING THE POSTERIOR 1877 NIKITA 1D-17 A-385 SEGMENT OF THE EYE FOR THE TREATMENT OF UVEITIS 1904 ROHIT 1D-18 A-369 FORMULATION AND EVALUATION OF IN SITU OCULAR GEL OF DORZOLAMIDE FORMULATION AND EVALUATION OF NOVEL MUCOADHESIVE CHITOSAN LOADED LIPOSOMES OF DILTIAZEM HYDROCHLORIDE AS OCULAR DRUG DELIVERY FOR THE TREATMENT OF 2085 DEV JAIN 1D-19 A-339 GLAUCOMA 313 VIKESH KUMAR SHUKLA 1D-2 A-78 OCULAR DELIVERY OF CARBOPLATIN FOR THE TREATMENT OF RETINOBLASTOMA. FORMULATION, CHARACTERIZATION AND EVALUATION OF NOVEL ELASTIC NANO-SIZED 2026 AAYUSH KUMAR JHA 1D-20 A-352 ETHONIOSOMES FOR OCULAR DELIVERY OF BRIMONIDINE TARTARATE SODIUM CROMOGLYCATE LOADED SOLUBLE OPHTHALMIC INSERTS FABRICATED WITH 407 SONAM KHURANA 1D-3 A-93 SODIUM ALGINATE 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title 551 JOAN VIJETHA R 1D-4 A-221 A REVIEW ON: FORMULATION OF NANOSUSPENSION INTENDED FOR OPHTHALMIC USE DEVELOPMENT OF HYBRID OCULAR DELIVERY SYSTEM FOR HYDROPHILIC DRUG 729 LALIT KUMAR KHURANA 1D-5 A-180 MOXIFLOXACIN HCL: EFFECT OF LYOPHILIZATION AND GAMMA STERILIZATION DEVELOPMENT AND EVALUATION OF POLYMERIC INSERTS LOADED WITH AZITHROMYCIN(AZ) 783 POOJA MALLYA 1D-6 A-236 FOR DRY EYE DISEASE DEVELOPMENT AND EVALUATION OF POLYMERIC INSERTS LOADED WITH AZITHROMYCIN(AZ) 811 POOJA MALLYA 1D-8 A-242 FOR DRY EYE DISEASE FORMULATION AND CHARACTERIZATION OF ERYTHROMYCIN MICRO EMULSION FOR OCULAR 855 MANSI BUTOLA 1D-9 A-256 DRUG DELIVERY 44 DONTHU VENKATA TEJA 1E-1 A-18 FORMULATION AND EVALUATION OF VALSARTAN NIOSOMES DEVELOPMENT AND EVALUATION OF SOLID LIPID NANO PARTICLES OF IVABRADINE FOR 115 K J MEGHANA 1E-10 A-50 TREATMENT OF ANGINA PECTORIS 116 PAVITHRA K 1E-11 A-51 DEVELOPMENT AND EVALUATION OF SOLID LIPID NANO PARTICLES OF LINAGLIPTINE DESIGN AND DEVELOPMENT OF GASTRORETENTIVE SUPERPOROUS HYDROGEL TABLETS OF 143 D NAGA SAI 1E-12 A-56 ESOMEPRAZOLE DUAL CROSS-LINKED BIOPOLYMERS BASED MULTI-PARTICULATE SYSTEM FOR COLONIC 166 WASIM AKRAM 1E-13 A-142 DELIVERY OF MESALAMINE DESIGN FORMULATION AND EVALUATION OF SOLID LIPID NANOPARTICLES FOR IMPROVED 173 HITESH KUMAR 1E-14 A-144 ORAL DELIVERY OF BCS CLASS II DRUG DEVELOPMENT AND EVALUATION OF SELF- EMULSIFYING DRUG DELIVERY SYSTEM FOR 174 ASHOK KUMAR RAJPOOT 1E-15 A-145 SOLUBILITY ENHANCEMENT OF POORLY WATER SOLUBLE DRUG DESIGN AND DEVELOPMENT OF LIPID NANOPARTICLES FOR EFFECTIVE TREATMNET TO 261 ASIYA MAHTAB 1E-16 A-70 RHEUMATOID ARTHRITIS. INTRANASAL DELIVERY OF ASENAPINE MALEATE LOADED NANOEMULSION IN THE TREATMENT 275 RASHMIN 1E-17 A-74 OF SCHIZOPHRENIA DESIGN OF NANOSIZED SELEGILINE LOADED BIO-NANOSUSPENSION FOR MANAGEMENT OF 339 YOGITA TYAGI 1E-18 A-86 DEPRESSION 416 SENORITA PODDAR 1E-19 A-96 A RECENT ADVANCEMENT OF MICROSPONGE DELIVERY SYSTEM: A REVIEW NOSE TO BRAIN TARGETED DELIVERY OF DONEPEZIL LIPOSOME BASED IN SITU GEL IN 46 AMARJITSING PREMSINH RAJPUT 1E-2 A-19 TREATMENT OF ALZHEIMER’S DISEASE 461 AMIT SUDESH SHARMA 1E-20 A-209 REVIEW: COMPUTER AIDED DRUG DESIGN A NEW STRATEGY IN DRUG DISCOVERY 466 PRITAM SEN 1E-21 A-211 VIROSOMES AS NOVEL DRUG DELIVERY SYSTEM FORMULATION AND CHARECTERIZATION OF DIDANOSINE LOADED 484 GAJAVELLY HARISH 1E-22 A-215 PEGYLATED NIOSOMES FOR PARENTERAL DELIVERY RALOXIFENE LOADED SOLID LIPID NANOPARTICLE IN BREAST CANCER AN EFFECTIVE 510 PRITI TAGDE 1E-23 A-103 HORMONAL CHEMOTHERAPY 527 DEVI PRASAD SARANGI 1E-24 A-107 DESIGN AND CHARACTERIZATION OF MESALAMINE LOADED EUDRAGIT S100 NANOPARTICLES 544 DEEPA MK 1E-25 A-113 DEVELOPMENT OF TARGETED HERBAL NANO PARTICLES FOR COLO-RECTAL CANCER BIOSYNTHESIS AND CHARACTERIZATION OF SILVER NANOPARTICLES USING AYURVEDIC 578 Thanvi Sharma A 1E-26 A-226 PLANT EXTRACTS –A NOVEL APPEOACH 612 ESTHER .M 1E-27 A-120 DESIGN, DEVELOPMENT AND EVALUATION OF KETOCONAZOLE NIOSOMAL GEL 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title FORMULATION AND COMPARATIVE EVALUATION OF LOSARTEN POTASSIUM NIOSOMES BY 629 AJMAL C 1E-28 A-130 USING DIFFERENT TECHNIQUES ADAPALENE LOADED NANO SIZED VESICLES: AN EFFECTIVE APPROACH FOR ACNE 635 MONIKA TARGHOTRA 1E-29 A-133 TREATMENT FORMULATION DEVELORMENT AND EVALUATION OF DOXORUBICIN HYDROCHLORIDE 64 THAMMA SAI APARNA TEJASWINI 1E-3 A-26 LIPOSOMES AS A TARGETED DRUG DELIVERY SYSTEMS PREPARATION AND EVALUATION OF BROMHEXINE HYDROCHLORIDE FLOATING MICROSPHERES USING DIFFERENT POLYMERS BY QUASI EMULSION SOLVENT DIFFUSION 639 HIRANJITH A 1E-30 A-134 METHOD FORMULATION AND EVALUATION OF GASTRO RETENTIVE DRUG DELIVERY SYSTEM OF 663 T.RAVI 1E-31 A-162 ZANAMIVIR USING DIFFERENT POLYMERS FOLATE-CONJUGATED NANOCARRIERS TO ENHANCE ANTITUMOR EFFICACY OF DOCETAXEL 665 ROSHANI D . AGRAWAL 1E-32 A-163 BY TARGETED DELIVERY 674 DEBOLINA CHAKRABORTY 1E-33 A-166 DENDRIMER AS NANOCARRIER FOR DRUG DELIVERY DRUG DELIVERY SYSTEMS FOR PROGRAMMED AND ON-DEMAND RELEASE USING MICRO 684 SUMAN MITRA 1E-34 A-169 SCALE DRUG DELIVERY DEVICES. DELIVERY OF NANOSIZED ATORVASTATIN THROUGH AN IMPRESSIVE NOVELISTIC TRANS- 724 KIRTI 1E-35 A-178 NABHI PLATFORM FORMULATION AND EVALUATION OF GASTRO RETENTIVE MULTIPARTICULATE DOSAGE 737 HIMANSHU MAKHOLIYA 1E-36 A-182 FORMS CONTAINING OFLOXACIN DEVELOPMENT AND CHARACTERIZATION MICRO-PARTICULATE SYSTEM AS AN EFFECTIVE 751 LAXMIKANT GAUTAM 1E-37 A-184 DELIVERY SYSTEM FOR LUNG CANCER TARGETING 781 VARUN AGGARWAL 1E-38 A-235 NANOCAPSULES: ENHANCING DRUG DELIVERY SYSTEM DESIGN, DEVELOPMENT AND EVALUATION OF SELF NANOEMULSIFYING DRUG DELIVERY 789 SARDAR SUBHASH SHELAKE 1E-39 A-237 SYSTEM OF GARLIC OIL USING CAPRYOL PGMC DESIGN, FORMULATION & EVALUATION OF A COLON TARGETED SUSTAINED RELEASE 75 KOLLURU LAKSHMI DEEPTHI 1E-4 A-29 MICROSPHERES OF FLURBIPROFEN USING A NOVEL NATURAL MATRIX FORMING AGENT FORMULATION AND EVALUATION OF PH MODULATED COLON SPECIFIC DRUG DELIVERY OF 796 NAGRAHAL MATADA VAGEESH 1E-40 A-238 NAPROXEN USING NATURAL POLYMERS 805 SIDDHARTHA ROY, LALIT SHARMA , SAMEER SH 1E-41 A-240 NANOMEDICINES: AN ADVANCED MODE OF DRUG DEIVERY 809 TORSA DAS 1E-42 A-241 POLYMERIC NANOPARTICLES OF QUETIAPINE FUMARATE FOR BRAIN DELIVERY FORMULATION AND IN-VITRO CHARACTERIZATION OF FLOATING MICROSPHERES OF 815 S.SURESH 1E-43 A-243 LAMIVUDINE FORMULATION AND CHARACTERIZATION OF PHOTOTHERMAL MAGNETIC NANOPARTICLES 821 CHARU BHARTI 1E-44 A-245 FOR THE TREATMENT OF CANCER DEVELOPMENT AND CHARACTERIZATION OF PHYTOSOME LOADED BERBERINE TARGETED 822 ZAHRA MAFIBANIASADI 1E-45 A-246 DRUG DELIVERY SYSTEM 919 FARHEEN 1E-46 A-272 DESIGN OF CETIRIZINE LOADED BIONANOSUSPENSION USING CORIANDARUM SATIVUM FRUIT 1020 DILLIP KUMAR SENAPATI 1E-49 A-293 COMPUTER AIDED DRUG DESIGN AND DELIVERY SYSTEM FORMULATION AND EVALUATION OF OLMESARTAN MEDOXOMIL MICROSPHERES USING 109 MADHURI M D 1E-5 A-45 SYNTHETIC POLYMERS 1043 PAVULURI BHARGAVI 1E-50 A-302 CROSSLINKED GUM BLEND AS A NOVEL TOOL FOR COLON DRUG DELIVERY 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title 1073 PRAGYA SHARMA 1E-51 A-309 NANOTECHNOLOGY FOR TARGETED DRUG DELIVERY: ITS CHALLENGES AHEAD FORMULATION AND CHARACTERIZATION OF NOVEL FLOATING IN SITU GELLING SYSTEM FOR 12 GUNJAN GAJENDRA GADGE 1E-52 A-12 THE TREATMENT OF PEPTIC ULCER DEVELOPMENT OF SELF EMULSIFYING DRUG DELIVERY SYSTEM (SEDDS) OF ANTIRETROVIRAL 10 VAISHNAVI SUHAS SHETE 1E-53 A-10 DRUG. 1123 JAYANTHI 1E-54 A-322 Formulation design and characterization of water soluble drug loaded polymeric nanoparticles 1173 NEHA AGNIHOTRI 1E-55 A-610 A REVIEW ON ROLE OF MICROSPHERE IN NOVEL DRUG DELIVERY SYSTEM 1187 ADITYA PATIL 1E-56 A-612 SOLID LIPID NANOPARTICLES OF GABAPENTIN FOR PARTIAL SEIZURES PREPERATION AND COMPARATIVE EVALUATION OF GASTRO RETENTIVE FLOATING TABLETS 1212 MOHAMMED SAEED 1E-57 A-581 USING DIFFERENT HYDROPHOBIC RETARDENTS SITE SPECIFIC DELIVERY OF DRUG VIA HA-PTX CONJUGATE FOR THE EFFECTIVE TREATMENT 1304 SAKET ASATI 1E-58 A-542 OF CANCER 1315 K.K.S.L.R.GAYATHRI DEVI 1E-59 A-545 Study of cytotoxic effect of transdermal invasomal anastrozole gel on MCF-7 breast cancer cell line PREPARATION, CHARACTERIZATION AND EVALUATION OF SILK FIBROIN LOADED DOCETAXEL 110 GANGADHARAPPA H V 1E-6 A-46 TRIHYDRATE NANOPARTICLES FOR BREAST CANCER THERAPY FORMULATION AND EVALUATION OF MUCOADHESIVE BUCCAL DRUG DELIVERY OF 7 TIMBADIYA AMITA ,BAFNA MINALI 1E-60 A-7 RIZATRIPTAN FOR THE TREATMENT OF MIGRAINE 1400 YASHIKA 1E-61 A-541 A SMART APPROACH FOR DELIVRY OF BIOCOLLOIDS VIA AURUM ROUTE 1401 HARSHITA 1E-62 A-511 AN INNOVATIVE APPROACH FOR DELIVERY OF CETERIZINE VIA OCCULAR ROUTE 1403 YASHIKA 1E-63 A-513 A SMART APPROACH FOR DELIVRY OF BIOCOLLOIDS VIA AURUM ROUTE 11 EMMANUEL OWINO 1E-64 A-11 BRAIN TARGETING SOLID LIPID NANOPARTICLES OF CHLORPROMAZINE 1430 DEVIKA JORAPUR 1E-65 A-520 PRONIOSOMES AS A CARRIER FOR DELIVERY OF METOPROLOL TARTRATE 1474 CHANDNI KHATUN 1E-66 A-505 ALBUMIN - A CARRIER FOR CANCER THERAPEUTICS BRAIN TARGETING OF CURCUMIN LOADED SELF MICRO EMULSIFYING DRUG DELIVERY 1558 SHAIK.BILKHIS 1E-67 A-463 SYSTEM (SMEDDS) THROUGH INTRANASAL ROUTE HYDROXYAPATITE BASED TARGETED NANOPARTICLES AGAINST RHEUMATOID 1574 SUSHAMA TALEGAONKAR 1E-68 A-465 ARTHRITIS: PHARMACOKINETIC AND PHARMACODYNAMIC INVESTIGATIONS FORMULATION AND EVALUATION OF NARINGENIN-LOADED TPGS PRONIOSOMES AGAINST 1624 P.AISHWARYAH 1E-69 A-450 CISPLATIN-INDUCED TOXICITY 111 SUSHMITHA K R 1E-7 A-47 FORMULATION AND EVALUATION OF NANOSUSPENSION FOR CARDIO VASCULAR WORDS DEVELOPMENT AND CHARACTERIZATION OF BRAIN CANCER CELLS TARGETED 1630 PRIYANKA JAIN 1E-70 A-453 NANOCARRIERS 1635 VIKAS 1E-71 A-457 TARGETED CHEMOTHERAPY FOR EFFECTIVE TREATMENT OF LUNG CANCER TPGS MODIFIED NARINGENIN PROLIPOSOMES:IMPROVE PHYSIO CHEMICAL PROPERTIES AND 1637 D.HEMAMALINI 1E-72 A-458 THEIR ANTI-INFLAMMATORY EFFECT PREPARATION AND EVALUATION OF SYSTEMATICALLY OPTIMISED POLYMERIC 1685 SUMANT SAINI 1E-73 A-437 NANOPARTICLES OF BROMOCRIPTINE FOR BRAIN TARGETING DESIGN AND RECENT APPLICATION OF NANOPARTICLE ON COLON TARGETED DRUG 1710 SUMON SHEEL 1E-74 A-419 DELIVERY:A REVIEW 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title PREPARATION & EVALUATION OF TOPICAL LIPOSOMAL GEL OF BIOCHANIN A FOR THE 1727 PUJA SAHA 1E-75 A-423 EFFECTIVE TREATMENT IN MELANOGENESIS FORMULATION AND EVALUATION OF PANTOPRAZOLE ENTERIC COATED TABLET BY USING 1731 V.KALAIYARASI 1E-76 A-424 DIFFERENT ENTERIC POLYMERS GOLD NANOPARTICLES COMPOSITE-FOLIC ACID CONJUGATED GRAPHENE OXIDE NANOHYBRIDS” FOR TARGETED CHEMO-THERMAL CANCER ABLATION: IN VITRO SCREENING 1801 RAKHI KUMARI 1E-77 A-389 AND IN VIVO STUDIES DEVELOPMENT AND CHARACTERIZATION OF NOVEL MEDICATED NANO FIBER FOR THE 1836 AJMER SINGH 1E-78 A-401 TREATMENT OF PERIODONTITIS 1844 ARUP DAS 1E-79 A-402 Osmotic Drug Delivery System as a Part of Modified Release Dosage Form PREPARATION, CHARACTERIZATION AND EVALUATION OF SILK FIBROIN LOADED DOCETAXEL 112 GANGADHARAPPA H V 1E-8 A-48 TRIHYDRATE NANOPARTICLES FOR BREAST CANCER THERAPY DEVELOPMENT AND CHARACTERIZATION OF CISPLATIN LOADED NANOFIBERS FOR THE 1845 DEEPANSHU TALWAR 1E-80 A-403 TREATMENT OF CERVICAL CANCER FABRICATION OF LAYERED TABLET OF CURCUMIN WITH NATURAL EXCIPIENTS FOR COLON 1867 SK ABDUL REHMAN 1E-81 A-383 TARGETING FORMULATION AND EVALUATION OF CISPLATIN AND PROBIOTIC LOADED SUPPOSITORIES FOR 1915 NAVIN JOSHI 1E-82 A-372 THE MANAGEMENT OF CERVICAL CANCER HYALURONIC ACID CONJUGATED SURFACE FUNCTIONALIZED MWCNTS LOADED DOXORUBICIN 1918 NIDHI JAIN SINGHAI 1E-83 A-373 HYDROCHLORIDE FOR TREATMENT OF BREAST CANCER FOLATE ANCHORED SOLID LIPID NANOPARTICLE FOR LUNG SQUAMOUS CARCINOMA CELL 1923 VAIBHAV RAJORIYA 1E-84 A-374 TARGETING: IN-VIVO, EX-VIVO EVALUATION, CELLULAR UPTAKE STUDY. 1950 ANKUR SRIVASTAVA 1E-85 A-380 PAMAM DENDRIMERIC DELIVERY OF DOXORUBICIN ENHANCEMENT OF SOLUBILITY OF LOW SOLUBLE DRUG RAMIPRIL BY SELF NANO 1965 JAYAPAL NALLAPU 1E-86 A-358 EMULSIFYING DRUG DELIVERY SYSTEM DESIGN, FORMULATION AND EVALUATION OF SELF NANO EMULSIFYING DRUG DELIVERY 1966 VEMULA AKHILA 1E-87 A-359 SYSTEM OF NISOLDIPINE DEVELOPMENT AND EVALUATION OF NEBIVOLOL LOADED NANOSPONGES FOR BUCCAL 2060 CHANDRAKANT D SAWARGAVE 1E-88 A-334 DELIVERY INORGANIC LAPONITE CLAY NANOCOMPOSITE SYSTEM FOR IMPROVED CHOLINESTERASE 2071 ANURAG KUMAR SINGH 1E-89 A-337 INHIBITION AND BRAIN PHARMACOKINETICS OF DONEPEZIL FORMULATION AND EVALUATION OF OLMESARTAN MEDOXOMIL MICROSPHERES BY USING 114 MADHURI M D 1E-9 A-49 SYNTHETIC POLYMERS 2095 RACHANA D.DAS 1E-90 A-342 A REVIEW ON MICROSPHERE:METHOD OF FORMULATION AND EVALUATION 2050 AANCHAL ARORA 1E-91 A-357 RESEALED ERYTHROCYTES: NOVEL CARRIER FOR TARGETED DRUG DELIVERY SYSTEM 324 LEISHANGTHEM ANITA 1F-1 A-81 Purification and Identification of major allergen of Periplaneta Americana. FORMULATION AND EVALUATION OF FAST DISSOLVING SUBLINGUAL TABLETS OF 406 MOHAMMADI J 1F-2 A-92 ADRENALINES 611 LEISHANGTHEM ANITA 1F-3 A-119 Purification and Identification of major allergen of Periplaneta americana SURFACE FUNCTIONALIZED RELEASE PROMOTER NANOCOMPOSITE(S) BASED APPROACH 1025 RAJEEV SHARMA 1F-4 A-296 FOR EFFECTIVE MELANOMA IMMUNOTHERAPY 1628 NAVNEET KUMAR 1F-5 A-452 DEVELOPMENT AND EVALUATION OF PROBILOSOMES FOR ORAL DELIVERY OF VANCOMYCIN 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title 1659 RAVI KUMAR SHARMA 1F-6 A-428 AQUASOMES: A PROMISING CARRIER FOR PEPTIDES AND PROTEIN DELIVERY 1663 PENDOR NAGMANI WAMANRAO 1F-7 A-429 Protein and Peptide drug delivery system: A Review DESIGN, IN-VITRO AND IN-VIVO EVALUATION OF FLOATING MULTIPARTICULATE DDS OF 151 LIPIMUDRA PADHY 1G-1 A-135 REPAGLINIDE DEVELOPMENT OF ORAL PROLIPOSOMAL FORMULATION OF DOLUTEGRAVIR SODIUM FOR 1585 R ANUDEEP REDDY 1G-10 A-468 PEDIATRIC POPULATION; OPTIMIZATION USING TAGUCHI DESIGN OF EXPERIMENTS 1632 AISHWARYA MANDHARE 1G-11 A-454 FORMULATION AND EVALUATION OF NANOCRYSTALS FOR MALNUTRITION SIZE DETERMINATION AND IMPACT OF PARTICLE CHARACTERISTICS ON DISSOLUTION OF 1639 YASH SUNIEL NANDWANI 1G-12 A-459 CELECOXIB NANOCRYSTALLINE SOLID DISPERSION 1736 RAUT DIPAK BALU 1G-13 A-425 FORMULATION AND EVALUATION ETOPOSIDE LOADED PRONIOSOMES 2003 P SUBHASH CHANDRA BOSE 1G-14 A-345 PREPARATION AND EVALUATION OF QUINAPRIL POLYMERIC BEADS USING NATURAL GUM DEVELOPMENT AND OPTIMIZATION OF SOLID LIPID NANOPARTICLE FORMULATION OF 2089 TARAKA SUNIL KUMAR K 1G-15 A-340 BORTEZOMIB USING DESIGN OF EXPERIMENTS 2096 BIKEE MONDAL 1G-16 A-343 NOVEL HERBAL DRUG DELIVERY SYSTEMS 515 NIKHILESWAR KUMAR RANA 1G-2 A-104 NANOPARTICLES OF COENZYME Q10 IN THE TREATMENT OF CARDIO VASCULAR DISEASES FORMULATION AND CHARACTERIZATION OF CO-CRYSTALS CONTAINING ORAL 686 SAUMYA DAS 1G-3 A-170 HYPOGLYCEMIC AGENT PHYSICOCHEMICAL INTERACTION OF NAPROXEN WITH ALUMINIUM HYDROXIDE AND ITS 980 SHWETA PAROHA 1G-4 A-285 EFFECT ON DISSOLUTION PROFILE AFTER CO-LYOPHILIZATION 1102 SATHYA PRABA.V 1G-5 A-316 FABRICATION AND CHARACTERIZATION OF VALSARTAN NANOPARTICLES OPTIMIZATION AND CHARACTERIZATION OF BOSENTAN LOADED NANOSTRUCTURED LIPID 1179 UMANG ROHITKUMAR VARIA 1G-6 A-611 CARRIERS FOR THE TREATMENT OF PULMONARY ARTERY HYPERTENSION PREPARATION AND EVALUATION OF SYSTEMATICALLY OPTIMISED POLYMERIC 1295 SUMANT SAINI 1G-7 A-574 NANOPARTICLES OF BROMOCRIPTINE FOR BRAIN TARGETING 1351 ANCHAL TYAGI 1G-8 A-528 FORMULATION AND EVALUATION OF NANOSUSPENSION OF STIRIPENTOL 1540 NIKHIL N BONAGERI 1G-9 A-488 DEVELOPMENT OF SILVER NANOPARTICLES USING MORINGA OLEIFERA FRUIT EXTRACT PREPARATION AND EVALUATION OF INHALABLE LIPOSOMAL DRY POWDER CONTAINING 393 ANJALI D DESAI 1H-1 A-199 POSACONAZOLE IN TREATMENT OF PULMONARY ASPERGILLOSIS PREPARATION AND CHARACTERIZATION OF SPRAY DRIED LIPOSOMAL DRY POWDER 394 DHWANI PREYAS KAPADIA 1H-2 A-200 CONTAINING BUDESONIDE FOR PULMONARY DELIVERY SYSTEMIC DEVELOPMENT AND CHARACTERIZATION OF CORE-SHELL NANOPARTICLES OF 833 RANJOT KAUR 1H-3 A-250 ANTIFUNGAL DRUG FOR DEEP LUNG DELIVERY CHARACTERIZATION OF TERBUTALINE SULPHATE AND ITRACONAZOLE NANOPARTICLES AS DRY POWDER INSUFFLATION FOR THE TREATMENT OF ASTHMA PREPARED BY PHYSICAL 1171 VENUGOPALAIAH PENABAKA 1H-4 A-608 MIXING, SPRAY DRYING DESIGN AND CHARACTERIZATION OF CHRONOMODULATED TABLET CONTAINING 1238 VAISHALI SAMBHAJI KANBARKAR 1H-5 A-596 MONTELUKAST SODIUM AND LEVOCETRIZINE DIHYDROCHLORIDE FORMULATION AND EVALUATION OF OFLOXACIN MICROSPHERES FOR LUNG INFECTION IN 1971 MANISHA SHAHADEO GARJE 1H-6 A-360 THE FORM OF DRY POWDER INHALER Optimization of Winsor IV type Isotropic Nanolipoidal system for Permeability Enhancement of a Model 76 AWANTIKA PANDEY 1I-1 A-30 BCS Class III drug 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title Enhancement in Solubility of a Poorly Water Soluble Drug Eprosartan Mesylate by Self Emulsifying Drug 1140 ARPIT JAIN 1I-10 A-326 Delivery System and In-Vitro Characterization 1317 HEMANT SAINI 1I-11 A-546 NANOEMULSION: A NOVEL DRUG DELIVERY SYSTEM TUMOR TARGETING OF MELPHALAN-PEG CONJUGATE THROUGH CHITOSAN/POLOXAMER 1397 AMIT ALEXANDER 1I-12 A-539 BASED THERMORESPONSIVE INJECTABLE HYDROGEL 1443 BODDUKAYALA. MOHANA SATYA SRI 1I-13 A-524 FORMULATION AND EVALUATION OF IBUPROFEN MICROSPHERES DESIGN AND EVALUATION OF LANSOPRAZOLE NANOEMULSIONS PREPARED BY PHASE 1457 T GAYATHRI 1I-14 A-497 INVERSION TEMPERATURE METHOD FORMULATION AND CHARACTERIZAIONOF SELF MICRO EMULSIFYING DRUG DELIVERY 1458 K. MOUNIKA REDDY 1I-15 A-498 SYSTEM OF ESMOLOL POLYHERBAL CONSTITUENTS LOADED NANOCARRIERS FOR EFFECTIVE MANAGEMENT OF 1525 VIJAY SHARMA 1I-16 A-483 DIABETES MELLITUS: PRE - FORMULATION, OPTIMIZATION AND THERAPEUTIC EVALUATION DESIGN AND EVALUATION OF LANSOPRAZOLE NANOEMULSIONS PREPARED BY PHASE 1532 GAYATHRI T 1I-17 A-486 INVERSION TEMPERATURE METHOD DEVELOPMENT AND CHARACTERIZATION OF CISPLATIN LOADED SOLID LIPID NANOPARTICLES 1679 INDRAYANI DAMODAR RAUT 1I-18 A-434 IN THE FORM OF COLLOIDAL DRUG DELIVERY SYSTEM IN-VITRO AND IN-VIVO STUDY OF NANOPARTICLES LOADED WITH INCLUSION COMPLEX OF ALTRETAMINE WITH CARBOXYMETHYL EPICHLOROHYDRIN BETA CYCLODEXTRIN FOR 1714 AMBER VYAS 1I-19 A-420 TREATMENT OF OVARIAN CANCER 89 TAPAS KUMAR MOHAPATRA 1I-2 A-35 Development and characterisation of self micro-emulsified tablets of simvastatin CYCLODEXTRIN BASED NANOPARTICLES FOR TREATMENT OF LEUKEMIA: PREPARATION 1813 BINA GIDWANI 1I-20 A-393 AND CHARACTERIZATION LONG CIRCULATING LIPOSOMES OF SEMISYNTHETIC ANTINEOPLASTIC AGENT FOR 1826 GEETA BHAGWAT 1I-21 A-398 PROLONGED EFFECT IMPROVEMENT OF ORAL DELIVERY OF LIPOPHILIC DRUGS BY SOLID SELF EMULSIFYING DRUG 1906 RAJAT KUMAR BHARTI 1I-22 A-370 DELIVERY SYSTEMS (S-SEDDS) Formulation, Characterisation, Optimisation and Evaluation of Negatively Charged Liposomes of 2009 ADITY SHARMA 1I-23 A-349 Sertraline Hydrochloride for Antidepressant activity 90 MANJIT PRADHAN 1I-3 A-36 Formulation, Development and characterisation of solid dispersion of Pioglitazone FORMULATION DEVELOPMENT AND EVALUATION OF LURASIDONE NANOEMULSION FOR THE 276 MRUNALI R PATEL 1I-4 A-75 TREATMENT OF SCHIZOPHRENIA STUDY OF IN VITRO DRUG RELEASE AND PERCUTANEOUS ABSORPTION OF MICROEMULSION 557 SAROJA.R 1I-5 A-222 TOPICAL DRUG DELIVERY SYSTEM OF KETOCONAZOLE 594 Arumugam Balasubramaniam 1I-6 A-230 OCCLUSIVE NIOSOMAL 5-FLUORO URACIL AGAINST LOCALIZED DALTON ASCITES LYMPHOMA METFORMIN LOADED STEARIC ACID-CONJUGATED F127 POLYMERIC NANOPARTICLES FOR 682 BHAVYA 1I-7 A-168 BREAST CANCER DESIGN, DEVELOPMENT AND CHARACTERIZATION OF SOLID LIPID NANOPARTICLES OF 694 SANDIP AKARAM BANDGAR 1I-8 A-171 PRAZOSIN BY HOT HOMOGENIZATION METHOD 1121 NEELESH KORI 1I-9 A-321 FORMULATION, OPTIMIZATION AND EVALUATION OF VALSARTAN NANOSUSPENSION 42 ADITI SINGHAL 1J-1 A-17 NANOROBOTS- ITS APPLICATIONS AND POTENTIAL IN PHARMACY FORMULATION AND EVALUATION OF RAPID DISSOLVING FILMS OF ZOLMITRIPTAN BY USIG 165 SHAIK NEHA AFRIN 1J-10 A-141 NATURAL POLYMER 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title 1211 MAYUKH MAJI 1J-100 A-580 BIODEGRADABLE POLYMERS IN THE DESIGN IN DOSAGE FORM 1216 NIKITA UTTAM KAKAD 1J-101 A-584 FORMULATION AND EVALUATION OF NANOSPONGES OF SIMVASTATIN FOR ORAL DELIVERY PHYSICOCHEMICAL PROPERTIES OF STARCH ISOLATED FROM FOXTAIL MILLETS OF ASSAM, 1232 KASHMIRI SONOWAL 1J-102 A-591 INDIA FORMULATION AND CHARACTERIZATION OF ATORVASTATIN TRIHYDRATE CALCIUM POROUS 1233 LALIT KUMAR 1J-103 A-592 TABLETS FOR THE ENHANCEMENT OF SOLUBILITY AND DISSOLUTION 1237 AADIL BASHIR 1J-104 A-595 FORMULATION AND EVALUATION OF FAST DISSOLVING ESOMEPRAZOLE TABLETS DEVELOPMENT OF BIO-CONJUGATED FLUORESCENT NANOPARTICLES FOR DETECTION OF 1256 ANJALI PANT 1J-105 A-563 PATHOGENIC BACTERIA CYCLODEXTRIN NANOSPONGES OF PALIPERIDONE FOR SOLUBILITY ENHANCEMENT: 1294 ATUL SHERJE 1J-106 A-573 PREPARATION AND CHARACTERIZATION PREPARATION AND CHARACTERIZATION OF MULTIDRUG LOADED LIPOSOMAL NANOCARRIERS 1299 GANGARAPU RAJENDRA PRASAD REDDY 1J-107 A-575 IN THE TREATMENT OF PANCREATIC CANCER Optimization and evaluation of Ocimum gratissimum mucilage as a Novel Superdisintegrant in the 1309 BHARATHI ARIGELA 1J-108 A-543 Formulation of Telmisartan Fast Dissolving Tablets 1327 RAHUL KUMAR SINGH 1J-109 A-552 FORMULATIONS FOR ELDERLY PATIENTS: A REVIEW FORMULATION AND EVALUATION OF MOUTH DISSOLVING TABLETS OF GLIPIZIDE BY USING 167 R.PRAVALLIKA 1J-11 A-143 NATURAL POLYMERS EXPERIMENTAL AND FORMULATION OPTIMIZATION OF FORMULATION VARIABLES FOR FAST 1340 ABHILASHA GEETHIKA 1J-110 A-556 DISSOLVING TABLET OF URAPIDIL USING BOX-BEHNKEN DESIGN 1344 RAHUL KUMAR SINGH 1J-111 A-558 FORMULATIONS FOR ELDERLY PATIENTS: A REVIEW 1359 SUDHAKAR K 1J-112 A-529 TITURATED CUSTOMIZED DENTAL CARE TOOTH CLEANING TABLET FORMULATION AND EVALUATION OF SOLID DISPERSION IMMEDIATE RELEASE VALSARTAN 1384 ARASHMEET KAUR 1J-113 A-533 TABLETS USING HIBISCUS ROSASINENSIS MUCILAGE AS SUPERDISINTEGRANT 1392 SD.YASMIN SULTHANA 1J-114 A-535 INFLUENCE OF NANOTECHNOLOGY ON HERBAL DRUGS FORMULATION AND EVALUATION OF FAST DISSOLVING TABLETS OF TIROFIBAN AS 1393 QURESHI NADEEM NAJIR 1J-115 A-536 ANTICOAGULANT Design and Characterization of Diclofenac Sodium Orodispersible Tablets Using Trigonella Foenum- 1396 SATYAJIT PANDA 1J-116 A-538 Graecum Seed Extract as a Novel Natural Superdisintegrant FORMULATION & EVALUATION OF CLOPIDROGEL TO FAST DISSOLVING TABLETS BY USING 1398 SHAIK ARIF 1J-117 A-540 SOLID DISPERSION FORMULATION OF TICAGRELOR FAST DISSOLVING TABLETS BY SOLID DISPERSION AND 1405 RLC SASIDHAR 1J-118 A-515 SOLID LIPID MICROPARTICLE TECHNIQUES STUDIES ON ENTADA SCANDENS SEED STARCH AS A NOVEL NATURAL CARRIER FOR THE 13 DOPPALAPUDI SANDEEP 1J-119 A-13 DESIGN OF DOLUTEGRAVIR FAST DISSOLVING FORMULATIONS FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS USING DRUG 175 NARAYANDAS.MADHURI 1J-12 A-146 CYTISINE ISOLATED FROM FAVA BEANS TO QUIT SMOKING 1411 K. LAKSHMI SRAVANTHI 1J-120 A-516 PREPARATION AND EVALUATION OF DIRECTLY COMPRESSIBLE VEHICLES ORALLY DISINTEGRATING TABLETS COMPRISING SOLID DISPERSIONS OF 1419 AYUSH HATWAL 1J-121 A-517 HYDROCHLOROTHIAZIDE WITH POLOXAMER 407 FOR DISSOLUTION RATE ENHANCEMENT 1424 YEDIRE BHARATH KUMAR 1J-122 A-518 SOLUBILITY ENHANCEMENT OF ANTI- VIRAL DRUG BY LIQUISOLID TECHNIQUE 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title 1445 BALUGURI SOWMYA SREE 1J-123 A-525 ENHANCEMENT OF DISSOLUTION RATE FOR VALSARTAN Study of Influence of Drug and coprocessed Excipient Ratios and nature of super disintegrant on 1478 M.SUPRAJA DEEP 1J-124 A-506 Solubility of Iloperidone CONVERTING CRYSTALLINE PARACETAMOL TO AMORPHOUS FORM BY CRYOMILLING 1503 DEBOSMITA DATTA 1J-125 A-475 TECHNIQUE 1520 MANINDERJEET KAUR GREWAL 1J-126 A-482 COCRYSTAL OF ETODOLAC: CHARACTERIZATION AND BIOPHARMACEUTICAL EVALUATION 1527 ASHA MOHAN JAGTAP 1J-127 A-484 In vitro hypoglycemic effects of unripe and ripe fruits of Musa sapientum COMPARATIVE EVALUATION OF AMLODIPINE MARKETED TABLETS WITH DIFFERENT 1528 SANJAY K 1J-128 A-485 PACKAGINGS 1538 SUJATA 1J-129 A-487 ROLE OF PROBIOTICS IN THE TREATMENT OF ACNE VULGARIS: A NOVEL APPROACH PREPARATION AND EVALUATION OF A MUCOADHESIVE POLYMER FROM THE EXTRACT OF 178 TANUJA.MUDUNURI 1J-13 A-147 SEEDS OF ANNONA SQUAMOSA LINN 1545 RAJNI 1J-130 A-490 MEDICATED CHEWING GUM: A NOVEL APPROACH FOR SELF DRUG DELIVERY IN-VITRO EVALUATION OF DIFFERENT MARKETED BRANDS OF PARACETAMOL TABLETS USING 1547 ABHISHEK SAHADEV PUJARI 1J-131 A-491 QUALITY CONTROL TESTS 1548 INDRAJEET VITTHAL MANE 1J-132 A-492 Formulation and evaluation of herbal scrub using guava 1553 LABANI PAL 1J-133 A-461 EMERGING MARKETS OF COSMETOLOGY 1556 SHAIK TASLEEM FATHIMA 1J-134 A-462 FORMULATION OF SILVER NANOPARTICLES USING JACKFRUIT MUCILAGE IN VITRO PHARMACOKINETIC MODIFICATION OF DIPHENHYDRAMINE HCL RAPID RELEASE 1569 R MARGRET CHANDIRA 1J-135 A-464 GELCAPS 25 MG 1583 NISHA MOHAN JAGTAP 1J-136 A-467 Passiflora incarnate as Natural pH Indicator 1603 PATIL AMOL MANIK 1J-137 A-442 Solubility enhancement and improvement of dissolution profile of Lornoxicam by spray drying technique 1605 RANJIT SHASHIKANT JADHAV 1J-138 A-443 FORMULATION, DEVELOPMENT AND EVALUATION OF BILAYER TABLET OF FLURBIPROFEN 1611 SHUBHAM CHOUDHARY 1J-139 A-447 FORMULATION AND EVALUATION OF LIPOTOMES Optimization of Starch itaconate as a Novel Superdisintegrant in the Formulation of Ibuprofen Fast 183 YAGNESH 1J-14 A-150 Dissolving Tablets ENHANCEMENT OF FENOFIBRATE SOLUBILITY BY SOLID DISPERSIONS USING NATURAL AND 1615 C PRAKASH 1J-140 A-448 SYNTHETIC CARRIERS Formulation and Evaluation of Quetiapine Fumarate Floating Microsphere Employing Spray Drying 1622 MADANE SANGRAM SHAMARAO 1J-141 A-449 Technique 3D Printing Technology in Formulation development of Oral Dosage forms: A review on its Process 1649 VIKRANT JAYANTILAL METHA 1J-142 A-472 parameters and there effect on drug release. 1650 POOJA GOVINDRAO KULKARNI 1J-143 A-473 WEARABLE MEDICAL TECHNOLOGY: RECENT TRENDS AND FUTURE 1676 SHITAL SANJAY SHEWALE 1J-144 A-433 FORMULATION AND EVALUATION OF LIQUISOLID COMPACT OF CLOPIDOGREL BISULFATE 1681 SHITAL SANJAY SHEWALE 1J-145 A-435 Formulation and evaluation of liquisolid compact of clopidogrel bisulfate FORMULATION AND EVALUATION OF ANTI-INFLAMMATORY ACTIVITY OF NABUMETONEAND LINSEED OIL BASED MICRO-EMULSION KRUSHNAKANT WABLE*, POOJA BHONDAVE, 1684 KRUSHNAKANT WABLE 1J-146 A-436 MUKESHMOHITE 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title ADDRESSING ETHNOPHARMACOLOGICAL AND ETHNOBOTANICAL MEDICINAL PLANTS USED 1691 PRIYANKA TIWARI 1J-147 A-439 FOR TREATMENT OF WOUND HEALING : A REVIEW FORMULATION AND EVALUATION OF ANTI-INFLAMMATORY ACTIVITY OF NABUMETONEAND 1692 KRUSHNAKANT WABLE 1J-148 A-440 LINSEED OIL BASED MICRO-EMULSION 1700 VAMSI KRISHNA CHERUKUMALLI 1J-149 A-441 INSULIN DRUG DELIVERY SYSTEMS: A REVIEW DISSOLUTION ENHANCEMENT OF FLURBIPROFEN BY MOUTH DISSOLVING TABLETS (MDTS) 188 RAMAKANT JOSHI 1J-15 A-153 FOR EFFECTIVE TREATMENT OF RHEUMATOID ARTHRITIS EFAVERINZ AND NANO-GOLD-LOADED MANNOSYLATED NIOSOMES: A HOST CELL-TARGETED 1763 BALRAM SINGH 1J-150 A-406 TOPICAL HIV-1 PROPHYLAXIS VIA THERMOGEL SYSTEM FORMULATION AND EVALUATION OF ANTI-INFLAMMATORY ACTIVITY OF NABUMETONE AND 1764 KRUSHNAKANT WABLE 1J-151 A-407 LINSEED OIL BASED MICRO-EMULSION Fabrication and characterization of cefazolin-loaded nanofibrous mats for the recovery of postsurgical 1765 SHWETA RAI 1J-152 A-408 wound DEVELOPMENT, CHARACTERIZATION AND ANTIOXIDANT ACTIVITY OF PICRORRHIZA 1787 SANTOSH R. KAMBLE 1J-153 A-414 PHOSPHOLIPID COMPLEX 1795 SHILPA P CHAUDHARI 1J-154 A-416 Formulation and evaluation of Pharmaceutical bougies for Urinary Tract Infection in women QUALITY CONTROL AND VALIDATION STRATEGIES OF SOLID DOSAGE FORM BY PHYSICAL 1804 SUKHDEV 1J-155 A-390 METHODS 1805 YASMIN SULTHANA SYED 1J-156 A-391 IMPORTANCE OF NANOTECHNOLOGY FOR POORLY WATER SOLUBLE DRUGS-A REVIEW Design, Optimization and Evaluation Piroxicam Fast Dissolving Tablets Employing Starch Malonate as a 1814 SANTOSH KUMAR RADA 1J-157 A-394 Novel Superdisintegrant PREPARATION AND EVALUATION OF LORATADINE NANOCRYSTALS FOR SOLUBILITY 1819 MOHIT BISHT 1J-158 A-395 ENHANCEMENT STABILITY ENHANCEMENT AND FORMULATION DEVELOPMENT OF L-CARNITINE FAST 191 ARIGO A 1J-16 A-154 DISSOLVING PELLETS THROUGH PRO-DRUG APPROACH DEVELOPMENT AND CHARACTERIZATION OF CURCUMIN LOADED CHITOSAN NANOPARTICLE 1848 MUKTA AGRAWAL 1J-164 A-404 FOR EFFECTIVE BRAIN DELIVERY MODIFICATION OF PHARMACOKINETIC PARAMETER OF FAST DISSOLVING TABLETS OF 1861 VENKATESWARLU 1J-166 A-381 RUPATADINE FUMARATE 1892 PITABAS NAYAK 1J-167 A-387 LOWER LEVEL LASER THERAPY FOR PAIN MANAGEMENT AN INTEGRATIVE REVIEW PREPARATION AND EVALUTION OF AQUEOUS ENTERIC COATED DELAYED RELEASE 196 N.SWETHASREE 1J-17 A-155 OMEPRAZOLE PELLETS “FORMULATION AND EVALUATION OF OSMOTICALLY CONTROLLED DRUG DELIVERY SYSTEM 1895 KAJAL D.PABALE 1J-170 A-388 OF AN ANTI-DIABETIC DRUG” SOLUBILITY ENHANCEMENT OF POORLY WATER SOLUBLE DRUG NIMUSELIDE BY SOLID 1980 PITTALA MANASA 1J-174 A-362 DISPERSION QUALITY CONTROL AND VALIDATION OF PACKAGING MATETIAL OF ORAL AND TOPICAL 2004 KOMAL RANI 1J-175 A-346 DOSAGE FORMS ACCORDING TO GMP GUIDELINES Formulation and In Vitro Evaluation of Fast Dissolving Tablet Containing Sildenafil Citrate 2008 MADAN DADASO POMAJE 1J-176 A-348 Nanocrystals. FORMULATION DEVELOPMENT OF URSODEOXYCHOLIC ACID SUSPENSION USING NATURAL 2078 RAVINDRA KUMAR 1J-177 A-338 AND SEMI SYNTHETIC POLYMER 2047 CH KAVYA SRI 1J-178 A-356 3D BIO PRINTING-AN EMERING TECHNOLOGY FULL OF OPPORTUNITIES AND CHALLENGES 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title FORMULATION AND EVALUATION OF FAST DISINTEGRATING TABLETS OF VALSARTAN BY 200 PAVANSAIKISHORE.V 1J-18 A-156 USING BANANA POWDER AS DISINTEGRATING AGENT FORMULATION AND EVALUATION OF FAST DISINTEGRATING TABLETS OF VALSARTAN BY 202 PAVANSAIKISHORE.V 1J-19 A-57 USING BANANA POWDER AS DISINTEGRATING AGENT ENHANCEMENT OF SOLUBILITY AND DISSOLUTION RATE OF BCS CLASS-II DRUG RITONAVIR BY 56 BRAHMAIAH BONTHAGARALA 1J-2 A-21 USING LIQUISOLID COMPACT TECHNOLOGY FORMULATION AND EVALUATION OF FAST DISINTEGRATING TABLETS OF VALSARTAN BY 203 V.PAVANSAIKISHORE 1J-20 A-58 USING BANANA POWDER AS DISINTEGRATING AGENT 205 DALAPATHI GUGULOTHU 1J-21 A-59 Exploring Plant Derived Mucilages as Pharmaceutical Excipients TUNING THE BIOPHARMACEUTICAL PROPERTIES OF GEFITINIB BY COCRYSTALLIZATION: 220 DIVYA PANDIT 1J-22 A-61 THERMAL STABILITY, CRYSTAL STRUCTURE, IN-VITRO AND IN-VIVO EVOLUTION 245 P.NANDEESHWAR 1J-23 A-66 OPTIMIZATION OF PLASTICIZERS USING DIFFERENT POLYMERS Supramolecular Synthon of Lamotrigine with Citric Acid: Characterization, Dissolution and In-Silico 265 ABHISHEK GHOSH 1J-24 A-72 Docking Studies OPTIMIZATION AND EVALUATION OF PRAZOCIN FLOATING MICRO-SPHERES USING RESPONSE 271 T.LAKSHMI ISHWARIYA 1J-25 A-73 SURFACE METHODOLOGY Formulation, Evaluation and Optimization of Fast Disintegrating Tablet of Glimepiride using Hordeum 279 SUNIL SAINI 1J-26 A-187 vulgare Hull 281 BHARTI MANGLA 1J-27 A-188 PREFORMULATION CHARACTERIZATION OF ANTI ESTROGEN RECEPTOR DRUGS 329 SAGAR S. TRIVEDI 1J-28 A-83 CHARACTERIZATION OF CICER ARIETINUM (CHIKPEA) AS A PHARMACEUTICAL EXCIPIENT 340 BOYENI SHIREESHA 1J-29 A-87 FORMULATION DEVELOPMENT AND EVALUATION OF TINIDAZOLE MICROSPHERES ENHANCEMENT OF DISSOLUTION RATE OF CLOFIBRATE BCS CLASS –II DRUG BY USING 63 DUDEKULA HASEENA BEGUM 1J-3 A-25 LIQUISOLID COMPACT TECHNOLOGY 362 SUDHA SUSHMA 1J-30 A-88 FORMULATION AND EVALUATION OF DIAZEPAM RECTAL GEL USING DIFFERENT POLYMERS ENGINEERING BIOPHARMACEUTICAL ASPECTS OF GEFITINIB THROUGH COCRYSTALLIZATION 368 JYOTI SHARMA 1J-31 A-90 WITH UREA 376 R AISHWARYA REDDY 1J-32 A-191 SOLUBILITY ENHANCEMENT OF VALSARTAN CABBALISTIC ACREAGE OF 3-DIMENSIONAL PRINTING: A NEW DISCRUPTIVE TECHNOLOGY 380 SHRADHA TOMAR 1J-33 A-193 WITH ITS RECENT OVERTURE IN FORMULATION DEVELOPMENT MOISTURE ACTIVATED DRY GRANULATION PROCESS (MADG): AN INNOVATIVE APPROACH IN 381 MANORANJAN SAHU 1J-34 A-194 SOLID DOSAGE FORM ENHANCEMENT OF BIOAVAILABILITY BY INHIBITING P-GLYCOPROTEIN EFFLUX PUMP: A NOVEL 397 KAPIL DAXINI 1J-35 A-202 CONCEPT 400 MANORANJAN SAHU 1J-36 A-204 Preservatives Used In Pharmaceutical Industry and Impact On Health PREPARATION AND EVALUATION OF NOVEL NANO CRYSTAL RALOXIFENE HYDROCHLORIDE 411 VINISHA E 1J-37 A-94 TABLETS DEVELOPMENT OF A SPECTROFLUORIMETRIC METHOD FOR THE DETERMINATION OF 423 RAJENDRA KUMAR JANGDE 1J-38 A-98 HESPERIDIN EFFECT OF ETHYL CELLULOSE AND POLY VINYL ALCOHOL ON THE GLIMEPIRIDE 431 MADHURI VERMA 1J-39 A-100 NANOSPONGES 93 R.SWATHI 1J-4 A-37 PHYTOSOME-A NOVEL DRUG DELIVERY SYSTEM 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title 433 SHILPA TAKAWANE 1J-40 A-101 FORMULATION AND EVALUATION OF TOPICAL MICROEMULSION GEL OF CITRONELLA OIL 441 DIVYA KAUSHIK 1J-41 A-207 FORMULATION AND EVALUATION OF PULSATILE DRUG DELIVERY SYSTEM OF FAMOTIDINE ENHANCEMENT OF THE SOLUBILITY AND DISSOLUTION RATE OF CEFEPIME DRUG BY SOLID 443 NILIMA NARNAWARE 1J-42 A-208 DISPERSION METHOD. COMPARISON OF PROPERTIES OF AVICEL VS. CEOLUS (MICROCRYSTALLINE CELLULOSE): A 473 SHRUTI GIRISH GUNDALE 1J-43 A-212 COMPREHENSIVE OVERVIEW 475 T.POOJITHA 1J-44 A-213 VISCOSUPPLEMENTATION THERAPY ENHANCEMENT OF DISSOLUTION RATE OF TELMISARTAN TABLETS: A COMPARISION OF CD 479 LAKSHMANARAO POTTI 1J-45 A-214 COMPLEXATION AND SOLID DISPERSION TECHNIQUES 550 GUNJA.VENKATASIVA S S KONDALA RAO 1J-46 A-220 Air Handling Unit Supply Air Temperature Optimization during Economizer Cycles FORMULATION DEVELOPMENT & EVALUATION OF NANOPARTICLES CONTAINING VANCOMYCIN 596 ANUJ PATEL 1J-47 A-231 HCL FOR TREATMENT OF BACTERIAL MENINGITIS COCRYSTALLIZATION APPROACH FOR IMPROVEMENT OF BIOASSESSIBILITY OF MESALAMINE 619 AKSHITA JINDAL 1J-48 A-124 UTILIZING GLUTARIC ACID SOLUBILITY ENHANCEMENT OF SIMVASTATIN BY SOLID DISPERSION TECHNIQUE USING 625 LAKSHMIKANTH G 1J-49 A-126 DIFFERENT POLYMERS 98 AMIT 1J-5 A-39 NEUTRACEUTICALS: AN ALTERNATIVE TO PHARMACEUTICALS 656 GUNJA VENKATASIVA S S KONDALA RAO 1J-50 A-160 STABILITY TESTING OF PHARMACEUTICAL PRODUCTS 660 GUNJA JOSHI 1J-51 A-161 DEVELOPMENT OF PICTOGRAMS TO EDUCATE PATIENTS FOR EASY DIRECTION 695 SHOBANA 1J-54 A-172 FORMULATION AND EVALUATION OF ACECLOFENAC BUCCOADHESIVE TABLETS 700 GUNJA JOSHI 1J-55 A-174 DEVELOPMENT OF PICTOGRAM TO EDUCATE PATIENTS FOR EASY DIRECTION Preparation, Stabilization and Taste Masking of Dry Powder Suspension Formulation of Unstable 731 SAHIL RAWAT 1J-58 A-181 Cephalosporin Antibiotics A COMPARATIVE STUDY OF SOLUBILITY ENHANCEMENT OF ACECLOFENAC BY SOLID 745 DIVYARAJ SINGH BHANDARI 1J-59 A-183 DISPERSION TECHNIQUE USING SEVERAL POLYMERS 99 PRIYA GUPTA 1J-6 A-40 4D PRINTING: A CHALLENGE IN PHARMACEUTICAL FORMULATION BETTER TABLETABILITY AND PRODUCT PERFORMANCE OF LOW MOLECULAR WEIGHT 771 SAURABH GUPTA 1J-60 A-234 KLUCEL™ HYDROXYPROPYL CELLULOSE AS DRY OR WET BINDER. SUPERIOR VISCOELASTIC AND MECHANICAL PROPERTIES OF NATROSOL™ 250 PHARM HYDROXYETHYLCELLULOSE (HEC) COMPARED TO OTHER RHEOLOGY MODIFIERS IN 826 SAURABH GUPTA 1J-61 A-247 FORMULATING PHARMACEUTICAL GELS FORMULATION AND EVALUATION OF HERBALLY MEDICATED HYDROGEL FOR DIABETIC FOOT 839 M.PARIDHAVI 1J-62 A-251 ULCER 866 SHEENU MITTAL 1J-63 A-258 CO-CRYSTALLIZATION: OPENING DOORS FOR A SUSTAINABLE FUTURE BRAIN DRUG TARGETING: A COMPUTATIONAL APPROACH FOR OVERCOMING BLOOD–BRAIN 877 RUCHI SANGWAN , SAVISA YADAV 1J-64 A-260 BARRIER DEVELOPMENT AND CHARACTERIZATION OF HERBAL GEL CONTAINING LIDENBERGIA INDICA 878 PRIYANKA BISHT 1J-65 A-261 EXTRACT 886 KIRTI NANDODE 1J-66 A-263 FORMULATION & EVALUTION OF NANOPLEX OF SULFAMETHOXAZOLE 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title FORMULATION AND EVALUATION OF MEDICATED NAIL LACQUER OF CLOTRIMAZOLE FOR 896 AKANKSHA GOJA 1J-68 A-266 EFFECTIVE TREATMENT OF ONCHOMYCOSIS MICROWAVE GENERATED BIONANOCOMOSITES FOR SOLUBILITY & DISSOLUTION 904 AISHWARYA MAHANUBHAV 1J-69 A-267 ENHANCEMENT OF POORLY WATER SOLUBLE DRUG NISOLDIPINE DEVELOPMENT OF NOVEL SELF-MICROEMULSIFYING DRUG DELIVERY SYSTEMS OF TELMISARTAN CONTAINING CINNAMON ESSENTIAL OIL: CHARACTERIZATION AND 152 SIVANI U. 1J-7 A-136 BIOAVAILABILITY ASSESSMENT 912 RUSHIKESH S. GORE 1J-70 A-269 Formulation and Evaluation of Paracetamol Tablets Using Natural Binder DEVELOPMENT, STATISTICAL OPTIMIZATION AND EVALUATION OF ANTIFUNGAL NAIL LACQUER 916 ASHWINI S 1J-71 A-271 FOR TRANSUNGUAL DRUG DELIVERY SYSTEM OF AN ANTIFUNGAL DRUG FORMULATION AND EVALUATION OF COLON TARGETED CHRONOMODULATED DRUG 921 CHINKEY MITTAL 1J-72 A-273 DELIVERY OF DOXOFYLLINE FOR THE TREATMENT OF NOCTURNAL ASTHMA PREPARATION, CHARACTERIZATION AND EVALUATION OF TASTE MASKED ORALLY 929 ABHIJIT PATIL 1J-73 A-277 DISINTEGRATING TABLET OF PROCHLORPERAZINE MALEATE FORMULATION AND EVALUATION OF ANTIBACTERIAL AND ANTIFUNGAL ACTIVITY OF CRUDE 934 SINDHU E 1J-74 A-278 COCONUT SHELL OIL 937 KANURI LAKSHMI PRASAD 1J-76 A-280 CHRONOPHARMACOKINETICS FORMULATION AND IN-VITRO EVALUATION OF ORODISPERSIBLE TABLETS OF DONEPEZIL 949 K.BHAVANA 1J-77 A-281 HYDROCHLORIDE BY SUBLIMATION METHOD DESIGN AND EVALUATION OF HYDRALAZINE HYDROCHLORIDE MOUTH DISSOLVING TABLET BY 958 SRI NANDHINI G 1J-78 A-282 DIRECT COMPRESSION FOR THE MANAGEMENT OF ECLAMPSIA AND PRE-ECLAMPSIA COCRYSTAL OF ETODOLAC: CHARACTERIZATION AND BIOPHARMACEUTICAL 966 MANINDERJEET KAUR GREWAL 1J-79 A-283 EVALUATION 158 RAJAT NAGALKAR 1J-8 A-139 EFFECT OF SURFECTANT AND ELECTROLYTE IN CRITICAL MICELLE CONCENTRATION Taste Masking Characterization and Development of Improved Dry Powder for oral Suspension of 986 SAHIL RAWAT 1J-80 A-286 Cefpodoxime Proxetil 1000 RAHUL KUMAR SINGH 1J-81 A-289 FORMULATIONS FOR ELDERLY PATIENT:A REVIEW FORMULATION AND EVALUTION OF FAST DISSOLVING TABLETS OF RIZATRIPTAN BENZOATE 1013 SHASHIDHAR BIRADAR 1J-82 A-291 USING SUPERDISINTEGRANTS Development and Characterization of Sulforaphane Conjugated Gold Nanoparticles for Anticancer Drug 1023 KRITI SONI 1J-83 A-295 Delivery DIACEREIN-SUCCINIMIDE COCRYSTAL: CHARACTERIZATION, EVALUATION AND STRUCTURAL 1028 SAKSHI 1J-84 A-297 LANDSCAPE 1042 MAYURI A.KADAM 1J-85 A-301 MODERN TECHBNIQUES IN SPACE MEDICINE PREPARATION OF SPHERICAL CRYSTAL AGGLOMERATES OF DABIGATRAN VIA CRYSTALLO- 1063 GAWADE ASHWINI RAMKRISHANA 1J-86 A-306 CO-AGGLOMERATION TECHNIQUE EFFECT OF BEVERAGES AND FRUIT JUICES ON DISSOLUTION OF OTC PRODUCT CONTAINING 1076 AKSHAY MOTILAL BAHETI 1J-87 A-310 PARACETAMOL PERSONALISED MEDICINE: ITS ADVANTAGES AND FUTURE CHALLENGES FOR HEALTHCARE 1094 NIKHIL KUMAR RANA 1J-88 A-314 INDUSTRIES ON DEMAND DRUG DELIVERY FROM SELF-ASSEMBLED HYDROGEL OF METHOTRIXATE FOR 1103 APEXA KAKA 1J-89 A-317 TREATMENT OF RHEUMATOID ARTHRITIS 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title DEVELOPMENT AND EVALUATION OF MOUTH DISSOLVING FILMS OF SUMATRIPTAN 162 SOHINI SEN 1J-9 A-140 SUCCINATE DEVELOPMENT OF NEW AMOXICILLIN FORMULATION WITH IMPROVED ANTI-MICROBIAL 1115 BADRI RAGHU 1J-90 A-320 ACTIVITY DEVELOPMENT AND EVALUATION OF VARIOUS SUSPENDING AGENT FOR ITS SUSPENDING 1133 GOURAB DEY 1J-91 A-325 BEHAVIOR USING PARACETAMOL AS MODEL DRUG FOR PEDIATRIC SUSPENSION DESIGN AND IN VITRO CHARACTERIZATION OF PHASE TRANSITION SYSTEM USING 1143 PAYAL H. DHOK 1J-92 A-327 RIVASTIGMINE TARTRATE FOR NASAL DRUG DELIVERY SYSTEM FORMULATION AND EVALUATION GASTRORETENTIVE MUCOADHESIVE MICROSPHERE OF 1153 SHUBHAM KUMAR 1J-93 A-599 ITRACONAZOLE 1158 KOUSHIK BANKURA 1J-94 A-603 IN VITRO EVALUATION OF PREPARED LIPOSOMAL FORMULATION OF ACYCLOVIR 1162 GANESH SAI MYNENI 1J-95 A-604 A REVIEW ON POLYMERS AND EXCIPIENTS DEVELOPMENT AND EVALUATION OF METRONIDAZOLE LOADED FILM-BASED DELIVERY 1165 MANGALSING SANTOSH RATHOD 1J-96 A-605 SYSTEM: A CURE FOR PERIODONTITIS STRATEGIC STUDY AND USE OF LOCAL RESOURCES FOR TREATMENT OF MALNUTRITION 1166 DIVYA DINESHKUMAR HARINKHEDE 1J-97 A-606 AMONG CHILDREN BELOW 12 YEARS 1168 AADIL ANSARI 1J-98 A-607 TABLET HARDNESS TESTER : A REVIEW A COMPARATIVE STUDY OF SOLUBILITY ENHANCEMENT OF ACECLOFENAC BY SOLID 1207 DIVYARAJ SINGH BHANDARI 1J-99 A-579 DISPERSION TECHNIQUE USING SEVERAL POLYMERS 922 KAMALLOCHAN BARMAN 2A-10 B-81 A REVIEW ON NOVEL APPROACHES OF HETEROCYCLIC COMPOUNDS PHARMACOKINETICS AND MOLECULAR DOCKING STUDIES OF PLANT-DERIVED NATURAL 1511 ANANTHALAKSHMI A 2A-11 B-168 COMPOUNDS TO EXPLORING POTENTIAL ANTI-HYPERTENSIVE ACTIVITY 2100 POOJA 2A-12 B-114 AN UPDATE REVIEW ON BIOLOGICAL ACTIVITIES OF HYDRAZONES DERIVATIVES QSAR, HQSAR AND DOCKING BASED DESIGNING OF PYRIDO[1,2]A BENZIMIDAZOLES 210 VIKRAM CHOUDHARY 2A-2 B-14 DERIVATIVES AS ANTI-MALARIAL AGENTS 290 KAMALLOCHAN BARMAN 2A-3 B-47 A REVIEW ON NOVEL APPROACHES OF HETEROCYCLIC COMPOUNDS 353 SAURABH TRIPATHI 2A-4 B-26 3D-QSAR STUDIES OF THIAZOLIDINE-2,4-DIONE ANALOGS AS PIM-1 KINASE INHIBITORS 372 KAMINI KACHANERIYA 2A-5 B-29 OXADIAZOLE DERIVATIVES: 3D-QSAR AND MOLECULAR DOCKING STUDIES AGAINST COX-2 378 BHUMIKA TAMRAKAR 2A-6 B-52 QSAR STUDIES FOR SOME THIAZOLIDINE-2,4-DIONE DERIVATIVES AS PIM-2 KINASE INHIBITORS DRUG DESIGN CENTERED MOLECULAR INSIGHTS INTO DIHYDROXYPYRIMIDINE DERIVATIVES 453 ANKIT GUPTA 2A-7 B-54 UNDERLYING ANTICANCER POTENCY AGAINST A549 CELL LINES DRUG DESIGN CENTERED MOLECULAR INSIGHTS INTO DIHYDROXYPYRIMIDINE DERIVATIVES 455 ANKIT GUPTA 2A-8 B-55 UNDERLYING ANTICANCER POTENCY AGAINST A549 CELL LINES Prediction of toxicity using QSAR modelling of C60 fullerene conjugates as anti-fungal agents. Design, 743 SRI NEHA BHANU MANGIPUDI 2A-9 B-44 synthesis and toxicity testing of safer analogues COMBINATORIAL CHEMISTRY AND PARALLEL SYNTHESIS IS THE NEW APPROACH IN DRUG 1721 SAKE PRAVIN SANJAY 2B-1 B-154 DISCOVERY STUDIES ON 1-(1H-BENZO[D]IMIDAZOL-2-YL)ETHANONE DERIVATIVES AS POSSIBLE 268 ASIF HUSAIN 2C-1 B-22 ANTICANCER AGENTS A REVIEW ON GREEN SYNTHESIS OF SILVER NANOPARTICLE USING PLANT EXTRACT OF 740 NABAJYOTI PATRA 2C-2 B-43 AZADIRACHTA INDICA 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title ANTIOXIDANT AND ANTIBACTERIAL ACTIVITY OF HYDROALCOHOLIC EXTRACT OF SEEDS OF 933 J. MUNI RAJA 2C-3 B-82 CUCURBITA MAXIMA. FORMALDEHYDE INDUCED ANTIARTHRITIC ACTIVITY OF HYDROALCOHOLIC EXTRACT OF 947 M.N.L. AISHWARYA 2C-4 B-83 MURRAYA EXOTICA LINN (LEAVES) SYNTHESIS OF 3-SUBSTITUTED-3-HYDROXYINDOLIN-2-ONES USING DABCO AS CATALYST AND 24 GARIMA CHAUHAN 2C-5 B-5 WATER AS SOLVENT MEDIA SYNTHESIS OF 3-SUBSTITUTED-3-HYDROXYINDOLIN-2-ONES USING DABCO AS CATALYST AND 1139 GARIMA CHAUHAN 2C-6 B-110 WATER AS SOLVENT MEDIA 1561 A.KRISHNA SWAROOP 2C-7 B-160 MECHANOCHEMISTRY- A FORCE OF SYNTHESIS DECOMPOSITION OF PHARMACEUTICAL INDUSTRIAL PLASTIC WASTE INTO ORGANIC LAB 1570 AISHWARYA SHANTARAM SHINDE 2C-8 B-162 SOLVENTS SYNTHESIS, ANTIOXIDANT ACTIVITY AND INSILICO STUDIES OF COVALENT CONJUGATES OF 57 SOMA MANDAL 2D-1 B-7 EDARAVONE IN-SILICO SCREENING AND EVALUATION OF IN-VITRO ANTIMALARIAL ACTIVITY OF SOME SYNTHESIZED PHENYLTHIAZOLYL CLUBBED S-TRIAZINE DERIVATIVES AGAINST PLASMODIUM 697 GARGI DAS 2D-10 B-38 FALCIPARUM 818 DIVYA PINGILI 2D-11 B-64 STRUCTURE BASED DRUG DESIGN OF NOVEL B-RAF INHIBITORS 825 SIVA KUMAR NEMALA 2D-12 B-66 entitled “Process Development and Optimization of Novel analogs of Lovastatin” DESIGN, SYNTHESIS AND SCREENING OF PHENYL PROPENOYL ANALOGUES AS POTENT ANTI 860 ARASAVILLI SRI SANDHYA 2D-13 B-71 –TUBERCULAR AGENT SYNTHESIS, MOLECULAR DOCKING AND ANTITUBERCULAR ACTIVITY STUDIES OF 889 T.C. AISWARYA 2D-14 B-75 PYRIMIDINES AS THYMIDINE MONOPHOSPHATE KINASE INHIBITORS 891 SHRADHA BORWAL 2D-15 B-76 MOLECULAR DOCKING STUDIES OF ACETAMIDE DERIVATIVES AS ANTITUBERCULAR AGENT DESIGN AND MOLECULAR DOCKING STUDY OF BIPHENYL DERIVATIVES AS ANTI- 903 SAMIKSHA BURDE 2D-16 B-77 INFLAMMATORY AGENTS MOLECULAR DOCKING STUDIES OF NEW SERIES OF BENZOTHIAZINONE DERIVATIVES AS NEW 906 PARIDHI JAISWAL 2D-17 B-78 ANTITUBERCULAR AGENTS MULTI-TARGETED LIGANDS FOR ALZHEIMER'S DISEASE: IN SILICO DESIGNING AND ADME 909 VARSHA GUPTA 2D-18 B-79 PREDICTION STUDIES OF SOME NEW LEAD COUMARIN CONJUGATES COMPUTER AIDED DESIGN OF NOVEL PYRIDONE DERIVATIVES AS POTENTIAL EIF3A 999 KHUSHBOO 2D-19 B-88 INHIBITORS MOLECULAR DOCKING & QSAR STUDY ON AMINOHYDANTOIN ANALOGUES AS ANTIMALARIAL 127 VIKRAM CHOUDHARY 2D-2 B-12 AGENT USING PDB-4RAO 1027 DEBASISH DEKA 2D-20 B-92 Evaluation of Antidiabetic Potential of Some Synthesized Chalcone Derivatives 1046 ARCHANA AWASTHI 2D-21 B-97 NOVEL IMIDAZOLE DERIVATIVES TARGETING P38MAPK INSILICO DESIGN AND APPLICATION OF COMPUTATIONAL TOOLS IN THE SYNTHESIS OF SOME 1087 J.BHARGAVI 2D-22 B-102 NOVEL 2-(3-OXO-DIHYDRO-2H-INDOL-2-YLIDENE) HYDRAZINECARBOXMIDE SCHIFF BASES In silico identification and evaluation of hits as a topoisomerase II inhibitors via ligand based 1096 T. PRABHA 2D-23 B-103 pharmacophore mapping and virtual screening 1099 RISHIKA AGARWAL 2D-24 B-104 PIM-1 KINASE INHIBITORS: VIRTUAL SCREENING, DFT AND MOLECULAR DOCKING STUDIES In-Silico Drug Design, Synthesis, Characterization and Pharmacological Evaluation of Selected Isatin 1128 Madhu Naidu G 2D-25 B-109 Derivatives as a Potential Anti-Inflammatory Agents 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title DESIGNING OF ORALLY ACTIVE PYRROLE DERIVATIVES HAVING ANTIMICROBIAL ACTIVITY 1169 CHAITANYA PRASAD MEHER 2D-26 B-189 THROUGH COMPUTATIONAL METHOD DISORDER-TO-ORDER TRANSITION OF N-TERM SIRTUIN-1: A TARGET FOR SMALL MOLECULE 1219 MRITYUNJAY 2D-27 B-184 MODULATOR DESIGNING 1243 AHMAD ZONOUBI 2D-28 B-188 In Silico biological screening for lead identification and optimization of antidiabetic compounds DESIGNING OF ORALLY ACTIVE PYRROLE DERIVATIVES HAVING ANTIMICROBIAL ACTIVITY 1255 CHAITANYA PRASAD MEHER 2D-29 B-180 THROUGH COMPUTATIONAL METHOD 233 SHALINI KAPOOR SAWHNEY 2D-3 B-15 STRUCTURE AND ANALOGUE/LIGAND BASED DRUG DESIGNING 1566 RAJEEV K SINGLA 2D-30 B-161 PHARMACOKINETICS PROFILING OF SURFACTIN B: AN IN SILICO APPROACH COMPARATIVE IN SILICO AND IN VIVO ACTIVITIES OF SOME NOVEL SCHIFF BASES OF 1829 PAVAN P CHINCHOLE 2D-31 B-143 PYRAZOLE DERIVATIVES SYNTHESIS, CHARACTERIZATION AND EVALUATION FOR ANTICONVULSANT ACTIVITY OF ACETYLNAPHTHALENE AND SUBSTITUTED ACETYLENAPHTHALENE DERIVATIVE OF 1888 SUNIL KUMAR 2D-32 B-140 HETEROCYCLIC COMPOUNDS DESIGN, DOCKING STUDIES ON NOVEL DUAL INHIBITORS OF THE PROSTAGLANDIN-H 1909 C.MANIKANTA 2D-33 B-131 SYNTHASE AND CARBONIC ANHYDRASE ACTIVITIES DESIGN, DOCKING STUDIES SOME NOVEL BENZO[B] THIOPHENE-2-CARBOXAMIDE 1910 POOJA RATHOD 2D-34 B-132 OXAZOLIDINONE AS ANTI-CANCER AGENTS. PROSTAGLANDIN-H SYNTHASE AND CARBONIC ANHYDRASE ACTIVITY INHIBITION STUDIES BY 1911 A. SUMA SHREE 2D-35 B-133 USING INSILICO METHODS WONDER MOLECULE: PHARMACOPHORE AND DOCKING-BASED INVESTIGATION OF PHENYL 1992 SHWETA MISHRA 2D-36 B-130 PROPIONIC ACID DERIVATIVES AS ANTI-DIABETIC AGENTS 2013 SHEELU DUBEY 2D-37 B-115 COMPUTER AIDED DRUG DESIGN IN EPIGENETICS DESIGN, SYNTHESIS AND EVALUATION OF ANTI-ANXIETY ACTIVITY OF 8-AZABICYCLO [3.2.1] 2022 A. SUMA SHREE 2D-38 B-118 OCTANES 2025 BHAVESH BHARAT AMRUTE 2D-39 B-120 Molecular Docking Study of Some Novel Hetrocycles INSILICO DESIGN AND APPLICATION OF COMPUTATIONAL TOOLS IN THE SYNTHESIS OF SOME 251 J. BHARGAVI 2D-4 B-19 NOVEL 2-(3-OXO-DIHYDRO-2H-INDOL-2-YLIDENE) HYDRAZINECARBOXMIDE SCHIFF BASES 2038 SANDEEP KUMAR BANSAL 2D-40 B-122 DOCKING OF GABA-AT INHIBITORS: REDEFINING THE ANTICONVULSANTS DESIGN, SYNTHESIS, ANTIOXIDANT SCREENING AND INSILICO STUDIES OF COUMARIN 262 STUTEE DAS 2D-5 B-21 DERIVATIVES 282 K. DURGA DEEPTHI 2D-6 B-46 INSILICO DESIGN AND DOCKING STUDIES OF SOME AZA RESVERATROL DERIVATIVES MOLECULAR DOCKING STUDY TO ELUCIDATE THE ANTI-PRURITIC MECHANISM OF SELECTED 317 DR GIRIRAJ T KULKARNI 2D-7 B-24 NATURAL LIGANDS IN PSORIASIS: AN IN SILICO APPROACH IN-SILICO DESIGN OF NOVEL (2-OXO-3-(ARYLIMINO)INDOLIN-1-YL)-N-ARYL ACETAMIDE 552 BIPLAB DEBNATH 2D-8 B-58 ANALOGS AS POSSIBLE ANTI-HUMAN IMMUNODEFICIENCY AGENTS IN-SILICO DRUG DISCOVERY FOR THE TREATMENT OF NIPAH VIRUS INFECTION BY USING 561 ABHIJIT DEBNATH 2D-9 B-59 STATE OF THE ART CUTTING EDGE TECHNOLOGY STRUCTURE-BASED DRUG DESIGN AND POTENT ANTI-CANCER ACTIVITY OF QUINOLINE 102 KULDEEP SINGH PATEL 2E-1 B-10 DERIVATIVES CHEMICAL DEGRADATION STUDIES OF BENZODIAZEPINE CLASS OF ANTIPSYCHOTICS: A 297 NITHIN J 2E-10 B-49 SPECIAL REFERENCE TO OLANZAPINE 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title SYNTHESIS, CHARACTERIZATION OF PYRAZOLONE DERIVATIVES AS ANTIBACTERIAL AND 1872 MOHAN.G 2E-100 B-138 ANTIFUNGAL AGENTS DESIGN, SYNTHESIS, BIOLOGICAL EVALUATION AND MOLECULAR MODELLING STUDIES OF NOVEL PYRAZOLYL CLUBBED THIAZOLIDINEDIONES AS POTENT PANCREATIC LIPASE 1890 VIKRAM DEEP MONGA 2E-101 B-141 INHIBITORS SYNTHESIS AND BIOLOGICAL SIGNIFICANCE OF NOVEL 3,4,5-SUBSTITUTED-1,2,4-TRIAZOLE 1934 PRABHAKAR KUMAR VERMA 2E-102 B-134 SCAFFOLDS 1H-BENZO[D]IMIDAZOL-2-YL)-N-SUBSTITUTED METHANAMINE DERIVATIVES: DESIGN, 1951 KIRANPREET KAUR 2E-103 B-123 SYNTHESIS, ANTIMICROBIAL AND ANTICORROSIVE STUDIES SYNTHESIS OF NOVEL 3-SUBSTITUTED PHTHALIDES BY USING BRONIC ACIDS REAGENTS AS 1953 MOHSIN HASAN 2E-104 B-124 ECO-FRIENDLY SYNTHESIS, CHARACTERIZATION AND BIOLOGICAL ACTIVITY OF AZETIDINONE DERIVATIVES 1962 NAMRATHA T V 2E-105 B-125 BEARING 1,3,4-THIADIAZOLE SCAFFOLD Synthesis, Molecular Docking and Antimicrobial Evaluation of New Tetrahydrobenzothienopyrimidine 1968 NEETU 2E-106 B-126 Derivatives 1973 Jaseela Majeed 2E-107 B-127 SYNTHESIS AND IN VIVO DIURETIC ACTIVITY OF SOME NOVEL PYRIMIDINE DERIVATIVES 1979 NIKITA KATYAL 2E-108 B-128 AZETIDINONE: A PROMISING MOLECULE WITH SPECTRUM OF BIOLOGICAL ACTIVITIES NITROGEN CONTAINS HETEROCYCLIC TARGET FOR DISEASE RELATED TO UNFOLDED 1990 GAUTAM BHARDWAJ 2E-109 B-129 PROTEIN DISORDER. SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF ARYL ACETIC ACID INTEGRATED 1,2,4-TRIAZOLE- 299 DHEERAJ KAMBOJ 2E-11 B-50 1,3,4-THIADIAZOLE DERIVATIVES DESIGN, SYNTHESIS AND EVALUATION OF ANTICANCER ACTIVITY OF SOME NOVEL 2020 SRUSHTI SHUKLA 2E-110 B-116 QUINAZOLINONE DERIVATIVES SYNTHESIS AND EVALUATION OF BENZIMIDAZOLE BEARING 1,2,3-TRAIZOLE DERIVATIVE FOR 2021 MIHIR KACHHIA 2E-111 B-117 ANTICANCER ACTIVITY SYNTHESES OF SOME NOVEL 2-IMINO HETEROARYL ANALOGUES OF 5-ARYLIDENE 2023 SACHIN PANDEY 2E-112 B-119 THIAZOLIDIN-4-ONES AS POTENTIAL ANTI-INFLAMMATORY AGENTS SYNTHESIS AND BIOLOGICAL EVALUATION OF SOME NOVEL COUMARIN-PIPERAZINYL HYBRID 2107 GOSHIYA BANU ANVARHUSSAIN KURESHI 2E-113 B-111 DERIVATIVES AS POTENTIAL ANTI-THROMBOTIC AGENTS SYNTHESIS, CHARACTERIZATION OF N-SUBSTITUTED TETRAHYDROCARBAZOLES AND 2086 A VENKATA SURESH BABU 2E-114 B-112 EVALUATION OF ANTI-CANCER ACTIVITY SYNTHESIS, CHARACTERIZATION AND BIOLOGICAL EVALUATION OF CHALCONE SCHIFF BASE 2098 SHUBHANGI DASWADKAR 2E-115 B-113 LIGANDS 2034 PAWAN KUMAR MISHRA 2E-116 B-121 SYNTHESIS SOME SUBSTITUTED 1,2,4-TRIAZOLES AS POTENTIAL ANTIMICROBIAL AGENTS DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF NOVEL QUINOLINE ANALOGUES AS 300 KULDEEP SINGH PATEL 2E-12 B-51 POTENTIAL ANTICANCER AGENTS FORMULATION DEVELOPMENT AND INVITRO EVALUATION OF MATRIX TYPE TRANSDERMAL 306 APPPALA DIVYA 2E-13 B-23 DRUG DELIVERY SYSTEM USING CETYL PYRIDINIUM 342 PRANEETHA VISAMPALLI 2E-14 B-25 NOVEL SYNTHESIS, CNS ACTIVITY OF SUBSTITUTED [1,2,4]TRIAZOLOPYRIDONE DERIVATIVES SYNTHESIS OF GEFITINIB BASED DERIVATIVES & ITS CYTOTOXICITY AND MECHANISTIC 357 MRUNAL SHARMA 2E-15 B-27 STUDIES DESIGN, SYNTHESIS AND MOLECULAR MODELING STUDIES OF NOVEL THIAZOLIDINE-2,4-DIONE 360 VIVEK ASATI 2E-16 B-28 DERIVATIVES AS POTENTIAL ANTI-CANCER AGENTS 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title 412 GEETA N LODHI 2E-18 B-30 ANTILEISHMANIAL ACTTIVITY OF SOME ANTIDEPRASSANT DRUG AND ANTIFUNGAL DRUGS REVIEW ARTICLES OF SOME CHALCONES AND HETEROCYCLIC COMPOUNDS: SYNTHESIS AND EVALUTION OF THEIR ANTIBACTERIAL, ANTIMICROBIAL, ANTI INFLAMMATORY AND 452 GEETA N. LODHI 2E-19 B-53 ANTILESHMANIAL ACTIVITY DESIGN, SYNTHESIS AND BIOLOGICAL SCREENING OF SOME 1,2,3-TRIAZOLYL LINKED 144 ADARSH SAHU 2E-2 B-13 PENICILLIN ANALOGS FOR IMPROVEMENT OF THEIR HALF-LIFE AND EFFICACY MICROWAVE ASSISTED SYNTHESIS OF AZA RESVERATROL DERIVATIVE: COMPARISON WITH 506 GOGINENI RACHANA 2E-21 B-31 CONVENTIONAL HYDRO DISTILLATION SYNTHESIS, CHARACTERIZATION AND POTENTIAL ANTICANCER ACTIVITY OF NOVEL 524 JEEVIKA RAHANGDALE 2E-22 B-32 SUBSTITUTED CHALCONE POLYMERS SYNTHESIS, MOLECULAR DOCKING AND BIOLOGICAL EVALUATION OF NOVEL HYBRIDS OF 548 SOJA.S 2E-23 B-56 QUINAZOLINES AS POTENT CYTOTOXIC AGENTS 549 ANITA SHAH 2E-24 B-57 TARGETED PROTEINS FOR RECENT AND EMERGING DIABETES MELLITUS RESEARCH DEVELOPMENT OF BIOLOGICALLY ACTIVE ANALOGUES FROM NATURAL PRODUCTS 562 GAZANFAR AHMAD 2E-25 B-60 INVOLVING MANNICH REACTION – A REVIEW SYNTHESIS OF SOME NOVEL 2- SUBSTITUTED BENZIMIDAZOLE DERIVATIVES & THEIR 568 ASHISH SENAPATI 2E-26 B-61 ASSESSMENT FOR ANTIMICROBIAL & ANTHELMINTIC ACTIVITY SYNTHESIS AND CHARACTERISATION OF SOME “N” CONTAINING HETEROCYCLIC SCHIFF BASE 582 V.SARVANI 2E-27 B-62 METAL COMPLEXES SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF 3-PROPYLBENZO[D]THIAZOL-2(3H)-ONE 603 SOWJANYA 2E-28 B-33 AND 3-PROPYLBENZO[D]OXAZOL-2(3H)-ONE DERIVATIVES DESIGN, SYNTHESIS AND MOLECULAR DOCKING STUDIES OF NEWLY HYBRID-PYRAZOLE 637 MD JAHANGIR ALAM 2E-29 B-34 LINKED THIADIAZOLE AS POTENTIAL ANTICANCER AGENTS IN-SILICO STUDY, DESIGN, AND MICROWAVE ASSISTED SYNTHESIS OF SOME NOVEL 4,6-AMINE 156 ANKITA KASHYAP 2E-3 B-35 SUBSTITUTED PYRIMIDINE DERIVATIVES AS DHFR INHIBITORS 645 ROSHANI MEHTA 2E-30 B-37 COMPARISON OF NATURAL AND SYNTHETIC CURCUMIN DESIGN, SYNTHESIS, IN-SILICO AND IN-VITRO ANTI-BACTERIAL SCREENING OF SOME NOVICE 703 PRASHANTHI EVANGELIN 2E-31 B-39 1, 2 - BENZODIAZINE DERIVATIVES SYNTHESIS AND CHARACTERISATION OF SOME “N” CONTAINING HETEROCYCLIC SCHIFF BASE 716 V. SARVANI 2E-32 B-40 METAL COMPLEXES DESIGN, SYNTHESIS AND BIOLOGICAL SCREENING OF SOME 1,2,3-TRIAZOLYL LINKED 722 ADARSH SAHU 2E-33 B-41 PENICILLIN ANALOGS FOR IMPROVEMENT OF THEIR HALF-LIFE AND EFFICACY 733 NILESH DWIVEDI 2E-34 B-42 Synthesis and antibacterial activity of N-heteroaryl substituted Gallamide SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF 3-PROPYLBENZO[D]THIAZOL-2(3H)-ONE 761 JYOTHI 2E-35 B-45 AND 3-PROPYLBENZO[D]OXAZOL-2(3H)-ONE DERIVATIVES 1,2,3-TRIAZOLE TETHERED INDOLE-3-GLYOXAMIDE DERIVATIVES AS MULTIPLE INHIBITORS OF 802 FATIMA NAAZ 2E-37 B-63 5-LOX, COX-2 & TUBULIN: THEIR ANTI-PROLIFERATIVE & ANTI-INFLAMMATORY ACTIVITY 824 DIVYA SINGH 2E-38 B-65 Recent advances on synthesis of Indole Derivatives having Anti Inflammatory potential. 838 KARTHIKA.C.THANKACHEN 2E-39 B-68 SYNTHESIS, CHARACTERIZATION OF NOVEL 1,3,4-OXADIAZOLE DERIVATIVES SYNTHESIS AND ANALGESIC ACTIVITY OF N-(4-OXO-2-SUBSTITUTED PHENYL THIAZOLIDIN-3- 195 LATHA SREE 2E-4 B-36 YL) BENZAMIDE DERIVATIVES 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title DESIGN, SYNTHESIS, IN-SILICO AND IN-VITRO ANTI-BACTERIAL SCREENING OF SOME NOVICE 859 MULAGANI P EVANGELIN 2E-40 B-70 1, 2 - BENZODIAZINE DERIVATIVES DESIGN AND SYNTHESIS OF QUINAZOLINE DERIVATIVES AS POTENT MULTI ACTING HDAC AND 863 DIBYAJYOTI DAS 2E-41 B-72 RECEPTOR TYROSINE KINASE INHIBITORS (RTKS) FOR THE TREATMENT OF CANCER SYNTHESIS, BIOLOGICAL EVALUATION AND DOCKING STUDY OF N-(2-(3,4,5- TRIMETHOXYBENZYL)BENZOXAZOLE-5-YL) BENZAMIDE DERIVATIVES AS SELECTIVE COX-2 869 AVNEET KAUR 2E-42 B-73 INHIBITOR AND ANTI-INFLAMMATORY AGENTS SYNTHESIS, CHARACTERISATION AND INVESTIGATION OF ANTI-OXIDANT ACTIVITY OF SOME NOVEL N-(SUBSTITUTED PHENYL)-2-(3-((HYDROXYIMINO)METHYL)-1H-INDOL-1-YL) ACETAMIDE 873 CHANDRAVADIVELU GOPI 2E-43 B-74 DERIVATIVES MOLECULAR DOCKING BASED DESIGN AND SYNTHESIS OF FUSED HETEROCYCLIC 910 MD AZHAR IQBAL 2E-44 B-80 DERIVATIVES: SEARCH FOR POTENTIAL ANTICANCER AGENTS SYNTHESIS AND EVALUATION OF 4-(2-CHLOROQUINOLIN-3-YL)-6-(6-NITRO-1H-BENZIMIDAZOL-2- 957 VEERESHA DALALI 2E-46 B-84 YL)PYRIMIDIN-2-AMINE AS POTENT CARDIO PROTECTIVE AGENTS SYNTHESIS AND EVALUATION OF 2-CHLORO-3-[3-(6-METHYL-1H-BENZIMIDAZOL-2-YL)-4,5- 972 SANJEEV MALI 2E-47 B-86 DIHYDRO-1H-PYRAZOL-5-YL]QUINOLINES AS POTENT ANTIMICROBIAL AGENTS SYNTHESIS, IN-SILICO STUDIES AND IN-VITRO EVALUATION OF PYRIDINE DERIVATIVES FOR 998 RUCHI VERMA 2E-48 B-87 LUNG CANCER DESIGN, SYNTHESIS AND IN-SILICO STUDIES OF NOVEL HETEROCYCLIC AS ESTROGEN 1004 TANMAY SAHA 2E-49 B-89 RECEPTOR LIGANDS SYNTHESIS AND BIOLOGICAL EVALUATION OF INDOLO[2,3-B]QUINOXALINE DERIVATIVES AS 1008 PATEL KISHAN BALDEV 2E-50 B-90 ANTI-ALZHEIMER’S AGENT. SYNTHESIS AND BIOLOGICAL EVALUATION OF INDOLO[2,3-B]QUINOXALINE DERIVATIVES AS 1018 PATEL KISHAN BALDEV 2E-51 B-91 ANTI-ALZHEIMER’S AGENT. SYNTHESIS AND BIOLOGICAL EVALUATION OF NOVEL 1,3,4-THIADIAZOLES AS FACTOR XA 1036 SHAH DHARTI BHAVESHKUMAR 2E-52 B-93 INHIBITORS SYNTHESIS, CHARACTERIZATION AND EVALUATION OF SOME BENZOTHIAZOLE DERIVATIVES 1041 GARIMA SINGH 2E-53 B-95 AS POTENTIAL ANTIBACTERIAL AGENTS SYNTHESIS AND BIOLOGICAL EVALUATION OF SOME NEWER 8-SUBSTITUTED XANTHINE 1044 SNEHA SINGH 2E-54 B-96 DERIVATIVES AS BRONCHOSPASMOLYTIC AGENTS SYNTHESIS CHARACTERIZATION AND BIOLOGICAL ACTIVITY OF SOME TETRAZOLE 1057 RALLAPALLI KHADAR BASHA 2E-55 B-98 DERIVATIVES SYNTHESIS, CHARACTERIZATION AND ANTIMICROBIAL ACTIVITY OF SOME NEW FORMAZAN 1061 ALISTINA KHARKHYR 2E-56 B-99 DERIVATIVES SYNTHESIS, CHARACTERISATION, PHYSIOCHEMICAL PROPERTIES AND OF SOME NOVEL 2-(3- 1068 B. SAI HARSHITHA 2E-57 B-100 OXO-DIHYDRO-2H-INDOL-2-YLIDENE) HYDRAZINECARBOXMIDE SCHIFF BASES PRENYLATED INDOLE DERIVATIVES FROM FUNGI: STRUCTURE DIVERSITY, BIOLOGICAL 1069 D.GOPAL KRISHNA 2E-58 B-101 ACTIVITIES, BIOSYNTHESIS AND CHEMOENZYMATIC SYNTHESIS IN-SILICO DESIGN, SYNTHESIS AND EVALUATION OF 2,5-DISUBSTITUTED INDOLES AS 1105 MADHURIMA SAHA 2E-59 B-105 ATYPICAL ANTIPSYCHOTICS FOR ANTI DOPAMINERGIC AND ANTI SEROTONERGIC ACTIVITY Phytochemical Evaluation of Anti-Inflammatory Activity of Different Solvents Extracts of Ixora javanica 235 RENUKA BODDULA 2E-6 B-16 Flowers NAPHTHOL DIAZENYL BASED SCHIFF BASES: SYNTHESIS, CHARACTERIZATION AND 1106 HARMEET KAUR 2E-60 B-106 ANTIMICROBIAL EVALUATION 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title Zinc Metal Complexes as Supramolecular Gelators of Nonsteroidal Anti-Inflammatory Drugs and Its 1125 SHAIK KHASIMBI 2E-61 B-107 Biological Application SYNTHESIS, EVALUATION AND DOCKING STUDIES OF AMINOTHIAZOLE DERIVATIVES AS ANTI- 1126 SMRUTI RANJAN PATRA 2E-62 B-108 INFLAMMATORY AGENTS WITH ANTI-OXIDANT ACTIVITY 1226 B.VENUPRIYA 2E-63 B-185 SYNTHESIS AND EVALUATION OF PYRIMIDONE DERIVATIVES AS ANTI-MICROBIAL AGENTS SYNTHESES OF SOME NOVEL 2-IMINO HETEROARYL ANALOGUES OF 5-ARYLIDENE 1227 SACHIN PANDEY 2E-64 B-186 THIAZOLIDIN-4-ONES AS POTENTIAL ANTI-INFLAMMATORY AGENTS SYNTHESIS & EVALUATION OF NOVEL THIOPHENE DERIVATIVES AS POTENT ANTIMICROBIALS 1260 C. V. HIMA VARSHITHA 2E-65 B-181 AGAINST RESISTANT BACTERIA 1287 GOPAVARAPU PRATHIBHA 2E-66 B-182 SYNTHESIS AND EVALUTION OFIN VITRO THROMBOLYTIC ACTIVITY OF PYRAZOLES SYNTHESIS, CHARACTERIZATION AND PHARMACOLOGICAL EVALUATION OF 5-FLUOROISATIN 1298 EKTA VERMA 2E-67 B-183 DERIVATIVE DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF NOVEL QUINOLINE ANALOGUES AS 1306 KULDEEP SINGH PATEL 2E-68 B-178 POTENTIAL ANTICANCER AGENTS SYNTHESIS, CHARACTERIZATION, & ANTICANCER ACTIVITY OF SULPHONAMIDE DERIVATIVES 22 BHARAT GOEL 2E-69 B-3 OF 4-AMINO-1,2-NAPHTHOQUINONE COMPUTATIONAL STUDY AND ANTIBACTERIAL EVALUATION OF SYNTHESIZED 240 SANGBIT PAUL 2E-7 B-17 SALICYLALDEHYDE-SULFONAMIDE SCHIFF BASE COMPOUNDS Molecular Docking, ADME studies of Schiff’s bases of Salicylaldehyde Derivatives as potent Anti 21 DIVYA SINGH 2E-70 B-2 Microbials. DESIGN AND SYNTHESIS OF BENZYLIDENE LINKED THIAZOLYL HYDRAZINES AS NOVEL ANTI- 1449 C.MAHESH REDDY 2E-72 B-177 MICROBIAL AGENTS IN SILICO DESIGN SYNTHESIS AND PHARMACOLOGICAL SCREENING OF PYRAZOLINE 1467 AMRUTHA P 2E-73 B-172 SUBSTITUTED THIAZOLONE DERIVATIVES ROLE OF 1,3,5- TRISUBSTITUTED 2- PYRAZOLINE DERIVATIVES IN NEUROLOGICAL DISORDERS: 1472 SNEHA SINGH 2E-74 B-173 MICROWAVE ASSISTED SYNTHESIS, BIOLOGICAL EVALUATION AND MOLECULAR DOCKING 1486 PRANEETHA VISAMPALLI 2E-75 B-174 NOVEL SYNTHESIS, CNS ACTIVITY OF SUBSTITUTED [1,2,4]TRIAZOLOPYRIDONE DERIVATIVES 1494 LAKHIMSETTI PRIYANKA 2E-76 B-175 BENZODIAZEPINES ABSTRACT BAND SUMMARY 1495 GONGATI RAJANIKANTH REDDY 2E-77 B-176 SYNTHESIS,CHARACTERISATION ANDANTIFUNGAL ACTIVITY OF SOME OXAZINE DERIVATIVES 1523 ANANDHI S 2E-78 B-169 SYNTHESIS AND BIOLOGICAL EVALUATION OF SOME PHENOTHIAZINE DERIVATIVES DESIGN, SYNTHESIS AND IN-VITRO BIOLOGICAL EVALUATION OF SCHIFF’S BASE OF 1529 E. KALAIVANI 2E-79 B-170 SULPHADIAZINE DERIVATIVES SYNTHESIS, CHARACTERISATION, PHYSIOCHEMICAL PROPERTIES AND OF SOME NOVEL 2-(3- 254 B.SAI HARSHITHA 2E-8 B-20 OXO-DIHYDRO-2H-INDOL-2-YLIDENE) HYDRAZINECARBOXMIDE SCHIFF BASES SYNTHESIS AND CHARACTERIZATION OF 3-HYDROXY-1, 2, 3, 4-TETRAHYDROQUINOXALINE -2- 1537 SHRIPAD S POTADAR 2E-80 B-171 CARBOHYDRAZIDE DERIVATIVES. SYNTHESIS, CHARACTERIZATION AND ANTIDIABETIC ACTIVITY OF NAPHTHAQUININOE 1575 NIKKI 2E-81 B-163 MOIETIES SYNTHESIS AND IN VITRO ANTIFUNGAL ACTIVITY OF SCHIFF AND MANNICH BASES OF ISATIN 1590 SATHIYA NARANARNAN.M 2E-82 B-164 DERIVATIVES SYNTHESIS AND PHARMACOLOGICAL SCREENING OF N-SUBSTITUTED AND 2-SUBSTITUTED 1591 PANKAJ SHANKAR KORE 2E-83 B-165 BENZIMIDAZOLE DERIVATIVES. 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title STANDARDIZATION, FORMULATION AND EVALUATION OF POLYHERBAL ANTIDANDRUFF AND 1594 RIYA 2E-84 B-166 ANTIHAIRFALL SHAMPOO. FIRST TOTAL SYNTHESIS AND BIOLOGICAL POTENTIAL OF A HEPTACYCLOPEPTIDE OF PLANT 1612 SUNIL SINGH 2E-85 B-156 ORIGIN DISCOVERY AND SYNTHESIS OF NOVEL M-TOR INHIBITORS FOR THE THERAPY OF CANCER BY 1616 BHAVNA M PATEL 2E-86 B-157 COMPUTATIONAL CHEMISTRY SYNTHESIS, CHARACTERIZATION AND MICROBIAL EVALUATION OF NOVEL PYRAZOLINE 1631 MOHD AFROZ 2E-87 B-158 DERIVATIVES DESIGN AND SYNTHESIS OF VALPROIC ACID LINKED 2,4 THIAZOLIDINEDIONE DERIVATES FOR 1646 AKSHADA DONGARE 2E-88 B-159 THEIR ANTIBREAST CANCER ACTIVITY SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF 3(1', 3', 4'- 1712 RANGAPURAM VASANTHI 2E-89 B-153 OXADIAZOLE-2'-YL-IMINO)-1H-BENZOINDOL-2-ONE DERIVATIVES SYNTHESIS OF SOME DERIVED 1, 3, 4-OXADIAZOLE RING SYSTEMS FROM MORPHOLINE AND P- 296 SOMASHEKHAR M METRI 2E-9 B-48 CHLOROBENZONITRILE: A NOVEL CLASS OF POTENTIAL ANTI-INFLAMMATORY AGENTS. DESIGN SYNTHESIS AND BIOLOGICAL EVALUATION OF SOME SUBSTITUTED ACRYLATES AS 1770 ROOPA BARSKAR 2E-90 B-147 ANTI-LEISHMANIAL AGENTS SYNTHESIS, CHARACTERIZATION AND PHARMACOLOGICAL EVALUATION OF NOVEL 1771 ASHOK SANISETTY 2E-91 B-148 QUINOLINE DERIVATIVES 1774 PRAGYA GAWANDE 2E-92 B-149 DOCKING, SYNTHESIS AND ANTI-MICROBIAL ACTIVITY OF BENZIMIDAZOLE DERIVATIVES SYNTHESIS, ADME PROPERTIES, MOLECULAR DOCKING, ANTIBACTERIAL AND 1775 UMA 2E-93 B-150 ANTIHELMINTICS EVALUATION OF NEW 2-AMINOBENZOTHIAZOLE DERIVATIVES 1785 ASHOK M.P 2E-94 B-151 ANTI INFLAMMATORY EFFECT OF SPERMACOCE HISPIDA LINN 1797 PRAKASH G 2E-95 B-152 SYNTHESIS AND CYTOTOXIC ACTIVITY OF 2-(PYRIDIN-3-YL)-4H-CHROMEN-4-ONE DERIVATIVES. SYNTHESIS, CHARACTERIZATION, ANTIOXIDANT AND ANTI-INFLAMMATORY ACTIVITY OF 2- 1822 SHWETA MISHRA 2E-96 B-142 SUBSTITUTED 4(3H)-QUINAZOLINONE SYNTHESIS AND EVALUATION OF BENZIMIDAZOLE BEARING 1,2,3-TRAIZOLE DERIVATIVE FOR 1842 MIHIR KACHHIA 2E-97 B-145 ANTICANCER ACTIVITY MICROWAVE ASSISTED SYNTHESIS, IN SILICO AND IN VITRO ANTI CANCER SCREENING OF 2- 1865 Y PRADEEP KUMAR 2E-98 B-136 OXOAZETEDINYL PYRAZINE-2-CARBOXAMIDE DERIVATIVES STUDY OF GASTROINTESTINAL SAFETY AND ANTI-INFLAMMATORY EFFECT OF 1,3,4- 1871 SUBHAM DAS 2E-99 B-137 OXADIAZOLE DERIVATIVES OF KETOPROFEN IN SILICO DOCKING STUDIES OF SECONDARY METABOLITE AND IN VITRO ANTI-PLASMODIUM 48 KRATIKA DANIEL 2F-1 B-6 FALCIPARUM ACTIVITY OF ALSTONIA SCHOLARIS 23 SHUBHAM DWIVEDI 2F-10 B-4 IN SILICO MOLECULAR MODELING AND DOCKING STUDY OF ANTICANCER DRUGS AN ASSESSMENT OF FLUORIDE CONCENTRATIONS IN DIFFERENT BHOPAL AREAS OF MADHYA 1175 AJEET SINGH 2F-11 B-190 PRADESH, INDIA SYNTHESIS AND EVALUATION OF NOVEL HETEROCYCLIC DERIVATIVES AS POTENTIAL ANTI- 1231 HETA DINESH CHHABHAIYA 2F-12 B-187 INFECTIVE AGENTS 1320 RAVI GUPTA 2F-13 B-179 CELLULAR ENERGY METABOLISM : RECENT AND EMERGING CANCER RESEARCH “SOLID AS SOLVENT”- ORGANIC SOLVENT FREE, ECO-FRIENDLY, SPECTROPHOTOMETRIC 1599 CHANDAN 2F-14 B-167 ANALYSIS OF TABLETS OF DICLOFENAC SODIUM USING MELTED UREA AS SOLVENT 1601 DESHBANDHU JOSHI 2F-15 B-155 INVIVO SCREENING METHODS OF ANTI-INFLAMMATORY DRUGS-AN APPROACH 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title 1751 ROJA.YARABOLU 2F-16 B-146 CHALLENGES IN THE CONFIGURATION OF NATURAL PRODUCTS 1837 RAVI SINGH 2F-17 B-144 GENDER DIFFERENCES IN CANCER SUSCEPTIBILITY & PREVENTION 1876 JENNIFER FERNANDES 2F-18 B-139 Determination of in vitro antidiabetic effects of unripe fruits of Artocarpus gomezianus DESIGN, SYNTHESIS AND SPECTROSCOPIC CHARACTERIZATION OF SOME NOVEL 1943 ARCHNA 2F-19 B-135 BENZOTHIAZOLE DERIVATIVES STREET DRUGS AS FROM THE HEIGHT OF ECSTASY TO THE DEPTHS OF HELL; AS QUICK AS A 69 PROF DR DHRUBO JYOTI SEN 2F-2 B-8 FLASH STREET DRUGS AS FROM THE HEIGHT OF ECSTASY TO THE DEPTHS OF HELL; AS QUICK AS A 70 PROF DR DHRUBO JYOTI SEN 2F-3 B-9 FLASH SYNTHESIS, CHARACTERIZATION AND POTENTIAL ANTICANCER ACTIVITY OF NOVEL 124 JEEVIKA RAHANGDALE 2F-4 B-11 SUBSTITUTED CHALCONE POLYMERS AN ASSESSMENT OF FLUORIDE CONCENTRATIONS OF WATER IN DIFFERENT ZONE OF 244 AJEET SINGH 2F-5 B-18 MADHYA PRADESH,INDIA 836 RAVI GUPTA 2F-6 B-67 CELLULAR ENERGY METABOLISM : RECENT AND EMERGING CANCER RESEARCH 841 BONDADA SRI NAGA VENKATA TEJASWI 2F-7 B-69 HERBAL MEDICINE IN TREATMENT OF POLYCYSTIC OVARY SYNDROME(PCOS) 969 FAIRY 2F-8 B-85 MICROWAVE HEATING IN ORGANIC SYNTHESIS AND DRUG DISCOVERY ISOLATION, PHYTOCHEMICAL INVESTIGATION AND BIOLOGICAL SCREENING OF FRUITS OF 1038 PRADEEPA PRASAD 2F-9 B-94 MORINDA CITRIFOLIA 43 ARCHANA SHARMA 3A-1 C-3 SCREENING OF LEAVES OF WEDELIA CHINENSIS FOR ANTIDIARRHOEAL POTENTIALITY 1536 RANI.S 3A-100 C-219 Anticancer and Antibacterial activity of marine sponge Sigmadocia carnosa 1572 RAGHVENDRA SINGH BHADAURIA 3A-101 C-209 ANTIDIABETIC ACTIVITY OF ECHINOPS ECHINATUS ROXB. 1582 ALKA AGARWAL 3A-102 C-211 EFFECT OF DIFFERENT EXTRACTS OF BOMBAX CEIBA LINN. ON ACUTE KIDNEY FAILURE. 1604 ROHIT .S. MUDLIAR 3A-103 C-203 ISOLATION OF PHYTOCONSTITUENTS BY USING SUPERCRITICAL FLUID EXTRACTOR: A REVIEW 1627 SHALU PAL 3A-104 C-205 ANTI-DEPRESSANT ACTIVITY OF DIFFERENT FRACTIONS OF EVOLVULUS ALSINOIDES L. 1647 DIVYA TAGORE 3A-105 C-214 FORMULATION AND EVALUATION OF HERBAL MOUTHWASH IN VITRO SCREENING OF ANTI-DIABETIC ACTIVITY AND ANTI-INFLAMMATORY ACTIVITY OF 1655 VAIBHAV MURLIDHAR TAYADE 3A-106 C-192 LEAVES EXTRACT OF BARLERIA GIBSONI DALZ. 1682 MANASA 3A-107 C-198 DNA FINGERPRINTING OF MEDICINAL PLANTS 1746 MEERA BHASKARAN 3A-108 C-191 Evaluation Of Anti-diabetic Activity Of Leaves Of Actinodaphne Hookeri Meissn. 1798 T.Sai 3A-109 C-187 Preparation & In-Vitro Evaluation of Hard Pastille Consisting of Herbal Extracts PRELIMINARY PHYTOCHEMICAL STUDIES AND IN VITRO ANTICANCER SCREENING BY SRB 154 S.K.LALITHA LAVANYA 3A-11 C-56 ASSAY ON METHANOLIC EXTRACT OF ROOTS OF HELIANTHUS ANNUS LINN. DETERMINATION OF ANTIOXIDANT AND ORAL TOXICITY IN SPRAGUE DAWLEY RATS OF 1806 GAURAV SAXENA 3A-110 C-178 DRACAENA CINNABARI RESIN EXTRACT. IN VITRO ANTIOXIDANT AND ANTI-INFLAMMATORY ACTIVITIES OF BARK EXTRACT OF ALBIZIA 1818 KAJAL JAIN 3A-111 C-179 AMRA BOIV. PHARMACOGNOSTICAL STUDY, PHYTOCHEMICAL EVALUATION AND IN VITRO 1875 DEEPENDRA SINGH CHAUHAN 3A-112 C-170 PHARMACOLOGICAL ACTIVITY OF LEAF AND BARK OF PLUMERIA OBTUSA LINN. 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title PHYTOCHEMICAL AND ANTIMICROBIAL STUDIES ON THE EXTRACTS FROM LEAVES OF 1884 RAMYA.L 3A-113 C-172 CAJANUS CAJAN 1885 ARPITHA J M 3A-114 C-173 ANTIMICROBIAL ACTIVITIES AND CHEMICAL PROPERTIES OF TAMARINDUS INDICA L. LEAVES Evaluation of Lens Aldose Reductase Inhibitory Activity of Extracts of Merremia emarginata leaves: 1896 THOMSON SANTOSH ALEX 3A-115 C-176 Potential for Diabetic Cataract treatment. 1900 MEGHA SHARMA 3A-116 C-177 Formulation development and evaluation of mosquito repellent herbal cream EVALUATION OF LENS ALDOSE REDUCTASE INHIBITORY ACTIVITY OF "DUAL ORGANISMS 1932 SHABNAM MANSURI 3A-117 C-165 LICHENS"-PERMOTREMA PERLATUM: POTENTIAL FOR DIABETIC CATARACT TREATMENT. 1975 RATANDEEP CHAUHAN 3A-118 C-158 Hepatoprotective Activity of Root extracts of Tephrosia purpurea 1988 RANI.S 3A-119 C-161 ANTICANCER AND ANTIBACTERIAL ACTIVITY OF MARINE SPONGE SIGMA DOCIA CARNOSA 170 SUCHARITA MOHAPATRA 3A-12 C-59 Evaluation of Anthelmintic Potential of Cucurbita maxima Linn. (Cucurbitaceae) Leaf PREPARATION OF ANTIMALASSEZIC FORMULATION BY USING DATURAMETAL AND 2018 G.VINODKUMAR 3A-120 C-151 RICINUSCOMMUNIS 2062 RITA DADARAO CHAKOLE 3A-121 C-139 ANTIASTHMATIC AND BRONCHODILATOR POTENTIAL OF CAREYA ARBOREA ROXB ANALYSIS OF ESSENTIAL AND TRACE ELEMENTS PRESENT IN ELAEOCARPUS GANITRUS 2074 SUNIL JAWLA 3A-122 C-142 FRUITS USING WAVELENGTH DISPERSIVE X-RAY FLUORESCENCE SPECTROMETER EFFECT OF ETHANOLIC EXTRACT OF MIMOSA RUBICAULIS LEAVES ON OXIDATIVESTRESS 2079 J.BANU REKHA 3A-123 C-144 COMPLICATIONS IN ANIMAL MODEL STUDY THE PHYTOCHEMICAL SCREENING OF VARIOUS EXTRACT OF METHANOLIC ACTIVITY 2082 S.SABARIMUTHUKUMAR 3A-124 C-145 OF TRIGONELLA FOENUM GRACEUM. INVITRO ANTICANCER ACTIVITY OF AQUEOUS EXTRACTS OF STEM AND LEAF OF ARTEMISIA 2091 ABDALLA SALIH ABDELGADER ABDALLA 3A-125 C-146 ANNUA 2094 SURYA PRAKASH GUPTA 3A-126 C-148 EVALUATION OF MEDICINALLY IMPORTANT AYURVEDIC PLANT ANTICONVULSANT AND ANTIOXIDANT POTENTIALS OF SARASVATA CHURNA-AN AYURVEDIC 2031 JAINENDRA JAIN 3A-127 C-152 FORMULATION FOR APASAMARA (EPILEPSY) ISOLATION AND IDENTIFICATION OF ENDOPHYTIC FUNGI FROM BERBERIS ARISTATA HOOK.F. & 2035 PRIYANKA AHLAWAT 3A-128 C-153 THOMSON Comparative evaluation of traditional and modern extraction techniques on in vitro phenolic content and 2040 ANNEGOWDA H V 3A-129 C-154 antioxidant activities of Cinnamomum iners bark extract 189 DATHI LAKSHMI GEETIKA 3A-13 C-60 ANTICONVULSANT ACTIVITY OF CITRUS GRANDIS LEAVES EXTRACT IN EXPERIMENTAL MICE 2053 AMARJEET SINGH 3A-130 C-138 Antimicrobial Activity of Butea monosperma (seeds) and Ficus bengalensis (aerial roots) EVALUATION OF HEPATOPROTECTIVE ACTIVITY OF POLYHERBAL FORMULATION IN 192 CHINTAPALLY JAHNAVI 3A-14 C-61 ETHANOL INDUCED LIVER TOXICITY IN ALBINO RATS 193 VAMSHI GAIKWOD 3A-15 C-62 EVALUATION OF IN-VITRO ANTIUROLITHIATIC ACTIVITY OF TERMINALIA CHEBULA 224 ROHAN RASOOR 3A-17 C-24 Antimicrobial activity of ethanol, methanol extracts of Plumeria pudica leaves Photochemical Screening And In-Vitro Antioxidant Activity Of Ethanolic Extract Of Poly Herbal 229 KALIVEMULA DIVYA 3A-18 C-25 Formulation Laghu Suthashekara Ras 231 P.NANDEESHWAR 3A-19 C-26 IN VITRO ANTHELMINTIC ACTIVITY OF GOSSYPIUM HERBACEUM QUALITATIVE ANALYSIS OF GALLIC ACID BY HPLC METHOD IN DIFFERENT EXTRACTS OF 47 MANISH PAL SINGH 3A-2 C-4 TERMINALIA BELLERICA ROXB. FRUIT 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title OCULOHYPOTENSIVE EFFECT OF SESBANIA GRANDIFLORA IN EXPERIMENTAL MODEL OF 242 N.RAMADEVI 3A-20 C-27 GLAUCOMA 270 CH.MANIDEEP 3A-21 C-29 IN-VITRO ANTHELMINTIC ACTIVITY OF SENNA OCCIDENTALIS 283 M.SRIVANI REDDY 3A-22 C-76 IN VITRO ANTHELMINTIC ACTIVITY OF CLORIS BARBATA 293 BASAVARAJ S HUNASAGI 3A-23 C-78 ANTIBACTERIAL ACTIVITY OF ROOTS AND LEAVES OF JASMINUM SAMBAC LINN PHYTOCHEMICAL SCREENING, ANTI-INFLAMMATORY AND ANTIOXIDANT STUDIES OF SIDA 305 VANAJA P 3A-24 C-32 CORDATA PLANT EXTRACT ON EXPERIMENTAL ANIMAL MODELS 351 K HIMABINDU 3A-26 C-34 IN VITRO ANTIOXIDANT ACTIVITY OF METHANOL EXTRACT OF ADONIS VERNALIS 359 KARNAIL SINGH 3A-27 C-35 Antimicrobial activity of stem and leaf of Cicer arietinum linn 363 JOGINDER SANGWAN 3A-28 C-36 PHYTOCHEMICAL SCREENING OF ROOTS OF EUPHORBIA TITHYMALOIDES Pharmacognostical Profile and Antipyretic Potential of Hydroalcoholic Extract of Santalum album Linn 371 SARITA NAYAK 3A-29 C-37 (Santalaceae) Leaf IN-SILICO MOLECULAR DOCKING AND ASSESSMENT OF INHIBITORY POTENTIAL OF DESMODIUM TRIFLORUM LINN ON OVALBUMIN- INDUCED AIRWAY HYPERRESPONSIVENESS IN 51 VEDPAL 3A-3 C-5 SWISS ALBINO MICE. SIMULTANEOUS ESTIMATION OF ANTIOXIDANT BIOMARKERS FROM LEAVES OF CUCUMIS 402 MONIKA S 3A-30 C-38 MELO VAR. AGRESTIS BY USING VALIDATED HPTLC METHOD EVALUATION INVITRO ANTI-INFLAMMATORY ACTIVITY OF METHANOLIC ROOT EXTRACT OF 404 LAKSHMI HARINI 3A-31 C-39 Cocculus hirsutus 426 OBILLANENI MOUNIKA 3A-32 C-41 SCREENING OF ANTIMICROBIAL ACTIVITY OF AQUEOUS LEAF EXTRACT OF SPIRAL PLANT EVALUATION OF ANTI-OXIDANT ACTIVITY AND DETECTION OF ANTIOXIDANT BIOMARKERS IN 434 P.PREEJA 3A-33 C-44 HOMALIUM ZEYLANICUM BENTH STUDY ON ANTIMICROBIAL EFFECT OF FONICULUM VULGARE AND ARMORACIA RUSTICANA 437 SHREECHANDAN PAIKARAY 3A-34 C-45 EXTRACTS AGINST SELECTED MICROORGANISMS ANTI TYROSINASE INHIBITOR ACTIVITY OF GOLD NANOPARTICLES SYNTHESIZED FROM 463 KISHORE KUMAR MAHTO 3A-36 C-80 AQUEOUS LEAF EXTRACTS OF BAUHINIA VAHLII CARDIO PROTECTIVE ACTIVITY OF THE FLOWERS OF ELAEAGNUS LATIFOLIA LINN.: A WILD 482 ANTARA CHOUDHURY 3A-37 C-81 EDIBLE PLANT OF MEGHALAYA, NORTHEAST INDIA PHYTOCHEMICAL VETTING AND COSTING OF ETHANOLIC & AQUEOUS EXTRACT OF 499 LOHIT KANTA 3A-38 C-83 FLOWERING STEM OF MUSA ACUMINATA FOR ANTHELMINTIC ACTIVITY PHYTOCHEMICAL INVESTIGATION AND IN VITRO ANTIOXIDANT ACTIVITY OF AN INDIGENOUS 501 SWATI PRIYA 3A-39 C-46 MEDICINAL PLANT MUTINGIA CALABURA 52 MANIKANTA M 3A-4 C-6 A NUTRACUETICAL FOR ANTIHYPERLIPIDEMIC CONDITION Evaluation of wound healing potential of ethanolic leave extracts of Oroxylum indicum(L.)vent in wistar 512 SHYAMA SUNDAR SAHU 3A-40 C-49 rats. 566 KARNAIL SINGH 3A-41 C-85 ANTIMICROBIAL ACTIVITY OF STEM AND LEAF OF CICER ARIETINUM LINN 567 JOGINDER SANGWAN 3A-42 C-86 PHYTOCHEMICAL SCREENING OF ROOTS OF EUPHORBIA TITHYMALOIDES BIOASSAY GUIDED FRACTIONATION OF CASUARINA EQUISETIFOLIA LINN. : A PLANT 571 DINESH KUMAR 3A-43 C-87 TRADITIONALLY USED IN FERTILITY REGULATION 620 FAHIMA BANU .M 3A-44 C-53 ETHANOLIC EXTRACTION AND EVALUATION OF FIBRINOLYTIC ACTIVITY OF ECLIPTA ALBA 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title PHARMACOGNOSTICAL, PHYTOCHEMICAL AND PHARMACOLOGICAL INVESTIGATION OF THE 671 PRAGATHI.K.S 3A-46 C-64 LEAVES OF DICHROSTACHYS CINEREA WIGHT ET ARN. PHARMACOGNOSTIC,PHYTOCHEMICAL AND ANALGESIC ACTIVITY OF VARIOUS EXTRACTS OF 676 PADMAJA VADDEPALLI 3A-47 C-65 LEAF OF MYRISTICA FATUA PLANT Pharmacognostical Profile and Antipyretic Potential of Hydroalcoholic Extract of Santalum album Linn 687 SARITA NAYAK 3A-48 C-66 (Santalaceae) Leaf 738 DIVYA REDDY 3A-49 C-72 EVALUATION OF IN VITRO ANTIHELIMINTIC ACTIVITY OF ELAOECARPUS GANITRUS 80 POOJA PREET BOSE 3A-5 C-11 Antipyretic Potential of Hydroalcoholic Extract of Grewia hirsuta Linn (Malvaceae) Leaf 793 PREETI R. JADHAV 3A-50 C-92 MELATONIN AS A SLEEP INDUCING AGENT 794 SNEHAPRIYA 3A-51 C-93 INVITRO ABORTIFACIENT ACTIVITY BY CALOTROPIS PROCERA 814 SHOBHIT PRAKASH SRIVASTAVA 3A-52 C-96 PHYTOCHEMICAL AND ANTI-INFLAMMATORY EVALUATION OF SOME BABOOL SPECIES 827 BHAVNA SAHU, KIRTI DEWANGAN, CHANDRAKANT 3A-53 C-97 IN-VITRO CHARACTTERIZAION OF POLY HERBAL SHMPOO ISOLATION AND EVALUTION OF TRITERPENOID FROM SHOREA ROBUSTA RESIN AND 879 RAKESH YASHWANTA BHUTE 3A-54 C-103 VALIDATION OF ITS ANTIPROLIFERATEIVE ACTIVITY 901 YORUM RINIA 3A-55 C-106 EXTRACTION AND APPLICATION OF MARIGOLD DYE ON COTTON AND JUTE FABRIC 902 BISWA MOHAN SAHOO 3A-56 C-107 MICROWAVE ASSISTED EXTRACTION OF MEDICINAL PHYTOCONSTITUENTS Estimation of total phenolic, flavonoid content and Antioxidant activity of Cryptolepis buchanani root 907 RAMAKANTA PATEL 3A-57 C-108 extracts Determination of total phenolic, flavonoid content and Antioxidant activity of Hemidesmus indicus aerial 923 SUBHAM KUMAR MEHER 3A-58 C-110 part FOURIER TRANSFORM INFRARED SPECTROSCOPY ANALYSIS FOR ETHANOLIC ROOT 952 RAMYA KUBER B 3A-59 C-113 EXTRACT OF MILLETTIA PINNATA 81 KIRTI KAUR 3A-6 C-12 Anti-inflammatory potential of different extracts of Putranjiva roxburghii Wall (Putranjivaceae) leaf 981 SHYAM PRAKASH RAI 3A-60 C-116 EVALUATION OF ANTHELMINTIC ACTIVITY OF THE ORCHID- DENDROBIUM MONILIFORME UPLC-ESI-MS/MS METHOD DEVELOPMENT OF 1-HYDROXY-5, 7-DIMETHOXY-2 NAPHTHALENE- 26 LUBNA AZMI 3A-61 C-2 CARBOXALDEHYDE A BIOACTIVE COMPONENT OF AEGLE MARMELOS L. EFFECT OF ABIOTIC ELICITORS ON THE PRODUCTION OF PICROSIDE I AND II IN CELL 25 PERALA KAVITHA 3A-62 C-1 CULTURES OF PICRORHIZA KURROA Determination of total phenolic, flavonoid content and Antioxidant activity of Hemidesmus indicus aerial 1033 SUBHAM KUMAR MEHER 3A-63 C-121 part 1040 KIRTI VASHIST 3A-64 C-122 FORMULATION OF ANTI-WRINKLE CREAM USING PEARL MILLET AND AVACADO EXTRACT ANTI-OXIDANT ACTIVITY OF METHANOLIC EXTRACT OF SEEDS OF MANILKARA ZAPOTA BY 1049 FATHIMA 3A-65 C-123 SCAVENGING OF HYDROXYL RADICAL BY P-NDA METHOD Pharmacognostical profile, phytochemical screening and pharmacological evaluation of leaf extracts of 1082 BISWAJIT KUMAR MEHER 3A-66 C-125 Mangifera indica(Anacardiaceae) ANTI-ARTHRITIC ACTIVITY OF TECOMARIA CAPENSIS LEAVES BY BOVINE SERUM ALBUMIN 1088 NAGA SUJAN MUNDRA 3A-67 C-126 DENATURATION METHOD 1104 K RAJA RAVINDRA 3A-68 C-131 EVALUATION OF ANTIMICROBIAL ACTIVITY OF COW URINE 1114 PARANDEEP BORA 3A-69 C-133 FORMULATION AND EVALUATION OF POLYHERBAL WOUND HEALING GEL 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title 100 MANISHA RAJ 3A-7 C-16 Exploration of Analgesic activity of different extracts of Bauhinia variegata Linn (Fabaceae) Leaf EVALUTION OF IN-VITRO ANTI-UROLITHITIC ACTIVITY OF METHANOLIC EXTRACT OF 1145 KONDAPALLI SAI SANTHOSHI 3A-70 C-135 TAMILNADIA ULIGNOSA FRUIT 1161 D.NEELIMA 3A-71 C-256 INVITRO SPF DETERMINATION OF HERBAL OILS IN COSMETICS 1178 BIDISHA BORDOLOI 3A-72 C-258 Phytochemical screening and antimicrobial activity of seeds extract of Carica papaya DETERMINATION OF IN-VITRO ANTI-MICROBIAL ACTIVITY AND ANTI-DIABETIC ACTIVITY OF 1182 MERGU.RAJA 3A-73 C-259 IXORA CHINENSIS PHYTOCHEMICAL EVALUATION AND CHARACTERIZATION OF ETHANOLIC AND AQUEOUS 1184 PARINA.M 3A-74 C-260 EXTRACT OF CISSUS QUADRANGULARIS HEPATOPROTECTIVE STUDIES OF DIFFERENT FRACTION OF ETHANOLIC EXTRACT OF NIGELLA 1201 SHIKHA SHARMA 3A-75 C-252 SATIVA L. SEEDS 1240 SHYAM PRAKASH RAI 3A-77 C-253 EVALUATION OF ANTHELMINTIC ACTIVITY OF THE ORCHID- DENDROBIUM MONILIFORME 1245 MOUNIKA. BAVANARI 3A-78 C-254 EVALUATION OF PHYTOCHEMICALS AND ANTIMICROBIAL ACTIVITY OF ACHYRANTHES ASPERA 1259 VIPUL MALGONDA PATIL 3A-79 C-245 IN-VITRO ANTIUROLITHIATIC ACTIVITY OF PLANT EXTRACTS OF ELEUSINE INDICA L. Study of Pharmacognostical Profile and Antimicrobial Activity of Clerodendrum serratum Linn 101 NIDHI NARULA 3A-8 C-17 (Lamiaeceae) Leaf PHYTOCHEMICAL ANALYSIS AND IN VITRO EVALUATION OF ANTIOXIDANT POTENTIAL OF DIFFERENT PARTS (LEAVES, STEM, FRUIT, SEED, FLOWER AND ROOT) EXTRACT OF CUCUMIS 1275 ARULKUMAR R 3A-80 C-246 MELO VAR. AGRESTIS IN-VITRO INHIBITORY POTENTIAL OF CAPSELLA-BURSA PASTORIS AGAINST KEY ENZYMES 1277 MOHD AKBAR DAR 3A-81 C-247 RESPONSIBLE FOR POST-PRANDIAL HYPERGLYCAEMIA IN DIABETES ANTIMICROBIAL AND ANTI-INFLAMMATORY ACTIVITY OF DOANI SIDR HONEY AND 1281 G SHIVA KUMAR 3A-82 C-249 MADECASSOSIDE AGAINST PROPIONIBACTERIUM ACNES EVALUATION OF WOUND HEALING ACTIVITY OF HYDROALCOHOLIC LEAF EXTRACT OF 1296 VINOD KUMAR 3A-83 C-250 EULALIOPSIS BINATA EVALUATION OF WOUND HEALING ACTIVITY OF HYDROALCOHOLIC LEAF EXTRACT OF 1300 VINOD KUMAR 3A-84 C-251 EULALIOPSIS BINATA 1311 P.TEJASWINI 3A-85 C-240 FORMULATION AND EVALUATION OF HERBOMINERAL TOOTHPASTE WOUND REPAIR AND ANTI-INFLAMMATORY POTENTIAL OF AMORPHOPHALLUS PAEONIIFOLIUS 1331 ARTI GAUTAM 3A-86 C-241 TUBER IN EXCISION WOUND-INDUCED IN DIABETIC RATS PHYTOCHEMICAL ANALYSIS AND EVALUATION OF IN VITRO ANTI INFLAMMATORY ACTIVITY OF 1335 KARTHIKA S 3A-87 C-242 STEM OF ZANTHOXYLUM RHETSA (ROXB.) DC. ANTIOXIDANT ACTIVITY OF THE SUCCESSIVE EXTRACTS OBTAINED FROM THE AERIAL PARTS 1376 RAJ KUMAR SINGH 3A-88 C-238 OF POTENTILLA FULGENS WALL. 1415 VEERAMANENI ALEKHYA 3A-89 C-229 EVALUATION OF ANTHOCEPHALUS CADAMBA FOR ANTIULCER ACTIVITY ANTIBACTERIAL & ANTHELMINTIC EFFICACY OF ETHANOLIC FLOWER EXTRACTS OF TECOMA 107 T. RAKESH VARMA 3A-9 C-18 STANS (L.) AND LAGERSTROEMIA SPECIOSA (L) PERS IDENTIFICATION OF POPULAR HERBS OF CHHATTISGARH AND THEIR USES IN THE TREATMENT 1416 TARANJEET KALSI 3A-90 C-230 OF COMMON DISEASES EVALUATION OF ANTI-STRESS ACTIVITY OF MURRAYA KOENIGII ON EXPERIMENTAL MICE AND 1418 K.YASWANTH 3A-91 C-231 RATS 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title EFFECTS OF SOME HERBAL PLANTS AND THEIR SYNERGISTIC EFFECT ON REPRODUCTIVE 1426 SONU SHARMA 3A-92 C-233 FUNCTIONS ON RATS GC-MS ANALYSIS AND MOLECULAR DOCKING OF BIOACTIVE COMPOUNDS FROM THE ALCOHOLIC AND ETHYLACETATE FRACTIONS OF COMMIPHORA MUKUL AGAINST MONO AMINE 1429 VIJETHA PENDYALA 3A-93 C-234 OXIDASE 1444 PARANDEEP BORA 3A-94 C-235 FORMULATION AND EVALUATION OF POLYHERBAL WOUND HEALING GEL 1446 PARANDEEP BORA 3A-95 C-236 FORMULATION AND EVALUATION OF POLYHERBAL WOUND HEALING GEL PRIMARY PHYTOCHEMICAL SCREENING AND EVALUATION OF ANTIMICROBIAL ACTIVITY ON 1461 ABHISHEK KUMAR PANDEY 3A-96 C-222 THE LEAF OF Xanthium strumarium ISOLATION AND CHARACTERIZATION OF CHEMICAL CONSTITUENTS FROM ROOTS OF 1464 M.SWAPNA REDDY 3A-97 C-223 CLERODENDRUM SERRATUM EFFECT OF AJOWAN (TRACHYSPERMUM AMMI) (L.) SPRAGUE FRUITS EXTRACT ON SPERM 1515 ROHIT 3A-98 C-215 COUNT AND MOTILITY IN MALE ALBINO RATS. STUDY OF PHYTOCHEMICAL SCREENING AND ANTI-INFLAMMATORY ACTIVITY OF ETHANOLIC 1535 SARAVANAPRAKASH.M 3A-99 C-218 LEAF EXTRACT OF IPOMOEA PES-TIGRIDIS. 97 ABHILASH DASH 3B-1 C-15 PREPARATION AND EVALUATION OF PHYTOSOME OF HERBAL PLANT OF LAWSONIA INERMIS L 448 PREETHAM S.P 3B-11 C-79 NATURAL MOSQUITO REPELLENT AS AN EXPECTORANT AND MUCOLYTIC EVOLUTION OF PRELIMINARY PHYTOCHEMICAL STUDIES, ANTIMICROBIAL AND IN VITRO 489 N.VENKATESH 3B-13 C-82 CYTOTOXIC STUDIES OF SELECTED POLYHERBAL MIXTURE OF DIETARY IMPORTANCE 505 SMRUTI SWARUP PRADHAN 3B-14 C-47 Antidiabetic Activity of Leaf Extracts of Bauhinia acuminate in Alloxan Induced Diabetic Rats. EVALUATION OF ANTICANCER POTENTIAL OF SILVER NANOCOMPOSITE NIGELLA SEED 546 AFREEN USMANI 3B-15 C-84 EXTRACT AGAINST HEPG2 CELLS THE STANDARDIZATION AND EVALUATION OF A POLYHERBAL OIL IN THE TREATMENT OF 576 NIKITA SARASWAT 3B-16 C-89 ALOPECIA IN WISTAR RATS DEVELOPMENT AND EVALUATION OF NOVEL ETHOSOMAL VESICULAR DRUG DELIVERY 606 SACHIN BALKRISHNA SOMWANSHI 3B-17 C-51 SYSTEM OF SESAMUM INDICUM L. SEED EXTRACT 634 ISMATH FARAHA.M 3B-19 C-55 STUDY OF IN VITRO ANTI-BACTERIAL ACTIVITY OF GARLIC OINTMENT 208 AADITYA THOLE 3B-2 C-21 HERABL EXTERNAL TEAT SEALANT 668 RAMA DEVI BANKAPALLI 3B-21 C-63 FORMULATION & EVALUATION OF POLYHERBAL FORMULATIONS 688 PRITI R. DONGRE 3B-22 C-67 “HERBAL HAIR FORMULATION: A SOLUTION FOR GREY HAIRS” 714 PRITI DONGRE 3B-23 C-70 A COMPARATIVE STANDARDIZATION OF LAB MADE AND MARKETED TRIPHALA CHURNA DETERMINATION OF SUN PROTECTING FACTOR (SPF) OF SANDALWOOD OIL BY ULTRAVIOLET 728 ANJALI MISHRA 3B-24 C-71 SPECTROPHOTOMETRY 846 ARUN KUMAR K.V 3B-25 C-99 FORMULATION AND EVALUATION OF HERBAL NIOSOMAL GEL FOR PSORIASIS LIKE EFFECT FORMULATION AND EVALUATION OF ANTI-DANDRUFF HERBAL SHAMPOO CONTAINING 858 GOWTHAM M 3B-26 C-100 DATURA METEL(LINN)LOADED SOLID LIPID NANOPARTICLES DEVELOPMENT OF CITRONELLA OIL IMPREGNATED ALGINATE MATRIX FOR ANTIBACTERIAL 874 SANDRA LALCHHUANAWMI 3B-27 C-101 ACTIVITY FORMULATION DEVELOPMENT AND EVALUATION OF AN ANTI DIABETIC POLY HERBAL 876 SATHYA V 3B-28 C-102 FORMULATION 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title FORMULATION AND EVALUATION OF POLYHERBAL SHAMPOO CONTAINING ZIZIPHUS JUJUBA, 890 PUSHPENDRA SINGH KANSANA 3B-29 C-105 HIBISCUS AND PIPER NIGRUM. 209 AADITYA THOLE 3B-3 C-22 HERBALEXTERNAL TEAT SEALANT FOR PREVENTION OF MASTITIS IN CATTLE 950 DIPALI B. BHURE 3B-30 C-112 Role of traditional medicinal herbs in the management of Jaundice FABRICATION AND EVALUATION OF A HERBAL GEL OF PLANT EXTRACT FOR TREATMENT OF 970 ROMAN KUMAR ANESHWARI 3B-31 C-115 FILARIASIS. FORMULATION AND EVALUATION OF ANTI-ACNE AND ANTI-AGEING CREAM USING 1021 V MOUNIKA 3B-32 C-120 METHANOLIC LEAF EXTRACT OF ANNONA SQUAMOSA EVALUATION OF IN-VIVO HISTAMINE RELEASE INHIBITORY POTENTIAL OF PIPER NIGRUM SEED 1092 RAHELA EYACHMIN LASKAR 3B-33 C-128 EXTRACT 1095 RIYA CHATURVEDI 3B-34 C-129 FORMULATION AND EVALUATION OF ECO-FRIEDLY HPERBAL PRFUME STANDARDISATION OF METHANOLIC EXTRACT OF ANDROGRAPHIS PANICULATE, ASSESSMENT OF ANTIOXIDANT ACTIVITY AND IN VITRO RELEASE OF ANDROGRAPHOLIDE 1097 AREEBA INSAF 3B-35 C-130 FROM IN SITU GEL USING GOATS’ EYE Formulation and Evaluation of Polyherbal methanol extract containing Hepatoprotective Herbal Tablets By 1177 NELLURI SOWJANYA 3B-39 C-257 3 2 Factorial Deign for optimum Disintegration time IN PROCESS QUALITY CONTROL TESTING OF INHOUSE MADE PASSIFLORA EUDILIS WOUND 1280 B VENKATA SANDHYA 3B-42 C-248 HEALING CREAM 1485 RAVINDRA PATIDAR 3B-43 C-225 FORMULATION AND EVALUATION OF HERBAL BURN WOUND HEALING CREAM 1531 AKSHATA SUHAS GAVADE 3B-44 C-216 IN VITRO EVALUATION OF SPF, PHOTOSTABILITY PUNICA GRANATUM FRUIT EXTRACT GEL 1534 SANGITA KALITA 3B-45 C-217 FORMULATION AND EVALUATION OF POLYHERBAL ANTI ULCER TABLETS 1550 NITIN ARVIND GAIKWAD 3B-46 C-221 “FORMULATION AND EVALUATION OF HAIR GEL CONTAINING UNANI MEDICINE” DEVELOPMENT, CHARACTERIZATION AND ANTIOXIDANT ACTIVITY OF PICRORRHIZA 1671 PRACHI P. UDAPURKAR 3B-47 C-197 PHOSPHOLIPID COMPLEX IN VITRO BLOOD COAGULANT ACTIVTY AND DEVELOPMENT OF HEMOSTATIC WOUND 1683 Y.SRINIVASA RAO 3B-48 C-199 DRESSING FROM THE METHANOLIC FRUIT EXTRACT OF MIMUSOPS ELENGI LINN COMPARISON OF WOUND HEALING ACTIVITY OF CURCUMIN NANOPARTICLES WITH NORMAL 1686 DONELA VEERA VENKATA MOUNIKA 3B-49 C-200 CURCUMIN USING WISTER RATS PHYTOCHEMICAL SCREENING AND ALBUMIN INDUCED ANTI-INFLAMMATORY ACTIVITY OF 256 TIRUNAHARI LAKSHMI ISHWARIYA 3B-5 C-28 PENTAS LANCEOLATA LEAVES COMPARISON OF WOUND HEALING ACTIVITY OF CURCUMIN NANOPARTICLES WITH NORMAL 1695 DONELA VEERA VENKATA MOUNIKA 3B-50 C-202 CURCUMIN USING WISTER RATS 1707 MAHESH APPASAHEB WAKSHE 3B-51 C-189 NIOSOMES: ADVANCED DRUG DELIVERY SYSTEM DETERMINATION OF SUN PROTECTING FACTOR (SPF) OF LEAF EXTRACTS OF EULALIOPSIS 1755 ANKITA SHARMA 3B-52 C-183 BINATA BY ULTRAVIOLET SPECTROPHOTOMETRY 1794 P.SRILAXMI 3B-53 C-185 PREPARATION & EVALUATION OF ANTI- ACNE GEL BY USING DIFFERENT HERBALS 1796 V.PRASANNA 3B-54 C-186 Formulation & Evaluation of Herbal Pain Gel by Box- Behnken 1800 M.SANA BEGUM 3B-55 C-188 Preparation & In-Vitro Evaluation of Bi layered Lozenges of Vasaka & Sonti 1828 V.SANTHOSHIMAI 3B-56 C-180 ROLE OF VARIOUS PRACTICES OF AYURVEDIC MEDCINE ARRAY 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title DEVELOPMENT AND CHARACTERIZATION OF HERBAL CREAM CONTAINING ROOT EXTRACT OF 1862 SHWETA SHRIWAS 3B-57 C-168 ACHYRANTHES ASPERA LINN. FOR VAGINAL APPLICATION FORMULATION DEVELOPMENT AND OPTIMIZATION OF WITHANIA COAGULANS EXTRACTS 1882 CHETHAN H V 3B-58 C-171 TABLET USING BOX-BEHNKEN DESIGN FORMULATION AND EVALUATION OF IN VIVO WOUND HEALING ACTIVITY AND IN-VITRO ANTI- 1905 HIMANSHU NILESH PANCHAL 3B-59 C-163 OXIDANT ACTIVITY OF HERBAL FORMULATION OF BRYOPHYLLUM PINNATUM PREPARATION AND EVALUATION OF COMPATIBILITY AND DRUG:EXCIP INTERACTION OF PHYTOCHEMICAL (CURCUMIN, PIPERINE AND ANDROGRAPHOLIDE) WITH ISOMALT 1908 SATYENDRA K RAJPUT 3B-60 C-164 DEVELOPED WITH HOT-MELT-MOLDING TECHNOLOGY (HMM-TECH.) 1961 SUSHRUTA RAHUL MULAY 3B-61 C-156 Development of Liquid Oral Formulation of Aloe Vera to Improve Nutraceutical Attributes. FORMULATION AND DEVELOPMENT OF AN AYURVEDIC FORMULATION INTO TABLET DOSAGE 1963 RISHI KUMAR 3B-62 C-157 FROM A PHASE II CLINICAL TRIAL OF AN INDIGENOUSLY PREPARED POLYHERBAL FORMULATION - A 2017 KANDASAMY 3B-63 C-150 POTENT HEPATOPROTECTIVE AGENT PHYTOCONSTITUENTS FUSION IN AMELIORATION OF NEURONAL MITOCHONDRIAL 2076 AMARJIT KAUR 3B-64 C-143 DYSFUNCTION IN NEUROMUSCULAR DEGENERATION A NEW ABSORPTION SUBTRACTION METHOD FOR SIMULTANEOUS ESTIMATION OF 2092 MANJU KAMRA 3B-65 C-147 RESVERATROL AND BENZOYL PEROXIDE FORMULATION AND IN-VITRO EVALUATION OF SUN PROTECTION FACTOR OF ANTI-AGEING 289 USHA KIRANMAI GONDRALA 3B-7 C-77 POLYHERBAL CREAM DRUG RESISTANCE REVERSAL POTENTIAL OF RESISTANCE MODIFYING 304 HITESH KUMAR SHARMA 3B-8 C-31 AGENTS/PHYTOMOLECULES AGAINST STAPHYLOCOCCUS AUREUS 424 PRAJWAL TRIPATHI 3B-9 C-40 PREPARATION AND EVALUATION OF HERBAL HAND WASH FORMULATION 74 MOHD MAZHAR 3C-1 C-9 STANDARDISATION OF BERBERIS ARISTATA USING THE HPTLC AND HPLC TECHNIQUES 614 SARA USMANI 3C-10 C-52 STABILITY STUDIES OF TRIPHALA PHARMACOGNOSTICAL AND PRELIMINARY PHYTOCHEMICAL EVALUATION OF PUTRANJIVA 690 AANCHAL LOSHALI 3C-11 C-68 ROXBURGHI (LEAVES) COMPUTATIONAL AUTHENTICATION OF HERBAL DRUGS: ONE STOP TECHNIQUE FOR QUALITY 705 PREET AMOL SINGH 3C-12 C-69 STANDARDIZATION AND IDENTIFICATION OF ADULTERANTS. 754 TEJASWINI K. MANKAR 3C-13 C-74 WATER PURIFICATION BY HERBS 784 SHANMUGA PRIYA.G 3C-14 C-91 CHROMATOGRAPHIC ANALYSIS OF SIDDHA FORMULATION BY HPTLC AND GC-MS METHOD PRELIMINARY PHYTOCHEMICAL INVESTIGATION OF SOME COMPOUNDS FROM THE LEAVES 795 PUNAM AGRAWAL 3C-15 C-94 EXTRACTS OF BAMBUSA VULGARIS LINN 801 DR.S.RAMACHANDRAN 3C-16 C-95 EFFECT OF FLAX MUCILAGE IN HYDROCORTISONE INDUCED DEPRESSION IN RATS STANDARDIZATION OF ABROMA AUGUSTA LEAVES BY PHARMACOGNOSTCAL AND 920 SUPRIYA GUPTA 3C-17 C-109 PHYTOCHEMICAL PARAMETERS Pharmacognostical and Phytochemical Evaluation of Nyctanthes arbor-tristis Linn. Roots of Sikkim 948 ANJALI SHARMA 3C-18 C-111 Himalayan region 953 CIDDI VEERESHAM 3C-19 C-114 EVALUATION OF VARIOUS MARKETED FORMULATIONS OF SENNA PREPARATION AND EVALUATION OF TRIPHALA CHURNA USING THE INGREDIENTS OBTAINED 82 GUNJI VENKATESWARLU 3C-2 C-13 FROM LOCAL MARKET AND COMPARATIVE STANDARDIZATION 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title 994 AJMERA RAMA RAO 3C-20 C-117 EVALUATION OF VARIOUS MARKETED FORMULATIONS OF BOSWELLIA STANDARDIZATION AND COMPERATIVE STUDY OF DIFFERENT AYURVEDIC LIQUID 1011 MAYANK SAINI 3C-21 C-118 FORMULATION OF ‘KUMARIASAVA’ 1058 RAMESWAR RATH 3C-22 C-124 FORMULATION AND EVALUATION OF ANTI DIABETIC TABLETS - A POLYHERBAL FORMULATION PREPARATION OF TRIPHALA CHURNA USING THE INGREDIENTS OBTAINED FROM LOCAL 1151 GUNJI VENKATESWARLU 3C-23 C-255 MARKET AND COMPARATIVE STANDARDIZATION EFFECT OF ALTITUDE AND GEOGRAPHICAL DISTRIBUTION ON THE VOLATILE OIL CONTENTS 1197 VINOD NAUTIYAL 3C-24 C-263 AND OTHER PARAMETERS ON SOME SELECTED MEDICINAL PLANTS. One step Green Synthesis , Characterization and In-vitro Antioxidant Activity of stem extract mediated 1303 SHEEJA GIRISH KOLIYOTE 3C-25 C-239 Gold nanoparticles from Tinospora cordifolia PHARMACOGNOSTICAL AND PHYTOCHEMICAL STANDARDIZATION OF THE AERIAL PARTS OF 1375 DAMANBHALANG RYNJAH 3C-26 C-237 POTENTILLA FULGENS WALL. 1496 K.CHANDRASHEKAR 3C-27 C-227 ANTI CANCER HERBAL TEA 1658 ANEKAR VAISHNAVI PRAVIN 3C-28 C-194 STANDARDIZATION OF HERBAL DRUGS : REVIEW PRELIMINARY PHYTOCHEMICAL SCREENING AND IN VIVO IMMUNOMODULATORY ACTIVITY OF 1720 SHAILY RASTOGI 3C-29 C-190 PYRACANTHA CRENULATA (D.DON) M. ROEM VALIDATED STABILITY INDICATING ASSAY METHOD FOR THE DETERMINATION OF STRYCHNINE 94 PALLAVI RAI 3C-3 C-14 IN KRIMIMUDGARA RASA BY RP-LC. DEVELOPMENT AND VALIDATION OF HPTLC METHOD FOR ESTIMATION OF CHARANTIN IN 1860 SATYAENDRA K. SHRIVASTAVA 3C-30 C-167 ANTIDIABETIC HERBAL FORMULATION STANDARDIZATION AND EVALUATION OF ANTI-OXIDANT PROPERTIES OF PUNICA GRANATUM 1889 PRITHIKA NAIK 3C-31 C-174 L LEAVE EXTRACTS 1945 BALAM VENKATA SIVA NAGA SAI BHARATH 3C-32 C-166 PLANTS BASED MEDCINES USED IN THE TREATMENT OF HIV ASHWAGANDHARISHTA PREPARED BY TRADITIONAL AND MODERN METHODS IN 2106 SUBHAJIT GHOSH 3C-33 C-136 EXPERIMENTAL RATS FOR DIURETIC ACTIVITY PHARMACOGNOSTICAL PHYTOCHEMICAL AND POLY HERBAL FORMULATION AND EVALUATION 126 RAMASUBRAMANIA RAJA 3C-4 C-19 OF ABUTILON INDICUM AND ARISTOLOCHEA BRACTEOLATE ANDROGRAPHIS PANICULATA PHARMACOGNOSTICAL AND PHYSICOCHEMICAL ANALYSIS OF RASAYANA CHURNA: AN 161 RAJESH BOLLEDDU 3C-5 C-58 AYURVEDIC POLY-HERBAL FORMULATION 206 T. MOUNIKA 3C-6 C-20 FORMULATION OF POLYHERBAL PREPARATION AND IT’S STANDARDIZATION A SURVEY ON ETHNO MEDICINAL PLANT FOR THE TREATMENT OF JUANDICE USED BY THE 273 SHYAM PRAKASH RAI 3C-7 C-30 GARO, JAINTIA AND KHASI TRIBES OF INDIA 320 POTU LAVANYA 3C-8 C-33 STANDARDISATION OF AVALEHA FORMULATION STUDIES OF ETHNOMEDICINAL PLANT OF NORTH- EAST REGION OF INDIA USED FOR THE 538 SHYAM PRAKASH RAI 3C-9 C-50 TREATMENT FOR HYPERTENSION. CALLUS INDUCTION, PHYTOCHEMICAL STUDIES AND BIOLOGICAL ACTIVITY OF BOERHAAVIA 1994 AJAY PAL SINGH 3D-1 C-162 DIFFUSA LINN. 59 NITIKA RAWAT 3E-1 C-7 THERAPEUTIC POTENTIALITY OF SAFFRON IN CONTROL OF METABOLIC DISORDERS 632 Zeashan Hussain 3E-10 C-54 Antihepatotoxicity activity of Amaranthus spinosus against paracetamol induced hepatic damage in rats MATRIX METALLOPROTEINASE INHIBITORS (MMPIS) FROM NATURAL PRODUCTS: THE 742 RASHMI WADHWA 3E-11 C-73 CURRENT SITUATION AND FUTURE PROSPECTS 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title A DISSERTAION ON PHYTOCHEMIKCAL AND PHARMACOLOGICAL EVALUATION OF FUMARIA 758 NITESH SOLANKI 3E-12 C-75 INDICA 777 PREETI R. JADHAV 3E-13 C-90 MELATONIN AS A SLEEP INDUCING AGENT 843 SAI KRUSHNA PADHY 3E-14 C-98 A REVIEW ON PHYTOESTROGENS AND IT’S BENEFITS EFFICACY OF MANGIFERA INDICA AND PUNICA GRANATUM FRUITS EXTRACT ON SHAIWAL 887 NITIN KUMAR 3E-15 C-104 BULL SEMON VAIBILTY AFTER CYROPRESERVATION . IN VITRO ANTIOXIDANT, PANCREATIC LIPASE INHIBITORY PROPERTIES OF JOHA RICE OF 1019 RAJA CHAKRABORTY 3E-16 C-119 ASSAM, INDIA 1090 SANJU 3E-17 C-127 HERBAL PANACEA FOR COMBATING SKIN AGING 1109 JUNAID SHEIKH 3E-18 C-132 “A PHARMACOGNOSTICAL REPORT ON THE RHIZOME OF ALPINIA GALANGA LINN. (WILLD).” 1117 TANISH KOCHAR 3E-19 C-134 INNOVATION: A TARGET FOR INDIAN PHARMACEUTICAL INDUSTRIES TO LEAD GLOBALLY A COMPLETE REVIEW ON " YARSAGUMBA - HALF INSECT- HALF FUNGUS-A WONDER CREATION 71 SOHINI SEN 3E-2 C-8 OF GOD" 1192 POOJA SINGH 3E-20 C-261 DATURA: A MAGIC HERBAL REMEDY IN TREATMENT OF CNS DISORDER 1196 ARULMANI BALAKRISHNAN 3E-21 C-262 ANTI-AGEING HERBS ACTIVITY - A REVIEW IMPACT OF STRUCTURED EDUCATIONAL PROGRAM ON KNOWLEDGE, ATTITUDE AND PRACTICE (KAP) TOWARDS AYURVEDIC MEDICINE AMONG PHARMACY STUDENTS: A QUASI- 1258 KV VEERABHADRAPPA 3E-22 C-244 EXPERIMENTAL DESIGN 1347 KRISHNANU DUTTA 3E-23 C-243 ABSTRACT FOR IPC 1408 KOMOL BHATI 3E-24 C-228 CADAMB-A POTENT HEPATOPROTECTIVE FROM NATURE Molecular Docking Assisted Azadirachtin-A, from Seeds of Azadirachta indica Extract against Cervical 1425 K. Rupa Devi 3E-25 C-232 Cancer 1475 SHIVANI 3E-26 C-224 HERBAL DRUGS VS SYNTHETIC DRUGS 1491 SONALI 3E-27 C-226 MICROBIAL BIOTRANSFORMATION:A PROCESS FOR CHEMICAL ALTERATIONS 1546 SHRUTI BIKA 3E-28 C-220 HERBAL NEUTRACEUTICALS: NATURE’S CURE 1557 MANJU PANDEY 3E-29 C-206 NUTRACEUTICAL SUPPLEMENTATION FOR DIABETES 79 DEEPIKA NP 3E-3 C-10 MARINE NATURAL PRODUCTS AS LEAD MOLECULES IN PARKINSON’S DISEASE 1564 ROHIT RAMCHANDRA TODKAR 3E-30 C-207 Zinnia bicolor as Natural pH Indicator 1568 PRAGYANDIP PARTHASARATHI DASH 3E-31 C-208 Haldina cordifolia: A Pervasive Review on Phytochemical and Therapeutic Potency. 1581 ARCHIT 3E-32 C-210 HERB’S USED IN THE TREAMENT OF ACUTE PANCREATITIS – AN OVERVIEW TO EVALUATE ANTI-ULCER ACTIVITY OF AQUEOUS EXTRACT OF BAUHINIA TOMENTOSA LINN. 1589 LALITA 3E-33 C-212 LEAVES ETHNOMEDICINAL USES OF CUSCUTA REFLEXA ROXB.(AMARBEL / AKASHBEL) FOR LIVER 1598 MANISH 3E-34 C-213 DISEASE, CONSERVED BY THE TRIBES OF ARAVALLI REGION IN RAJASTHAN ETHANOLIC EXTRACT OF ARISTOLOCHIA BRACTEOLATA FLOWER AS A NATURAL INDICATOR 1614 GANESH BHARAT VAMBHURKAR 3E-35 C-204 FOR ACID-BASE TITRATION COMPARATIVE STUDY OF ANTIMICROBIAL ACTIVITY OF SOYMIDA FEBRIFUGA AND SARACA 1656 BARHEWAR PRALAY ANATRAM 3E-36 C-193 ASOCA WITH ZITROMAX 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title 1661 NITISH PANT 3E-37 C-195 ANTI-EPILEPTIC ACTIVITY OF LANTANA CAMARA (LINN.) FLOWERS 1662 MALODE KAJAL PRAVIN 3E-38 C-196 PHARMACEUTICAL IMPORTANCE OF ANTI-INFLAMMATORY HERBAL DRUGS INVESTIGATION OF ANTIASTHMATIC EFFECTS OF S. XANTHOCARPUM SCHRAD AND WENDL. IN 1687 MOHD FAISAL KHAN 3E-39 C-201 OVALBUMIN INDUCED MURINE MODEL OF ASTHMA IDENTIFICATION OF KERATINOPHILIC FUNGI FROM SILIGURI, WEST BENGAL, INDIA USING 160 NEHA 3E-4 C-57 FOLDSCOPE 1754 B.JYOSHNA 3E-40 C-182 TINOSPORA CARDIFOLIA- A MULTI PURPOSE MEDICINAL PLANT 1777 ANIKET B. BANGAR 3E-41 C-184 ANTIASTHMATIC ACTIVITY OF CASSIA AURICULATA EXTRACTION, EVALUATION & FORMULATION OF LEAF ESSENTIAL OIL FROM MURRAYA 1834 ANAGHA CHAITANYA RAUT 3E-42 C-181 KOENIGII FOR ANTI-DIABETIC ACTIVITY AN OVERVIEW OF ABELMOSCHUS ESCULENTUS FOR THE PREVENTION, MITIGATION AND 1874 RENU RANI 3E-43 C-169 TREATMENT OF INSULIN DEPENDENT DIABETES MELLITUS 1893 TARUN KUMAR VERMA 3E-44 C-175 SCREENING OF ANTIOXIDANT ACTIVITY OF SOME NEW PLANT ACTIVE 1955 KANEEZ FATIMA 3E-45 C-155 RECENT ADVANCES AND APPLICATIONS OF FUNCTIONALIZED NANOSILVER SIMULTANEOUS ESTIMATION OF ANTI-ASTHMATIC DRUGS IN PURE AND PHARMACEUTICAL 1977 MONIKA 3E-46 C-159 DOSAGE FORM BY UV SPECTROSCOPY METHOD 1985 MONIKA 3E-47 C-160 UPLC-MS: A POWERFUL TOOL IN ANALYTICAL RESEARCH 2012 PRIYANKA 3E-48 C-149 ANTIOXIDANT PROPERTIES OF GARLIC 2108 CHETNA VERMA 3E-49 C-137 IN-VITRO MODELS FOR THE SCREENING OF ANTI-AGING AND ANTI-WRINKLE ACTIVITY 217 LINGARAJ NAYAK 3E-5 C-23 Milkweed—A Potential Sustainable Natural Resource 2069 GHAZALA ZIA 3E-50 C-140 ANTIDIABETIC POTENTIAL OF NEUTRACEUTICALS 2070 MAHIMA CHAUHAN 3E-51 C-141 ANTICANCER POTENTIAL OF LYOPHILIZED JUICES 430 SWARUP SENAPATI 3E-6 C-42 IN VITRO EFFICACIES OF DESMOSTACHYA BIPINNATA AGAINST ESCHERICHIA COLI QUALITATIVE EVALUATION OF THE ANTISTAPHYLOCOCCAL ACTIVITY OF PERISTROPHE 432 NIKHIL RANJAN PRUSTI 3E-7 C-43 BICALYCULATA 511 ADARSH JHA 3E-8 C-48 CARIPILL- A PILL FOR DENGUE FEVER 572 DIVYA SHARMA 3E-9 C-88 HEALTH BENEFITS OF APIGENIN: A NATURAL FLAVONOID ANTI-INFLAMMATORY ACTIVITY OF SYNTHESIZED INDOLE DERIVATIVES ON CARRAGEENAN 301 ABHITEJA VEERAPANENI 4A-1 D-31 INDUCED PAW EDEMA SYNERGISTIC ANTI-INFLAMMATORY ACTIVITY OF ETHANOLIC LEAVES EXTRACT OF FICUS 1012 ROHTASH SINGH 4A-10 D-177 CARICA & CORDIA DICHOTOMA EFFECT OF CURCUMIN ON IL-1Β AND NF-ΚΒ IN INFLAMMATORY BOWEL DISEASE: AN 1024 SAMANTIKA HALDER 4A-11 D-179 OVERVIEW PROTECTIVE EFFECT OF REPAGLINIDE ON ACETIC ACID INDUCED ULCERATIVE COLITIS IN 1064 BOOLCHANDANI KHUSHBU PRAKASH 4A-12 D-186 TYPE 2 DIABETIC MICE CLOVE OIL AND PEPPERMINT OIL ATTENUATES OVALBUMIN INDUCED ALLERGIC ASTHMA IN 1205 ARABINDA CHANGMAI 4A-13 D-382 WISTAR RAT BY INHIBITING TH2 CYTOKINES AND NORMALIZING AIRWAY MECHANICS RENO AND HEPATOPROTECTIVE POTENTIAL OF MACA AGAINST CCL4 INDUCED INJURY IN 1367 SURAJ SHARMA 4A-14 D-344 RATS 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title RENOPROTECTIVE POTENTIAL OF COROSOLIC ACID: LAGERSTROEMIA SPECIOSA (BANABA) 1369 NIDHI SHARMA 4A-15 D-345 AGAINST GENTAMICIN-INDUCED NEPHROTOXICITY IN RATS STRESS-MEDIATED INCREASES IN SYSTEMIC AND LOCAL EPINEPHRINE IMPAIR SKIN WOUND 1385 GALLA LAVANYA 4A-16 D-354 HEALING: POTENTIAL NEW INDICATION FOR BETA BLOCKERS , 1414 EMBADI SAI NIKHITHA 4A-17 D-325 TOPHACEOUS DROP NOT TO BE IGNORED BEFORE PERIARTICULAR TUMOURS; ABOUT A CASE EVALUATION OF WOUND HEALING POTENTIAL OF DIFFERENT TOPICAL FORMULATIONS OF 1702 LOKESH PRASAD MS 4A-18 D-261 WHOLE PLANT AQUEOUS EXTRACTS OF BIOPHYTUM SENSITIVUM L. IN RATS IN-VITRO ANTI-INFLAMMATORY (LEAVES, BARK AND ROOT) PHYTOCHEMICAL SCREENING OF 1938 PUJA BAG 4A-19 D-233 FICUSS RUMPHII EFFECT OF LUPEOL IN GRANULOMATOUS INFLAMMATION: INVOLVEMENT OF CYTOKININS AND 346 LINU DASH 4A-2 D-39 OXIDATIVE STRESS THE COMBINATIONAL APPROACH OF BETA- CARYOPHYLLENE AND L- ARGININE IMPROVES THE 1998 GINPREET KUAR 4A-20 D-221 LIPID PROFILE AND CONTROL HYPERGLYCEMIA IN TYPE 2 DIABETES MELLITUS EVALUATION OF ANTI-ARTHRITIC EFFECT OF BRASSICA OLERACEA IN FREUND’S ADJUVANT 492 SOMADIP MUKHERJEE 4A-3 D-125 ARTHRITIC RAT: A ROLE OF CYTOKINES EVALUATION INVITRO ANTI-INFLAMMATORY ACTIVITY OF METHANOLIC ROOT EXTRACT OF 579 LAKSHMI HARINI 4A-4 D-134 COCCULUS HIRSUTUS EVALUATION INVITRO ANTI-INFLAMMATORY ACTIVITY OF METHANOLIC ROOT EXTRACT OF 613 ABBARAJU LAKSHMI HARINI 4A-5 D-61 COCCULUS HIRSUTUS EFFECT OF ISOTHIOCIYANATE FROM BROCCOLI Brassica oleracea IN GRANUlOMATOUS 721 SUSMITA BEHERA 4A-6 D-92 INFLAMATION IN RAT ACECLOFENAC VERSES DICLOFENAC: A COMPARATIVE STUDY OF SAFETY, EFFICACY AND TOLERABILITY IN OSTEOARTHRITIS SUBJECTS ATTENDING A SECONDARY CARE HOSPITAL IN 746 C.S.SIRAJ AHMED 4A-7 D-97 KURNOOL 773 REEMA RANI SANDHA 4A-8 D-135 Anti-Inflammatory Potential of Different Extracts of Pergularia daemia Forssk (Asclepiadaceae) Leaf ANTI-PROLIFERATIVE AND APOPTOSIS INDUCTION POTENTIALS OF CYNANCHUM CALLIALATUM 782 KARTHIKEYAN M 4A-9 D-139 ON MCF CANCER CELL LINES AND IN INVIVO MODELS 53 GOPALA KRISHNA CH 4B-1 D-8 Protective Role of Rhizophoramucronata Leaves against Streptozotocin-Induced Diabetic Nephropathy ANTIHYPERGLYCEMIC ACTIVITY OF CUCUMIS MELO VAR. AGRESTIS LEAVES IN STREPTOZOTOCIN- NICOTINAMIDE INDUCED TYPE 2 DIABETIC RATS AND IDENTIFICATION OF 427 GOPALASATHEESKUMAR K 4B-10 D-48 ANTIDIABETIC BIOMARKERS BY HPTLC EVALUATION OF ANTI-OXIDANT ACTIVITY OF ADIANTUM INCISUM FORSK ETHANOLIC EXTRACT 454 ASWIN.K 4B-11 D-114 IN STZ INDUCED TYPE 2 DIABETIC RATS EVALUATION OF ANTIDIABETIC EFFECT OF ALLIUM CEPA AND ALLIUM SATIVUM JUICE ON 508 ABHISHEK PRAJAPATI 4B-12 D-51 EXPERIMENTALLY INDUCED DIABETES MELLITUS AND ITS COMPLICATIONS IN RATS EVALUATION OF ANTIDIABETIC ACTIVITY OF ETHANOLIC EXTRACT OF CATUNAREGAM 667 G.VINOTHRAJ 4B-13 D-79 SPINOSA LINN. FRUITS IN ALLOXAN INDUCED DIABETIC RATS ISOLATION AND CHARACTERIZATION OF ANTI-DIABETIC COMPOUND FROM DESMODIUM 708 RAMKUMAR K 4B-14 D-89 TRILORUM ANTIDIABETIC ACTIVITY OF ETHANOLIC EXTRACT OF HOMALIUM ZEYLANICUM BARK IN 892 PUGAL S 4B-15 D-154 STREPTOZOTOCIN INDUCED DIABETIC RATS CHOLESTEROL LOWERING EFFECT OF ANTIDIABETIC DRUGS IN TYPE-2 DIABETES MELLITUS 985 RAM KUMAR SINGH 4B-16 D-173 PATIENTS 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title REPURPOSING SCREENINGS OF SOME COMMONLY PRESCRIBED DRUGS AS POTENTIAL 29 ARPAN BISWAS 4B-17 D-4 ANTIDIABETIC AGENTS BY IN-SILICO APPROACHES 1059 ULASA PRASHANTHI 4B-18 D-184 INVITRO GLUCOSIDASE INHIBITORY ACTIVITY OF CYPERUS ROTANDUS PREVENTION OF TYPE 2 DIABETES MELLITUS BY CHANGES IN LIFESTYLE AMONG SUBJECT 1060 P.NIHARIKA 4B-19 D-185 WITH IMPAIRED GLUCOSE TOLERANCE 65 GOPALA KRISHNA 4B-2 D-9 Protective Role of Rhizophoramucronata Leaves against Streptozotocin-Induced Diabetic Nephropathy ANTI DIABETIC AND HEPATOPROTECTIVE EFFECT OF BLUEMEA BALSAMIFERA (L) IN STREPTOZOTOCIN INDUCED DIABETIC RATS AND PARACETAMOL INDUCED HEPATOTOXIC 1112 HIMAL BANJARA 4B-20 D-192 RATS BIOEQUIVALENCE STUDY OF ANTIDIABETIC ACTIVITY BETWEEN TWO MARKETED 1116 SOKI DAEME MALANG 4B-21 D-193 FORMULATION OF METFORMIN ON GLUCOCORTICOID INDUCED HYPERGLYCEMIA IN RABBIT THE PROTECTIVE EFFECT OF SHOREA ROXBURGII IN HFD- STZ INDUCED SEXUAL 1170 SRILAKSHMI N 4B-22 D-397 DYSFUNCTION IN RATS 1185 V.APARNA SUSHMI 4B-23 D-399 Epidemiology Of Severe Hypoglycemia Incidence In Insulin Users EFFECT OF VERAPAMIL ON LOWERING FASTING BLOOD GLUCOSE IN HYPERTENSIVE TYPE 2 1220 A.KARUNA 4B-24 D-385 DIABETES PATIENTS EVALUATION FOR ANTIDIABETIC AND HYPOLIPIDEMIC ACTIVITY BIS-(QUERCETINATO)- 1276 ANIL TUKARAM PAWAR 4B-25 D-377 DECAVANADIUM CONJUGATE IN WISTAR RATS IN-VITRO INHIBITORY POTENTIAL OF CAPSELLA-BURSA PASTORIS AGAINST KEY ENZYMES 1284 MOHD AKBAR DAR 4B-26 D-379 RESPONSIBLE FOR POST-PRANDIAL HYPERGLYCAEMIA IN DIABETES 1473 KONDETI TEJASRI 4B-27 D-311 Extraction and Evaluation of Esterified Lutein from Mari gold flower petals ANTI-DIABETIC ACTIVITY OF ETHYL ACETATE EXTRACT OF ADIANTUM INCISUM IN 1513 HARI BASKAR B 4B-28 D-302 STREPTOZOTOCIN INDUCED DIABETIC RATS Pharmacokinetic study of antidiabetic and antihyperlipidemic herbal preparations and herb drug 1697 GANESH BHAURO CHOUDHARI 4B-29 D-283 interaction in streptozotocin induced diabetic rats Effect of ethanolic extract of bark of Bassia latifolia on adrenaline induced hyperglycemia and high fat diet 132 ABINASH KUMAR SAHU 4B-3 D-13 induced insulin resistance on rats. 1701 SOWMYA RUDRARAJU 4B-30 D-260 BCG VACCINE IN DIABETES 1757 MOHITE PRIYANKA MANIK 4B-31 D-255 Herbal drugs used for diabetes: A review POTENTIAL COMBINATIONS EXHIBITING SYNERGISM AND EFFECTIVENESS IN HYPOTHYROIDISM VIA PERIPHERAL 5’MONODIODINASES STIMULATION: INSIGHTS FROM 1853 ARSHVIR KAUR 4B-32 D-236 PRECLINICAL STUDIES INVESTIGATION OF ANTIOXIDAT AND ANTIDIABETIC POTENTIAL OF TRICHOSANTHES DIOCIA BY 1919 POONAM 4B-33 D-226 IN VITRO AND INVIVO METHOD 2024 MEENAKSHI 4B-34 D-210 POSSIBLE ROLE OF VITAMINS IN THE MANAGEMENT OF DIABETES MELLITUS COMBINED EFFECT OF ACTIVE FRACTIONS ISOLATED FROM THE LEAF EXTRACTS OF DREGEA VOLUBILIS AND LEPTADENIA RETICULATA ON PLASMA GLUCOSE CONCENTRATION AND LIPID 214 N.VENKATESAN 4B-4 D-14 PROFILE IN STREPTOZOTOCIN-INDUCED DIABETIC R PHARMACOLOGICAL AND PHYSIOLOGY OF MELATONIN IN THE REDUCTION OF OXIDATIVE 253 NOOTHI NAVYA 4B-5 D-26 STRESS IN VIVO EVALUATION OF ANTI-DIABETIC ACTIVITY OF SYZYGUM CUMINI AND PSIDIUM GUAJAVA IN 295 MASULA TEJA LINGAM RAO 4B-6 D-104 STREPTOZOTOCIN INDUCED DIABETES IN ALBINO WISTAR RATS 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title ANTIDIABETIC ACTIVITY OF ETHANOLIC EXTRACT OF PERSEA AMERICANA. FRUIT (AVOCADO) 319 NELSON MANDELA K 4B-7 D-38 IN STREPTOZOTOCIN INDUCED DIABETIC RATS PHYTOCHEMICAL ANALYSIS, IN VITRO ANTIOXIDANT AND ANTIDIABETIC ACTIVITIES OF LEAF 387 KOWSALYA M 4B-8 D-109 EXTRACT OF CUCUMIS MELO VAR AGRESTIS ANTIDIABETIC ACTIVITY: ABUTILON INDICUM (L.) SEED EXTRACT AGAINST ALLOXAN INDUCED 415 KOTA AMULYA 4B-9 D-46 TYPE 2 DIABETES IN RATS. EVALUATION OF CNS ACTIVITY OF BALIOSPERMUM MONTANUM IN NEUROPHARMACOLOGICAL 78 SRILEKHA PATI 4C-1 D-10 MODELS EVALUATION OF ANTI-EPILEPTIC ACTIVITY OF CARICA PAPAYA LINN. SEED EXTRACT IN 456 SHETTY SHRADHA 4C-10 D-115 EXPERIMENTAL ANIMALS 457 D.HARSHITHA VARMA 4C-11 D-116 EFFECT OF DISSOCIATIVE ANAESTHETICS ON EXCITATION OF CENTRAL NEURONS BY NMDA 469 KATEEJA MEHANEESHA 4C-12 D-119 EVALUATION OF ANTI-EPILEPTIC ACTIVITY OF BRIDELIA SCANDENS (ROXB)WILLD LIPID BASED NANOCARRIERS OF PENTOXIFYLLINE FOR THE TREATMENT OF ALZHEIMER’S 471 SAURAV CHAKRABORTY 4C-13 D-120 DISEASE 494 DEEP SHIKHA 4C-14 D-126 EFFECT OF FLAVONOID APIGENIN IN MANGANESE-INDUCED NEUROTOXICITY IN RATS 516 MONIKA DUHAN 4C-15 D-54 AMYOTROPHIC LATERAL SCLEROSIS- FOCUS ON DISEASE PROGRESSION A CLINICAL STUDY ON EPIDEMIOLOGY AND RECURRENCE RATIO OF CEREBROVASCULAR 553 GANGA NAGARJUNA 4C-16 D-127 ARREST WITH ITS INCIDENCE AND PREVALANCE IN KHAMMAM LOCALITY NEUROPROTECTIVE EFFECT OF ADENYL CYCLASE ACTIVATOR FORSKOLIN IN PROPIONIC ACID INTOXICATED MITOCHONDRIAL COMPLEXES DYSFUNCTION: A BREAKTHROUGH TO 575 SIDHARTH MEHAN 4C-17 D-133 DEVELOP NEW BEHAVIORAL AND BIOCHEMICAL STRATEGIES HIPPOCAMPAL HISTAMINERGIC TRANSMISSION MODULATES ETHANOL INDUCED 659 NISHANT S. JAIN 4C-18 D-78 ANTIDEPRESSANT-LIKE EFFECT EVALUATION OF NEPHROPROTECTIVE ACTIVITY OF MORUS ALBA IN GENTAMICIN INDUCED 693 PATEL DIPAL JITENKUMAR 4C-19 D-85 NEPHROTOXICITY IN RATS MEMORY ENHANCING ACTIVITY OF HYDROALCOHOLIC EXTRACT OF SORGHUM BICOLOR 159 AASHRUTI AGRAWAL 4C-2 D-65 GRAINS 702 RINKI 4C-20 D-86 EFFECT OF NARINGIN IN NEUROTOXICITY INDUCED RATS: A ROLE OF NEUROPROTECTIVES 893 HARIHARA BEHERA 4C-21 D-155 CNS STUDY OF HYDROALCOHOLIC EXTRACT OF LITSEA GLUTINOSA LEAF NEUROPROTECTIVE EFFECT OF ANACARDIUM OCCIDENTALE AGAINST ALUMINUM TOXICITY: AN EXPERIMENTAL STUDY ON COGNITIVE DYSFUNCTION AND BIOCHEMICAL ALTERATIONS IN 900 GADDE.TEJASWINI 4C-22 D-157 RATS CELLULAR LEAPFROGGING: A RECENT DEVELOPED CELL BASED THERAPY FOR NEURAL 917 TANMAY SARMA 4C-23 D-161 DISORDER Evaluation of Nootropic activity of ‘PANCHAGAVYA GHRITYA’ in combination with some other herbal 982 PURAVI NAYAK 4C-24 D-170 drugs FORMULATION AND EVALUATION OF ANTI-WRINKLE CREAM BY USING SEEDS OF PENNISETUM 1001 PRIYANSHU SHEKHAR 4C-25 D-175 GLAUCUM AND PERSEA AMERICANA MEMORY ENHANCING ACTIVITY OF MOMORDICA COCHINCHINENSIS FRUIT BY SCOPOLAMINE 1026 PRIYANSHU SHEKHAR 4C-26 D-180 INDUCED AMNESIA IN RATS EVALUATION OF NEUROPROTECTIVE EFFECTS OF NOVEL SULFONAMIDE DERIVATIVES 28 GAYATRI THAPA 4C-27 D-3 AGAINST PERMANENT BILATERAL COMMON CAROTID ARTERY OCCLUSION IN THE RAT 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title NEUROPROTECTIVE EVALUATION OF COMBINATION OF AT1 AND NMDA RECEPTOR 1035 TENZIN CHOEPHEL 4C-28 D-182 ANTAGONISTS IN ICV-STZ ANIMAL MODEL OF ALZHEIMER'S DISEASE. ROLE OF MONOAMINE OXIDASE - B MODULATOR IN CHRONIC CEREBRAL HYPOPERFUSION 1055 SUPRIYA MISHRA 4C-29 D-183 INDUCED VASCULAR DEMENTIA PHARMACOLOGICAL INTERVENTIONS TARGETING PI3K/AKT/GSK-3Β PATHWAY OF INSULIN SIGNALING IN INTRACEREBROVENTRICULAR-STREPTOZOCIN MODEL OF ALZHEIMER’S 215 ANSAB AKHTAR 4C-3 D-15 DISEASE ENHANCEMENT OF COGNITION IN AGED AND NEURODEGENERATED RATS USING TAURINE 1080 S. RAMACHANDRAN 4C-30 D-190 FROM SEAWEED RED ALGAE. EVALUATION OF ANTI-PARKINSON’S ACTIVITY OF A NON-SELECTIVE SIGMA RECEPTOR 1098 SAYANI BANERJEE 4C-31 D-191 LIGAND, 1,3-0 DITOLYLGUANIDINE IN 6-HYDROXYDOPAMINE LESIONED RAT MODEL EFFECT OF LACOSAMIDE IN AN EXPERIMENTAL MODEL OF CHRONIC CONSTRICTION INDUCED 1127 PADMAJA S. GIRAM 4C-32 D-197 NEUROPATHIC PAIN EVALUATION OF NEUROPROTECTIVE EFFECTS OF NOVEL SULFONAMIDE DERIVATIVES 1142 GAYATRI THAPA 4C-33 D-199 AGAINST PERMANENT BILATERAL COMMON CAROTID ARTERY OCCLUSION IN THE RAT EFFECT OF CHRONIC STRESS ON DEPRESSION AND LEUKOCYTE COUNT: INVOLVEMENT OF 1164 PRIYANKA BOURI 4C-34 D-395 GABAPENTIN EFFECT OF HYDROXY CITRIC ACID ON LEAD-INDUCED OXIDATIVE STRESS IN DIFFERENT 1167 SWATHI PUTTA 4C-35 D-396 REGIONS OF RAT BRAIN EFFECTS OF PSYCHOBIOTICS ON MENTAL HEALTH IN DEPRESSIVE AND COGNITIVE IMPAIRED 1186 J ANISHA EBENS 4C-36 D-400 PATIENTS THROUGH HYPOTHALAMIC- PITUITARY- ADRENAL AXIS. A PSYCHOMETRIC ASSESSMENT ON SEVERITY OF DISEASE WITH SLEEP DEPRIVATION & COGNITIVE IMPAIRMENT, AFFECTING THE QUALITY OF LIFE IN INDIVIDUALS WITH 27 TUSHAR SINGHAL 4C-37 D-2 NEURODEGENERATIVE DISORDERS A CROSS SECTIONAL STUDY OF CENTRAL NERVOUS SYSTEM EFFECTS ASSOCIATED WITH 1229 S. THABITHA KUMARI 4C-38 D-388 THE USE OF ERTAPENUM 1246 SHAMNA HARIS 4C-39 D-390 LONG ACTING INJECTABLE ANTIPSYCHOTICS IN SCHIZOPHRENIA 267 K.MANASVIJYOTHIRMAI 4C-4 D-28 MOYAMOYA DISEASE 1249 SHAMNA HARIS 4C-40 D-391 LONG ACTING INJECTABLE ANTIPSYCHOTICS IN SCHIZOPHRENIA INVITRO CYTOTOXIC EFFECT AND APOPTOSIS INDUCTION OF HYDROALCOHOLIC EXTRACT OF 1254 N.CHIDAMBARANATHAN 4C-41 D-372 BOERHAAVIA DIFFUSA LINN AGAINST HUMAN CANCER CELL LINES A CROSS SECTIONAL STUDY OF CENTRAL NERVOUS SYSTEM EFFECTS ASSOCIATED WITH 1301 S. THABITHA KUMARI 4C-42 D-360 THE USE OF ERTAPENUM PROTECTIVE EFFECT OF TOONA CILIATA LEAF EXTRACT ON CHRONIC UNPREDICTABLE MILD 1316 MEGHA SAINI 4C-43 D-362 STRESS (CUMS) INDUCED BEHAVIORAL AND BIOCHEMICAL ALTERATION IN MICE POSSIBLE NEUROPROTECTIVE STRATEGIES OF FORSKOLIN: AC/CAMP/PKA/CREB ACTIVATOR 1354 AARTI TIWARI 4C-44 D-334 IN RODENT MODEL OF INTRA-CEREBRAL HEMORRHAGE NEUROPROTECTIVE EFFECT OF ADENYL CYCLASE ACTIVATOR IN PROPIONIC ACID 1355 DIKSHA SALUJA 4C-45 D-335 INTOXICATED MITOCHONDRIAL COMPLEXES DYSFUNCTION NEUROPROTECTIVE STRATEGY OF DIRECT ADENYL CYCLASE ACTIVATOR FORSKOLIN IN 3-NP INTOXICATED MITOCHONDRIAL COMPLEXES DYSFUNCTION ASSOCIATED WITH BEHAVIORAL 1356 AKANSH GOEL 4C-46 D-336 AND BIOCHEMICAL ALTERATIONS 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title NEUROPROTECTIVE ROLE OF COQ10 PRECURSOR SOLANESOL AGAINST 3-NITROPROPIONIC ACID INDUCED BEHAVIORAL BIOCHEMICAL CHANGES IN NEURODEGENERATIVE DISORDER 1358 SALONI RAHI 4C-47 D-337 SUCH AS HUNTINGTON’S DISEASE ANTI-ALZHEIMER EFFECT OF TEPHROSIA PURPUREA LEAVES IN SCOPOLAMINE INDUCED 1360 SNEHA PANDEY 4C-48 D-338 BEHAVIORAL AND BIOCHEMICAL ALTERATIONS IN MICE RESTORATION OF ENERGY DYSFUNCTION RELATED MITOCHONDRIAL COMPLEX I AND IV IN 6- 1363 BHARTI VERMA 4C-49 D-341 OHDA INDUCED LESIONS IN PARKINSONIAN RATS 356 AISWORYA ACHARYA 4C-5 D-41 ANTIDEPRESSANT POTENCY OF BHRINGARAJ GHRITA IN ANIMAL MODELS EFFECT OF AMPK ACTIVATOR AND NNOS INHIBITOR IN COGNITIVE DYSFUNCTION AND 1366 NEELAM SHARMA 4C-50 D-343 OXIDATIVE STRESS INDUCED BY CEREBRAL ISCHEMIA USING BCAO MODEL PROTECTIVE EFFECT OF TOONA CILIATA LEAF EXTRACT ON CHRONIC UNPREDICTABLE MILD 1370 MEGHA SAINI 4C-51 D-346 STRESS (CUMS) INDUCED BEHAVIOURAL AND BIOCHEMICAL ALTERATION IN MICE PROTECTIVE EFFECT OF TRAMADOL AND TRAMADOL PLUS IMIPRAMINE ON RESTRAINT 1373 CHHAYA SINGH 4C-52 D-348 STRESS INDUCED ALTERATION IN BEHAVIOURAL PARAMETER IN MICE INVIVO NEUROPROTECTIVE EFFECT OF AZILSARTEN (ANGIOTENSION RECEPTOR BLOCKER) IN 1374 N.CHIDAMBARANATHAN 4C-53 D-349 HALOPERIDOL INDUCED ANIMAL MODEL OF PARKINSON’S DISEASE EXPLORATION OF NEUROPROTECTIVE EFFECTS OF ELLAGIC ACID ON SCOPOLAMINE 1378 NITISH 4C-54 D-350 INDUCED ALZHEIMER’S TYPE DEMENTIA IN RATS NEUROMODULATORY POTENTIAL OF MANGOSTEEN IN 3-NITROPROPIONIC ACID INTOXICATED 1381 BHAWNA GARG 4C-55 D-352 MITOCHONDRIAL DYSFUNCTION ASSOCIATED HUNTINGTON’S DISEASE IN RATS EVALUATION OF LEARNING AND MEMORY ENHANCING ACTIVITY IN AQUEOUS AND ETHANOLIC 1388 MEERA SUMANTH 4C-56 D-356 EXTRACTS OF SIDA VERONICAEFOLIA IN RAT COMPARATIVE ASSESSMENT OF THE EFFECT OF MAGNESIUM SUPPLEMENT AND NICARDIPINE 1391 SHUBHAM BALIYAN 4C-57 D-358 IN ETHANOL INDUCED NEURODEGENERATION IN RATS. 1420 REDDY GUNA NIKITHA 4C-58 D-327 TRAMADOL ADDICTION VS DEPENDENCE 1439 A.SRUTHI 4C-59 D-332 EFFECT OF FLAX MUCILAGE IN HYDROCORTISONE INDUCED DEPRESSION IN RATS COMBINED THEARPY OF SIMVASTATIN AND LEVODOPA IN 6-OHDA INDUCED PARKINSON’S 366 SATYA PRAKASH DIXIT 4C-6 D-42 DISEASE IN RAT MODEL NEUROPROTECTIVE EFFECT OF SAKURANETIN AGAINST ROTENONE-INDUCED HUMAN 1497 B.SATHYA 4C-60 D-319 NEUROBLASTOMA CELLS MODEL IN PARKINSON’S DISEASE NEUROPROTECTIVE ACTION OF ASTAXANTHIN AGAINST HIPPOCAMPAL INSULIN RESISTANCE 1505 SYED OBAIDUR RAHMAN 4C-61 D-301 IN AN AMYLOID-Β FIBRILS INDUCED ANIMAL MODEL OF ALZHEIMER’S DISEASE EVALUATION OF THE POTENTIAL EFFECT OF CURCUMIN AND QUERCETINE IN SCOPOLAMINE 1544 SHUBHAM SHAILY 4C-62 D-308 INDUCED DEMENTIA IN RATS 1571 NIDHI YADAV 4C-63 D-294 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1576 ANJALI KUMARI ATAL 4C-64 D-295 PERIPHERAL NEUROPATHY BIOLOGICAL ASSESSMENT OF MULTI-TARGETED DIRECTED LIGAND FOR THE TREATMENT OF 1648 PATEL DUSHYANTKUMAR VISHNUBHAI 4C-65 D-300 ALZHEIMER’S DISEASE AMELIORATIVE EFFECTS OF ELLAGIC ACID EXPERIMENTALLY INJURY INDUCED NEUROPATHIC 1664 AMAN BABANRAO UPAGANLAWAR 4C-66 D-277 PAIN IN RATS LONG TERM AT1 RECEPTOR BLOCKADE WITH TELMISARTAN ALLEVIATES ASTROGLIAL AND DOPAMINERGIC FUNCTIONS, IN TURN, LOCOMOTOR DEFICITS IN A MOUSE MODEL OF 1670 AMBIKA M S 4C-67 D-278 PARKINSONISM 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title "THANGA PARPAM", A GOLD CALCINED HERBOMINERAL SIDDHA MEDICINE, IMPROVES 1678 SAHYADRI M 4C-68 D-281 COGNITIVE FUNCTION AND NEURO-IMMMUNE RELATED RESPONSES IN SLEEP DEPRIVED MICE 1689 PENKI PRASSANA 4C-69 D-282 AGMATINE IN DEMENTIA CHRONIC UNPREDICTABLE MILD STRESS INDUCED ALTERATIONS IN BRAIN INSULIN 367 MUHAMMED BISHIR 4C-7 D-43 RESISTANCE IN MICE: EFFECTS OF DULOXETINE, PIOGLITAZONE AND CO-ENZYME Q10 EVALUATION OF NEUROPROTECTIVE AND IN-VITRO ANTI-OXIDANT ACTIVITY OF FRACTION 1698 NAGARAJU BANDARU 4C-70 D-284 ISOLATED FROM BIOPHYTUM REINWARDTII (WHOLE PLANT) COMPARATIVE ASSESSMENT OF THE EFFECT OF MAGNESIUM SUPPLEMENT AND NICARDIPINE 1711 SHUBHAM BALIYAN 4C-71 D-265 IN ETHANOL INDUCED NEURODEGENERATION IN RATS NEUROPROTECTIVE ACTIVITY OF CURCUMIN IN COMBINATION WITH PIPERINE AGAINST 1719 SHAKSHI SHARMA 4C-72 D-267 QUINOLINIC ACID INDUCED NEURODEGENERATION IN RATS PHARMACOLOGICAL POTENTIAL OF TOCOPHEROL AND DOXYCYCLINE AGAINST TRAUMATIC 1722 ARTI RANA 4C-73 D-268 BRAIN INJURY INDUCED COGNITIVE/ MOTOR IMPAIRMENT IN RATS A PROSPECTIVE INTERVENTIONAL APPROACH FOR CORRELATION BETWEEN AUTISM & 1734 TUSHAR SINGHAL 4C-74 D-269 CRANIOSYNOSTOSIS: AN EVIDENCE BASED ASSESSMENT DOXYCYCLINE AND TOCOPHEROL PREVENT NEUROINFLAMMATION AND NEUROTRANSMITTERS ALTERATION AGAINST ROTENONE INDUCED PARKINSON’S DISEASE IN 1739 URVASHI 4C-75 D-270 RATS A PSYCHOMETRIC ASSESSMENT ON SEVERITY OF DISEASE WITH SLEEP DEPRIVATION & COGNITIVE IMPAIRMENT, AFFECTING THE QUALITY OF LIFE IN INDIVIDUALS WITH 1740 TUSHAR SINGHAL 4C-76 D-271 NEURODEGENERATIVE DISORDERS A PROSPECTIVE INTERVENTIONAL APPROACH FOR CORRELATION BETWEEN AUTISM & 1756 TUSHAR SINGHAL 4C-77 D-254 CRANIOSYNOSTOSIS: AN EVIDENCE BASED ASSESSMENT IN SILICO EVALUATION OF SOME ANTI-PARKINSON TARGETS USING SHAPE BASED AND 1817 MUDITA MISHRA 4C-78 D-248 LIGAND BASED HYBRID SCREENING METHODS COMPARATIVE ASSESSMENT OF THE EFFECT OF MAGNESIUM SUPPLEMENT AND NICARDIPINE 1830 SHUBHAM 4C-79 D-251 IN ETHANOL INDUCED NEURODEGENERATION IN RATS. PHARMACOLOGICAL EVALUATION OF C.N.S DEPRESSANT ACTIVITY OF A FLAVANOID 398 B.JANAKIRAM 4C-8 D-111 GLYCOSIDE RUTIN HYDRATE NOVEL NEUROPROTECTIVE MECHANISM OF FLUPIRTINE AGAINST 3-NPA INDUCED MEMORY IMPAIREMENT AND MOTOR INCORDINATION IN EXPERIMENTAL MODEL OF HUNTINGTON'S 1894 AVNESH KUMAR 4C-80 D-240 DISEASE EVIDENCE BASED NEUROPROTECTIVE EFFECT OF BLACK TEA TV 25 VARIETY IN EARLY ONSET 1897 SANJEEV KUMAR 4C-81 D-241 OF ALZHEIMER 1901 ANKAN ADAK 4C-82 D-222 Study of Passive Incorporation of Drugs in Fishes & Developing Fish Depression-Related Models 1903 KULWANT SINGH 4C-83 D-223 A REVIEW ON ROLE OF TRPC CHANNELS IN THE NEUROPHYSIOLOGY OF BRAIN 1907 VAIBHAV WALIA 4C-84 D-224 NO-SGC-CGMP PATHWAY INFLUENCE THE ANXIOLYTIC-LIKE EFFECT OF PYRIDOXINE IN MICE Neuroprotective activity of tetramethylpyrazine against 3-nitropropionic acid induced Huntington’s 1920 RAVI CHANDRA SEKHARA REDDY DANDUGA , MS 4C-85 D-227 disease-like symptoms in rats Neuroprotective activity of tetramethylpyrazine against 3-nitropropionic acid induced Huntington’s 1922 RAVI CHANDRA SEKHARA REDDY DANDUGA ,VASA 4C-86 D-229 disease-like symptoms in rats 1954 SHER SINGH 4C-87 D-216 SCHIZOPHRENIA: A REVIEW ON PATHOPHYSIOLOGY AND PHARMACOTHERAPY 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title EVALUATION OF ANTIPARKINSONIAN ACTIVITY OF HYDROALCOHOLIC EXTRACT OF CAPPARIS 1987 ANSARI IMTIYAZ EJAZ AHMED 4C-88 D-220 MOONII THE SEEDS IN ZEBRAFISH AND SWISS ALBINO MICE. EVALUATION OF SEDATIVE AND HYPNOTIC POTENTIAL OF ETHANOLIC EXTRACT OF 2001 YASODHA KRISHNA JANAPATI 4C-89 D-205 HOLOSTEMMA ADA KODIEN SCHULTS IN MICE. EVALUATION OF SPONTANEOUS LOCOMOTOR ACTIVITY OF CRUDE EXTRACT OF MILLETTIA 409 KANDRAKONDA RAJU 4C-9 D-45 PINNATA IN THE RATTUS NORVEGICUS EVALUATION OF THE ANTIPARKINSONIAN AND ANTICONVULSANT ACTIVITY OF HYDRO- 2014 INAYAT ISAK KABIR 4C-90 D-208 ALCOHOLIC EXTRACT OF THE SEEDS OF CANAVALIA GLADIATE IN EXPERIMENTAL ANIMALS PROBABLE MECHANISM FOR THE ANTIDEPRESSANT-LIKE POTENTIAL OF CELASTRUS 2019 REKHA VALECHA 4C-91 D-209 PANICULATUS SEED OIL IN MICE SUBJECTED TO UNPREDICTABLE MILD STRESS STUDIES ON NEUROPROTECTIVE MECHANISMS AND EFFICACY OF COATED NANO 2099 TARAKA SUNIL KUMAR K 4C-92 D-204 ANTIOXIDANTS IN CHRONIC STRESS INDUCED NEUROLOGICAL DISEASES 2036 M VAISHNAVI BAI 4C-93 D-213 BIOMARKERS AND FUTURE TREATMENTS FOR PARKINSON’S DISEASE 123 ARLIN GEORGE 4D-1 D-12 PCSK9 INHIBITORS: TO SOLVE OUT MANY CVS COMPLICATIONS CARDIO-PROTECTIVE ACTIVITY OF AMYGDALIN ISOLATED FROM MALUS DOMESTICA BORKH 311 K.SUPRIYA 4D-10 D-34 SEEDS ON RAT HEART CARDIOPROTECTIVE EFFECT OF AVENA SATIVA LINN AGAINST ISOPROTERENOL INDUCED 312 HARIKA PATIBANDLA 4D-11 D-35 MYOCARDIAL INFARCTION IN MALE SPRAGUE DAWLEY RATS 314 TANMOY SAHA 4D-12 D-36 TENUALOSA ILISHA: A REVIEW OF TREATMENTS IN HYPERCHOLESTEROLEMIA TO EVALUATE THE CARDIOPROTECTIVE EFFECT OF HYDRO-ALCOHOLIC EXTRACT OF MATRICARIA CHAMOMILLA LINN IN ISOPROTERENOL INDUCED MYOCARDIAL INFARCTION IN 419 GAUTAM ADHIKARI 4D-13 D-47 WISTAR RATS 799 MAJJI.SAI HARSHA 4D-14 D-141 SUPERIOR VENACAVA SYNDROME 913 ANKIT KUMAR 4D-15 D-160 PRECLAMPSIA AND ECLAMPSIA: ONE OF MAJOR DISORDER AMONG INDIAN WOMENS 1017 VISHAL KUMAR VISHWAKARMA 4D-16 D-178 PATHOPHYSIOLOGIC ROLE OF ISCHEMIA REPERFUSION INJURY AT MOLECULAR LEVEL EVALUATION OF DAPAGLIFLOZIN IN DIABETES INDUCED ENDOTHELIAL DYSFUNCTION IN 1159 AARTI POKHRIYAL 4D-17 D-392 DIABETES INDUCED ENDOTHELIAL DYSFUNCTION IN RATS CARDIOPROTECTIVE EFFECT OF ALGINIC ACID ON DOXORUBICIN INDUCED MYOCARDIAL 1208 UZWALA REDDY 4D-18 D-383 INJURY IN EXPERIMENTAL RATS Angiotensin (1-7) facilitates cardioprotection of ischemic preconditioning on ischemia-reperfusion- 1235 PRADEEP KANT PACHAURI 4D-19 D-389 challenged rat heart. DIMINUTION OF DEMENTIA BY IC87114-PI3K INHIBITOR IN ICV-STZ INDUCED SPORADIC 168 V.ADITHI 4D-2 D-67 ALZHEIMER'S DISEASE RAT MODEL RECENT INSIGHTS INTO THE ROLE OF VITAMIN B12 AND VITAMIN D UPON CARDIOVASCULAR 1251 RAJA CHAKRAVERTY 4D-20 D-371 MORTALITY: A SYSTEMATIC REVIEW CARDIOPROTECTIVE POTENTIAL OF BOSWELLIC ACIDS AGAINST ISOPROTERENOL 1362 PALLAVI SEN 4D-21 D-340 ASSOCIATED EXPERIMENTAL ANIMAL MODEL OF MYOCARDIAL INFARCTION EXPLORATION OF MYOCARDIAL PRECONDITIONING POTENTIAL OF SONIC HEDGEHOG 1365 SHELLY AGARWAL 4D-22 D-342 PATHWAY AGAINST ISCHEMIA REPERFUSION IN DOCA SALT INDUCED HYPERTENSION INTERVENTION OF ANGIOTENSIN (1-7)/MAS RECEPTOR IN EXPERIMENTAL DIABETIC 1383 RAGINI SINGH 4D-23 D-353 NEPHROPATHY IN RATS 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title PRECONDITIONING POTENTIAL OF PROTEIN TYROSINE PHOSPHATE-1B (PTP1B) INHIBITOR SODIUM ORTHOVANADATE AGAINST ISCHEMIC REPERFUSION INJURY OF DYSLIPIDEMIC RAT 1399 ELIZABETH MINJ 4D-24 D-359 HEART MARINE OMEGA-3 POLYUNSATURATED FATTY ACIDS SUPPRESSES THE LIPOPOLYSACCHARIDE AND HIGH FAT DIET INDUCE INFLAMMATION AND ATHEROSCLEROSIS 1410 PARAKH BASIST 4D-25 D-322 IN C57BL/6 MICE 1551 SARILLA JHANSI 4D-26 D-288 HYPOGLYCEMIC DRUGS IN TREATMENT OF CARDIOVASCULAR DISEASE CARDIOTONIC EFFECT OF HYDROALCOHOLIC ETRACT OF Ipomoea sepiaria Koenig ex. Roxb. 1595 K,PURNA KISHORE 4D-27 D-297 LEAVES COMPARISON OF NOVEL ANGIOTENSIN II RECEPTOR BLOCKER AZILSARTAN MEDOXOMIL VS TELMISARTAN USING AMBULATORY BLOOD PRESSURE MONITORING: A PROSPECTIVE, 1929 MEGHA GARG 4D-28 D-230 RANDOMIZED, DOUBLE BLIND, PARALLEL-ARM STUDY SUBSTRATE UTILIZATION IN FAILING HEART: ROLE OF GLUCOSE TRANSPORTERS AND FATTY 2030 UBAID TARIQ BHAT 4D-29 D-211 ACID TRANSPORTERS EVALUATION OF CARDIOPROTECTIVE ACTIVITY OF OF HYPERICUM PERFORATUM (HPE) AGAINST PRESSURE OVERLOAD INDUCED CARDIAC HYPERTROPHY BY AORTIC STENOSIS IN 169 Swathi Akella 4D-3 D-68 MALE WISTAR RATS. EVALUATION OF HYDRO ALCOHOLIC EXTRACT OF FRUITS OF CASCABELLA THEVETIA FOR ITS 190 SOMNATH SAHA 4D-4 D-70 CARDIOTOXIC ACTIVITY EFFECT OF OMEGA-3-POLYUNSATURATED FATTY ACIDS ON INFLAMMATORY STATUS, LIPID LEVELS AND DISEASE SEVERITY USING ANKLE-BRACHIAL INDEX IN PERIPHERAL ARTERY 218 NEETU OJHA 4D-5 D-17 DISEASE EFFECT OF PRETREATMENT WITH SWERTIA CHIRATA (GENTIANACEAE)ON DOXORUBICIN 239 SOWMYA PATLOLLA 4D-6 D-22 INDUCED CARDIOTOXICITY IN RATS. 277 Batamsetty Lakshmi Suja 4D-7 D-29 STUDY ON ASSESSMENT OF RISK FACTORS ASSOCIATED WITH SECONDARY HYPERLIPIDEMIA SHOWING PRO ARRHYTHMIC EFFECTS IN VITRO AND IN VIVO OF DEHYDRO EVODIAMINE AND 292 K.NITHEESH KUMAR / G.PRASAD REDDY / G.SR 4D-8 D-102 HORTIAMINE ALKALOIDS FOR TRADITIONAL CHINESE HERBAL DRUG EVODIA RUTECARPA GARCINIA INDICA FRUIT EXTRACT MODULATE SALT INDUCED LEFT VENTRICULAR 310 NAMIT KUDATARKAR 4D-9 D-33 HYPERTROPHY IN RATS CD4+ HELPER T CELLS TARGETING IN CANCER – THROUGH SUPERCHARGED NATURAL KILLER 806 B.NIKTHA SINGH 4E-1 D-142 CELLS EVALUATION OF ANTI-OXIDANT AND IMMUNOMODULATORY POTENTIAL OF 1974 DENCITA MERLYN DSOUZA 4E-10 D-218 TABERNAEMONTANA DIVARICATA LINN. ROOT EXTRACT 2045 SURESH AHIR 4E-11 D-215 “IN VIVO ANTIULCER ACTIVITY OF ETHANOLIC EXTRACT JASMINUM OFFICINALE LEAF” 870 GANGAVALLI BHARATH SRINIVAS 4E-2 D-151 PHARMACOLOGICAL POTENTIAL OF DIOSMIN AS IMMUNOMODULATORY AGENT EFFECT OF HYDROALCOHOLIC EXTRACT OF BOERHAAVIA DIFFUSA LINN AGAINST ESTRODIAL 1282 N.CHIDAMBARANATHAN 4E-3 D-378 VALERATE INDUCED POLY CYSTIC OVARIAN SYNDROME IN WISTAR RATS NATTOKINASE: A FIBRINOLYTIC ENZYME FOR THE PREVENTION OF CARDIOVASCULAR 1325 VAGOLU SUSMITHA PRIYA 4E-4 D-363 DISEASE 1476 SHABEENA MOHAMMAD 4E-5 D-312 NICOTINE VACCINATION NOVEL ANTIBODIES AGAINST GPIBA INHIBIT PULMONARY METASTASIS BY AFFECTING VWF - 1484 JYOTHI KANAGALA 4E-6 D-315 GPIBA INTERACTION 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title 1533 NOOPUR SRIVASTAVA 4E-7 D-305 ROLE OF MYCOBACTERIUM VACCAE IN MELANOMA CANCERS 1810 UDDANDI SATYA KARTHIK 4E-8 D-245 REGULATION OF IMMUNE SYSTEM IN CANCER THERAPY 1936 GARAPATI NAGA MANIKANTA 4E-9 D-232 GOLD IN IMPROVING IMMUNE SYSTEM 45 ARCHANA SHARMA 4F-1 D-7 SCREENING OF LEAVES OF WEDELIA CHINENSIS FOR ITS ANTIBACTERIAL POTENTIALITY 778 PAVITHRA.K 4F-10 D-138 PHYTOCHEMICAL SCREENING AND ANTIMICROBIAL EVALUATION OF SIDDHA FORMULATION 807 R.SRUTHI 4F-11 D-143 ANTI-MICROBIAL ACTIVITY OF NEWLY SYNTHESIZED 1-METHYL IMIDAZOLE DERIVATIVE 926 SOURIN SARMA 4F-12 D-162 ANTIOXIDENT AND ANTIMICROBIAL PROPERTIES OF TABERNAEMONTANA DIVARICATA PLANT STUDY OF ANTI MICROBIAL ACTIVITY OF FOLKLORIC CLAIMED CIPADESSA BACCIFERA (ROTH) 961 ANANYA MOHAPATRA 4F-13 D-167 MIQ STUDY ON THE EFFECT OF CIPROFLOXACIN AND SODIUM CHLORIDE AND THEIR COMBINATION 1009 PIJUS NANDI 4F-14 D-176 ON BIOFILM PHYSICO-CHEMICAL PROPERTIES, VITAMIN C CONTENT, AND ANTIMICROBIAL PROPERTIES OF 1065 S.SUMANTH 4F-15 D-187 POMEGRANATE FRUIT (PUNICA GRANATUM L.) BIOLOGICAL EVALUATION OF SOME NOVEL 2-(3-OXO-DIHYDRO-2H-INDOL-2-YLIDENE) 1072 A. SAI GEETHIKA 4F-16 D-188 HYDRAZINECARBOXMIDE SCHIFF BASES PRESCRIPTION PATTERN OF ANTIBIOTICS IN PEDIATRICS WITH RESPIRATORY TRACT 1488 KODURI PRAVALLIKA 4F-17 D-316 INFECTIONS AND GASTRO INTESTINAL TRACT INFECTIONS Challenges in the treatment Carbapenem resistant klebsiella infection, with emphasis on safe and 1555 THOMAS GEORGE L 4F-18 D-289 effective treatment regimens available. SAFETY AND EFFICACY OF AZITHROMYCIN WITH VARIOUS CEPHALOSPORINS:A PROSPECTIVE 1718 SANDADI SUSHMA REDDY 4F-19 D-266 OBSERVATIONAL STUDY 198 BHAVESH K GABEL & MS. SOURVE PRIYA GAVE 4F-2 D-73 “Pharmacological Evaluation of Leaf of Triumfetta Rhomboidea for Antibacterial Activity” 1864 SUMEET DWIVEDI 4F-20 D-237 EVALUATION OF ANTIFUNGAL ACTIVITY OF VARIOUS EXTRACT OF PLUMERIA PUDICA LINN. 1916 DR. SYED RAZI UDDIN FAISAL 4F-21 D-225 ADVERSE DRUG REACTIONS OF ANTIBIOTICS RISK ASSOCIATED WITH EMPIRICAL USE OF ANTIBIOTICS AND INITIATIVES TO REDUCE THE 248 SANGA SWATHI 4F-3 D-24 PROBLEM BIOLOGICAL EVALUATION OF SOME NOVEL 2-(3-OXO-DIHYDRO-2H-INDOL-2-YLIDENE) 252 A. SAI GEETHIKA 4F-4 D-25 HYDRAZINECARBOXMIDE SCHIFF BASES EVALUATION OF ANTHELMINTIC AND ANTI-MICROBIAL ACTIVITY OF A MEDICO-RELIGIOUS 523 TAPAS KUMAR KHUNTIA 4F-5 D-56 PLANT: CORCHORUS DEPRESSUS LINN. (TILIACEAE), WITH ITS HPLC FINGERPRINT. 570 ANAND SAGAR TIWARI 4F-6 D-132 NANOPARTICLES AS AN ALTERNATE TO ANTIBIOTICS A COMPARATIVE STUDY OF THE ANTIMICROBIALACTIVITY OF JATROPHA GOSSYPIIFOLIA LEAF 633 KOLLI PAVANI 4F-7 D-62 EXTRACTS STUDY ON ANTI-MICROBIAL ACTIVITY OF METHANOLIC EXTRACT OF THE WHOLE PLANT OF 757 T.M. FARHATH HASEENA 4F-8 D-99 MOLLUGO CERVIANA SER SUMMARY: PSYCHOPHARMACOLOGICAL EVALUATION OF PROBIOTIC BACTERIA IN CHRONIC FATIGUE SYNDROME IN RAT MODEL INTRODUCTION: CHRONIC FATIGUE SYNDROME (CFS) IS 766 TRAYAMBICA ACHARYA 4F-9 D-100 COMPLEX ILLNESS WITH UNKNOWN ETIOLOGY. THE P 88 AVIJIT MAZUMDER 4G-1 D-11 CHALLENGING ROLES OF PHARMACISTS IN ENSURING SAFETY OF HERBAL MEDICINES 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title EFFECT OF VITAMIN E SUPPLEMENTATION ON DEPRESSION AND QUALITY OF LIFE IN 219 ATHEENA MUKUNDAN.V 4G-10 D-18 POLYCYSTIC OVARY SYNDROME (PCOS). 1176 NUVERA AQEEL YUSUF 4G-100 D-398 A CASE REPORT ON VIRAL MYOCARDITIS WITH GLOMERULONEPHRITIS WITH SEROSITIS 1191 SP.SAI SARVANI 4G-101 D-401 RECENT ADVANCES IN NANOPARTICLE-BASED CANCER DRUG DELIVERY EVALUATION OF WOUND HEALING ACTIVITY OF HYDROALCOHOLIC LEAF EXTRACT OF 1198 VINOD KUMAR 4G-102 D-402 EULALIOPSIS BINATA Anti-anemic activity of hydro-alcoholic extract of Solanum Melongena in phenylhydrazine induced anemic 1199 DIPALI AHIRWAR 4G-103 D-403 rats A STUDY ON CHEMOTHERAPY INDUCED BIOCHEMICAL ABNORMALITIES IN PATIENTS WITH 1202 A. CHANDRIKA REDDY 4G-104 D-381 GYNAECOLOGICAL CANCERS PHYTOPHARMACOLOGICAL EVALUATION OF LICHENS FLAVOPARMELIA CAPERATA AND 1209 ILA SHUKLA 4G-105 D-384 RAMALINA CONDUPLICANS AGAINST ALCOHOL INDUCED LIVER DAMAGE IN RATS PRESCRIBING PATTERN OF ANTI-CRAVING MEDICATION IN ALCOHOL DEPENDENCE-A 1221 SHIVANI ANAND 4G-107 D-386 PROSPECTIVE STUDY ANTIOXIDANT CAPACITY AND FREE RADICALS SCAVENGING ACTIVITIES OF AERIAL ROOTS OF 1228 MANGAL SAIN HOODA 4G-108 D-387 FICUS BENGHALENSIS LINN AITON (MORACEAE) 1263 ARATI MALPANI 4G-109 D-373 Antifertility potential of extracts of the whole plant of Cynodon dactylon Linn.in female Wistar rats. Cytotoxic and anti-apoptotic activities of Aloe vera leaf extract against human Breast carcinoma cell line 221 R.SAI MAHALAKSHMI 4G-11 D-19 MCF-7. ANTI ANEMIC ACTIVITY OF HYDRO-ALCOHOLIC EXTRACT OF FRUIT SOLANUM MELONGENA IN 1264 DIPALI AHIRWAR 4G-110 D-374 PHENYLHYDRAZINE INDUCED ANEMIA IN RATS A PHARMACOLOGICAL AND TOXICOLOGICAL ASSESSMENT OF GREEN PORPHYRINS ISOLATED 1265 DEBASHREE DAS 4G-111 D-375 FROM SPINACIA OLERACEA IN VITRO CYTOTOXICITY OF BLACK PEPPER OIL AND CARROT SEED OIL ON HUMAN SKIN, 30 CHETAN MANJUNATH 4G-112 D-5 GASTRIC AND BRAIN CANCER CELL LINE. A REVIEW ON VASCULAR ENDOTHELIAL GROWTH FACTOR(VEGF) AND IT'S ROLE IN NON- 1271 RAJA DHARA 4G-113 D-376 ENDOTHELIAL CELLS Evaluation of Acute Toxicity Study of AgNPs coupled with Andrographispaniculata in Experimental Murine 1297 SOUMENDRA DARBAR 4G-114 D-380 Model PROTECTIVE EFFECT OF LAKSHADI GUGGUL ON ETHYLENE GLYCOL INDUCED UROLITHIASIS 1312 MUSKAN KHOSA 4G-115 D-361 IN RATS A STUDY ON INCIDENCE AND PATTERN OF ADVERSE DRUG REACTIONS IN GERIATRIC 1332 NATARAJ GR 4G-116 D-364 PATIENTS 1336 MOHAMMED MUZAMMIL 4G-117 D-365 PHARMACO ECONOMICAL STUDY OF DIABETES MELLITUS PATIENTS 1337 D. SARIKA 4G-118 D-366 PHARMACOEPIDEMIOLOGICAL SURVEY OF DIABETES MELLITUS PATIENTS ENHANCEMENT IN IRON ABSORPTION ON INTAKE OF CHEMOMETRICALLY OPTIMIZED RATIO OF PROBIOTIC STRAIN LACTOBACILLUS PLANTARUM 299V WITH IRON SUPPLEMENT PEARL 1342 NEELIMA RANI SANA 4G-119 D-367 MILLET 227 POOJA ARORA 4G-12 D-20 Extraction and Phytochemical Evaluation of the Plants Plectranthus ambonicus and Persicaria hydropiper A REVIEW ON VASCULAR ENDOTHELIAL GROWTH FACTOR(VEGF) AND IT'S ROLE IN NON- 1343 RAJA DHARA 4G-120 D-368 ENDOTHELIAL CELLS 1348 SWAMITA 4G-121 D-369 ASTHMA EXACERBATION PREVALANCE & CONTROL IN INDIA 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title EVALUATION OF ANTICANCER, ANTIOXIDANT AND ANTHELMINTIC ACTIVITIES OF AMARANTHUS 1350 JAMPALA.HEMANTH SRINIVAS 4G-122 D-370 SPINOSUS AND CASCABELA THEVETIA NEPHROPROTECTIVE EFFECT OF ELLAGIC ACID THERAPY IN THE GENTAMICIN TOXICATED 1361 KULDEEP SINGH 4G-123 D-339 RATS INVESTIGATION OF MARIGOLD EXTRACT: CALENDULA OFFICINALIS PRE-TREATMENT IN RATS 1372 KIRTI GUPTA 4G-124 D-347 WITH ACUTELY ISOPROTERENOL INDUCED MYOCARDIAL INFARCTION TREATMENT OF NON UNION AND DELAYED UNION FRACTURES WITH THE AID OF 1380 DAISY SAMITHA 4G-125 D-351 INTRAMEDULLARY INJECTION OF BONE MARROW ASPIRATE CONCENTRATE. 1386 JALAPARTHI HEMA SARVANI 4G-126 D-355 Study of Symptoms, Risk Factors and Prescribing Patterns in Cerebral Stroke Patients ROLE OF EPLERENONE VERSUS AMLODIPINE IN THE MANAGEMENT OF SYSTOLIC 1389 N.BHAVYA SRI 4G-127 D-357 HYPERTENSION: AN OBSERVATIONAL STUDY 1407 SHANMUKHA VINAY PILLI 4G-128 D-321 HEALTH BENEFITS OF PROBIOTICS BY ANTIOXIDANT ACTIVITY 1412 NEHA 4G-129 D-323 THALASSEMIA PREVALENCE OF RISK OF INSULIN RESISTANCE OF FEMALE PATIENTS WITH POLYCYSTIC 236 NIKHITHA GOUD REDDYPALLY 4G-13 D-21 OVARIAN SYNDROME 1413 GUDALA SATHYA SREE 4G-130 D-324 OLD DRUGS- NEW ADRS EVALUATION OF ANTIULCER ACTIVITY OF BISMUTH OXIDE NANOPARTICLES BY PYLORIC 1417 CHALAPATI BHARATHI 4G-131 D-326 LIGATION IN RATS 1421 DILEKHA 4G-132 D-328 WOUND HEALING ACTIVTY OF ASTAXANTHIN ALONG WITH CURCUMIN IN WISTER RATS 1422 LANKE SRAVANI 4G-133 D-329 ASSESSMENT OF DRUG USE PATTERNS AND QUALITY OF LIFE IN HEMODIALYSIS PATIENTS 1432 VIJJAPU SAI MUKUNDA SRIJA 4G-134 D-330 COLD CAPS IN PREVENTING CHEMOTHERAPY INDUCED ALOPECIA HEPATOPROTECTIVE ACTIVITY OF DIFFERENT EXTRACTS OF LEAVES OF ROSTELLULARIA 1433 ENUPOTHULA NANDINI 4G-135 D-331 PROCUMBERS ASSESSMENT OF RISK FACTORS INFLUENCING FUNCTIONAL OUTCOMES IN CEREBRAL 1447 GALLI RAJEEV KUMAR 4G-136 D-333 STROKE PATIENTS USING MODIFIED RANKIN SCALE. 1466 P.V.V AYYAPPA KUMAR 4G-137 D-309 Nicotine Degrading Enzyme -A New Strategy to kick out Smoking Addiction 1471 ABUBAKER SIDDIQ 4G-138 D-310 UTILISATION STUDY OF ORAL HYPOGLYCAEMIC MEDICINES AT A TERTIARY CARE HOSPITAL 1480 REDNAM SUBBA LAKSHMI 4G-139 D-313 A CASE STUDY ON PEMPHIGUS VULGARIS . 243 RAVI GUPTA 4G-14 D-23 CELLULAR ENERGY METABOLISM : RECENT AND EMERGING CANCER RESEARCH A PROSPECTIVE STUDY ON COMMUNITY ACQUIRED PNEUMONIA AND ITS SEVERITY 1481 M.SRIKANTH 4G-140 D-314 ASSESSMENT SCORE BY USING PNEUMONIA SEVERITY INDEX 1490 POOJA 4G-141 D-317 APOPTOSIS :A TARGET FOR ANTICANCER THERAPY THE ROLE OF RAMOSETRON IN THE PREVENTION OF POST-SPINAL SHIVERING IN OBSTETRIC 1492 ASEEM SETHI 4G-142 D-318 PATIENTS: A PROSPECTIVE RANDOMIZED DOUBLE BLIND STUDY 1498 SACHIN 4G-143 D-320 CORONARY ARTERY DISEASE SULFHEMOGLOBINEMIA: A DARK GREEN BLOOD IN FOUR PATIENTS EXPOSED TO SULFUR- 1514 ABHAY RANJAN RAI 4G-144 D-303 CONTAINING COMPOUNDS: A REVIEW A COMPARATIVE STUDY ON THE ANTI-AGING THERAPY BY Punica granatum L. PEEL EXTRACT & 1526 AKANKSHA SAMUEL 4G-145 D-304 JUICE 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title 1539 D. PARVATHI 4G-146 D-306 Statins as modulators in bone formation 1541 P. KRISHNA MOUNICA 4G-147 D-307 RELEVANCE OF GUTMICROBIOTA IN ALZHEMER'S DISEASE 1559 P.SANJULA CHOWDARY 4G-148 D-290 COLOR CHANGING CONTACT LENS 1560 YADAMREDDY.SOWMYA 4G-149 D-291 ANKYLOSING SPONDYLITIS 266 B.LAXMI PRASANNA 4G-15 D-27 MEDICATION NONADHERENCE 1563 MANI TANEJA 4G-150 D-292 AN OVERVIEW : URTICARIA 1565 PAPOLU PRIYANKA NAGA SATYA SAI DURGA 4G-151 D-293 ASPIRIN IN TREATMENT OF COLON CANCER BEG BINDS WITH LXR (Α & Β) TO RE-MODEL NDEA+2-AAF INDUCED HEPATOCELLULAR 1584 SHAKTI P. PATTANAYAK 4G-152 D-296 CARCINOMA IN SD-RATS 1596 P. RAMYA SRI 4G-153 D-298 GOLD NANOPARTICLES IN CANCER THERAPY 1597 BOLLAREDDY LAKSHMI PRASANNA 4G-154 D-299 Cancer therapy by negative immune system regulation 1607 L.HARINI 4G-155 D-285 AN OVERVIEW ON WEST SYNDROME 1625 PRANATHI S.R.K 4G-156 D-286 GENRATION OF FUNCTIONAL ORGANS BY STEM CELLS 1640 UDAIVIR SINGH SARA 4G-157 D-287 IMPACT OF PHARMACOVIGILANCE ON HERBAL MEDICINES - OVERVIEW 1652 K PREETHI SAGAR 4G-158 D-274 ANTI – CANCER ACTIVITY OF SPINACIA OLERACEA BY HIGH THROUGHPUT SCREENING SCREENING OF BARLERIA LONGIFLORA L.F. AND POTENTILLA ANSERINA LINN FOR 1657 RAJAPUTANA MANISHA 4G-159 D-275 ANTIUROLITHIC ACTIVITY STUDY ON ASSESSMENT OF PRESCRIBING PATTERN OF HYPERTENSION IN GERIATRICS 278 MURALI KRISHNA KANDUKURI 4G-16 D-30 ACCORDING TO JNC 8 GUIDELINES 1660 SACHDEO RAHUL ASHOK 4G-160 D-276 COLORECTAL CANCER : AN OVERVIEW ANTI OXIDANT POTENTIAL OF MINOCYCLINE IN JAPANESE ENCEPHALITIS INFECTION IN 1673 RIYA JHA 4G-161 D-279 MURINE NEUROBLASTOMA CELLS INVESTIGATION OF BENEFICIAL EFFECT OF UNIQUE DIVINE NONI IN PRESENCE OF CYCLOPHOSPHAMIDE IN TRANSPLANTABLE TUMOUR BEARING MICE : A CHOICE FOR 1675 JOHN MANI PHILIPS NATHALA 4G-162 D-280 ADJUVANT THERAPY A CLINICAL STUDY OF INCIDENCE, PREVALANCE,AND OUTCOME OF CONGENITAL 1704 MONDAIAH .M 4G-163 D-262 ABNORMALITIES IN NEONATES ,ITS RISK FACTORS AND MANAGEMENT EPIDEMIOLOGICAL INVESTIGATION TO EVALUATE THE EFFECTIVENESS OF POISONING CASES 1706 B.LEENA 4G-164 D-263 IN A TERTIARY CARE HOSPITAL EVALUATION OF ANALGESIC ACTIVITY OF ETHANOLIC EXTRACT OF ANACARDIUM 1708 ARAVINDHAN.V.R , YUVARAJ.D.K , KIRUBAGAR 4G-165 D-264 OCCIDENTALE LINN .BARK BIOLOGICAL EVALUATION OF NEW HYBRIDS OF 4-THIAZOLIDINONE AND 4(3H)-QUINAZOLINONE 1744 SAMPADA JANGAM 4G-166 D-272 AS ANTICONVULSANT AGENTS 1750 BHAWNA KASANA 4G-167 D-273 PEPDUCINS: NEW THERAPEUTIC APPROACHES FOR ASTHMA AND COPD 1 TIRUMALASETTY LAKSHMI KAVYA 4G-168 D-1 Treating endothelial dysfunction with vitamin D in chronic kidney disease: a meta-analysis ANTI-UROLITHIATIC POTENTIAL OF KIGELIA PINNATA LEAVES EXTRACT ON ETHYLENE GLYCOL 1753 SWATI JOSHI 4G-169 D-253 INDUCED NEPHROLITHIASIS IN RATS 294 URMISTHA SARKAR 4G-17 D-103 Anti-ulcer Activity of Hydro alcoholic Extract of Piper Betle Leaf on Experimental Animals 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title 1761 ASHANAND 4G-170 D-256 Societal perspectives on over-the-counter (OTC) medicines INCIDENCE OF SERIOUS ADVERSE SEIZURE EVENTS IN INFANTS FOLLOWING POLIO AND 1781 SACHIN B 4G-171 D-257 PENTAVALENT VACCINATION; A PROSPECTIVE OBSERVATIONAL STUDY. THERAPEUTIC IMPLICATIONS OF THYMOQUINONE IN THE PREVENTION OF TRIPLE NEGATIVE 1783 KAJAL SHARMA 4G-172 D-258 BREAST CANCER A STUDY ON THE MEDICINAL PLANTS USED BY THE LOCAL TRADITIONAL HEALERS IN INDIA 1784 SNEHANAGANWAR 4G-173 D-259 FOR CURING REPRODUCTIVE HEALTH RELATED DISORDERS EVALUATION OF EX VIVO ANTICATARACT ACTIVITY OF ETHANOLIC EXTRACT OF ALSTONIA SCHOLARIS LEAVES ON DEXAMETHASONE-INDUCED CATARACT BY USING ISOLATED GOAT 1802 VUPPALA SRI RAJA BABUJEE MANI PRAHLAD 4G-174 D-243 LENS INCIDENCE OF SERIOUS ADVERSE SEIZURE EVENTS IN INFANTS FOLLOWING COMBINED 1809 SACHIN B 4G-175 D-244 VACCINATION; A PROSPECTIVE OBSERVATIONAL STUDY. 1812 NELAPUDI BHAVANI 4G-176 D-246 APPLICATION OF GRAPHENE IN CANCER THERAPY EVALUATION OF PURGATIVE ACTIVITY OF AQUEOUS PERICARP EXTRACT OF SAPINDUS 1816 LALITHA 4G-177 D-247 EMARGINATUS VAHL. 1823 K.PADMA KRANTHI 4G-178 D-249 HEALTH BENEFITS OF PROBIOTICS BY ANTIOXIDANT ACTIVITY 1827 V.NAGA HARIKA 4G-179 D-250 NUTRACEUTICALS IN OBESITY A COMPARATIVE STUDY ON THE ANTIOXIDANT ACTIVITY OF TWO CONVENTIONAL AYURVEDIC 318 SAVITHA MOL G M 4G-18 D-37 FORMULATIONS CONTAINING TERMINALIA ARJUNA PARTHA ARISHTA AND ARJUNA GHRITA 1850 NITIN CHAUDHARY 4G-180 D-252 NANOSTRUCTURE BASED DRUG DELIVERY SYSTEM: AN APPROACH TO TREAT CANCER 1881 P.ASMA AFREEN 4G-181 D-238 HERBAL MEDICINE USE AMONG DIABETES MELLITUS PATIENTS 1891 RAJESH SHARMA 4G-182 D-239 ADVERSE EFFECTS OF NIMESULIDE DUE TO WHICH IT WAS BANNED 1899 PATRIC MANAKUZHIYIL REJIMON 4G-183 D-242 BEDAQUILINE: A PROMISING NEW AGENT FOR THE TREATMENT OF MDR-TB 1921 SARIKA 4G-184 D-228 PHARMACOEPIDEMICOLOGICAL SURVEY OF DIABETES MELLITUS PATIENTS 1935 MIRNMOY SARKAR 4G-185 D-231 IN-VITRO ANTI-OXIDANT ACTIVITY (BARK AND ROOT) OF FICUSS RUMPHII. INVITRO ANTI-OXIDANT ACTIVITY OF PORTULACA PILOSA LINN. BY DPPH AND NITRIC OXIDE 1939 R. KOTHAI 4G-186 D-234 SCAVENGING METHODS EVALUATION OF EX VIVO ANTICATARACT ACTIVITY OF ETHANOLIC EXTRACT OF ALSTONIA SCHOLARIS LEAVES ON DEXAMETHASONE-INDUCED CATARACT BY USING ISOLATED GOAT 1947 VUPPALA SRI RAJA BABUJEE MANI PRAHLAD 4G-187 D-235 LENS CHANGES IN HEALTH RELATED QUALITY OF LIFE IN PATIENTS WITH CHRONIC HEPATITIS C DURING THE CLINICAL COURSE OF DACLATASVIR/ VELPATASVIR THERAPY: A PROSPECTIVE 1969 DIVYANSHI RASTOGI 4G-188 D-217 OBSERVATIONAL STUDY 1978 ARCHANA 4G-189 D-219 INVITRO EVALUATION OF ANTI-CATARACT ACTIVITY OF TERMINALIA BELLERICA. 352 VINAY JHAWAR 4G-19 D-40 PHARMACOVIGILANCE: AN OVERVIEW IN INDIA Combination Therapy of Wheat Grass (Triticum aestivum Linn)Hydro Alcoholic Extracts With Omeprazole 2002 PRASANTA KUMAR BISWAL 4G-190 D-206 for Gastro protective Effects in Normal And Streptozotocin Induced Diabetic Rats 2011 PALAK AGARWAL 4G-191 D-207 APPROPRIATE METHODS OF USING INHALER DEVICES FOR ASTHMA 2073 TANYA VERMA 4G-192 D-202 PROTECTIVE EFFECT OF DIOSCIN AGAINST INTESTINAL ISCHEMIA 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title FORMULATION AND CHARACTERIZATION OF ANNONA MURICATA LOADED SOLID LIPID NANOPARTICLES FOR INVITRO CYTOTOXIC EFFECT AGAINST MCF-7 CELL LINES ( BREAST 2088 T L P CHANDANA 4G-193 D-203 CANCER) INVITRO HEPATOPROTECTIVE ACTIVITY OF METHANOLIC EXTRACT OF BRASSICA NIGRA L. ON 2032 S. BABY VANITHA 4G-194 D-212 THE BRL3A CELL LINE HEPATOPROTECTIVE ACTIVITY OF MOMORDICA CHARANTIA IN OXALIPLATIN INDUCED 2042 AMIT KUMAR VASHISTH 4G-195 D-214 TOXICITY IN WISTAR RATS 145 NAVEEN SEKAR 4G-2 D-63 INTEREPTING CELL SIGNALLING:AN APPROACH TO TREAT NEUROBLASTOMA 374 DEEPARANI K.UROLAGIN 4G-20 D-105 "EFFECT OF POLYHERBAL FORMULATION ON DIFFERENT CANCER CELL LINES" 377 RANDEEP PATRO 4G-21 D-106 ANTI ULCER PROPERTY OF MUSSAENDA PHILIPPICA PHARMACOLOGICAL EVALUATION OF ANALGESIC ACTIVITY OF A FLAVANOID GLYCOSIDE 383 GUMMA VENKATA KISHORE 4G-22 D-107 RUTIN HYDRATE ANTIOXIDANT CAPACITY AND FREE RADICALS SCAVENGING ACTIVITIES OF AERIAL ROOTS OF 386 MANGAL SAIN HOODA 4G-23 D-108 FICUS BENGHALENSIS LINN AITON (MORACEAE) 392 SIPU KUMARI 4G-24 D-110 WOUND HEALING ACTIVITY OF Bauhinia vahlii LEAF EXTRACT IN INFECTED RATS PROTECTIVE EFFECT OF HYDROALCOHOLIC EXTRACT OF CUCUMIS MELO VAR AGRESTIS 405 VAANADHI N 4G-25 D-44 LEAVES IN STREPTOZOTOCIN-NICOTINAMIDE INDUCED DIABETIC RATS EVALUATION OF IN VITRO BINDING EFFICACY OF PULVERIZED CHLORELLA FOR MERCURY 429 MAHENDRA YADAV 4G-26 D-49 UNDER DIFFERENT PHYSIOLOGICAL CONDITIONS OF G.I.T. 436 AMIYA RANJAN SATAPATHY 4G-27 D-50 Evaluation of diuretic potential of Eclipta alba in rat 446 D.NEELIMA 4G-28 D-112 PANTOPRAZOLE INDUCED DELIRIUM WOUND HEALING ACTIVITY OF THE HYDRO-ALCOHOLIC EXTRACT OF FRAGARIA ANANASSA 450 NEHA BAIS 4G-29 D-113 FRUITS IN WISTAR ALBINO RATS 147 NAVEEN SEKAR 4G-3 D-64 INTERUPTNG CELL SIGNALLING: AN APPROACH TO TREAT NEUROBLASTOMA 459 SHAIK CHANDHINI 4G-30 D-117 EFFECT OF METHYL COBALAMINE IN NON PROLIFERATIVE DIABETIC RETINOPATHY EXRACTION, CHARACTERIZATION AND WOUND HEALING ACTIVITY OF MARINE ALGAE SPECIES, 467 KARPAKAVALLI M 4G-31 D-118 OEDOGONIUM INTERMEDIUM AND OEDOGONIUM GLOBOSUM 472 MEGHA BISHNOI 4G-32 D-121 PROBLEM IN PCOD 474 IBRAHIM SHANFAR 4G-33 D-122 Anti-obesity Activity of Vateria Indica Linn. Stem Bark in Rats 483 BHARGAB DEKA 4G-34 D-123 Personalized approach to converse cognitive weakening in Alzheimer's disease: A review. 486 MRUNAL CHANDAN 4G-35 D-124 RISK BASED MONITORING IN CLINICAL TRIALS: IN DEPTH REVIEW EVALUATION OF HEPATOPROTECTIVE EFFECT OF ZINGIBER OFFICINALE JUICE ON 509 KIRAN CHAMOLI 4G-36 D-52 PARACETAMOL INDUCED HEPATIC DAMAGE IN RATS 514 PRIYANKA SUHAGIYA 4G-37 D-53 ASSESSMENT OF RISK FACTORS FOR DRUG RELATED PROBLEMS IN AMBULATORY PATIENT ANTI-ANGIOGENIC ACTIVITY OF MANGO(MANGIEFERA INDICA)LEAVES EXTRACT ON 521 AVILAS BHATTACHARJEE 4G-38 D-55 CHORIOALLANTOIC ASSAY OF CHICKEN EMBRYO 526 MINAKSHI 4G-39 D-57 NEPHROTOXICITY CAUSED BY GENTAMICIN 164 AKANKSHA SA 4G-4 D-66 Evaluation of Antipyretic Activity of Ethanolic Extract of Moringa oleifera Lam. (Moringaceae) Leaf 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title ANTIOXIDANT CAPACITY AND FREE RADICALS SCAVENGING ACTIVITIES OF AERIAL ROOTS OF 543 MANGAL SAIN HOODA 4G-40 D-58 FICUS BENGHALENSIS LINN AITON (MORACEAE) EVALUATION OF HYPOGLYCEMIC ACTIVITY OF DERRIS SCANDENS& PULICARIA 558 T.VIJAY KUMAR 4G-41 D-128 WIGHTIANA IN NORMAL ALBINO RATS 559 ROSHAN KESHARI 4G-42 D-129 CHRONIC KIDNEY DISEASE IN CONTEXT TO INDIA Comparative Evaluation of Zingiber Officinale and Ocimum Sanctum in Experimental Anxiety and 560 HARSHITA.S 4G-43 D-130 Depressive Models in Mice PROTECTIVE EFFECT OF AQUEOUS EXTRACT OF MURRAYA KOENIGII LEAVES (CURRY LEAVES) AGAINST ALUMINIUM CHLORIDE INDUCED OXIDATIVE STRESS IN RAT LIVER AND 569 VED PRAKASH PANDA 4G-44 D-131 KIDNEY. TO EVALUATE ANOGEISSUS LATIFOLIA FOR IN VITRO ANTI-OXIDANT AND ANTI-CANCER 601 RUKHSAR KHAN, SABA YASMIN, D SUJA RANI 4G-45 D-59 ACTIVITY PREVENTION OF PSYCHOLOGICAL STRESS INDUCED-ULCER IN RATS TREATED WITH FRUIT 610 KIRAN BABASAHEB KOTADE 4G-46 D-60 EXTRACT OF GYMNOSPORA MONTANA PHYTOCHEMICAL SCREENING, ANALGESIC AND ANTI-INFLAMMATORY ACTIVITIES OF ROOT 644 SUNITA WAILA TIWARI 4G-47 D-75 EXTRACT OF WILD BITTER APRICOT (PRUNUS ARMENIACA L.) IN EXPERIMENTAL ANIMALS EFFICACY OF ETHYL ACETATE EXTRACT OF HOMALIUM ZEYLANICUM BARK ON HEPATIC KEY 652 SWAMINATHEN VM 4G-48 D-76 ENZYMES OF GLUCOSE METABOLISM IN STREPTOZOTOCIN INDUCED TYPE 2 DIABETIC RATS PROTECTIVE EFFECT OF HYDROALCOHOLIC EXTRACT OF BOERHAAVIA DIFFUSA LINN 654 N.CHIDAMBARANATHAN 4G-49 D-77 AGAINST NSAID INDUCED ULCER IN SPRAGUE DAWLEY RATS NANO TECHNOLOGY AN NOVEL APPROACH IN DIAGNOSING AND TREATMENT OF RARE NEURO 186 HARSHAD DUBEY 4G-5 D-69 DEGENERATIVE DISORDERS 670 PRAGYAN PARIMITA MANSINGH 4G-50 D-80 WOUND HEALING ACTIVITY OF HYBANTHUSENNEASPERMUSIN EXPERIMENTAL DIABETIC RATS IN VIVO DIURETIC AND IN-VITRO ANTILITHIATIC POTENTIAL OF KALANCHOE PINNATA, EMBLICA 672 ATUL KUMAR SOHGAURA 4G-51 D-81 OFFICINALIS, BAMBUSA NUTAN AND CYNODON DACTYLON 680 SUNETRA CHATTERJEE 4G-52 D-82 ROLE OF SPONSORSHIP IN CLINICAL TRIALS BY PHARMACEUTICAL INDUSTRY: BOON OR BANE EXPLORATION OF THE EFFECT OF SEASMUM INDICUM IN HYPOTHYROIDISM INDUCED 681 RAJNISH KUMAR 4G-53 D-83 ERECTILE DYSFUNCTION IN RATS 689 PRAGYAN PARIMITA MANSINGH 4G-54 D-84 WOUND HEALING ACTIVITY OF HYBANTHUSENNEASPERMUSIN EXPERIMENTAL DIABETIC RATS ANTIOXIDANT EFFECT OF ETHANOLIC EXTRACT OF HOMALIUM ZEYLANICUM BARK AGAINST 704 AKASHRAJ K 4G-55 D-87 STREPTOZOTOCIN GENERATED OXIDATIVE STRESS INDUCED DIABETIC RATS PRECLINICAL EVALUATION OF ANTIULCER ACTIVITY OF HYDROALCOHOLIC EXTRACT OF 706 SAMARJIT BOSE 4G-56 D-88 MACROTYLOMA UNIFLORUM SEED PHARMACOLOGY OF A NOVEL FORMULATION OF PEGYLATED INTERFERON α2B FOR BETTER 711 SUBHASHREE RATH 4G-57 D-90 CLINICAL EFFICACY IN SOLID TUMORS (COLORECTAL CANCER). EVALUATION OF NEPHROPROTECTIVE ACTIVITY OF K.PINNATA ON CISPLATIN INDUCED 713 MINAKSHI JOSHI 4G-58 D-91 NEPHROTOXICTY IN RATS EVALUATION OF SAFETY AND EFFICACY OF METFORMIN IN REDUCTION OF TSH LEVELS IN 37 KOMARAGIRI GOPI 4G-59 D-6 SUBCLINICAL HYPOTHYROIDISM PATIENTS THYROXINE ACTIVITY OF PHYLLANTHIN & HYPOPHYLLANTHIN ON FEMALE & MALE WISTAR 194 AKSHAY KUMAR 4G-6 D-71 RATS 730 VIKAS SHARMA 4G-60 D-93 IMMUNOTHRAPY:A SECURE WAY BEAT EARLY STAGE CANCER 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title SURVEY ON COMPLICATIONS ARISING DURING PREGNANCY AND THEIR MANAGEMENT IN 732 KANCHAN SINGH 4G-61 D-94 DEHRADUN DISTRICT 739 RITTWIK DAS ADHIKARY 4G-62 D-95 EVALUATION OF NEUROPROTECTIVE ROLE OF FENOPROFEN IN EXPERIMENTAL PD 744 EKTA SAINI 4G-63 D-96 HYDROTHRAPY :A NATURAL TREATMENT BY UNIVERSAL SOLVENT 756 ANIRBAN ROY 4G-64 D-98 DIALYSIS FOR TREATING CHRONIC KIDNEY DISEASE 770 L.KARTHIKA 4G-65 D-101 STUDY ON ANTI-PYRETIC ACTIVITY OF MOLLUGO PENTAPHYLLA LINN EVALUATION OF IN VITRO ANTIOXIDANT, ANTI-LIPASE AND ANTI-CHOLESTEROL PROPERTIES 774 SAIKAT SEN 4G-66 D-136 OF BLACK RICE OF MANIPUR, INDIA 776 PALLE PRASHANTH REDDY 4G-67 D-137 VEVALUATION OF HEPATOPROTECTIVE ACTIVITY OF ECOBOLIUM VIRIDE IN ALBINO RATS 787 SATHYA POOJA.G 4G-68 D-140 HEPATOPROTECTIVE STUDIES ON LEAF EXTRACT OF ERYTHRINA INDICA LAM IN ALBINO RATS DIURETIC ACTIVITY OF HYDROALCOHOLIC EXTRACT FRAGARIA × ANANASSA FRUIT IN WISTAR 810 POOJA LODHI 4G-69 D-144 ALBINO RATS INVESTIGATION OF IN VITRO ANTHELMINTIC ACTIVITY OF MUSA SAPIENTUM L. FRUITS 197 JAYDEEP RATHORE YOGESHWAR CHANDRAM VAIBH 4G-7 D-72 ALCHOLIC EXTRACT WOUND HEALING ACTIVITY OF THE HYDRO-ALCOHOLICEXTRACT OF DALBERGIA LATIFOLIA 828 NIRAJ VISHWAKARMA 4G-70 D-145 LEAVES IN WISTAR ALBINO RATS 834 ABIR LAL SAMANTA 4G-71 D-146 MEDICATION ERROR AND PREVENTION 847 SHOBHIT PRAKASH SRIVASTAVA 4G-72 D-147 IMPACT OF PHARMACOVIGILANCE ON HERBAL MEDICINE: AN OVERVIEW 848 VINAY JHAWAR 4G-73 D-148 PHARMACOVIGILANCE: AN OVERVIEW IN INDIA 849 B.RAJESHWARI 4G-74 D-149 EFFECTS OF THE MEDICATIONS ON QUALITY OF LIFE ON ONE YEAR POST STROKE PATIENTS HEPATOPROTECTIVE ACTIVITY OF BRIDELIA SCANDENS ROXB WILD AGAINST CCL4 INDUCED 862 V.GOMATHI 4G-75 D-150 HEPATOTOXICITY IN RATS. A REIEW ON VASCULAR ENDOTHELIAL GROWTH FACTOR(VEGF) AND IT'S ROLE IN NON- 875 RAJA DHARA 4G-76 D-152 ENDOTHELIAL CELLS AN AUDIT ON GERIATRIC PRESCRIBING AND ANTICHOLINERGIC DRUG USE PRE- AND POST- 885 G.KISHORE KUMAR 4G-77 D-153 HOSPITAL ADMISSION 895 PRALAY ALU 4G-78 D-156 A REVIEW ON THE RECENT OUTBREAKS OF THE DEADLIEST DISEASES AN INVESTIGATION ON THE THERAPEUTIC POTENTIAL OF A NOVEL COMPOUND AGAINST 905 PRASANTI SHARMA 4G-79 D-158 PEPTIC ULCER 199 YOGESHWAR CHANDRAM BHAVESH GABEL 4G-8 D-74 “Epidemiological Study of Estrogens and Phytoestrogens” 908 PREETI ARYA 4G-80 D-159 GREEN TEA: FRIEND OR FOE? 931 A.DIVYASRI 4G-81 D-163 SKELETAL MUSCLE RELAXANT ACTIVITY BY USING ROTA ROD APPARATUS IN ALBINO MICE 936 ABHAY KUMAR RAJAK 4G-82 D-164 A REVIEW ON EFFECT OF TEA ON IMMUNE SYSTEM 942 S.MUZAFFAR AHMAD 4G-83 D-165 EVALUATION OF ANTIOBESITY ACTIVITY OF APIUMGRAVEOLENS STEMS IN RATS 943 MAINAK MONDAL 4G-84 D-166 A CASE STUDY OF MACULAR DEGENERATION EVALUATION OF INVITRO ANTIUROLITHIATIC ACTIVITY OF ETHANOLIC AND METHANOLIC 962 ALLA MOUNICA 4G-85 D-168 EXTRACTS OF LEAVES OF ACALYPHA INDICA.L 976 SUDIP KUMAR OJHA 4G-86 D-169 BIOLOGICAL AND PHARMACOLOGICAL ACTIVITIES OF PHYLLANTHUS EMBLICA (AMLA) 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title EVALUATION OF AUTONOMIC ACTIVITY OF CURCUMA LONGA BY USING RAT ILEUM 983 NIRMALYA KAHN 4G-87 D-171 PREPARATION A PROSPECTIVE OBSERVATIONAL STUDY ON MEDICATION ERRORS IN A MULTI 984 AVANISH ILLURI 4G-88 D-172 SUPERSPECIALITY HOSPITAL EVALUATION OF ANTIULCER ACTIVITY OF TUBEROUS EXTRACT OF GLORIOSA SUPERBA LINN 996 SHRIDHAR N DESHPANDE 4G-89 D-174 IN EXPERIMENTAL RAT. 216 SHUBHAM DWIVEDI 4G-9 D-16 IN SILICO MOLECULAR MODELING AND DOCKING STUDY OF ANTICANCER DRUGS Comparative studies on wound healing potential of the hydro alcoholic leaf extract of Garuga pinnata and 1029 DEBAJYOTI SAHA 4G-90 D-181 Blumea balsamifera 1078 ARJITA JHA 4G-91 D-189 IMPORTANCE OF PHARMACOVIGILANCE IN CLINICAL PRACTICE IN INDIAN CONTEXT IN-VITRO PHARMACOLOGICAL SCREENING OF TECOMARIA CAPENSIS ON MCF- 7 CELLLINE 1119 GIRISH NIDUMUKKALA 4G-92 D-194 (BREAST CANCER) 1120 AKSHATA SHRIYAN 4G-93 D-195 BANNED FIXED DRUG COMBINATION: AN OVERVIEW URINARY LEVELS OF NOVEL KIDNEY BIOMARKERS AND RISK OF TRUE WORSENING RENAL 1122 CH. SUREKHA 4G-94 D-196 FUNCTION AND MORTALITY IN PATIENTS WITH ACUTE HEART FAILURE EVALUATION OF WOUND HEALING ACTIVITY OF THE LEAF EXTRACT FROM AEGLE MARMELOS 1137 VIVEK PATIDAR 4G-95 D-198 AND OCIMUM SANCTUM 1146 T.LAKSHMI KAVYA 4G-96 D-200 Euphorbia prostata – A Clinically Proven Drug in Early Grades Of Symptomatic Haemorrhoids EVALUATION OF CYTOPROTECTIVE ACTIVITY OF HYDROETHANOLIC LEAVES EXTRACT OF 1148 AKRITI CHETTRI 4G-97 D-201 FICUS SEMICORDATA BUCH.HAM ON RATS PROTECTIVE EFFECT OF THE MONOAMINO GLYCYRRHIZINATE AGAINST ETHYLENE GLYCOL 1160 TEJASWI I 4G-98 D-393 INDUCED LITHIASIS IN RATS 1163 ADAPA PAVAN VENKATA SAI TEJA 4G-99 D-394 EBOLA VIRUS DISEASE DETERMINATION OF ENASIDENIB IN DRIED BLOOD SPOTS OF MICE BLOOD: APPLICATION TO 250 SREEKANTH DITTAKAVI 5A-1 E-3 PHARMACOKINETIC STUDY INVITRO-INVIVO CORRELATION OF PARACETAMOL AND TRAMADOL ON RABBITS USING RP- 321 MADHU KAVYA SREE PAMARAJU 5A-2 E-4 HPLC BIOANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE QUANTIFICATION OF ARTEMETHER AND ITS METABOLITE DIHYDRO ARTIMISININE (DHA) IN HUMAN K3 EDTA 588 DEVARAKONDA ASHOK 5A-3 E-27 PLASMA BY LCMS/MS -5500 BY USING STABILIZATION BIOANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE QUANTIFICATION OF ARTEMETHER AND ITS METABOLITE DIHYDRO ARTIMISININE (DHA) IN HUMAN K3 EDTA 591 DEVARAKONDA ASHOK 5A-4 E-28 PLASMA BY LCMS/MS -5500 BY USING STABILIZATION Development and validation of oral sustained release dosage form of Nateglinide and its pharmacokinetic 133 KAVYA SREE VELALA 5B-1 E-1 evaluation in rabbit plasma using RP-HPLC FORMULATION AND EVALUATION OF TELMISARTAN MOUTH DISSOLVING TABLETS FOR THE 723 S. PRIYA DHARSHINI 5B-10 E-16 TREATMENT OF HYPERTENSION FORMULATION AND EVALUATION OF BILAYER TABLET OF METOPROLOL TARTARATE SR AND 741 K.YUVASHRI 5B-11 E-17 ROSUVASTATIN CALCIUM FORMULATION AND EVALUATION OF MODIFIED RELEASE GLICLAZIDE TABLETS FOR THE 803 VISHNU PRIYA.R 5B-12 E-30 TREATMENT OF DIABETES 1195 GAURAV KUMAR BHARGAV 5B-13 E-60 IN VIVO EVALUATION OF MICRO-BALLOONS BY GAMMA SCINTIGRAPHY 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title DEVELOPMENT AND VALIDATION OF METHODOLOGY TO STUDY THE GENETIC POLYMORPHISM OF RFC1-G80A AND MTHFR C677T GENES AND THEIR IMPACT ON THE TREATMENT OUTCOMES 1215 JITHENDRAN S 5B-14 E-58 OF METHOTREXATE IN RHEUMATOID ARTHRITIS PATIEN RALOXIFENE HCL -PHOSPHOLIPID COMPLEX: PRODRUG APPROACH WITH ENHANCED 1293 ATUL JAIN 5B-15 E-57 BIOPHARMACEUTICAL ATTRIBUTES AND ANTICANCER ACTIVITY FORMULATION DEVELOPMENT AND EVALUATION OF MEBEVERINE EXTENDED RELEASE 171 K. JYOTHSNA 5B-2 E-11 PELLETS 1846 URMILA JANGALE 5B-21 E-50 BIOEQUVALENCY STUDY OF PHARMACOKINETIC PROPERTIES OF AVIAN IMMUNOGLOBULIN (IGY) TO QUALIFY AS 1913 MEJO C KORAH 5B-22 E-45 THERAPEUTIC PROTEIN TO TREAT SNAKE -BITE VICTIMS FORMULATION AND EVALUATION OF MUCOADHESIVE BUCCAL PATCHES FOR DELIVERY OF 1930 SUNITA BABA SHINDE 5B-23 E-46 FLUOXETINE HYDROCHLORIDE APPLICATION OF TRANSDERMAL DRUG DELIVERY SYSTEM TO OPTIMIZE BIOPHARMACEUTICAL 1933 AMARAJA RAJENDRA BURANDE 5B-24 E-48 CHARACTERISTICS OF CLOTRIMAZOLE DESIGN , DEVELOPMENT AND EVALUATION OF GRISIOFULVIN NANOEMULSION GEL FOR 1952 AKASH PRALHAD GAYAKWAD 5B-25 E-40 TOPICAL FUNGAL INFECTION FORMULATION DEVELOPMENT AND EVALUATION OF MEBEVERINE EXTENDED RELEASE 172 K. JYOTHSNA 5B-3 E-12 PELLETS ENHANCING THE SOLUBILITY OF PROLONGED-RELEASE DIPYRIDAMOLE CAPSULES BY 496 S RUCHI SUNAYANA 5B-4 E-25 EMPLOYING TARTARIC ACID Preparation, Characterization and In Vitro – In Vivo Study of Rosuvastatin Calcium Loaded Solid Lipid 539 HARJEET SINGH 5B-5 E-8 Nanoparticles (SLNs) 636 SHWETA PAROHA 5B-6 E-10 NANO-FORMULATIONS OF COENZYME Q-10: MODULATION OF PRE-CLINICAL BIOAVAILABILITY COMPARITIVE PHARMACOKINETIC STUDY OF 5-FLUOROURACIL SUSPENSION AND 5-FU 650 D.MUSTAFA 5B-7 E-13 NANOPARTICLES INCORPORATED IN SUCRALFATE SUSPENSION USE OF SUPER DISINTEGRANTS AS SOLID DISPERSION CARRIER FOR ENHANCING 655 SOUVIK GIRI 5B-8 E-14 DISSOLUTION PROFILE OF MESALAMINE A COMPARATIVE PHARMACOKINETIC STUDY OF ASPIRIN SUPPOSITORIES AND ASPIRIN 685 AASIF.K 5B-9 E-15 NANOPARTICLES LOADED SUPPOSITORIES EFFECT OF SUPER DISINTEGRANT AND LUBRICANT ON OPTIMISED FAST DISINTEGRATING 298 ANNAPAREDDY PARVATHI 5C-1 E-19 TABLETS OF VERAPAMIL HYDROCHLORIDE 1851 MOHAMED ALEMAM IBRAHIM 5C-10 E-49 DMPK OR DRUG METABOLISM AND PHARMACOKINITICS OF CYTOCHROMEP450 IN SILICO, IN VITRO AND IN VIVO METABOLITE DETECTION AND DEPICTION OF 345 FARAH IRAM 5C-2 E-5 ESLICARBAZEPINE ACETATE 390 MORUSU KEERTHANA 5C-3 E-20 FUNGAL PRODUCTION OF NORCLOBAZAM - AN ACTIVE METABOLITE OF CLOBAZAM EFFECT OF SUPER DISINTEGRANT AND LUBRICANT ON OPTIMISED FAST DISINTEGRATING 449 ANNAPAREDDY PARVATHI 5C-4 E-21 TABLETS OF VERAPAMIL HYDROCHLORIDE 480 SUMIT DASH 5C-5 E-23 Design and Evaluation of Sustained Release Matrix Tablets of Gliclazide Development and Evaluation Nanoemulsions Gel for Transdermal Drug Delivery System using 500 MONALISA NAYAK 5C-6 E-26 Dexibuprofen FORMULATION AND EVALUATION OF TELMISARTAN IMMEDIATE RELEASE TABLET BY SOLVENT 1174 K.SRI GREESHMA SWETHA 5C-7 E-59 EVAPORATION METHOD 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title 1352 PIYUSH LODHI 5C-8 E-56 DRUG METABOLISM 1730 MOHAMED ALEMAM IBRAHIM 5C-9 E-52 DMPK OR DRUG METABOLISM AND PHARMACOKINITICS OF CYTOCHROMEP450 CURCUMIN ENHANCE THE INTESTINAL TRANSPORT OF VINBLASTINE BY INSITU PERMEABILITY 522 SHANKARAIAH PULIGILLA 5D-1 E-6 AND INHIBITION OF P-GLYCOPROTEIN &CYP3A4 IN RATS 1562 U.V.S.S.SREENIDHI 5D-2 E-54 NANOPARTICLE BASED DRUG DELIVERY SYSTEM TO FIGHT AGAINST CANCER 1578 U.V.N.S.S.SREENIDHI 5D-3 E-55 NANOPARTICLE BASED DRUG DELIVERY SYSTEM TO FIGJT AGAINST CANCER 2044 DEBIPARNA BISWAS 5D-4 E-38 V-SMART: A NEWER BRAIN TARGETING TECHNIQUE 234 YASH SINHA 5E-1 E-2 RELOXCIFEN LOADED FOLATE CONJUGATED MULTIWALLED CARBON NANOTUBES. SOLID SELF‑NANOEMULSIFYING SYSTEM OF HYDROCHLOROTHIAZIDE: FORMULATION AND 872 DEEPIKA JOHN 5E-10 E-33 EVALUATION PREPARATION AND EVALUATION OF PH DEPENDENT AMORPHOUS SOLID DISPERSION OF 1052 POOJA BIDLA 5E-11 E-34 FEBUXOSTAT BY SPRAY DRYING TECHNIQUE 1709 M.NAGA SRAVYA 5E-16 E-51 SOLID LIPID NANO PARTICLES EVALUATION OF ANTI-SCHIZONTAL ACTIVITY OF LIPID-BASED NANOMICELLAR FORMULATION 1745 GUNEET SINGH RANDHAWA 5E-17 E-53 OF LUMEFANTRINE Development of herbal formulation with Ajwa seed (phoenix dactylifera l.) Extract and zam-zam water for 1931 IBRAHIM AFSAL 5E-18 E-47 invitro-and invivo Anticancer Activity 1956 NABHAN KP 5E-19 E-41 Delayed Release Of Rabeprazole Sodium Tablet Using Eudragit L30d55 Polymer 470 AKHIL ARUN ELANGO 5E-2 E-22 FORMULATION AND EVALUATION OF ORAL FAST FILM OF VITAMIN B6 1958 HAFIS A 5E-20 E-42 Formulation And Evaluation Of Stealth Nanoparticles Containing Methotrexate FORMULATION AND EVALUATION OF CITRIZINE ORAL DISPERSIBLE TABLET BY USING ION 1959 VINAY KRISHNA RK 5E-21 E-43 EXCHANGE RESINS 1964 DHANASHREE ASHOK PAWAR 5E-22 E-44 DESIGN, DEVELOPMENT AND CHARACTERIZATION OF ORNIDAZOLE LOADED NANOSPONGES TITLE: DEVELOPMENT AND CHARACTERIZATION OF MORIN DIHYDRATE LOADED 2010 MOHIT SAHNI 5E-23 E-37 MICROPARTICULATE CARRIERS FOR MANAGEMENT OF HEPATOTOXICITY DEVELOPMENT AND CHARACTERIZATION OF MORIN DIHYDRATE LOADED MICROPARTICULATE 2056 MOHIT SAHNI 5E-24 E-35 CARRIERS FOR MANAGEMENT OF HEPATOTOXICITY 2063 PRIYANKA SHARMA 5E-25 E-36 FOOD ADULTERATION AND WATER IMPURITIES AND ITS EFFECT ON HUMAN HEALTH ENHANCEMENT OF SOLUBILITY, DISSOLUTION RATE AND MICROMERITIC PROPERTIES OF 2046 THATIKONDA MANOJ PRABHAKAR 5E-26 E-39 AMIODARONE USING SPHERICAL AGGLOMERATED SOLID DISPERSIONS EFFECT OF SUPER DISINTEGRANT AND LUBRICANT ON OPTIMISED FAST DISINTEGRATING 495 ANNAPAREDDY PARVATHI 5E-3 E-24 TABLETS OF VERAPAMIL HYDROCHLORIDE 532 YASH SINHA 5E-4 E-7 RELOXCIFEN LOADED FOLATE CONJUGATED MULTIWALLED CARBON NANOTUBES. FORMULATION AND IN VITRO EVALUATION OF FLOATING TABLETS OF 623 KUNAKU RAVI CHANDRA 5E-5 E-9 HYDROCHLOROTHIAZIDE BY USING VARIOUS POLYMERS DESIGN,DEVELOPMENT AND EVALUATION OF MUCOADHESIVE MICROPARTICULATE CONTROLLED RELEASE PERORAL THERAPEUTIC SYSTEM OF VERAPAMIL HYDROCHLORIDE 765 PAKPI DOYE 5E-6 E-18 USING COMBINED PROCESSED PLANT EXUDATES DEVELOPMENT AND CHARACTERISATION OF FLOATING MICRO BALLOONS CONTAINING 780 S.MD ABBAS 5E-7 E-29 ORNIDAZOLE 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title FORMULATION AND INVITRO EVALUTION OF FLOATING TABLETS OF HYDROCHLORO THIAZIDE 835 KUNAKU RAVI CHANDRA 5E-8 E-31 BY USING VARIOUS POLYMERS. SOLID LIPID NANOPARTICLES: A NOVEL PLATFORM FOR THE DELIVERY OF ROPINIROLE 868 GRACE SEBASTIAN 5E-9 E-32 HYDROCHLORIDE A NEW ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF SACUBITRIL ANA 50 SUTHAKARAN RAJ 6A-1 F-7 VALSARTAN IN PHARMACEUTICAL DOSAGE FORMS BY USING RP-HPLC RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF 146 KAPU SAI PRIYANKA 6A-10 F-50 HYDROCORTISONE AND ACYCLOVIR IN PHARMACEUTICAL DOSAGE FORMS. DEVELOPMENT AND VALIDATION OF NOVEL ANALYTICAL FOR SIMULTANEOUS ESTIMATION OF 1641 PRAMOD KUMAR 6A-100 F-192 TOFACITINIB AND METHOTREXATE BY RP-HPLC ESTIMATION OF DIETHYLHEXYL PHTHALATE IN DIFFERENT PACKAGED FOOD PRODUCTS BY 1643 GAJENDRA T A 6A-101 F-193 HIGH PERFORMANCE LIQUID CHROMATOGRAPHY RP-HPLC METHOD FOR ESTIMATION OF VALSARTAN AND AMLODIPINE BESYLATE IN BULK AND 1644 K.VARA PRASADA RAO 6A-102 F-194 PHARMACEUTICAL DOSAGE FORM DEVELOPMENT AND VALIDATION OF NOVEL ANALYTICAL METHOD FOR SIMULTANEOUS 1651 AMAN KAPOOR 6A-103 F-172 ESTIMATION OF METFORMIN AND PIOGLITAZONE BY RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-HPLC METHOD FOR ESTIMATION OF HYDROXYCHLOROQUINE SULPHATE IN PHARMACEUTICAL LIQUID DOSAGE 1653 APOORVA BAUSKAR 6A-104 F-173 FORM DEVELOPMENT AND VALIDATION OF A STABILITY INDICATING RP-HPLC METHOD FOR THE 1654 SACHIN GHOLVE 6A-105 F-174 DETERMINATION OF CARVEDILOL IN BULK AND PHARMACEUTICAL DOSAGE FORM RP HPLC METHOD FOR QUANTITATIVE ESTIMATION OF BREXPIPRAZOLE IN TABLET DOSAGE 1665 SHRAWAN KUMAR SINGH 6A-106 F-175 FORM QBD-ENABLED ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR QUANTIFICATION OF CHRYSIN EMPLOYING ECO-FRIENDLY ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY 1672 TEENU 6A-107 F-176 TECHNIQUE STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF HYDROXYCHLOROQUINE SULPHATE IN PHARMACEUTICAL LIQUID DOSAGE FORM. MR. 1693 APOORVA BAUSKAR 6A-108 F-179 APOORVA BAUSKAR*, DR. (MRS) SONALI MAHAP 1716 JADHAV AMIT APPASO 6A-109 F-168 REVIEW OF HYPHENATED TECHNIQUES SIMULTANEOUS ESTIMATION OF HYDROCORTISONE AND KETOCONAZOLE IN 148 DIVYA KALASANI 6A-11 F-51 PHARMACEUTICAL DOSAGE FORM BY RP-HPLC METHOD “DEVELOPMENT OF DEGRADATION PROFILE FOR ESTIMATION OF ANTIVIRAL DRUG IN THEIR 1732 BHISE AMARJEET MAHADEV 6A-110 F-169 COMBINED DOSAGE FORM BY RP-HPLC” STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION 1743 ABHAY BHARAMBE 6A-111 F-171 OF DIMETHYL FUMARATE IN PHARMACEUTICAL DOSAGE FORM QUANTITATIVE ESTIMATION OF ROPINIROLE HYDROCHLORIDE IN API AND TABLET DOSAGE 1772 SADASHIVAIAH R 6A-112 F-165 FORM BY REVERSE PHASE HPLC METHOD. VALIDATED RP-HPLC METHOD FOR QUANTITATIVE ESTIMATION OF ELUXADOLINE IN 1803 EDNA D'SOUZA 6A-113 F-164 PHARMACEUTICAL FORMULATIONS 1852 ROHIT KUMAR 6A-114 F-152 RP HPLC METHOD FOR DETERMINATION OF NEFOPAM TABLET DOSAGE FORM Quantitative estimation and Validation of Clevidipine in Bulk and Emulsion dosage form by Reverse 1855 MADHURI VYANKATRAO JADHAV 6A-115 F-154 Phase High Performance Liquid Chromatography 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title 1856 ANKITA DATTARAM SOLKAR 6A-116 F-155 RP HPLC method for determination of Evogliptin tartrate in bulk and tablet dosage form DEVELOPMENT AND VALIDATION OF RP HPLC METHOD FOR QUANTITATIVE ESTIMATION OF 1857 PRIYA RAMDAS TEMGIRE 6A-117 F-156 LENVATINIB IN CAPSULE DOSAGE FORM 1858 NIKHIL BHAGYAWAN DHANVIJAY 6A-118 F-157 RP HPLC method for determination of Alverine in bulk and capsule dosage form 1859 RHUDDHI NARESH RAUT 6A-119 F-158 RP HPLC method for determination of Oxaceprol in bulk and tablet dosage form SIMULTANEOUS ESTIMATION OF HYDROCORTISONE AND KETOCONAZOLE IN 149 K.DIVYA 6A-12 F-52 PHARMACEUTICAL DOSAGE FORM BY RP-HPLC METHOD “BIO-ANALYTICAL METHOD DEVELOPMENT AND ITS VALIDATION FOR THE ESTIMATION OF IRINOTECAN HCL IN RAT PLASMA AND ITS APPLICATION FOR PHARMACOKINETIC STUDIES BY 1863 KUMUDHA VALLI SURESHKUMAR 6A-120 F-159 RP-HPLC” METHOD DEVELOPMENT AND VALIDATION OF RAMIPRIL AND AMLODIPINE BESYLATE IN 1870 SHAIK. MOBINA BEGUM 6A-121 F-160 PHARMACEUTICAL DOSAGE FORM BY USING RP-HPLC ESTIMATION OF DIETHYLHEXYL PHTHALATE IN DIFFERENT PACKAGED FOOD PRODUCTS BY 1883 GAJENDRA T A 6A-122 F-162 HIGH PERFORMANCE LIQUID CHROMATOGRAPHY ANALYTICAL METHOD DEVELOPMENT AND SIMULTANEOUS ESTIMATION OF 1886 ANANDKUMAR TENGLI 6A-123 F-163 ANTIHYPERTENSIVE DRUGS IN NEWLY FORMULATED CONTROLLED RELEASE DOSAGE FORM STABILITY INDICATING ASSAY METHOD FOR ESTIMATION OF DOMPERIDONE AND 1917 MANOJ SHRAWAN CHARDE 6A-124 F-146 PANTOPRAZOLE IN THEIR COMBINED DOSAGE FORMULATION METHOD DEVELOPMENT FOR THE ESTIMATION OF DEGRADATION PRODUCTS OF METHYL, ETHYL AND PROPYL PARABENS IN PHARAMCEUTICALS BY USING UV-SPECTROSCOPY AND 1925 LALIT SINGH 6A-125 F-147 HPLC METHOD DEVELOPMENT FOR THE ESTIMATION OF DEGRADATION PRODUCT OF SODIUM 1928 SHEFALI MEHLA 6A-126 F-148 BENZOATE IN FOOD SAMPLES BY USING UV-SPECTROSCOPY & HPLC. STABILITY-INDICATING RP-HPLC-UV METHOD FOR SIMULTANEOUS DETERMINATION OF 1944 PANKAJ SONI 6A-127 F-150 PIOGLITAZONE AND ATORVASTATIN. DEVELOPMENT AND VALIDATION OF MEFENAMIC ACID, DICYCLOMINE HCL AND PAMABROM IN 1989 AJAY KUMAR 6A-128 F-144 MARKETED FORMULATION BY HPLC TITLE: METHOD DEVELOPMENT AND VALIDATION OF MEFENAMIC ACID (MEF), DICYCLOMINE 1996 RAJAT RANA 6A-129 F-145 HCL (DCL) AND PAMABROM (PABR) OF MARKETED FORMULATION BY RP-HPLC Development and validation of a RP-HPLC method for the simultaneous determination of Picroside I, 157 CHARU PANDYA 6A-13 F-53 Cordifolioside A, Berberine and Cucurbitacin B in Patolakaturohinyadi Kashayam & Kashayam Tablets STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE SIMULTANEOUS DETERMINATION OF SOFOSBUVIR AND VELPATASVIR IN TABLET DOSAGE 2059 JAHNAVI 6A-130 F-137 FORMS A SIMPLE, PRECISE RP-HPLC METHOD FOR THE DEVELOPMENT AND VALIDATION OF FOOD 2066 KRANTHI YALLA 6A-131 F-138 SUPPLEMENTS, L-CARNITINE AND L-TARTRATE IN BULK AND TABLET FORMS A NOVEL RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF 176 BITLA SAI 6A-14 F-54 EFONIDIPINE IN BULK AND TABLET DOSAGE FORMS STABILITY INDICATING RP-HPLC METHOD FOR SIMULTANEOUS QUANTIFICATION OF EZETIMIBE 179 P. SARA HEENA REHMATH KHAN 6A-15 F-55 AND GLIMEPIRIDE IN BULK AND PHARMACEUTICAL DOSAGE FORM. Development and Validation of Bioanalytical HPLC Method For Estimation of Fenoprofen In Rabbit 225 BHASKAR KUMAR CHODAVARAPU 6A-16 F-24 Plasma: Application To Pharmacokinetic Studies 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF 238 SHAIK MOHAMMED YSUF 6A-17 F-26 CLONAZEPAM AND PAROXETINE IN TABLET DOSAGE FORMS DEVELOPMENT AND OPTIMIZATION OF A STABILITY INDICATING HPLC METHOD FOR APIXABAN 274 POOJA NANDLAL TIWARI 6A-18 F-30 USING QBD APPROACH. VALIDATION OF DEVELOPED ANALYTICAL METHOD FOR ESTIMATION OF METOPROLOL 285 MOHAN KUMAR A 6A-19 F-73 SUCCINATE PRESENT IN METOPROLOL SUCCINATE FLOATING TABLETS BY RP-HPLC PANTOPRAZOLE AND ROSUVASTATIN REDUCE THE ABILITY OF CLOPIDOGREL TO INHIBIT PLATELET AGGREGATION IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY 66 JINESH BAHUBALI NAGAVI 6A-2 F-8 INTERVENTION. A PROSPECTIVE DRUG-DRUG INTERACTION STUDY DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR ESTIMATION OF EDOXABAN 286 A.HIMAJA 6A-20 F-74 TOSYLATE IN TABLET DOSAGE FORMS METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF LINAGLIPTIN 288 N SIVASUBRAMANIAN 6A-21 F-75 AND EMPAGLIFLOZIN IN TABLETS BY RP-HPLC Stability Indicating RP-HPLC Method for Simultaneous Estimation of Vildagliptin and Mirabegran in 307 SUNEETHA ACHANTI 6A-22 F-31 Pharmaceutical Dosage Form METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF TENELIGLIPTIN IN PHARMACEUTICAL FORMULATIONS BY REVERSE PHASE HIGH PERFORMANCE LAYER 323 KRISHNAMOORTHY D 6A-23 F-33 CHROMATOGRAPHY A NOVEL VALIDATED STABILITY INDICATING RP – HPLC METHOD FOR THE ESTIMATION OF 341 INDIRA PRIYADARSHINI 6A-24 F-35 BAMIFYLLINE HYDROCHLORIDE IN BULK DRUG AND PHARMACEUTICAL FORMULATION DEVELOPMENT AND VALIDATION OF RP – HPLC METHOD FOR THE ESTIMATION OF 344 INDIRA PRIYADARSHINI 6A-25 F-36 AGOMELATINE IN TABLET DOSAGE FORM STABILITY INDICATING METHOD FOR SIMULTANEOUS ESTIMATION OF LEVODOPA AND BENSERAZIDE HYDROCHLORIDE IN BULK AND ITS PHARMACEUTICAL DOSAGE FORMS BY RP- 396 MOUNIKA BANNARAVURI 6A-26 F-76 HPLC METHOD 403 RAVALA SRAVANI 6A-27 F-37 DIFFERENT ANALYTICAL EVALUATION METHODS FOR TARENNA ASIATICA GUM RESIN STABILITY INDICATING UPLC METHOD FOR SIMULTANEOUS ESTIMATION OF EPALRESTAT AND 408 PERURU LAKSHMI SOWMYA 6A-28 F-38 PREGABALIN IN TABLET DOSAGE FORM A NEW STABILITY INDICATING METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF ROSUVASTATIN AND FENOFIBRATE IN BULK AND PHARMACEUTICAL DOSAGE 414 DARBHA GNANAPRASOONA 6A-29 F-39 FORM BY UPLC CHROMATOGRAPHIC RELEASE PROFILE OF ACTIVE PHARMACEUTICAL INGREDIENTS OF SYNTHESIZED PRODRUG AND CODRUG OF ASPIRIN+PARACETAMOL AND 68 PROF DR DHRUBO JYOTI SEN 6A-3 F-10 INDOMETHACIN+PARACETAMOL IN PHYSIOLOGICAL FLUIDS A NON-INVASIVE GLUCOSE ESTIMATION IN SALIVA SAMPLES BY USING PRE COLUMN 442 DUGGINENI MANOGNA CHOWDARY 6A-30 F-77 DERIVATISED RP-HPLC DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE ESTIMATION OF 458 BASALA BABJI 6A-31 F-79 AGOMELATINE IN TABLET DOSAGE FORM STABILITY INDICATING RP-HPLC METHOD FOR ESTIMATION OF MOXIFLOXACIN IN TABLET 462 SRADHANJALI NATH 6A-32 F-80 DOSAGE FORMS. METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF VALSARTAN PRESENT IN 464 VISWANATH M 6A-33 F-81 VALSARTAN FLOATING TABLETS BY RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF GLECAPREVIR AND PIBRENTASVIR IN PURE AND 476 NARLA SUNITHA 6A-34 F-82 PHARMACEUTICAL DOSAGE FORMS BY RP-HPLC METHOD 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title METHOD DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-HPLC METHODS FOR SIMULTANEOUS ESTIMATION OF FLURBIPROFEN AND GATIFLOXACIN IN BULK AND 477 T.VISHNAVI 6A-35 F-83 OPHTHALMIC DOSAGE FORM DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-HPLC METHODS FOR SIMULTANEOUS ESTIMATION OF MOXIFLOXACIN HCL AND KETOROLAC TROMETHAMINE IN 485 TENTU.PRIYA MOUNIKA 6A-36 F-84 BULK AND OPHTHALMIC DOSAGE FORM. NEW STABILITY INDICATING VALIDATED RP-HPLC METHOD FOR SIMULTANEOUS DETERMINATION OF METFORMIN HYDROCHLORIDE AND ERTUGLIFLOZIN IN BULK AND 520 VENKATESWARA RAO P 6A-37 F-44 PHARMACEUTICAL DOSAGE FORM FORMULATION OF NOVEL NANO CRYSTAL QUERCETIN TABLETS AND ITS METHOD 531 LAHARI PRIYA. M 6A-38 F-45 DEVELOPMENT AND VALIDATION BY RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF NOVEL UV AND RP-HPLC METHODS FOR DETERMINATION OF CILNIDIPINE ( A NEW GENERATION CA CHANNEL BLOCKER) IN PHARMACEUTICAL DOSAGE 580 J.SAI ESWAR 6A-39 F-86 FORM A NOVEL BIO-ANALYTICAL RP-HPLC METHOD FOR SIMULTANEOUS DETERMINATION OF METFORMIN HYDROCHLORIDE AND VLIDAGLIPTIN IN TABLET DOSAGE FORMS AND HUMAN 84 GANDLA KUMARASWAMY 6A-4 F-11 PLASMA (IN VITRO) STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT AND VALDATION OF DAPAGLIFLOZIN 587 D.SANDEEP 6A-40 F-87 IN BULK AND PHARMACEUTICAL DOSAGE FORM DEVELOPMENT AND DETERMINATION OF EZOGABINE IN PURE AND PHARMACEUTICAL 600 M.NAGA RAJU 6A-42 F-88 DOSAGE FORM Stability Indicating RP-UPLC Method for Simultaneous Estimation of Saxagliptin and Dapagliflozin in Pure 664 RAMESH DHANI 6A-43 F-57 and Pharmaceutical Dosage Form 712 GANESH BHAURAO CHOUDHARI 6A-44 F-61 Stability indicating RP-HPLC method for estimation of Terizidone in bulk and capsule dosage form NEW RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF CYPROTERONE ACETATE AND ETHINYL ESTRADIOL IN BULK AND PHARMACEITICAL DOSAGE 715 BISWA MOHAN SAHOO 6A-45 F-62 FORM STABILITY INDICATING RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF FLUTICASONE 735 V MOUNIKA 6A-46 F-64 AND VILANTEROL IN PHARMACEUTICAL DOSAGE FORMS A NOVEL VALIDATED STABILITY INDICATING RP – HPLC METHOD FOR THE ESTIMATION OF 749 M.LAKSHMI SOWMYA 6A-47 F-67 BAMIFYLLINE HYDROCHLORIDE IN BULK DRUG AND PHARMACEUTICAL FORMULATION METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF SITAGLIPTIN 767 R.MAHESWARI 6A-48 F-71 PHOSPHATE AND METFORMIN HCL IN TABLETS BY RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF SIMVASTATIN IN BULK 808 K.SHIRISHA 6A-49 F-89 AND TABLET DOSAGE FORM BY RP-HPLC SIMULTANEOUS ESTIMATION OF SAXAGLIPTINE AND DAPAGLIFLOZIN IN BULK, DOSAGE FORMS 96 VINUTHA KOMMINENI 6A-5 F-12 AND IN PLASMA SAMPLES IN PHARMACOKINETIC STUDIES IMPLEMENTATION OF 3 LEVEL POLYNOMIAL DESIGNS FOR OPTIMISATION, METHOD DEVELOPMENT & VALIDATION FOR SUMATRIPTAN & NAPROXEN SODIUM BY USING RP-HPLC 812 P MANOHAR REDDY 6A-50 F-90 METHOD METHOD DEVELOPMENT AND VALIDATION OF NEVIRAPINE IN DOSAGE FORM BY RP-HPLC 813 CHERIPELLY SRINIJA 6A-51 F-91 METHOD SIMULTANEOUS DETERMINATION OF LINAGLIPTIN AND METFORMIN IN HUMAN PLASMA BY RP- 820 BALAMURUGAN K 6A-52 F-93 HPLC METHOD USING QUALITY BY DESIGN 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title AQBD BASED REGULATORY FLEXIBLE RP-HPLC METHOD FOR SIMULTANEOUS ANALYSIS OF 844 SANGALA VENKATA RAMI REDDY 6A-53 F-95 PROPRANOLOL HYDROCHLORIDE AND ETIZOLAM DEVELOPMENT OF A NEW STABILITY INDICATING RP-HPLC METHOD FOR ESTIMATION OF 851 MEGHA SYAM VARMA 6A-54 F-96 SOFOSBUVIR AND ITS VALIDATION AS PER ICH GUIDELINES SIMULTANEOUS DETERMINATION OF SITAGLIPTIN AND METFORMIN IN HUMAN PLASMA BY RP- 856 KIRTIMAYA MISHRA 6A-55 F-97 HPLC METHOD USING QUALITY BY DESIGN AN IMPROVED HPLC METHOD FOR SIMULTANEOUS DETERMINATION OF PHENOLIC 857 BSB RAKESH 6A-56 F-98 COMPOUNDS, PURINE ALKALOIDS AND THEANINE IN CAMELLIA SPECIES A NEW STABILITY INDICATING METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF ROSUVASTATIN AND FENOFIBRATE IN BULK AND PHARMACEUTICAL DOSAGE 867 DARBHA GNANAPRASOONA 6A-57 F-99 FORM BY UPLC A STABILITY INDICATING UPLC METHOD FOR SIMULTANEOUS ESTIMATION OF EPALRESTAT 882 PERURU LAKSHMI SOWMYA 6A-58 F-101 AND PREGABALIN IN TABLET DOSAGE FORM RP- HPLC METHOD DEVELOPMENT AND VALIDATION OF EPROSARTAN MESYLATE IN BULK AND 884 AZRA SULTANA 6A-59 F-103 ITS PHARMACEUTICAL DOSAGE FORM DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR SIMULTANEOUS DETERMINATION 117 KAUSHIK SANTOSH AGRAWAL 6A-6 F-13 OF EMPAGLIFLOZIN AND LINAGLIPTIN IN BULK & ITS FORMULATION RP-HPLC METHOD FOR DETECTION OF DEGRADATION IN PIPERACILLIN AND TAZOBACTAM IN 897 JWALAPURAM RAMYASREE 6A-60 F-104 INJECTION SAMPLES COLLECTED FROM HOSPITALS METHOD DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR ESTIMATION OF 930 RAJANIKANT BALASAHEB GHOTANE 6A-63 F-107 DROTAVERINE HYDROCHLORIDE AND OMEPRAZOLE FROM ITS TABLET FORMULATION DEVELOPMENT AND VALIDATION OF STABILITY INDICATING UPLC METHOD FOR THE 956 S PRANUSH KUMAR 6A-65 F-112 QUANTITATION OF REPAGLINIDE STABILITY-INDICATING HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC METHOD FOR 959 BHUMIRAJSINH D. VANSIA 6A-67 F-113 PRANLUKAST HYDRATE SIMULTANEOUS ESTIMATION OF ZINC PYRITHIONE AND PHENOXYETHANOL IN ANTI-DANDRUFF 963 RAJAN VERMA 6A-68 F-114 SHAMPOO BY HPLC DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR ESTIMATION OF EDOXABAN 1050 A. HIMAJA 6A-69 F-123 TOSYLATE IN TABLET DOSAGE FORMS METHOD DEVELOPMENT AND VALIDATION OF RP-HPLC FOR TENELIGLIPTIN AND METFORMIN 134 ABHISHEK SANJAY BANSAL 6A-7 F-14 IN PHARMACEUTICAL DOSAGE FORMS 1070 D ASHWITHA PAI 6A-70 F-126 HPLC METHOD FOR SIMULTENOUS DETERMINATION OF LUMEFANTRINE & ARTEMETHER VALIDATION OF DEVELOPED ANALYTICAL METHOD FOR ESTIMATION OF BALOFLOXACIN 1130 SASIKUMAR L 6A-71 F-132 PRESENT IN BALOFLOXACIN FLOATING TABLETS BY RP-HPLC FORCED DEGRADATION STUDY AND VALIDATION OF A RP-HPLC METHOD FOR SIMULTANEOUS 1138 SUHASINI NAYAL 6A-72 F-133 ESTIMATION OF LEVODOPA, CARBIDOPA AND ENTACAPONE IN COMBINED DOSAGE FORM ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF RELATED SUBSTANCES IN 1147 K.PREETHI ALEKHYA 6A-73 F-134 REGADENOSON API BY RP-HPLC AQBD APPROACH FOR DEVELOPMENT AND VALIDATION OF HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF IRBESARTAN, CILNIDIPINE AND CHLORTHALIDONE IN 1157 BHAVSAR JANKI P 6A-74 F-224 CLINDASARTAN TABLET A NEW TECHNICAL METHOD FOR GLECAPREVIR AND PIBRENTASVIR IN COMBINED DOSAGE 1188 NDVR SARADHI 6A-75 F-225 FORMS USING NON POLAR HPLC 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title APPLICATION OF A VALIDATED HPLC-PDA METHOD FOR QUANTITATIVE DETERMINATION OF 1189 SNEHABEN DHANSUKHBHAI PATEL 6A-76 F-226 RELATED SUBSTANCES IN BUDESONIDE A NEW STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF EMTRICITABINE AND TENOFOVIR WITH DEGRADATION 1210 K S SUMANTH 6A-77 F-222 KINETICS DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF 1222 RADHARAPU SATCHIT 6A-78 F-223 THREE COMPONENTS IN CREAM FORMULATION USED IN HAEMORRHOIDS DISEASE. AQBD BASED LC-UV METHOD FOR SIMULTANEOUS QUANTIFICATION OF ETIZOLAM AND 1270 SANGALA VENKATA RAMI REDDY 6A-79 F-219 PROPRANOLOL HYDROCHLORIDEV DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR SIMULTANEOUS DETERMINATION 135 SHAIK AZEEM AHMED 6A-8 F-15 OF CLONAZEPAM AND IMIPRAMINE HYDROCHLORIDE IN TABLETS METHOD DEVELOPMENT AND VALIDATION OF ACITRETIN IN BULK AND PHARMACEUTICAL 1274 INDIRA PRIYADARSHINI 6A-80 F-220 DOSAGE FORM BY RP - HPLC RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR DETERMINATION OF SITAGLIPTIN 1278 E MAHESH 6A-81 F-221 PHOSPHATE & METFORMIN HCL IN BULK & TABLET DOSAGE FORM DEVELOPMENT AND VALIDATION OF NOVEL RP-HPLC METHOD FOR SIMULTANEOUS 1310 M.VIJAY RAJ 6A-82 F-213 ESTIMATION OF EPLERENONE AND TORSEMIDE IN PHARMACEUTICAL DOSAGE FORMS METHOD DEVELOPMENT AND VALIDATION FOR THE SIMULTANEOUS ESTIMATION OF NEBI AND 1322 SRI PAVANKUMAR CHIKKALA 6A-83 F-214 VALSARTAN BY USING RP-HPLC METHOD ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR 1333 MEHANAZ 6A-84 F-215 DETERMINATION OF AMLODIPINE BESYLATE IN BULK AND PHARMACEUTICAL FORMULATION SIMULTANEOUS ESTIMATION OF SAXAGLIPTINE AND DAPAGLIFLOZIN IN BULK, DOSAGE FORMS 18 VINUTHA 6A-85 F-4 AND IN PLASMA SAMPLES IN PHARMACOKINETIC STUDIES DEVELOPMENT AND STABILITY INDICATING HPLC METHOD FOR DAPAGLIFLOZIN IN 1477 YASH KHEDEKAR 6A-86 F-206 API AND PHARMACEUTICAL DOSAGE FORM BIOANALYTICAL METHOD DEVELOPMENT, VALIDATION AND QUANTIFICATION OF METAXALONE 1493 P NALLA KUMAR 6A-87 F-208 IN RAT PLASMA BY LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY RP-HPLC Method Development and Validation of Simultaneous Estimation of Gallic Acid and Oleanolic 1507 HEMEMANGINI HEMANT PANCHAL 6A-88 F-202 Acid in Antihyperlipidemic Poly Herbal Tablets METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF APIXABAN IN TABLET 1530 SARASWATHI R 6A-89 F-204 DOSAGE FORM BY UPLC QbD Based Analytical Method Development through Creation of Design Space for Critical Attributes – 136 SACHI KUDCHADKAR 6A-9 F-16 Application on RP-HPLC Method Development for Five Fluoroquinolone Antibacterials 1552 BHARATI CHAUDHARI 6A-90 F-195 Development and Validation of RP-HPLC Assay Method for Mesalamine QBD-ENABLED DEVELOPMENT AND VALIDATION OF A GREEN ANALYTICAL METHOD FOR CHRYSIN QUANTIFICATION EMPLOYING ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY 1573 TEENU 6A-91 F-198 (UPLC) DEVELOPMENT AND VALIDATION OF REVERSE PHASE HIGH PERFORMANCE LIQUID 1587 SANYAM SHARMA 6A-92 F-200 CHROMATOGRAPHY(RP-HPLC) METHOD FOR THE ESTIMATION OF TOFACITINIB AQBD APPROACH- RPHPLC METHOD FOR SIMULTANEOUS ASSESSMENT OF ANTI-VIRAL 1600 J.RAMA TULASI 6A-93 F-201 DRUGS 1613 PANKAJ P THAKUR 6A-94 F-183 RP HPLC METHOD FOR ESTIMATION OF PALBOCICLIB IN CAPSULE DOSAGE FORM DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR APREMILAST IN BULK DRUG AND 1618 DAYANAND SAMBHAJIRAO MANJARAMKAR 6A-95 F-185 ITS APPLICATION IN STABILITY STUDIES. 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION 1623 ABHAY BHARAMBE 6A-96 F-188 OF DIMETHYL FUMARATE IN PHARMACEUTICAL DOSAGE FORM RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF OLMESARTAN MEDOXOMIL AND 1629 P CHIRANJEEVI 6A-97 F-189 AMLODIPINE BESYLATE IN BULK AND PHARMACEUTICAL FORMULATION STABILITY INDICATING RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF SOFOSBUVIR 1636 MOHAN GANDHI BONTHU 6A-98 F-190 AND VELPATASVIR IN PURE AND PHARMACEUTICAL DOSAGE FORMS METHOD DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR SIMULTANEOUS 1638 P V KAMALA KUMARI 6A-99 F-191 ESTIMATION OF VALSARTAN AND HYDROCHLOROTHIAZIDE COMPARATIVE PHYSICOCHEMICAL CORRELATION STUDY OF SYNTHESIZED PRODRUG AND CODRUG OF ASPIRIN+PARACETAMOL AND INDOMETHACIN+PARACETAMOL BY COVALENT AND 67 PROF DR DHRUBO JYOTI SEN 6B-1 F-9 NON–COVALENT BONDING METHOD DEVELOPMENT OF VALIDATION OF LOSARTAN POTASSIUM IN BULK AND TWO 624 KAUSTAV DASGUPTA 6B-10 F-46 MARKETED TABLET DOSAGE FORM AS PER ICH GUIDELINESS SPECTROPHOTOMETRIC SPECTROPHOTOMETRIC DETERMINATION OF MYCOPHENOLATE 719 R.VIJAYALAKSHMI 6B-11 F-63 MOFETIL BY USING MBTHDETERMINATION OF MYCOPHENOLATE MOFETIL BY USING MBTH VALIDATED RP-HPLC METHOD FOR THE ESTIMATION OF OLANZAPINE IN PURE AND 736 Y. AMRUTHA VARSHINI 6B-12 F-65 FORMULATIONS SPECTROSCOPIC METHOD DEVELOPMENT AND VALIDATION OF MESALAMINE TRANSDERMAL 748 SHELAKE AKSHAY SANJAY 6B-13 F-66 PATCH VALIDATED VISIBLE SPECTROPHOTMETRIC METHODS FOR ESTIMATION OF IMATINIB IN PURE 759 CH. SRUTHI 6B-14 F-68 AND FORMULATIONS BY CONDENSATION AND OXIDATION METHODS. UVSPECTROPHOTOMETRIC METHOD FOR THE QUANTITATIVE ESTIMATION OF ASPIRIN AS AN ACTIVE PHARMACEUTICAL INGREDIENT AND ITS TAABLET DOSAGE FORM IN DIFFERENT 760 A.VIGNESWARA REDDY 6B-15 F-69 BRANDS “SOLID AS SOLVENT”- MELTED DIMETHYL UREA AS SOLVENT TO ANALYSE INDOMETHACIN 763 ANIRUDH PADIYAR 6B-16 F-70 CAPSULES SPECTROPHOTOMETRICALLY AT 265 NM (MIXED SOLVENCY CONCEPT) DEVELOPMENT AND VALIDATION OF UV SPECTROPHOTOMETRIC METHOD FOR THE 830 SURAPANENI YOGENDRA KUMAR 6B-17 F-94 ESTIMATION OF CURCUMIN IN BULK DRUG AND PHARMACEUTICAL DOSAGE FORMS 881 RUBINA BHUTANI 6B-18 F-100 SPECTROPHOTOMETRIC ABSORBANCE CORRECTION METHOD FOR THE ESTIMATION OF DIFFERENCE SPECTROPHOTOMETRIC METHOD FOR SIMULTANEOUS ESTIMATION OF 883 GARIMA KAPOOR 6B-19 F-102 MOXIFLOXACIN AND CEFIXIME TRIHYDRATE IN BULK AND COMBINED DOSAGE FORM Development and Validation of UV Spectrophotometric Method for Simultaneous Estimation of 138 SWARNALATHA B M 6B-2 F-17 Chloroquine phosphate and Paracetamol In Bulk and Their Pharmaceutical Formulation METHOD DEVELOPMENT AND VALIDATION OF TENELIGLIPTIN HYDROBROMIDE IN TABLET 915 DIVYA KUNWAR 6B-20 F-105 DOSAGE FORM USING UV SPECTROPHOTOMETRY DEVELOPMENT AND VALIDATION OF NOVEL SPECTROPHOTOMETRIC METHODS FOR SIMULTANEOUS ESTIMATION OF PIOGLITAZONE AND METFORMIN IN BULK AND FIXED DOSAGE 932 RAVI KANT 6B-21 F-108 FORMS BY AREA UNDER CURVE AND DUAL WAVELENGTH MODE METHOD DEVELOPMENT AND VALIDATION OF TENELIGLIPTIN HYDROBROMIDE IN TABLET 938 DIVYA KUNWAR 6B-22 F-109 DOSAGE FORM USING UV SPECTROPHOTOMETRY AREA UNDER CURVE UV SPECTROPHOTOMETRIC METHOD FOR THE DETERMINATION OF 964 SHARANAGOUD BIRADAR 6B-23 F-115 CEFPODOXIME PROXETIL IN SINGLE COMPONENT TABLETS FORMULATION AND EVALUATION OF TOPICAL BEPOTASTINE BESILATE GEL BY USING 973 KOMAL CHAUDHARY 6B-24 F-117 DIFFERENT POLYMERS 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title A RAPID COLORIMETRIC METHOD FOR THE DETERMINATION OF IRON IN BIOLOGICAL SAMPLES 979 ATHOTA VINAY MOHAN 6B-25 F-118 USING O-PHENANTHROLINE METHOD DEVELOPMENT AND VALIDATION OF UV SPECTROPHOTOMETRIC METHOD FOR THE 1014 RAMSHANKAR NAYAK 6B-26 F-122 ESTIMATION OF RIOCIGUAT IN ITS FORMULATIONS TO DEVELOP AND VALIDATE ANALYTICAL METHOD FOR DETERMINATION OF SITAGLIPTIN BY 1075 POOJA KUMARI 6B-27 F-127 UV-SPECTROPHOTOMETRY IN PURE AS WELL AS IN PHARMACEUTICAL DOSAGE FORMS. UV SPECTROPHOTOMETRIC METHOD FOR DETERMINATION OF CINITAPRIDE IN PURE AND IT’S 1079 ABIRAMI.K.R.S 6B-28 F-128 SOLID DOSAGE FORMS UV SPECTROPHOTOMETRIC DETERMINATION OF TINIDAZOLE IN BULK AND PHARMACEUTICAL 1089 JYOTI RAWAT 6B-29 F-129 DOSAGE FORM USING HYDROTROPIC SOLUBILIZATION TECHNIQUE DEVELOPMENT AND VALIDATION OF UV SPECTROMETRIC METHODS FOR THE SIMULTANEOUS ESTIMATION OF ETORICOXIB AND SERRATIOPEPTIDASE IN BULK AND PHARMACEUTICAL 139 AISHWARYA R K 6B-3 F-18 FORMULATIONS SIMULTANEOUS ESTIMATION OF DOXORUBICIN HYDROCHLORIDE AND MOXIFLOXACIN 1118 SHAJIDUL KARIM 6B-30 F-130 HYDROCHLORIDE UV SPECTROPHOTOMETRIC METHOD VALIDATION FOR DETERMINATION OF ACOTIAMIDE 1129 ANNU SINGH 6B-31 F-131 HYDROCHLORIDE HYDRATE IN PHARMACEUTICAL DOSAGE FORM DEVELOPMENT AND VALIDATION OF STABILITY INDICATING UV-VISIBLE SPECTROPHOTOMETRIC METHOD FOR ESTIMATION OF CILNIDIPINE AND DEGRADATION 1149 HITIKA BHARATBHAI PATEL 6B-32 F-135 KINETIC STUDY USING QUALITY BY DESIGN APPROACH 1267 PATEL HIRAL KAUSHIKBHAI 6B-34 F-218 METHOD FOR SIMULTANEOUS ESTIMATION OF DAPAGLIFLOZIN AND SAXAGLIPTIN TO PERFORM THE PROCESS VALIDATION OF PARACETAMOL TABLET DOSAGE FORM IN 1308 ANOOP SHARMA 6B-36 F-212 LABORATORY SCALE FORMULATION AND EVALUATION OF TOPICAL BEPOTASTINE BESILATE GEL BY USING 1549 KOMAL CHAUDHARY 6B-37 F-205 DIFFERENT POLYMERS DEVELOPMENT AND VALIDATION OF UV-VISIBLE SPECTROSCOPIC METHOD OF METHOTREXATE AND TOFACITINIB IN BULK DRUG PRODUCTS BY SIMULTANEOUS EQUATION 1609 RAHUL SHARMA 6B-38 F-182 METHOD DEVELOPMENT AND VALIDATION OF STABILITY-INDICATING UV SPECTROPHOTOMETRIC 1620 PAVAN KALYAN 6B-39 F-186 METHOD FOR DETERMINATION OF DASATINIB IN BULK AND PHARMACEUTICAL DOSAGE FORM DEVELOPMENT AND VALIDATION OF UV SPECTROPHOTOMETRIC METHOD FOR THE SIMULTANEOUS ESTIMATION OF LEVOFLOXACIN AND PHENYLPROPANOLAMINE IN BULK AND 140 PRATIMA KUMARI JAIN J 6B-4 F-19 PHARMACEUTICAL AND FORMULATIONS DEVELOPMENT AND VALIDATION OF METHOD FOR MEFENAMIC ACID, DICYCLOMINE 2105 GAGANDEEP 6B-41 F-136 HYDROCHLORIDE, AND PAMABROM IN MARKETED FORMULATION BY UV SPECTROSCOPY NEW UV SPECTROPHOTOMETRIC METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF SAXAGLIPTIN AND PIOGLITAZONE IN PHARMACEUTICAL DOSAGE FORMS AND 2077 T SREENIVASA RAO 6B-42 F-139 BULK DRUG A NOVEL APPROACH AND WAVELET BASED METHODOLOGY FOR DEVELOPMENT AND VALIDATION OF SIMULTANEOUS ANALYSIS CURCUMIN USING UV-VISIBLE 2048 MD NOUSHAD JAVED 6B-43 F-142 SPECTROPHOTOMETRIC METHOD. Development and Validation of UV Spectrophotometric Methods for Simultaneous Estimation of 141 SHUBHA D B 6B-5 F-20 Cyclobenzaprine Hydrochloride and Aceclofenac in Bulk and Their Pharmaceutical Formulations 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title Development and Validation of UV Spectrophotometric Methods for the Simultaneous Estimation of 142 RAKSHITHA G R 6B-6 F-21 Ofloxacin and Serratiopeptidase in Bulk and Pharmaceutical Formulations FORMULATION OF LAMOTRIGINE ORODISPERSIBLE TABLETS BY USING NEW GENERATION 280 GAYATHRI AVUSAALA 6B-7 F-72 SUPER DISINTEGRANTS DEVELOPMENT AND VALIDATION OF UV SPECTROPHOTOMETRIC METHOD FOR 418 HIMANSHU KUSHWAH 6B-8 F-40 DETERMINATION OF MENTHOL 507 SHILPI PATHAK 6B-9 F-43 Colorimetric Method for Determination of Dapagliflozin from its Pharmaceutical Formulation SIMULTANEOUS HPTLC MMETHOD DEVELOPMENT AND VALIDATION OF SOFOSBUVIR AND 269 SANIKA ATUL DICHWALKAR 6C-1 F-29 LEDIPASVIR A VALIDATED HPTLC METHOD FOR THE ESTIMATION OF FLUVOXAMINE IN ITS TABLET DOSAGE 1371 J.RAMYA 6C-10 F-211 FORM VALIDATION OF A HIGH-PERFORMANCE THIN-LAYER CHROMATOGRAPHIC METHOD FOR QUANTITATIVE ANALYSIS OF DAPAGLIFLOZIN IN ACTIVE PHARMACEUTICAL INGRIDIENT (API) 1602 DHURI VIVEK GAJANAN 6C-11 F-181 AND TABLET FORMULATION. PHYTOCHEMICAL ANALYSIS AND QUANTIFICATION OF QUERCETIN IN MIMOSA PUDICA L. BY 1617 SUMAN SHRIVASTAVA 6C-12 F-184 HPTLC QUALITATIVE AND QUANTITATIVE ESTIMATION OF RESERPINE IN RAUWOLFIA SERPENTINA BY 1690 SANJAY J DAHARWAL 6C-13 F-178 HPTLC DEVELOPMENT AND VALIDATION OF HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHIC 1788 AKSHITA H SHUKLA 6C-14 F-167 METHOD FOR ESTIMATION OF RIVAROXABAN IN ITS TABLET DOSAGE FORM A Validated HPTLC method for simultaneous estimation of Escitalopram oxalate with Flupentixol 1880 VIDYA 6C-15 F-161 dihydrochloride in combination MODIFICATION OF CHROMATOGRAPHIC SILICA STATIONARY PHASES VIA THE ADDITION OF N- OR C -LINKED PEPTIDO-CALIX[4]ARENE MACROCYCLE TOWARDS EFFECTIVE 1949 NAGARAJ 6C-16 F-151 CHROMATOGRAPHIC SEPARATIONS OPTIMIZATION OF QUANTITATIVE HPTLC METHOD FOR ESTIMATION OF LISINOPRIL AND 504 RAHUL DHIRAJBHAI LALWANI 6C-2 F-42 HYDROCHLOROTHIAZIDE IN PHARMACEUTICAL DOSAGE FORM HPTLC METHOD VALIDATION FOR DETERMINATION OF ACOTIAMIDE HYDROCHLORIDE 642 RAGINI KUSHWAHA 6C-3 F-48 HYDRATE IN PHARMACEUTICAL DOSAGE FORM DEVELOPMENT AND VALIDATION OF HPTLC METHOD FOR ESTIMATION OF CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN IN 971 ROHITKUMAR S. SINGH 6C-4 F-116 COMBINED DOSAGE FORM STABILITY INDICATING METHOD FOR THE DETERMINATION OF TRAMADOL HYDROCHLORIDE IN 988 NAINA NISHANT JAIN 6C-5 F-119 PHARMACEUTICAL FORMULATION BY HPTLC DEVELOPMENT AND VALIDATION OF HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY (HPTLC) METHOD FOR DETERMINATION OF AFLATOXIN IN LAWSONIA INERMIS – HENNA 990 AANAL JAYDEEP PANDYA 6C-6 F-120 LEAVES DEVELOPMENT AND VALIDATION OF RP-CHIRAL METHOD FOR QUANTIFICATION OF (R)- 17 ASHOK KUMAR 6C-7 F-3 ENANTIOMER IN LERCANIDIPINE HYDROCHLORIDE Development and validation of UV-Spectrophotometric and HPTLC methods for simultaneous estimation 1261 PATEL HARSHKUMAR MAYURBHAI 6C-8 F-217 of Tiotropium bromide (TB), Formoterol fumarate (FF) and Ciclesonide (CIC) in marketed formulation. DEVELOPMENT AND VALIDATION OF HPTLC METHOD FOR ESTIMATION OF CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN IN 1357 ROHITKUMAR S. SINGH 6C-9 F-210 COMBINED DOSAGE FORM 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title 211 YOGITA VYAS 6D-1 F-22 STUDY AND DETERMINATION OF ELEMENTAL IMPURITIES IN PHARMACETICALS 447 SHASHANK B RAO 6D-11 F-78 QUALITY CULTURE- CHALLENGE OR RESPONSIBILITY? DEVELOPMENT AND VALIDATION OF NOVEL RP-HPLC METHOD FOR SIMULTANEOUS 490 GUTTA PAVAN KUAMR 6D-13 F-85 ESTIMATION OF LOTEPREDNOL AND TOBRAMYCININ PHARMACEUTICAL DOSAGE FORMS VALIDATED ESTIMATION OF SITAGLIPTIN PHOSPHATE AND METFORMING HCL IN BULK DRUG 503 GAYATRI. A. LOBHE 6D-14 F-41 AND FORMULATION BY USING DIFFERENT ANALYTICAL METHODS DEVELOPMENT AND VALIDATION OF LC-MS METHOD FOR THE ESTIMATION OF N-ACETYL- 20 VAISHALI AGRAWAL 6D-15 F-6 TRYPTOPHAN AND ITS IMPURITIES UNDER STRESS CONDITIONS COMPARATIVE ASSESMENT OF MULTIBRAND AND GENERIC ATENOLOL TABLETS MARKETED IN 641 AKASH GUPTA 6D-16 F-47 INDIA 643 URVI DAS SHARMA 6D-17 F-49 GREEN CHEMISTRY: IONIC LIQUID CATALYSTS PHARMACEUTICAL “QUALITY BY DESIGN (QBD)” APPROACH IN THE OPTIMIZATION OF 658 CHIRANJEEVI POKURI 6D-18 F-56 MANUFACTURING PROCESS FOR ACETYL SALICYLIC ACID” 675 AYUSHI JAYESHBHAI PATEL 6D-19 F-58 ANALYSIS OF PHYTOSTEROLS FROM FRUIT OF OPUNTIA ELATIOR MILL 212 YOGITA VYAS 6D-2 F-23 STUDY AND DETERMINATION OF ELEMENTAL IMPURITIES IN PHARMACETICALS 691 SUMIT S. BHATIA 6D-20 F-59 R.O. WATER CONSUMPTION: A HIDDEN THREAT TO HEALTH BIOANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF 698 K.NAGA POOJITHA 6D-21 F-60 PRASUGREL INACTIVE METABOLITE IN HUMAN K2EDTA PLASMA BY LC-MS/MS TLC BIOAUTOGRAPHY AND LCMS-MS STUDIES FOR IDENTIFICATION OF COMPOUNDS 817 MRUNAL BULBULE 6D-22 F-92 INHIBITING ACTIVITY OF STAPHYLOCOCCUS AUREUS IN ABIES WEBBIANA DEVELOPMENT AND VALIDATION OF NOVEL STABILITY INDICATING RP-UPLC METHOD FOR 918 KANTHI SHEELA ANIPE 6D-23 F-106 SIMULTANEOUS ESTIMATION OF PHENYLEPHRINE AND FEXOFENADINE. 944 SINGHAL ANAND MUKESH 6D-24 F-111 Nootropic activity of Spinach leaves. DETECTION AND VALIDATION OF 25 PESTICIDE RESIDUES IN VASAKA LEAVES (ADHATODA VASICA) BY QUECHERS METHOD AND GAS CHROMATOGRAPHY- MASS SPECTROMETRY 991 RUPALBEN DODIYA 6D-25 F-121 BASED APPROACH. DETECTION OF HEAVY METALS IN FOUR TRADITIONAL HERBS BY INDUCTIVE COUPLED 1051 RIDDHIBEN JAYSWAL 6D-26 F-124 PLASMA MASS SPECTROSCOPY (ICP-MS) IDENTIFICATION AND EVALUATION OF ALLAMANDA CATHARTICA CHERRIES JUBILEE FLOWER 1054 KRISHNAMURTHY BHAT 6D-27 F-125 AS AN ACID-BASE INDICATOR DEVELOPMENT AND VALIDATION OF FTIR SPECTROPHOTOMETRIC METHOD FOR THE 15 SNEHAL SANJAYSINGH DIXIT 6D-29 F-1 QUANTITATIVE ESTIMATION OF LORNOXICAM IN TABLET DOSAGE FORM DEVELOPMENT AND VALIDATION OF SPECTROFLUOROMETRIC METHOD FOR THE ESTIMATION 230 PANCHAL NIRAVKUMAR RAJNIKANT 6D-3 F-25 OF CANAGLIFLOZIN IN BULK AND PHARMACEUTICAL FORMULATION 1346 K .DIVYA BHARATHI 6D-32 F-216 THE ESSENCE OF CGMPS AND MODERN QUALITY SYSTEMS IN PHARMACEUTICAL INDUSTRY BIO ANALYSIS OF DIMETHYL FUMARATE IN RAT PLASMA WITH MEASUREMENT UNCERTAINTY 16 SUNEETHA ACHANTI 6D-33 F-2 ESTIMATION BY LIQUID CHROMATOGRAPHY–TANDEM MASS SPECTROMETRY BIOANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF CANAGLIFLOZIN IN HUMAN 1406 T. DEEPAN 6D-34 F-209 PLASMA BY LC-MS/MS COMPARATIVE QUALITY CONTROL STUDY ON DIFFERENT GENERIC BRANDS OF RIBOFLAVIN 1482 AFSANA MAHZABIN 6D-35 F-207 TABLETS 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title 1522 HARA GOURI MISHRA 6D-37 F-203 Solubility Enhancement of Poorly Water Soluble Drug Ibuprofen 1554 MEER.ASIF ALI 6D-38 F-196 BIO-TANNING MATERIAL FOR PROCESSING OF FISH SKIN INTO LEATHER SIMULTANEOUS ESTIMATION OF METFORMIN AND PIOGLITAZONE HYDROCHLORIDE BY UV 1567 SHWETA SHARMA 6D-39 F-197 SPECTROPHOTOMETER USING SIMULTANEOUS EQUATION IDENTIFICATION, ISOLATION AND CHARACTERIZATION OF ALKALINE DEGRADATION PRODUCT 247 FARAH IRAM 6D-4 F-27 OF ESLICARBAZEPINE ACETATE 1586 KOYA KESETHA 6D-40 F-199 QUALITY RISK MANAGEMENT HPTLC-DENSITOMETRIC ANALYSIS OF MELATONIN IN PHARMACEUTICAL TABLET DOSAGE 1621 D.UMAMAHESWARI 6D-41 F-187 FORM 1674 K.KESETHA 6D-42 F-177 QUALITY RISK MANAGEMENT 1699 KOYA KESETHA 6D-43 F-180 QUALITY RISK MANAGEMENT 1742 SHARMILA 6D-44 F-170 QUALITY ASSURANCE AND VALIDATION STRATEGIES OF DRY POWDER INJECTION COMMON GMP CONCEPT: A QUALITY TOOL FOR GLOBALIZATION OF PHARMACEUTICAL 1773 HARSHAL WADHWANI 6D-45 F-166 MARKET 1854 Dharmendra Dhritlahare 6D-46 F-153 Drugs for their quality control aspects and drug research EVALUATION OF ANTI- RHEUMATOID AND ANTI-INFLAMMATORY ACTIVITY OF POLYPHENOL 1941 NIKITA R NILAWAR 6D-47 F-149 CONTAINING MEDICINAL PLANTS 1970 FUKE YOGESH SHRIKANT 6D-48 F-143 DEGRADATION STUDY OF DICLOFENAC SODIUM ORAL FORMULATIONS BY UV SPECTROSCOPY 2007 VIRKAR NIKHIL SHANKAR 6D-49 F-140 REVIEW ON HYPHENATED SEPARATION TECHNIQUES Simultaneous determination of alcohol and carbohydrate content in commercial Beverages by ultrasound 2028 MANDEEP KAUR 6D-51 F-141 frequency analysis. NEW STABILITY INDICATING UPLC METHOD FOR THE ESTIMATION OF AFATINIB DIMALEATE IN 260 I.SRILATHA 6D-6 F-28 BULK PHARMACEUTICAL DOSAGE FORM 315 PRASHANT PUROHIT 6D-7 F-32 QUALITY BY DESIGN: CHANGING OUTLOOK OF PHARMACEUTICAL DEVELOPMENT 19 SUKANYA SAHU 6D-8 F-5 ESTIMATIOIN OF PESTICIDES IN SOIL USING NEW LC-MS SPECTROMETRY ENHANCEMENT OF BRAIN DELIVERY OF METHOTREXATE THROUGH REVERSIBLE 326 KHUSBU KUMARI 6D-9 F-34 CONJUGATION TO L-TYROSINE 91 PULIPATI SOWJANYA 7A-1 G-1 AMARANTHUS TRICOLOR: PHYTOCHEMICAL, IN-SILICO ANALYSIS AND CYTOTOXIC ACTIVITY 586 PARNIKA HARESHWAR KHATAL 7A-10 G-18 INNOVATION IN PHARMACEUTICAL INDUSTRY 597 SANDHYA CHIPURUPALLI 7A-11 G-19 TARGETING HYPOXIA INDUCED ADAPTIVE RESPONSES TO PREVENT CANCER PROGRESSION 651 ANAS K 7A-12 G-9 CRISPR/CAS9 A NEW EMERGING TOOL FOR GENOMIC MODIFICATION BIOSYNTHESIS OF SILVER NANOPARTICLES FROM STREPTOMYCES GRICEUS AND ITS 666 K.GOWTHAM 7A-13 G-10 EVALUATION OF ANTIMICROBIAL ACTIVITY 679 SHEETAL SINGH 7A-14 G-11 ROLE OF BIOINFORMATICS IN THE TREATMENT OF AUTOIMMUNE DISEASES 707 POSANI BHAVANI 7A-15 G-12 MULTIPLE DISEASE VACCINE CHARACTERISATION AND APPLICATIONS OF INDUSTRIALLY IMPORTANT ENZYMES ISOLATED 710 BADRUD DUZA MOHAMMAD 7A-16 G-13 FROM SOIL OF COASTAL ANDHRA PRADESH, INDIA. 755 R.MOUNIKA REDDY 7A-17 G-14 PHARMACOGENOMICS 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title 768 CHITRA S. PAYTODE 7A-18 G-15 SYNTHETIC VIRUSES 769 ANKITA A. KAWADE 7A-19 G-16 APPLICATION OF 3D PRINTING TECHNOLOGY IN MEDICAL SCIENCES 92 PULIPATI SOWJANYA 7A-2 G-2 AMARANTHUS TRICOLOR: PHYTOCHEMICAL, IN-SILICO ANALYSIS AND CYTOTOXIC ACTIVITY HUMAN PLURIPOTENT STEM CELLS MAY REVOLUTIONIZE DRUG DISCOVERY IN HEART 779 S RAMACHANDRAN 7A-20 G-20 DISEASE 853 DEEKSHA 7A-21 G-21 Studies on Polyhydroxybutyrate (PHB) producing bacteria isolated from marine and terrestrial soils Formulation and evaluation of doxorubicin loaded thermosensitive mucoadhesive hydrogel and its 951 D. MONIKA 7A-22 G-22 evaluation in HeLa cell line DESIGNING OF NEW EPITOPE VACCINE AGAINST DENV3 ENVELOPE PROTEIN BASED ON THEIR 955 RAJESH 7A-23 G-23 IMMUNOINFORMATIC DATA COMPARATIVE EFFICACY OF IMMUNO AND MAGNETIC LIPOSOMES USING GEMCITABINE FOR 977 DEVIKA UNNITHAN 7A-24 G-24 OVARIAN CANCER 1006 VAISHNAVI GUPTA 7A-25 G-25 Preparation and Characterization of pH Sensitive Liposomes of Dichloroacetate against Breast cancer ANTIGEN LOADED MANNOSYLATED CHITOSAN NANOPARTICLE FOR THE EFFECTIVE 1010 ANAMIKA JAIN 7A-26 G-26 TREATMENT OF MALARIA DEVELOPEMENT AND CHARACTERISATION OF SCAFFOLD CONTAINING POLYMERIC 1030 RACHNA RANA 7A-27 G-27 NANOPARTICLES OF DOXORUBICIN FOR CERVICAL CANCER 1031 MD. DILSHAD 7A-28 G-28 RADIOPHARMACEUTICALS BASIC PRINCIPLE FOR PET/CT EVALUATION OF RADIO-PROTECTIVE EFFICACY OF NANOPARTICULATED MYRICETIN IN COMBATING WHOLE BODY GAMMA-IRRADIATION INDUCED LIVER TISSUE DAMAGE IN RAT 1039 SOUMYA GANGULY 7A-29 G-29 MODEL. PONGAMIA PINNATA (L) PIERRE: ANTIMICROBIAL EFFICACY AGAINST DENTAL CARIES 106 P. VIJAYA SRI 7A-3 G-3 PATHOGENS OF CLINICAL ORIGIN 1086 IKBAL MONDAL 7A-30 G-30 Molecular Docking Studies of Dihydroorotate Dehydrogenase as Anti- Malarial Agents GEL ELECTROPHORESIS TECHNIQUE AS AN ANALYTICAL TOOL IN COMPATIBILITY STUDY OF 1100 LANDGE ANIL VIJAY 7A-31 G-31 CHONDROITINASE ENZYME FOR INTRALESIONAL COLLOIDAL DELIVERY 1290 CHALAPATI.SRAVANI 7A-32 G-47 Synergistic and additive effects of Levofloxacin and other Antimicrobials against Bacteria DIFFERENTIAL EXPRESSION ANALYSIS AND IDENTIFICATION OF SIGNIFICANTLY MUTATED 1510 SHIVANGI AGRWAL 7A-35 G-45 GENE SUBNETWORKS IN MAJOR MOLECULAR CLASSES OF BREAST INVASIVE CARCINOMA ISOLATION AND CHARACTERIZATION OF PHOSPHATE SOLUBILIZING BACTERIA FROM URINE 1521 M RAMYA 7A-36 G-46 SAMPLE OPTIMIZATION OF KERATINASE PRODUCTION BY PLACKETTE-BURMAN DESIGN USING A 1579 S.SATYALAKSHMI 7A-38 G-44 MARINE FUNGUS AND DETERMINATION OF BIOLOGICAL ACTIVITIES 303 GADIPARTHI SRIKANTH 7A-4 G-4 COLLECTION AND IDENTIFICATION OF POLYTHENE DEGRADING ACTIVITY BY BASIDIOMYCETES 1724 SMITA L JOSHI 7A-41 G-43 NANOTECHNOLOGY IMAGING AGENTS IN DIAGNOSIS OF CANCER NON-VIRAL VECTORS BASED ON CATIONIC NIOSOMES AS EFFICIENT GENE DELIVERY 1767 NATASHA MANNERS 7A-42 G-41 VEHICLES TO THE BRAIN GALLIC ACID AND AGNPS SHOW SYNERGESTIC EFFECT AGAINST MCF-7 BREAST CANCER 1792 AMRISH CHANDRA 7A-43 G-42 CELL LINE 1807 ABHINAV GAURAV 7A-44 G-38 NANOGELS: AN ADVENT IN CANCER TREATMENT 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title 1811 KAJAL SHARMA 7A-45 G-39 NEW AVENUES OF SILVER NANOPARTICLES AND THEIR BIOMEDICAL APPLICATIONS 1849 KILLANI MANJARI 7A-46 G-40 BESPONSA-A RECENTLY APPROVED DRUG 1879 SMITA L JOSHI 7A-47 G-37 NANOTECHNOLOGY IMAGING AGENTS IN DIAGNOSIS OF CANCER AN OVERVIEW OF PROKARYOTIC TRANSCRIPTION FACTORS : A SUMMARY OF FUNCTION AND 1902 ANIKET DAS 7A-48 G-35 OCCURRENCE IN BACTERIAL GENOMES 1924 LIMAN DAS 7A-49 G-36 Neural stem cell differentiation into mature neurons PHYTOCHEMICAL INVESTIGATION AND ANTIMICROBIAL PROPERTIES OF ETHANOLIC FLOWER 335 SADHU NAGA SIVA KUMAR 7A-5 G-5 EXTRACT OF TECOMA STANS (L.) GRADING UP BREEDING METHOD ,TO CONVERT NON-DESCRIPT INDIAN COW HERD TO PURE 2104 RAUNAK I.TADAVI 7A-50 G-32 BREED EXOTIC HF HERD TO AVOID EXTRA EXPENSE ON PURCHASING PURE HF COWS 2081 LIMAN DAS 7A-51 G-33 Neural stem cell differentiation into mature neurons 2037 PREETI M. BAGDE 7A-52 G-34 A REVIEW ON STEM CELL THERAPY EVALUATION OF ANTIMICROBIAL EFFICACY AND PHARMACOGNOSTICAL, PHYSICOCHEMICAL 420 SREE TEJA PARITALA 7A-6 G-6 STANDARDIZATION OF ALTERNANTHERA PHILOXEROIDES (MART.) GRISEB 428 ANAS K 7A-7 G-7 CRISPER/Cas9 as an Emerging Tool for Treating Hereditary Diseases ISOLATION, IDENTIFICATION AND ANTIMICROBIAL ACTIVITY OF BIOSURFACTANT FROM OIL 435 DRONADULA HONEYSHMITHA 7A-8 G-8 SPILLED SOILS 491 ROHIT 7A-9 G-17 VACCINE APPROACH IN HIV TREATMENT STUDY OF PRESCRIPTION PATTERN OF ANTI-THYROID DRUGS AMONG RURAL POPULATION OF 39 SWATI YADAV 8A-1 H-7 WESTERN UP 259 VASAVI KONERU 8A-10 H-14 CASE REPORT ON LINEZOLID+CEFUROXIME INDUCED LEUKOCYTOCLASTIC VASCULITIS 1091 JISHA SURESH 8A-100 H-104 OVER THE COUNTER DRUGS: BOON OR BANE- AN INTERVENTIONAL STUDY 1108 ARYA LEKSHMI U S 8A-101 H-105 CURRENCY NOTES:A POTENTIAL CARRIER FOR MICROBIAL CONTAMINATION AN EPIDEMIOLOGICAL STUDY OF OVERWEIGHT AND OBESITY AMONG LOCAL GUNTUR-URBAN 1134 Srikanth Annavarapu 8A-102 H-106 PEOPLE 1135 VADDADI D C SRAVAN KUMAR 8A-103 H-107 TRANSLATION VALIDATION AND RELIABILITY OF S- LANSS IN TELUGU 1141 MATHANGI ISHITHA JASMINE 8A-104 H-108 EFFECT OF GENERIC AND INNOVATIVE MEDICINE ON HYPERTENSION AN EPIDEMIOLOGICAL STUDY OF STRESS HYPERGLYCEMIA AMONG LOCAL GUNTUR-URBAN 1144 Mayuri reddy Mallireddy 8A-105 H-109 PEOPLE 1181 AHALYA KRISHNAN 8A-106 H-183 ELECTRONIC MEDICAL RECORDS IN HEALTH CARE SETTINGS ASSESSMENT OF THE IMPACT OF STRUCTURED EDUCATION ON HEALTH SCREENING 1183 AMALA ELIZABETH ELLICKAMURY 8A-107 H-184 SERVICES AMONG SCHOOL CHILDREN IN CHITRADURGA 1194 T.POOJITHA 8A-108 H-185 ONDANSETRON INDUCED SEIZURES 31 LARISSA CAROLA BAMURANGE 8A-109 H-3 Prevalence and Management of Polycystic Ovarian Syndrome in a Tertiary Care Hospital. ASSESSMENT OF THE PRESCRIBING PATTERN OF ANTIBIOTICS AMONG SURGICAL PATIENTS 263 BOYAPATI NAVYA 8A-11 H-15 IN A TERTIARY CARE HOSPITAL PHARMACIST DRIVEN MEDICATION INAPPROPRIATENESS ASSESSMENT IN EMERGENCY 1239 JINISHA SANDEEP JAIN 8A-110 H-179 DEPARTMENT OF A TERTIARY CARE HOSPITAL 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title 1247 ATHIRA MOHAN S 8A-111 H-180 ECOPHARMACOVIGILENCE AND PHARMACEUTICAL INDUSTRY 1248 AHALYA KRISHNAN 8A-112 H-181 ELECTRONIC HEALTH RECORDS 1250 AHALYA KRISHNAN 8A-113 H-182 ELECTRONIC HEALTH RECORDS 1257 ANKITA SINGH 8A-115 H-176 CASE REPORT ON STEROID INDUCED DERMOPATHY PRESCRIBING PATTERN OF ANTI-CRAVING MEDICATION IN ALCOHOL DEPENDENCE – A 1268 SHIVANI ANAND 8A-116 H-177 PROSPECTIVE STUDY 1291 KRISHNA SAI. JASTI 8A-117 H-178 STUDIES ON ANTIMICROBIALS PRESCRIPTION PATTERNS 1305 AHALYA KRISHNAN 8A-118 H-171 ELECTRONIC MEDICAL RECORD STUDY ON PERINATAL AND FETAL OUTCOMES AND COMPLICATIONS IN RHESUS ANTIGEN NEGATIVE PREGNANCY (IMMUNIZED AND UNIMMUNIZED) AND MEASURES TO PREVENT THE 32 VIJAPURAPU SAI VAISHNAVI 8A-119 H-4 ADVENTITIOUS ONSET. ASSESSING KNOWLEDGE ATTITUDE AND PRACTICE AS DETERMINANTS OF SEDENTARY 272 UNNATI PERISHETTY 8A-12 H-16 LIFESTYLE AMONG INDIAN YOUNG ADULTS: A CROSS-SECTIONAL SURVEY. FACTORS ASSOCIATED WITH ANAEMIA IN KIDNEY TRANSPLANT RECEPIENTS AFTER 1313 APARNA SUSHMI 8A-120 H-172 TRANSPLANTATION 1324 GARIKAPATI NAVYA 8A-121 H-173 STUDY OF DEMENTIA ON SMART PHONE USERS ASSESSMENT OF USAGE OF GENERIC MEDICINES OVER BRANDED DRUGS IN DIABETIC 1328 BATHULA ALEKHYA 8A-122 H-174 PATIENTS A PROSPECTIVE OBSERVATIONAL STUDY AND DRUG USE EVALUATION IN POST- OPERATIVE PATIENTS WITH ANALGESICS AND ANTIBIOTICS USED IN SURGICAL WARDS OF A TERTIARY 1339 CHALAPAKA DOONDAY 8A-123 H-175 CARE HOSPITAL PREVALANCE OF SELF MEDICATION FOR VARIOUS COMMUNICABLE DISEASES AMONG 1353 KUMBA SRIVANI 8A-124 H-167 HOSTEL STUDENTS 1382 ROHIT BANGWAL 8A-125 H-168 A CASE REPORT ON ANTI-TUBERCULAR DRUGS INDUCED HEPATOTOXICITY A COMMUNITY BASED SURVEY ON THE PRACTICES OF SELF MEDICATION OF ALLOPATHIC 1387 SUNAINA 8A-126 H-169 DRUGS AMONGST URBAN POPULATION OF DEHRADUN DISTRICT. 1395 ANKITA DANDRIYAL 8A-129 H-170 To evaluate the drug utilization in hypertension patients through patient monitoring ANTIBIOTICS DRUG UTILIZATION IN A SECONDARY REFERRAL HEALTHCARE SETTING OF 287 MOHANRAJ RATHINAVELU 8A-13 H-63 RURAL SOUTH INDIA A SURVAY BASED STUDY ON POLYPHARMACY AND ASSOCIATED PROBLEMS AMONG 1409 VANDANA 8A-132 H-158 PATIENTS IN DEHRADUN 1423 GARIKAPATI NAVYA 8A-134 H-159 STUDY OF DEMENTIA ON SMART PHONE USERS 1427 MADHAV KALYAN CH 8A-136 H-160 FEAR OF MISSING OUT IN STUDENTS ADDICTED TO SOCIAL MEDIA SAFETY AND EFFICACY OF UNDENATURED TYPE II COLLAGEN IN THE TREATMENT OF 1431 CHANDRIKA DEVARAPALLI 8A-137 H-161 OSTEOARTHRITIS OF THE KNEE PRESCRIBING PATTERNS AND HEALTH RELATED QUALITY OF LIFE IN PATIENTS WITH 1438 MAHITHA KARIMSETTI 8A-138 H-165 HYPERTENSION IN A TERTIARY CARE HOSPITAL STUDY OF PRESCRIBING PATTERN OF DRUGS IN CHRONIC OBSTRUCTIVE PULMONARY 1441 G. MADHURI 8A-139 H-166 DISEASE IN TERTIARY CARE TEACHING HOSPITAL 328 S RAMACHANDRAN 8A-14 H-17 COMPUTER ASSISTED DIAGNOSIS AND DISEASE RECOGNITION USING DEEP LEARNING 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title A PROSPECTIVE STUDY TO COMPARE THE EFFECTS OF ORAL PYRIDOXINE AND ORAL DOXYLAMINE PLUS PYRIDOXINE FOR TREATING NAUSEA AND VOMITING IN PREGNANT 34 SAKHAMURI VIKAS 8A-140 H-6 WOMEN IN A TERTIARY CARE HOSPITAL A PROSPECTIVE STUDY ON COMMUNITY ACQUIRED PNEUMONIA AND ITS SEVERITY 1512 M. SRIKANTH 8A-141 H-156 ASSESSMENT SCORE BY USING PNEUMONIA SEVERITY INDEX STUDY TO EVALUATE KNOWLEDGE AND PRACTICE FOR SELF-MEDICATION OF ANTIBIOTICS 1543 SHALINI RAWAT 8A-143 H-157 AMONG MULTI-DISCIPLINARY STUDENTS A PROSPECTIVE STUDY ON PRESCRIBING PATTERN OF ANTIBIOTIC IN CHRONIC OBSTRUCTIVE 1434 ARYA RAJAN 8A-145 H-162 PULMONARY DISORDER 1435 SUMIT 8A-146 H-163 PATIENT INFORMATION LEAFLET: LEGISLATIVE FRAMEWORK, DESIGN AND IMPROVEMENTS A STUDY ON PRESCRIPTION PATTERN OF ANTIBIOTICS IN INPATIENT PEADIATIC POPULATION 1436 MOLLETI URMILA 8A-147 H-164 OF GOVERNMENT HOSPITAL 1669 SHITAL S. SHEWALE 8A-148 H-153 RARE BLOOD GROUP- BOMBAY BLOOD GROUP ASSESSMENT OF DRUG UTILIZATION IN PEDIATRIC POPULATION AT A TERTIARY CARE 330 HEBSIBA JOSEPH 8A-15 H-18 TEACHING HOSPITAL 1680 DAPARTI SRI DEVI PRASANNA 8A-150 H-154 A PILOT STUDY ON DRUG UTILIZATION IN TYPE II DIABETES MELLITUS PATIENTS 1696 CHANDRAKANT SAHU 8A-151 H-155 TELEMEDICINE: RE-SHAPING THE FUTURE OF HEALTHCARE IN DIGITAL INDIA STRESS, ANXIETY, AND DEPRESSION AMONG M.PHARMA STUDENTS: A CROSS-SECTIONAL 1713 EHRAZ M SIDDIQUI 8A-152 H-146 STUDY IN ISF COLLEGE OF PHARMACY 1715 DEGALA SRI KALYANI 8A-153 H-147 A STUDY ON DRUG PRESCRIBING IN URINARY TRACT INFECTIONS IN A RURAL HOSPITAL ATTITUDES AND PERCEIVED BARRIERS AMONG M.PHARM 2ND YEAR STUDENTS TOWARDS 1725 RAJESHWAR KUMAR YADAV 8A-154 H-148 PHD DEGREE: A CROSS-SECTIONAL STUDY IN ISF COLLEGE OF PHARMACY KNOWLEDGE AND PERCEPTIONS OF PHARM D STUDENTS TOWARD GENERIC MEDICINES: A 1733 MEENA YADAV 8A-155 H-149 QUESTIONNAIRE-BASED SURVEY 1747 AMAL JOHN JAMES 8A-156 H-150 SHEDULDE H1:AN IMPERATIVE NEED IN INDIAN HEALTHCARE SETTING PERCEPTIONS OF FACULTY MEMBERS AND STUDENTS ABOUT INTAKE OF TEA/COFFEE: A 1748 ABHA KUMARI 8A-157 H-151 QUESTIONNAIRE-BASED SURVEY IN ISF COLLEGE OF PHARMACY COMPARATIVE EFFECT OF METFORMIN AND ITS COMBINATION ON LIPID PARAMETERS AMONG NEWLY DIAGNOSED TYPE II DIABTIC PATIENTS WITH DYSLIPIDEMIA- A PROSPECTIVE 1749 ARIYA MOL R 8A-158 H-152 OBSERVATIONAL STUDY KNOWLEDGE ASSESSMENT OF BREAST CANCER AND IT’S PREVENTION AMONG WOMEN FROM 1752 BENY MARGRAT C F 8A-159 H-139 SEMI – URBAN AREA 331 CHINNU SCARIA 8A-16 H-19 A Study on Drug Prescribing Pattern in Patients with Psychiatric Disorders EVALUATION OF MEDICATION ERRORS WITH DRUG INTERACTIONS INVOLVED IN TERTIARY 1759 NAVEEN KUMAR D 8A-160 H-140 CARE HOSPITAL 1760 MEDIBOINA CHANDRALEKHA 8A-161 H-141 A PILOT STUDY ON DRUG PRESCRIBING IN PSYCHIATRY SPECIALTY HOSPITAL A PROSPECTIVE STUDY OF MEDICATION ERROR IN A MULTISPECIALITY HOSPITAL AT 1766 MOHAN K 8A-162 H-142 ERODE, TAMILNADU A CASE REPORT ON CLASS III ANTIARRHYTHMIC DRUG INDUCED SEVERE VENTRICULAR 1769 NEHA KUKRETI 8A-163 H-143 TACHYCARDIA A QUESTIONNAIRE-BASED SURVEY TO IDENTIFY HEALTH RELATED PROBLEMS AMONG RURAL 1776 SANJANA CHAHUAN 8A-164 H-144 POPULATION OF PUNJAB 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title 1790 ANOOP UNIYAL 8A-165 H-145 CASE REPORT ON SCRUB TYPHUS WITH MYOCARDITIS AND PULMONARY EDEMA A novel marker of volume overload and mortality risk in hemodialysis patients – Assessed by rise in 1815 K.V.S.L.PRASANNA 8A-166 H-133 interdialytic creatinine PUBLIC PERCEPTIONS, KNOWLEDGE AND AWARENESS OF CHOLESTEROL MANAGEMENT: A 1835 AMAL M SURESH 8A-167 H-134 PROSPECTIVE STUDY A POPULATION - BASED STUDY ON AWARENESS OF CARDIOVASCULAR DISEASE RISK 1839 ABDULLA SHAREEF 8A-168 H-135 FACTORS PUBLIC PERCEPTIONS, KNOWLEDGE AND AWARENESS ABOUT DIABETES MELLITUS: A 1840 JAMSHEED AHAMED KALANGADAN 8A-169 H-136 PROSPECTIVE STUDY 332 JITTU P BABU 8A-17 H-20 A STUDY ON SEVERITY OF PAIN AND ITS MANAGEMENT IN PATIENTS WITH CANCER 1843 ANNAPURNA 8A-170 H-137 CASE REPORT ON SEIZURE WITH HEMIPLEGIA AND SEPSIS/SHOCK 1847 CHANDRIKA DEVARAPALLI 8A-171 H-138 DRUG UTILIZATION STUDY IN THE DEPARTMENT OF MEDICINE AT A TEACHING HOSPITAL 36 BALABHADRA V B BALAJI 8A-172 H-1 A STUDY ON AWARENESS ON MALARIA - IMPACT OF PHARMACIST EDUCATION REVIEW ON COMMUNITY PHARMACY PRACTICE WITH RESPECT TO MINOR AILMENTS TREATMENT IN INDIA - A CROSS SECTIONAL STUDY TO SUGGEST A CHANGE IN THE PRACTICE 1898 MOHATHASIM BILLAH A 8A-173 H-132 FOR BETTERMENT OF PUBLIC HEALTH 1914 NAMAN ARORA 8A-174 H-129 CASE REPORT ON ALPRAZOLAM WITHDRAWAL DELIRIUM THE ROLE OF HEALTHCARE PROFESSIONALS IN CONTROLLING THE SPREAD OF ZIKA VIRUS IN 1926 ISHA PATEL 8A-175 H-130 INDIA ANALYSIS OF PRESCRIBING PATTERN OF COPD PATIENTS IN A TERTIARY CARE HOSPITAL, 1940 B. ARUL 8A-176 H-131 SALEM A PROSPECTIVE OBSERVATIONAL STUDY OF ALCOHOL INDUCED ACUTE PANCREATITIS - A 1957 K.RACHANA 8A-177 H-123 DIAGNOSTIC APPROACH A PROSPECTIVE CLINICAL OBSERVATIONAL STUDY ON ASSESSMENT OF RISK FACTORS, 1960 SHAHEELA 8A-178 H-124 DIAGNOSIS AND PRESCRIBING PATTERNS OF MEDICATION FOR MIGRAINE 1972 AMMU MURALEEDHARAN 8A-179 H-125 PHARM. D: FUTURE OF INDIAN HEALTH CARE SYSTEM ASSESSMENT OF DRUG PRESCRIBING IN THE MANAGEMENT OF CHRONIC OBSTRUCTIVE 334 JUSTIN SABIN 8A-18 H-21 PULMONARY DISEASE IN A TERTIARY CARE HOSPITAL Changes in liver stiffness and steatosis in patients with chronic hepatitis C during the clinical course of 1982 VIBHOR AGGARWAL 8A-180 H-126 daclatasvir/ velpatasvir therapy: A prospective observational study A STUDY ON PRESCRIPTION PATTERN OF DRUGS IN OUTPATIENTS DERMATOLOGY 1995 G V N SRAVYA SUDHA 8A-181 H-127 DEPARTMENT OF GOVERNMENT AND PRIVATE HOSPITALS 1999 DIVYA 8A-182 H-128 THE EFFECT ON COPD PHARMACOTHERAPY 2006 KARRI BINDU 8A-183 H-119 IMPACT OF DRUG TREATMENT ON HIV INFECTED PATIENTS 2102 BHAVESH BHARAT AMRUTE 8A-184 H-110 Effects of dust and pollution on Peak Expiratory Flow Rate in Bus Conductors and Drivers 2109 PONNAMANDA ARJUN SRI VATSAV 8A-185 H-111 GULLAIN BARR SYNDROME COMPARITIVE STUDY OF TRAMADOL HYDROCHLORIDE INJECTION VERSUS DICLOFENAC 2058 GEENA K REJI 8A-186 H-112 SODIUM INJECTION IN POST - OPERATIVE ORTHOPEDIC PATIENTS KNOWLEDGE ASSESSMENT OF BREAST CANCER AND IT’S PREVENTION AMONG WOMEN FROM 2065 BENY MARGRAT C F 8A-187 H-113 SEMI – URBAN AREA 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title Impact of patient counselling on medication adherence, smoking cessation and HRQoL among COPD 2072 RAHUL HARSHA 8A-188 H-114 diagnosed patients in tertiary care hospital A RETROSPECTIVE STUDY TO PREVENT THE CONTRAST INDUCED NEPHROPATHY BY USING 2075 MEGHA K BAIJU 8A-189 H-115 N- ACETYL CYSTEINE 336 SHRADDHA GHORUI 8A-19 H-22 AWARENESS IN TYPE 2 DIABETIC PATIENTS IN A TERTIARY CARE TEACHING HOSPITAL 2080 PARVATI SINGH 8A-190 H-116 ALEXITHYMIA: A SHORT REVIEW RISK OF URINARY TRACT INFECTIONS AMONG DIABETIC PATIENTS IN A TERTIARY CARE 2087 SOWMYA GOTETI 8A-191 H-117 HOSPITAL 2090 PANEM.VENKATA SAI PRAVEENA 8A-192 H-118 SLEEP QUALITY ON ACADEMIC PERFOMANCE A PROSPECTIVE STUDY OF MEDICATION ERROR IN A MULTISPECIALITY HOSPITAL AT 2027 MOHAN K 8A-194 H-120 ERODE, TAMILNADU 2039 MANSI CHANDRASHEKHAR AMRITKAR 8A-195 H-121 SURVEY ON SWINE FLU 2049 AVIJIT MAZUMDER 8A-196 H-122 Evaluation of various types of Medication Errors in Multispecialty Hospital in Delhi FACTORS AFFECTING ASTHMATIC PATIENTS IN DELHI & NCR REGION AND THEIR 40 DEEPIKA PANDEY 8A-2 H-8 PRESCRIPTION PATTERN : A COMPREHENSIVE STUDY 338 DIVYA RAO M 8A-20 H-23 EVALUATION OF DRUG- DRUG INTERACTIONS IN PATIENTS RECEIVING CHEMOTHERAPY DEVELOPMENT, VALIDATION AND READABILITY OF PATIENT INFORMATION LEAFLET FOR 343 BLESSY SUSAN GEORGE 8A-21 H-24 UROLITHIASIS PATIENTS A STUDY OF PRESCRIPTION PATTERN OF DYSLIPIDEMIC AGENTS AND COMORBID CONDITIONS 347 ANISA JOSEPH 8A-22 H-25 IN DYSLIPIDEMIA A Study of Prescription Pattern for the empirical therapy in Urinary Tract Infection and its Comparison with 348 MUFIZA 8A-23 H-26 the Hospital Antibiotic Policy STUDY OF DRUG PRESCRIPTION PATTERN OF CHRONIC KIDNEY DISEASE PATIENTS 349 CHRISTINA ELSA POTHEN 8A-24 H-27 UNDERGOING MAINTENANCE HEMODIALYSIS CAUSALITY, SEVERITY, PREVENTABILITY AND TREATMENT ANALYSIS OF STATIN INDUCED 350 ROSHNA ROY 8A-25 H-28 DIABETES 354 BITTU BABU 8A-26 H-29 A PROSPECTIVE STUDY ON PERIPHERAL NEUROPATHY INDUCED BY CISPLATIN 358 SILVA JESSICA JOSEPH 8A-27 H-30 MANAGEMENT OF TYPE 2 DIABETES MELLITUS IN A TERTIARY CARE TEACHING HOSPITAL ASSESSMENT OF DRUG RELATED PROBLEMS AND THE DRUG CLASSES ASSOCIATED WITH IT 361 MERRIN MATHEW 8A-28 H-31 IN THE GENERAL MEDICINE WARD OF A MULTISPEACILITY TEACHING HOSPITAL EVALUATION OF DRUG USE PATTERN IN RESPIRATORY TRACT INFECTION AMONG PAEDIATRIC 365 ANARGHYA V NAIK 8A-29 H-32 POPULATION COMPARATIVE STUDY OF NUTRITIONAL STATUS AND LIFE STYLE DISEASE AMONG PEOPLE IN 85 ARJESH RAJ 8A-3 H-9 RURAL AREAS OF PATNA DISTRICT OF BIHAR IDENTIFICATION AND EVALUATION OF ADVERSE DRUG REACTIONS IN PATIENTS WITH 369 ANANTHU SATHEESH 8A-30 H-33 PSYCHIATRIC DISORDER 370 ANEETTA MARIA THOMAS 8A-31 H-34 A Study on the Role of Pharmacist in Educating Patients with Anaemia during Pregnancy PRESCRIBING PATTERN AND APPROPRIATENESS OF PROTON PUMP INHIBITORS IN GENERAL 375 ARYA RAJAN 8A-32 H-64 MEDICINE WARD OF A TERTIARY CARE HOSPITAL A RETROSPECTIVE STUDY ON PREVALENCE OF STATIN INDUCED DIABETES MELLITUS AND 384 ARCHITHA AJITHAN 8A-33 H-65 RISK FACTORS 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title ASSESSMENT OF THE EFFECT OF AGE AND POLYPHARMACY ON THE INCIDENCE OF DRUG 389 BIBISHA JOY 8A-34 H-66 RELATED PROBLEMS CASE REPORT ON GABAPENTIN INDUCED DIZZINESS & PERIPHERAL EDEMA IN 401 VEDANTHAM SATYA CHAKRAVARTHY 8A-35 H-35 OSTEOARTHRITIC PATIENT 410 VIGNESH KUMAR K 8A-36 H-36 CORTICOSTEROIDS INDUCED UTERINE BLEEDING: A CASE REPORT 417 VEDANTHAM SATYA CHAKRAVARTHY 8A-37 H-37 CASE REPORT ON DICLOFENAC INDUCED EPIGATSRIC PAIN IN OSTEOARTHRITIC PATIENT ROLE OF CLINICAL PHARMACIST ON PATIENT COUNSELING ON SMOKING CESSATION AND 444 S. VISWA 8A-38 H-67 NICOTINE REPLACEMENT THERAPY A PROSPECTIVE OBSERVATIONAL STUDY ON ADVERSE DRUG REACTIONS IN GENERAL 445 RISHAB P 8A-39 H-68 MEDICINE DEPARTMENT OF A TERTIARY CARE TEACHING HOSPITAL 113 ANITA 8A-4 H-10 TARGETED PROTEINS FOR RECENT AND EMERGING DIABETES MELLITUS RESEARCH A PILOT STUDY ON THE PRESCRIBING PATTERN OF ANTIBIOTICS AND CORTICOSTEROIDS IN 451 SRINIDHI B.C 8A-40 H-69 AN OUTPATIENT DERMATOLOGY DEPARTMENT A RETROSPECTIVE STUDY ON POST-OPERATIVE USAGE PATTERN OF ANALGESICS IN 468 KADEEJA VADAKKAN 8A-41 H-70 ORTHOPAEDICS DEPARTMENT OF A TERTIARY CARE TEACHING HOSPITAL. A RETROSPECTIVE STUDY ON DRUG PRESCRIBING PATTERN IN DIABETIC FOOT ULCER 478 MARIYAM ATHIKA RAFA 8A-42 H-71 PATIENTS IN A TERTIARY CARE TEACHING HOSPITAL COMPARING THE SAFETY BETWEEN FERROUS CARBOXYMALTOSE AND IRON SUCROSE THERAPY IN IRON DEFICIENCY ANEMIA DURING PREGNANCY IN OBSTETRICS AND 481 KAMAL SAINI 8A-43 H-72 GYNECOLOGY WARD AT TERTIARY CARE HOSPITAL, JAIPUR 487 RUPA MAZUMDER 8A-44 H-73 CHALLENGING ROLE OF PHARMACISTS BY APPLICATIONS OF IOTS IN PATIENT HEALTH CARE A SURVEY ON PRICES OF DIFFERENT BRAND OF AN ANTI-HYPERLIPIDIMIC AGENT IN LOCAL 497 YOGESH SHRIKANT FUKE 8A-45 H-74 COMMUNITY PHARMACIST OF CHIKHLI (MAHARASHTRA). A PROSPECTIVE STUDY OF DETECTION AND REPORTING OF MEDICATION ERRORS IN 513 MIDHUN M NAIR 8A-46 H-38 PEADIATRIC DEPARTMENT AT A TERTIARY CARE TEACHING HOSPITAL ASSESSMENT OF MEDICATION ADHERENCE, OUT OF POCKET EXPENDITURE AND PATTERN OF 517 SHILPA MARIUM THOMAS 8A-47 H-39 DRUG USE AMONG URBAN FIELD PRACTICE AREA OF BAGALKOT, AN INTERVENTIONAL STUDY IMPLEMENTATION OF CLINICAL PHARMACY SERVICES IN PEDIATRIC INPATIENTS AT TERTIARY 519 HASIF K 8A-48 H-40 CARE TEACHING HOSPITAL A PROSPECTIVE STUDY OF ADVERSE DRUG REACTIONS MONITORING AND REPORTING OF IN- 529 BASIL WILSON 8A-49 H-41 PATIENTS ADMITTED AT A TERTIARY CARE TEACHING HOSPITAL. 150 RAVIKUMAR 8A-5 H-2 TEST PAPER EVALUATION OF MICROBIAL CONTAMINATION IN THE MARKETED PEDIATRIC LIQUID ORAL 530 MOHAN.S 8A-50 H-42 FORMULATIONS DURING THE CONSUMPTION PERIOD SALE OF SCHEDULE H1 ANTIBIOTICS WITHOUT PRESCRIPTIONS IN GUNTUR, ANDHRA 542 VINEELA CHADALAVADA 8A-51 H-43 PRADESH, INDIA COMPARISON OF CLINICAL OUTCOMES WITH DIFFERENT INHALER DEVICES IN PATIENTS WITH 555 AMAL ANAND 8A-52 H-75 ASTHMA AND COPD “A STUDY TO IDENTIFY, ASSESS AND EVALUATE THE INCIDENCE OF INTENTIONAL AND UNINTENTIONAL ORGANOPHOSPHOROUS POISONING IN A SOUTH INDIAN TERTIARY CARE 556 ABDUL HASEEB 8A-53 H-76 TEACHING HOSPITAL, KARNATAKA” 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title A STUDY TO ASSESS THE UTILIZATION PATTERN OF ANTIBIOTICS FOR TREATMENT OF LOWER RESPIRATORY TRACT INFECTION IN PEDIATRIC DEPARTMENT OF A TERITIARY CARE 581 GOLDA RAJEEVAN 8A-54 H-77 TEACHING HOSPITAL IDENTIFICATION AND EVALUATION OF DRUG RELATED PROBLEMS AND ITS PREVALENCE IN 584 SHERIL SUNNY THOMAS 8A-55 H-78 MEDICAL AND EMERGENCY WARD OF A TERTIARY CARE TEACHING HOSPITAL IDENTIFICATION, ASSESSMENT AND ANALYSIS OF SUSPECTED ADVERSE DRUG REACTIONS IN 595 ARLIN GEORGE 8A-56 H-79 A TERTIARY CARE TEACHING HOSPITAL ,KARNATAKA. A STUDY ON TENDERNESS AND DISABILITY ASSESSMENT IN MIGRAINE PATIENTS OF SVIMS, 615 RIHANA BEGUM PATNOOL 8A-57 H-44 TIRUPATI ASSESSMENT OF SOCIO-DEMOGRAPHIC FACTORS INFLUENCING KNOWLEDGE, ATTITUDE AND PRACTICE TOWARDS MEDICATIONS AMONG URBAN FIELD PRACTICE AREA OF BAGALKOT. A 638 AKHIL JOSEPH 8A-58 H-45 CROSS-SECTIONAL STUDY. ASSESSMENT AND INTERVENTION OF HEALTH EDUCATION PROGRAM REGARDING KNOWLEDGE, ATTITUDE AND PRACTICE TOWARDS MEDICATION AMONG URBAN FIELD 640 REGINA MERINE 8A-59 H-46 PRACTICE AREA OF BAGALKOT. AN INTERVENTIONAL STUDY. ASSESSMENT OF PATIENTS HEALTH-RELATED QUALITY OF LIFE DURING COMPLICATIONS OF 177 VARTIKA JAIN 8A-6 H-47 PREGNACY IN A TERTIARY CARE TEACHING HOSPITAL: A PROSPECTIVE STUDY EVALUATION ON COMPARATIVE EFFICACY AND PLEIOTROPHY OF THREE SGLT2 INHIBITORS 646 NARMADHA.P 8A-60 H-48 IN TYPE 2 DIABETES MELLITUS SUBJECTS CLINICAL EVALUATION OF THE EFFICACY AND SAFETY OF FLUPIRTINE IN THE MANAGEMENT 648 R. RESHMA 8A-61 H-49 OF CANCER PAIN AND ORTHOPEDIC PAIN CLINICAL EVALUATION OF SULFASALAZINE IN PREVENTION OF RADIATION INDUCED GASTRO 661 S. YOGANANTHI 8A-62 H-50 INTESTINAL COMPLICATIONS IN PELVIC MALIGNANCIES 662 BANDARU SILVANUS STANCHRIS 8A-63 H-51 EFFECT OF DIABETIC THERAPY 678 SHAIK MINISHA 8A-64 H-52 AWARNESS OF TELEMEDICINE IN THE PRACTICE OF HOSPITAL PHARMACY ASSESSMENT OF ADVERSE DRUG REACTIONS IN PATIENTS WITH TUBERCULOSIS IN A 692 BHARATH RAJ K C 8A-65 H-53 TERTIARY TEACHING HOPITAL A PROSPECTIVE STUDY ON THE IMPACT OF PATIENT COUNSELLING IN COMMON SKIN DISEASE 709 MALAVIKA ASHOK 8A-66 H-54 IN TERTIARY CARE HOSPITAL 717 ANSEE KURUVILA 8A-67 H-55 EFFICACY OF NEUROPROTECTION IN STROKE STUDY ON DRUG UTILIZATION PATTERN OF OTC MEDICATION BASED ON CLASS OF KNOWLEDGE OF PEOPLE ABOUT OTC MEDICINES IN A SOUTHERN VILLAGE OF AND 726 ARANYA SREEKUMAR 8A-68 H-56 MANUFACTURER AND ASSESSMENT IN KERALA. STUDY ON DRUG UTILISATION PATTERN OF ANTIBIOTICS BASED ON CLASS AND MANUFACTURER AND ASSESSEMENT OF KNOWLEDGE OF PEOPLE ABOUT ANTIBIOTICS IN A 734 BENCY BERNARD 8A-69 H-57 SOUTHERN VILLAGE OF KERALA 207 HIMA SANTHOSH 8A-7 H-11 MOTHER TO CHILD TRANSMISSION OF HIV : CURRENT NEED FOR PREVENTION ASSESSMENT OF ANXIETY AND DEPRESSION LEVEL IN DIABETES MELLITUS IN PATIENT IN 747 MAZHAR IMAM 8A-70 H-58 TERTIARY CARE TEACHING HOSPITAL 750 R.PAVITHRA 8A-71 H-59 OPIOID WITHDRAWAL: A THERAPEUTIC REASONING A STUDY ON EFFECT OF CO EXISTING HYPERTENSION, BLOOD PRESSURE CONTROL AND ANTI HYPERTENSIVES TREATMENT ON QT INTERVAL PARAMETERS IN TYPE II DIABETICS IN A 752 SAKEENA A 8A-72 H-60 TERTIARY CARE HOSPITAL 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title 753 BEERA SANTHISREE 8A-73 H-61 STUDY OF ANTIMICROBIAL USE IN A TERTIARY CARE HOSPITAL EVALUATION OF HYPERTENSIVE DRUG PRESCRIPTION PATTERN AND CONTROL IN 762 SHILPA SS NAIR 8A-74 H-62 OUTPATIENTS ATTENDING IN A COMMUNITY PHARMACY ORAL NIFEDIPINE VERSUS INTRAVENOUS LABETALOL FOR CONTROL OF BLOOD PRESSURE IN 775 HEPHZEEBA JOYCE 8A-75 H-80 SEVERE PRE-ECLAMPSIA 790 SMITHA S 8A-76 H-81 FORMULATION AND EVALUATION OF TOPICAL ANTI-BACTERIAL GEL ASSESSMENT OF PRESCRIBING PATTERN OF ANTIBIOTICS IN THE MANAGEMENT OF DIABETIC 797 RINSA CHERIAN AMPRAYIL 8A-77 H-82 FOOT ULCERS IN A TERTIARY CARE HOSPITAL IMPACT OF PATIENT COUNSELLING IN QUALITY OF LIFE IN IMPROVING THE OUTCOME OF 804 G.J. VAISHNAVEE 8A-78 H-83 SCHIZOPHRENIA PATIENT IN A TERTIARY TEACHING HOSPITAL EVALUATION OF DRUG USE IN HIV PATIENTS WITH DIFFERENT OPPORTUNISTIC INFECTIONS IN 816 MALLINATH P 8A-79 H-84 A TERTIARY CARE HOSPITAL A STUDY OF AWARENESS, KNOWLEDGE, PERCEPTION AND ATTITUDE TOWARDS THE USE OF OVER THE COUNTER ANALGESICS AMONG THE GENERAL PUBLIC AND THE PHARMACISTS IN 222 SHATAKSHI LALL 8A-8 H-12 URBAN AREAS OF DEHRADUN 837 BINI SUSAN ISAAC 8A-80 H-85 A STUDY ON MANAGEMENT OF STROKE IN A TERTIARY CARE HOSPITAL FACTORS AFFECTING THE OUTCOME OF ACUTE RENAL FAILURE AMONG THE ELDERLY 842 MOHAMMED MAJID IQBAL 8A-81 H-86 POPULATION IN INDIA: A HOSPITAL BASED STUDY 850 A. PADMA PRIYA 8A-82 H-87 FOOT CARE EDUCATION IN PATIENTS WITH DIABETES 33 CHETANKUMAR S. M 8A-83 H-5 EVALUATION OF DRUG INFORMATION SERVICES IN A TERTIARY CARE HOSPITAL CASE REPORT ON GABAPENTIN INDUCED DIZZINESS & PERIPHERAL EDEMA IN 898 VEDANTHAM SATYA CHAKRAVARTHY 8A-84 H-88 OSTEOARTHRITIC PATIENT 927 K.H.S RAJA RAVINDRA 8A-85 H-89 ASSESSING THE RATIONAL USE OF ANTIBIOTICS IN DIFFERENT TYPE OF HOSPITALS 940 S. LAKSHMANA PRABU 8A-86 H-90 A NOVEL APPROACH FOR THE TREATMENT OF TYPE II DIABETES PRESCRIBING PATTERNS OF NON-STEROIDAL ANTI INFLAMMATORY DRUGS (NSAIDS) IN OUT 945 BALASUBRAMANYAM BASKARAPANDITH 8A-87 H-91 PATIENT DEPARTMENT OF AN ORTHOPEDIC SPECIALTY HOSPITAL 946 VEDANTHAM SATYA CHAKRAVARTHY 8A-88 H-92 CASE REPORT ON DICLOFENAC INDUCED EPIGATSRIC PAIN IN OSTEOARTHRITIC PATIENT 960 REDDY SASI MANOHAR 8A-89 H-93 STUDY OF MEDICATION ERROR 257 PANKAJ RAMDAS KHUSPE 8A-9 H-13 SURVEY ON AWARENESS ABOUT SWINE FLU IN NASRAPUR RURAL REGION. ADVERSE DRUG REACTION IN PATIENTS UNDERGOING CISPLATIN CHEMOTHERAPY 965 PASUPULA MOSES PAUL 8A-90 H-94 RADIOTHERAPY FOR HEAD AND NECK CANCER: A PROSPECTIVE STUDY DRUG UTILIZATION STUDY AND CLINICAL PHARMACIST INTERVENTIONS IN ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) PATIENTS OF A TERTIARY CARE 974 SIDDARUDA BIRADAR 8A-91 H-95 HOSPITAL MAINTENANCE TREATMENT OF BIPOLAR I DISORDER WITH LURASIDONE IN COMBINATION 975 PEDDINTI SRI DEVI 8A-92 H-96 WITH LITHIUM OR VALPROATE CUSHING SYNDROME, A SECONDARY PROLONGED USE OF STEROIDS (PREDNISOLONE): CASE 987 SANTHOSH R. AWASTHI 8A-93 H-97 REPORT ASSOCIATION BETWEEN IMPULSE CONTROL DISORDER AND REM SLEEP BEHAVIOUR IN 993 NEELAM SAI MOUNICA 8A-94 H-98 PATIENTS OF PARKINSON'S DISEASE 1002 JANNU SUDHA RANI 8A-95 H-99 GUILLIAN BARRE’S SYNDROME CASE STUDY 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title 1007 AALA SUBHA SRI 8A-96 H-100 EFFECT OF POLYPHARMACY ON CAD ASSESSMENT OF PATIENT ACTIVATION MEASURE (PAM) IN END STAGE RENAL DISEASE (ESRD) 1045 SUNAINA SUNIL ANAND 8A-97 H-101 PATIENTS ON MAINTENANCE HEMODIALYSIS 1053 VIPULA 8A-98 H-102 PHARMACEUTICAL POLLUTION AND SUPERBUGS---THE SCALE OF THREAT PROSPECTIVE STUDY ON PREVALENCE ,RISK FACTORS,TREATMENT,OUTCOME AND ASSESSMENT OF QUALITY OF LIFE IN PATIENTS WITH MIGRAINE AT VARIOUS HOSPITALS, 1074 UMA.R 8A-99 H-103 PALAKKAD. ROLE OF REGULATORY BODIES IN MAINTAINING THE QUALITY OF PHARMACEUTICAL 49 NEHA YADAV 9A-1 I-1 EDUCATION 1016 K.SRI NIKHILA REDDY 9A-10 I-10 PERSONALIZED MEDICINES: DO PHARMACISTS KEEP REINVETING THE WHEEL? 1093 PALESH S RAJKONDAWAR 9A-11 I-11 Advancement of Online Pharmacy in India- Thriving Present, But an Ambiguous Future 1136 SHAIK RIYAZ AHAMAD 9A-12 I-12 AWARENESS ABOUT ROLES OF PHARMACISTS 1285 BOMMALI VYSHNAVI 9A-13 I-29 PSYCHOMETRIC VALIDATION OF HEADACHE 1302 BETHA DEEPIKA 9A-14 I-27 PREVALENCE OF HYPERSENSITIVITY GENERAL ATTITUDE OF PHARMA POSTGRADUATE STUDENTS TOWARDS THE USE OF OTC 1307 D SREEDHAR 9A-15 I-28 MEDICINES IMPACT OF CO-CURRICULAR AND EXTRA-CURRICULAR ACTIVITIES ON OVERALL 1368 AVIKSHA SEMANTHA 9A-16 I-26 DEVELOPMENT AND THEIR ROLE IN STRESS MANAGEMENT SURVEY ON LIFE STYLE DISEASES AND NUTRITIONAL STATUS AND ALSO TFR AMONG PEOPLE 125 HEMANT KUMAR SINGH 9A-2 I-2 IN RURAL AREAS OF PATNA DISTRICT OF BIHAR 1645 AJAY B. MADREWAR 9A-21 I-25 STUDENTS’ PERSPECTIVES ON PG SYLLABUS GIVEN BY PCI NEUROPROTECTIVE ROLE OF ALLICIN AGAINST METALS INDUCED EXPERIMENTAL DEMENTIA 1717 KHADGA RAJ 9A-24 I-20 IN RATS: POSSIBLE NEUROINFLAMMATORY AND NEUROMODULATORY MECHANISM 1728 GOOD.PADMA PRAVEENA 9A-25 I-21 NANOSPONGES PROTECTIVE EFFECT OF SPERMIDINE AGAINST EXCITOTOXIC NEURONAL DEATH INDUCED BY QUINOLINIC ACID IN RATS: POSSIBLE NEUROTRANSMITTERS AND NEUROINFLAMMATION 1729 SHIVAM KUMAR 9A-26 I-22 MODULATION MECHANISM NEUROPROTECTIVE ACTIVITY OF CURCUMIN IN COMBINATION WITH PIPERINE AGAINST 1735 ROYAL PATEL 9A-27 I-23 QUINOLINIC ACID INDUCED NEURODEGENERATION IN RATS PIPERINE POTENTIATE THE NEUROPROTECTIVE EFFECT OF QUERCETIN AGAINST MPTP 1741 MAHADEV DHAMI 9A-28 I-24 INDUCED NEUROTOXICITY IN RATS ATTITUDE AND PERCEIVED BARRIER AMONG PHARMACY STUDENTS TOWARD INDIAN PHARMACEUTICAL CONGRESS (IPC): A CROSS SECTIONAL STUDY IN ISF COLLEGE OF 1758 SWATI KAUSHAL 9A-29 I-17 PHARMACY, MOGA 184 MUSKAN TOMAR 9A-3 I-5 BIODEGRADABLE​ PACKAGING FOR PHARMACEUTICAL FORMULATIONS Preferences of classical and advance teaching and learning methods among M. Pharm Students of ISF 1791 RIMA SINGH 9A-30 I-18 College of Pharmacy, Moga: A questionnaire based Survey A CROSS-SECTIONAL STUDY TO ASSESS THE INTEREST OF STUDENTS IN CHOOSING SPECIFIC 1793 MERIN RENJITH 9A-31 I-19 REFERENCE MATERIAL FOR THEIR STUDIES 1873 SANDRA K S 9A-32 I-15 A CROSS-SECTIONAL STUDY ON TIME UTILIZATION OF PHARMACY STUDENTS IN THE LIBRARY 70TH INDIAN PHARMACEUTICAL CONGRESS

LIST OF SELECTED PAPERS FOR POSTER PRESENTATION Dr.A.RAMKISHAN, CONVENER, SSC PrOF.KPR CHOWDARY, Co-CONVENER, SSC Dr.ARUN GARG, LOC - SSC S.No Author Name Paper Code Poster Code Paper Title COMPARISON OF HEALTH RELATED QUALITY OF LIFE OF IN NON-METASTATIC BREAST CANCER PATIENTS TREATED WITH AC-TAXANE VS AC-TAXANE + CARBOPLATIN VS AC-TAXANE 1878 FAHEEMA K 9A-33 I-16 + TRASTUZUMAB REGIMENS : A PROSPECTIVE COHORT S 2055 RUCHITHA V 9A-34 I-13 RESEARCH ON LATEST TRENDS IN PHARMA RETAILS ENGAGEMENT OF AUGMENTED REALITY( AR) & ARTIFICIAL INTELLIGENCE( AI) IN 2068 SHUBHAM GUPTA 9A-35 I-14 PHARMACEUTICAL & HEALTHCARE INDUSTRY A PARADIGM STRATAGEM OF A PHARMACIST WITH CURRENT INSIGHTS TOWARDS PATIENT 327 RAVI PRATAP PULLA 9A-4 I-3 CENTERED PRACTICES IN RANGA REDDY DISTRICT, TELANGANA STATE 540 AJESH CHAUHAN 9A-5 I-4 REVIEW ON RISKS AND BENEFITTS OF INTERNET PHARMACY JOURNALS IN PHARMACEUTICAL SCIENCES – A STUDY BASED ON SCOPUS AND WEB OF 577 YOGENDRA NAYAK 9A-6 I-7 SCIENCES DATABASES 725 C.SAI MANOJ 9A-7 I-6 NANO-TECHNOLOGY IN CANCER DRUG DELIVERY AND SELECTIVE TARGETING. 772 MANISHA 9A-8 I-8 AWARENESS ON VAGINAL DISCHARGE AND REPRODUCTIVE HEALTH 941 BATCHU. SAITEJASWINI 9A-9 I-9 AWARENESS ABOUT VACCINATION AMONG PARAMEDICALS